viprox effect on hiv/aids patients
TRANSCRIPT
CONTENTS
African nutrition study report by David L. Weston ……………... 1
Letter from Dr. Deberry ……………………………………………… 6
1- Survey Report …………………………………………………………. 7
(a) Abbreviations and Acronyms ………………………………………. 8
(b) List of tables and graphs ……………………………………………. 9
(c) List of participants in the Survey…………………………………… 10
1.1 Introduction …………………………………………………………….. 11
2- Context and Justifications …………………………………………… 11-12
3- Research Hypothesis…… …………………………………………… 12
4- Objectives ………………………………………………………………. 13
4.1 General Objective ……………………………………… 14
4.2 Specific Objectives ……………………………………… 13
4.3 Strategy ………………………………………………….. 13
4.4 Nutraceutical products Management ………………….. 13
5- Framework of the Survey…………………………………………… 14
5.1 Overview of Togo …….…………………………… 14
5.2 Presentation on the Health Sector.. ………………… 14
5.2.1 Organization of the Health Delivery System ……… 14
5.2.2 Health Delivery Infrastructures ……………………… 15
5.2.3 Human Resources …………………………………… 15
6- Methodology ………………………………………………………… 16
6.1 Type of Survey ……………………………………… 16
6.2 Definition and Measurement of variables …………… 16
6.3 Patient Selection Criteria……….. …………………….. 17
6.4 Survey Population and Sampling…………..… ………. 17
6.5 Intervention ………………..…………………………….. 17-18
6.6 Duration of the Survey……..… ……………………….. 18
6.7 Data Collection…………. ………………………………. 18
6.8 Data Management………….……………………………. 18
6.9 Ethical Issues…………….……………………………… 18
7- Difficulties Encountered …………………………………………….. 18-19
8- Findings ………………………………………………………………… 19
8.1 The Kodjoviakopé Site ………………………….………… 19-20
8.2 The Agou Site ……………………………………………… 20-21
8.3 The Kouvé Site …………………………………………….. 21-22
9- General Conclusion ………………………………………………….. 23
10- Annexes ………………………………………………………………… 24-61
11- Bio Impedance Analysis……………………………………………… 62
10.1 BIA background ……………………………………………... 64-68
10.2 BIA data collected in course of survey ……………………. 69
AFRICAN NUTRITION STUDY REPORT—SUMMARY OF A NUTRITIONAL
APPROACH DESIGNED TO FORTIFY, MAINTAIN FUNCTION AND
REVERSAL OF WASTING IN HIV2 PATIENTS LIVING IN WEST AFRICA
“INCREASE IN WEIGHT AND PHASE ANGLE IN TOGO HIV-2 PATIENTS
USING VIPROX. OCTOBER 2007.
Principal Investigators: B. Deberry, K Anthony, R Gauthier, R Bender, R
Alexander, L Lorenzen, Z Wang. Representing University of California Irvine
Medical School, Togo Ministry of Health, Nutraxis Group, the New Jersey Institute
of Technology and the All Around the World Foundation.”
BACKGROUND
This is a background report and independent review written by a former US FDA-
California Department of Health Investigator (Retired) on the recent clinical validation of
trials on West African HIV2-AIDS patients using Viprox Nutritional Complex (VNC).
This study was designed, administered and evaluated under World Health Organization
HIV Therapy guidelines. The therapy is designed as a nutritional life extension
intervention program, appropriate for resource-poor communities with little or no local
institutional medical support for HIV2-AIDS populations. The study population had no
exposure to anti viral therapies before or during the Viprox trial.
The study objective is, “To evaluate the effect of Viprox on HIV-2 patients in Togo
West Africa for three months. Viprox is a peptide-enzyme delivered with a
functional cluster water delivery system complex designed to be a low-cost, non-
toxic, nutritional approach to fortify, extend and maintain function and quality of
life for HIV-2 patients.” The summary of clinical data is contained on a power point
presentation, while the full review text of the clinical data contributors is available on
separate format and awaits journal publication.
It is the opinion of this investigator that VNC has immediate application for
reconstructive remedial nutritional therapy protocols designed for severely mal-nourished
HIV2-AIDS patients. The therapy seems to be most appropriate for resource-poor
communities with little or no local institutional medical support. Safety and efficacy of
the West African Study has been shown in the study summary and is being validated by
World Health Organization and a number of third party scientists, MD’s and public
health experts.
THE CURRENT NEED IN TOGO, WEST AFRICA
The current focus is upon the great and immediate need in Africa as outlined in the
President’s Emergency Plan for AIDS Relief and recently manifested in US funding
appropriations for effective containment of the epidemic. The Prime Minister, Health
Secretary and the IDH Microfinace Minister of Togo, West Africa, who have seen and
evaluated the results of this initial trial, have made a formal written request that Viprox
Nutritional Complex be made widely and immediately available to as many HIV-AIDS
1
patients as possible. The HIV-AIDS infected population of Togo alone is conservatively
estimated at 180,000.
In his letter of request for assistance dated January 20, 2008, Prime Minister Kwasse
Klutse advised all involved parties that the VNC nutrition program is seen to be a cost-
effective approach to returning previously non-functioning HIV-2 patients to work,
family and society after less than three months of daily administration of the Viprox
Nutritional Complex. The letter on behalf of IDH Micro Finance and Human
Development Program, the Secretary of Health and other parties of interest states, in
part, that:
1—All parties are “anxious to move the use of Viprox to a much larger scale” and on
“a very broad use” in West Africa;
2—All parties wish to incorporate “broad availability” of Viprox because it restores
HIV-2 patients to fully functional status enabling positive economic and social benefits
for families, governments and the local economy. “Once the individual is physically
capable, he/she will re-enter the work force in their former vocation or be trained
by the IDH Human Development Program in new skills, accompanied by
microlending to initiate their new business.” (this is of particular interest to the West
African IDH Microfinance Program);
3—“The Viprox Program is the most successful, low cost approach (to restoring
HIV-2 patients to functionality) we have seen” and most importantly;
4—“We desperately need more Viprox to expand our (HIV-AIDS) health rebuilding
program”.
THE ROLE OF FAITH BASED ORGANIZATIONS IN EXPANSION OF THE
VIPROX STUDY
Because the need for the VNC program in Africa is immediate, the All Around the World
Foundation (AATWF.ORG) and Associates propose to begin work with Churches to
enable the humanitarian intervention that is required. We believe that eventually, the
global body of the church (as described in Pastor Warren’s visionary PEACE Plan) is
uniquely positioned to enable the church to lead the way for this compassionate life
enhancing intervention ministry for HIV-AIDS patients around the world.
We believe this nutritional program can be expanded to meet the Prime Minister’s
request as soon as funding becomes available. Unlike antiviral protocols, this approach
can be administratively integrated with local churches, medical clinics, schools,
communal kitchens, hospitals and humanitarian organizations wherever the Church and
its local leaders have ministerial influence and enabling resources. Also, this program
may be incorporated with other trials involving anti-viral administration if the hosting
study protocol administrator requires a life enhancing-extension component and
conditions allow for appropriate cross-waivers of liability.
Clinical studies prove that tangible physiological results (see below) are reported by HIV-
2 patients within several weeks and continue with the maintenance of the nutritional
2
program. In addition, clinical studies show the Viprox Nutritional Complex is safe, non-
toxic and inexpensive when compared with pharmaceutical trials (the estimated cost per
person per day of Viprox appears, in this study, to be on the order of a typical morning
beverage at Starbucks), requires no special medical devices or clinical apparatus and is
easily administered orally (twice a day) with no reported side effects.
Many patients fortunate to be selected into pharmaceutical trials are not able to withstand
the rigors of these trials due to extreme malnutrition, compounding the wasting of the
immune system. This is an important ethical consideration expressed by the National
Institutes of Health and investigators concerning anti-viral pharmaceutical testing
protocols in Africa. Many HIV2-AIDS patients die due to poor nutritional status and the
toxicity of the medications before anti-viral studies can be fully evaluated. The tragedy
in these situations is that neither the patient nor the clinical study is well served. In
contrast, VNC nutritional program deals primarily with the issue of reversing of
physiological, wasting restoration of function and quality of life issues, including return
to work and family.
TREND ANALYSIS SUMMARY
The study summary (available on power point) shows rapid restoration (beginning within
30 days) of these physiological metrics:
1—Bio-phase angle (90 % increase). This is the most reliable indicator / predictor of
survival in HIV-AIDS patients and has been used for many years in conjunction with
highly-active retroviral treatments in HIV epidemiology studies.
2—Total Body weight (trend line slopes upward for the 111 surviving patients in the
study, an average body weight increase of 6.9 pounds in 3 months).
3—Total Body Water (67% increase)
4—CD-4 Count (trend line slopes upward for the 115 patients in the study).
This investigator is not aware of another study that shows the above evidence for rapid
improvement of health and well-being parameters for HIV2-AIDS patients. For this
reason, we are advocating that all possible means be explored to expand this nutritional
protocol to Togo, West Africa and to other locations as resources become available.
EXPANSION FUNDING FOR THE EXPANSION OF VIPROX IN WEST AFRICA:
Currently, no funding exists to expand the program.
3
DELIVERY SYSTEM FOR VIPROX:
The primary functional / delivery component for this nutritional therapy (“the Viprox
Complex”) is a patented “clustered water solution” whose molecular geometry, energy
resonance, dynamic hydration capability and other properties is protected by two US
patents and whose efficacy has found application in a number of other clinically-tested,
peer reviewed, trials for a variety of physiological disorders. Similar highly-hydrating
functional waters have been sold commercially under the VIVO label with pre-market
approval from US FDA for over four years. The food-grade nutritional wafer (peptide–
enzyme complex) is delivered to the patients orally with the clustered water twice daily.
L. H. Lorenzen is the patent holder and a principal investigator in the Viprox study,
performed his undergraduate studies at the University of California Berkeley and
graduate studies at Cal State Fullerton and foreign Institutes while a researcher at the
University of California Irvine School of Medicine. At about the same time, the study
evaluator, David Weston was pursuing an MPH at Berkeley and working for California
Department of Health Services and the US Food and Drug Administration working with
Pharmaceutical NDA and efficacy reviews near the Berkeley campus. Lorenzen was in
process of receiving two US patents on his invention of functional or clustered water. He
spent the next 20 years in water research and clinical studies and has been involved in
development of a number of applications that promise to have efficacy in delivery of
substances at the cellular and molecular level.
A number of peer reviewed studies show the patented clustered waters are delivered or
channeled to the cellular level at a rate many times that of distilled water or drinking
water. Many of these studies, although well researched, remained relatively obscure and
many were not widely published. The science of clustered water as a delivery system for
molecular cellular therapies is not yet well known in medical journals.
However, the theory and functionality of Lorenzen’s patents received wide attention in
2003 with the Nobel research by McKinnon and Agree in the chemistry and physics of
Water Channeling. The practical applications for enhancement of nutritional and
pharmaceutical delivery at the sub-cellular level (as described in their ground breaking
research) appear to be very effective and innovative. It is of more than passing interest
that Lorenzen was patenting and designing clinical research with his “designed” cluster
waters long before the concept of water channeling was introduced or accepted as an
explanation of the mechanism of hydration.
Lorenzen recently invited David Weston and Associates to join his team in developing
further commercial applications for cluster water solutions and implementing commercial
manufacture of solutions premised upon these clustered water patents. Weston has been
given access to a number of research papers and clinical research studies on functional
water that Lorenzen & Associates have conducted. The efficacy shown in many of the
studies under review is most helpful in evaluating role of “functional” or “clustered”
water in the subject African HIV2-AIDS study. The range of functional application of
4
these solutions in nutrition, human performance, reversal of bodily wasting and select
symptom reversal, appears to be very far-reaching.
SUMMARY AND FOLLOW UP
1--We advocate that the Viprox Nutritional Program be made available at the request of
the Prime Minister and Secretary of Health of Togo, West Africa as funds and resources
become available. It is remarkable that the reversing of the average weight gain in
severely-immune compromised, nutritionally deprived HIV2-AIDS patients is 6.9 pounds
in 90 days for 115 participants. The nutritional factor alone is worthy of expanding the
Viprox program to a much larger level (perhaps as a stand-alone African Nutrition Plan
to enhance existing programs sponsored by, for example, the World Food Programme) as
enabling resources allow. As the Viprox African Nutrition Plan is designed, funded and
implemented, the following steps may be included in the Plan, specific to HIV, Malaria
and related interventions.
2--Considering the demonstrated weight gains and reversal of wasting in the latter-stage
HIV patients, it would be of extreme interest to study the effects of administration of
Viprox to patients with a less-advanced stage of HIV compared to the more-advanced
results demonstrated in the initial trial. Establishing the optimal time during the
progression of the disease to begin the Viprox Nutritional Program would be of great
value as a more comprehensive intervention program is designed and expanded.
3--As the nutritional factors evaluated above become more well understood, it is
recommended that the Viprox Nutritional Program be incorporated into a recognized
anti-viral trial for the purpose of reversing the bodily wasting trends (demonstrated
above) in the trial group, with the hope of increasing / maximizing the amount of time for
the anti-viral course and viral load trend to be fully evaluated for efficacy.
4—Should the findings from the above studies show meaningful results, an independent
anti-viral protocol using clustered water as a delivery system (with the appropriate double
blind distilled water for control) should be considered for design and implementation.
David L. Weston, Senior Investigator Ret.
1288 C Street
Arcata, CA 95521
Voice & Fax: (707) 822-8227
5
ABBREVIATIONS AND ACRONYMS
ARV Anti- Retro Viral
CAMEG General Centre for the Purchase of Essential Generic Medicines
CDVA Centre for Counselling, Anonymous and Voluntary Testing
CHR Regional Hospital Centre
DRS Regional Health Delivery Directorate
IDH Investing in Human
INH National Institute of Hygiene
NFS Blood Formula Numeracy
ONG Non-Governmental Organisation
PVVIH Person Living with HIV
PTME Prevention of Mother-Child Transmission
8
LIST OF TABLES AND GRAPHS
Table 1 : Distribution of patients according to sites and age
Table 2 : Distribution of patients according to sites and sex
Table 3 : Distribution of patients according to sites and occupations
Table 4 : : Distribution of patients according to sites an matrimonial status
Table 5 : Distribution of patients according to sites of and educational standards
Table 6 : Distribution of patients according to sites and temperature
Table 7 : Distribution of patients according to sites and weights
Table 8 : Distribution of patients according to sites and transaminases
Table 9 : Distribution of patients according to sites and lymphocytes (%)
Table 10 : Distribution of patients according to sites and white corpuscles
Table 11 : Distribution of patients according to sites and glycaemia
Table 12 : Distribution of patients according to sites and cholesterol (g/l)
Table 13 : Distribution of patients according to sites and red corpuscles
Table 14 : Distribution of patients according to sites and creatinine (mg/l)
Table 15 : Distribution of patients according to the sites and triglycerides (g/l)
Table 16 : Recapitulation of variables at Kodjoviakopé
Table 17 : Recapitulation of variables at Agou
Table 18 : General health status of patients
Table 19 : Changes in the patient’s defence system according the duration of treatment
Table 20 : Changes in the patient’s hepatic system according the duration of treatment.
Table 21 : Changes in the patient’s kidney system according the duration of treatment
Table 22 : Change in the patient’s general status according to the duration of treatment.
Table 23 : Recapitulation of data analysis after :
Fig N°1 : The changes in the blood pressure according to the duration of treatment (Lome-
Commune)
Fig N°2 :The changes in weight according to the duration of treatment (Lome- Commune)
9
LIST OF PARTICIPANTS IN THE SURVEY Names Occupations Dr Kodzo ANTHONY MD MPH Project Coordination
Officer Dr DJOBO Chief Medical Officer in charge of
Kodjoviakope Health Delivery Centre Dr ADOSSI Chief Medical Officer in charge of
Care and Support of Patients on the Agou-Nyogbo
Mme GOUNA Akuavi Chief Nurse in charge of site supervision
Mrs Essinu Akoua ANTHONY Chief Nurse in charge of site supervision
Mr DJOKE Agbeviade Population Statistician Sister DORES In-charge of Care and Support on
Kouve site Mr AHIADJITSE Joel K. Associate Laboratory Technician in
charge of care and support on Kodjoviakope site
Mrs. CODJIE Yvette Secretary /Computer operator Mr Pascal Chief Nurse at Kouve Health Delivery
Centre 6 Health workers (2 workers per site)
Auxiliaries for the preparation and distribution of products
10
I - INTRODUCTION For many decades, the Togolese state, highly concerned with the welfare of her citizens and acknowledging the importance of health as a factor of productivity, has made Health one of her priorities: “Health For All and All For Health”. HIV/AIDS is one of the deadly diseases plaguing the nation calling for the mobilization of efforts to fight it and to provide care and support for people living with the HIV/AIDS disease. The average HIV prevalent infection rate among the adult population rose from 5% in 1995 to over 6% in 1998 (according to PNLS source) but dropped below 4% in 2006. The disease affects all the regions in Togo; however, the urban areas are relatively more vulnerable. In 82.8% cases the transmission of the disease is heterosexual. The mother-to-child transmission accounts for 6.5% of the cases. II - CONTEXT AND JUSTIFICATIONS HIV/AIDS infection is rising in exponential proportion in spite of the noticeable efforts being deployed to prevent the transmission of the virus and to provide care and support for persons infected by HIV virus.
Africa pays the heaviest toll for this pandemic; over a total of 40 million people infected by the HIV in December 2001 throughout the world, 28.1 million, representing 70% of the total number live in the sub-Saharan region of Africa. Developing countries account for over 95% of the 14,000 new cases occurring everyday. HIV/AIDS in TOGO: In Togo, the HIV epidemic is of the mature type and generalized; the prevalence among the general population is 4.2% in 2006 with a high rate of AIDS-orphaned children. Women constitute the most vulnerable target of HIV. From 4.2% in 1985, the sex ratio dropped to 1.1 in 2000. This female vulnerability to HIV infection has many reasons: women’s biological constitution and their socio-cultural and economic conditions. According to the data collected by the National HIV/AIDS PREVENTION PROGRAM from sentinel sites for the surveillance of the epidemic at the regression period show that the prevalence rate was 4.7% in 2003, 4.5% in 2004 and 4.2% in 2006. The HIV epidemic is getting stabilised in Togo thereby concealing major differences in the regions as well as within the populations. . On the basis of the analysis of the data collected from the sentinel sites among the target populations such as sex workers and their customers, blood donors, the UN experts on the surveillance of HIV/AIDS and STI reckoned HIV prevalence in Togo to be 3.2% in 2005 among the sexually active population of the 15- 49- year- olds. These data range from 1.9 to 4.7 representing the gap mark. The study carried out in 2005 by AIDS3 with the help of the Canadian cooperation among sex workers in Lome revealed a prevalence of 44.5%.
11
On the basis of the present prevalence of 3.2% it was noted that 110,000 adults and children lived with HIV; 9,700 children from 0 to14 years old lived with HIV; 9,100 adults and children died of AIDS; the epidemic rendered orphan 88,000 children from 0 to 17 years.(period). In September 2006 ending the number of people living with HIV who benefited from the total care and support including the ARV was 5,300 out of a target population of 15,000 persons from now to year 2010. In this respect the national strategy was in line with the universal access to prevention, treatment, care and support services. It emphasized prevention of new infections, treatment of people living with HIV by ARV and medicines for opportunistic infections, care and support to infected and affected persons. The coverage rate of mother-child prevention and transmission (MCPT) was 11.1% in 2006 in the 34 sites spreading over the 14 districts that were covered. This low rate is the result of difficulties of access to mother-child prevention and transmission services. Up to 2006, out of 65,455 pregnant women admitted to CPN (Pre-natal Consultation), 58,693 benefited from free tests, counseling; 35,130 were tested for HIV; 1,794 HIV-positive women received Nevirapine treatment and 1,038 delivered after taking the Nevirapine; 159 received ARV treatment; 1,144 children were born of HIV-positive mothers; 1,077 children received Nevirapine syrup treatment; after testing104 children aged 18 months, 81 were found negative, i.e.78%; 1,021 children were treated with Cotrimoxazol; pregnant women partners accepted to be tested and 24.4% were found HIV-positive. In spite of efforts made to combat the disease, the virus on account of its multiple mutations remains out of control. This calls for new researches and mechanisms of treatment to enable the immune system to combat or control this aggressive disease. In 1994 J.A. Levy one of the first researchers involved in the studies to isolate the AIDS virus and member of the Department of Medicine and Cancer Research Institute of the University of California, San Francisco, expressing his personal view said, “The secret of controlling HIV/AIDS resides not in the medicines which directly attack the virus, but in the body’s own defence mechanism. By strengthening the body’s immune system the HIV-positive can avoid the attacks of the disease for some decades and probably until their natural death. The aim of our survey is to assess the effects of VIPROX on the health of people infected with HIV/AIDS. III- Research Hypothesis The health condition of HIV/AIDS patients was considerably improved by taking VIPXOX TM: the combination of (GSH COMPLEX ®), STRUCTURED WATER (VIVO TM) and TRIOSYME TM. GSH COMPLEX®: substrate which helps in Glutathione intracellular production. VIVO TM : structured water which helps in intracellular conductivity.
12
TRIOSYME TM: enzyme complex which helps in the assimilation of vitamins and minerals. IV – OBJECTIVES 4.1 General Objective To assess the effect of VIPROX on the health of people infected with HIV/AIDS over a period of 3 months. 4.2 Specific Objectives
1. To describe the profile of the sample of study To assess the initial and monthly anthropometric measurements of patientsTo assess the initial and monthly biological constants of patientsTo analyze the resultsTo draw conclusionsto make suggestions and recommendations to various partners
4.3 STRATEGY The strategy used, is an experimental study, a randomized double-blind clinical test with a controlled placebo on half of the sample for a period of one month. This strategy involved active practicing partners on the field in providing psychosocial and clinical care for persons living with HIV. This implies involving those partners in taking care of persons living with HIV through the introduction of VIPROX for a period of three months. The total cost of the biological tests was borne by the project budget. A particular incentive was given to the patients selected to make good transport expenses so that these products could be taken under the supervision of the care providers.
4.4 Care and Support and nutraceutical product Management:
Patients’ Care and Support: The care and support for patients organized on a global basis involved their follow up in their homes. The procedures used tallied with the general procedures proposed by the Kpalime National Workshop on the Care and Support for Persons Living with HIV, viz. a prior diagnostic confirmation by a laboratory test. . An initial general medical check up comprising as a rule, blood formula numeracy, CD4, and the other laboratory tests if possible.
Nutraceutical product Management Each of the selected field partners received a take-off stock of VIPROX and a subsequent stock is supplied by IDH NGO.
13
V. FRAMEWORK OF THE SURVEY
MAP OF THE ADMINISTRATIVE SET UP OF TOGO
5.1 OVERVIEW OF TOGO Togo is a narrow strip of land situated in West Africa in the Gulf of Guinea. It stretches over 600 km lengthwise and its width varies between 50 and 150 km. It is limited on the north by Burkina Faso, on the south by the Atlantic Ocean, on the east by Benin and on the west by Ghana. 5.2 Presentation of the Togolese Health Sector 5.2.1 Organization of the Togolese Health System The health sector is organized on a three-tier-pyramidal system.
The Central Tier. The administrative structure of this tier comprises the Ministry, a general directorate, 5 central directorates, 5 divisions and 39 central services and various programs. Regarding health service delivery, there are 300 University Teaching Hospitals as well as national institutions such as the National Institute of Hygiene, the National Blood Transfusion Center constituting the major national health delivery system.
14
The Intermediate or Regional Tier This is made up of 6 regional directorates:
The Lome Commune, the Maritime Region, the Plateau Region, the Central Region, the Kara Region, the Savannah Region and 6 regional central hospitals which constitute the second major health delivery system;
The Peripheral or District Health Delivery Centre This tier comprises 35 district health delivery centres including public hospitals, mission hospitals, health centres and private clinics and offices As a matter of the district and mission hospitals represent the first reference centres but often they are the first contact centres for the beneficiaries of the delivery service 5.2.2 Health Delivery Infrastructures
There are 618 public and mission health delivery services of all kinds including 3 University Teaching Hospitals, 6 Regional Hospitals, 2 specialized hospitals, 25 district hospitals, 9 private/mission hospitals and about 573 peripheral heath delivery units composed of polyclinic, health delivery centres, infirmaries and mother-child protection centres. There are about 236 private clinics and offices 90% of which are found in the Lome Commune. In spite of all these health delivery infrastructures, the health coverage rate still remains low as a result of the population growth and development of settlement areas.
Access to peripheral health delivery units within a range of 5km is reckoned at 88% according to AS/SR 2003.
5.2.3 Human Resources In 2004 the public health sector comprised 7,459 staff of all categories working in the administration and health delivery centres including military hospitals. Now in 2005 ending it comprised only 6,953.
From a medical viewpoint, the ARV was accessible to 5,400 persons living with HIV through state funding and by the agency of the World Fund as well as the Essential Generic Purchase Centre i.e.30% of the overall needs involving18, 000 persons. Twenty (20) health delivery structures and NGO/Associations were regularly supplied with medicines for opportunistic diseases.
5.2.4 PTME (Prevention of Mother-Child Transmission)
The number and of tested pregnant women and their follow up as well as the care and follow up of
children has improved thanks to integrated plans put in place in 10 districts, the regular supply of
ARV and medicines to combat opportunistic infectious diseases and laboratory equipment, the
increase in the number of sites (Prevention of Mother-Child Transmission) from 16 to 34 by their
rehabilitation and the supervision of the activities.
15
6. METHODOLOGY
6.1 Type of Survey
A randomized double-blind clinical test with placebo was carried out for a one-month period using half of the sample. Target Population: HIV/AIDS patients selected and followed up according to precise criteria in one urban area and 2 rural areas. 6.2 Definition and Measurement of Variables The Patient’s general health condition. This is measured with respect to the following variables: temperature, weight and blood pressure The function of the defence system of the body This is measured with respect to the following variables: the number of red corpuscles, the haemoglobin rate, the number of white corpuscles and the lymphocyte rate. The Hepatic Function This is measured with respect to the following variables: transaminases, glycaemia, triglycerides and cholesterol. The Kidney Function This measured with respect to the following variable: Creatinine TABLE OF THE VARIABLES
VARIABLES NORMS MESURE UNITS
T° : Temperature 36°.6 – 37° Degree centigrade
Weights 45kg plus Kilogramme
B.P (Blood Pressure) 13/8 Hg (mm of mercury)
Red Corpuscles 4500 000 – 5500 000 N° Corpuscles /mm3 of blood
Haemoglobine Rate 12.5 – 15 g/mml
White Corpuscles 5000 – 10 000 N° Corpuscles /mm3 of
blood
Lymphocytes Rate 20 – 40 %
Transaminase
SGOT
SGPT
12 -20
12 - 25
mUl/ml
mUl/ml
Glycemia 0.8 - 1 g/liter of blood
Triglycerides 0.4 – 1.4 g/liter of blood
Cholesterol 1.3 – 3 g/liter of blood
Creatinine 6 – 12 Mg/l of blood
16
6.3 Patient Selection Criteria
We selected in one urban area and one rural a group of HIV infected persons (aged 18 – 45) whose
CD4 rate was above 150 and who weighed between 55 and 75kg. These patients were consulted
and selected according to the following exclusion criteria:
- Patients with liver disorders.
- Alcoholic patients
- Medically dependent patients
- Patients undergoing anti-AIDS treatment (ARV)
- Milk protein-allergic persons
- Person undergoing immuno-depressant treatment
6.4 Target Population and Sampling
The target population which was selected in three sites (Kodjoviakope, Kouve and Agou)
comprised HIV-positive persons of either sex according to the above mentioned criteria.
The sampling which was done at random was based on exclusion criteria.
On account of the variation of rate of HIV-prevalence from one region to another we opted for the
selection of the maximum number representing 5% (p)
After making good the number of withdrawals during the survey period, we found thereby, on the
basis of our calculations, 82 patients. This figure was raised to 115 to further minimize sampling
errors.
In all our study involved 115 HIV persons.
In recruiting the HIV persons for the survey we took into account the gender approach, thus 58
women and 57 men were selected.(see table above).
6.5 Intervention
First Month:
Group N° 1:
The selected HIV persons received placebos having similar physical properties as the other
products except that they were not active.
Group N° 2:
Members of this group received active products:
- Active proteins (GSH Complex) 20g x 2 a day for one month.
17
- 500 ml of structured water for the preparation of active protein.
- 2g of enzyme complex twice a day during meals.
These two groups were formed by a random selection by lot.
2nd and 3rd Months
At this time all the patients were subjected to active products.
6.6 Duration (3months):
The first phase of the survey consisted in writing the protocol, designing the data collection cards,
training the interviewers.
The second phase consisted in data gathering and patient follow up.
The third phase consisted in data analysis.
6.7 Data Gathering
The data were collected by means of questionnaire coupled with an observation grid.
The data to be collected concerned clinical and para-clinical information items on the individual
files of the patients namely the above-mentioned variables.
6.8 Data Management
The keying of the data was done by means of Epi Data and their analysis with SPSS 11 software.
6.9 Ethical Issues
A prior written permit was obtained from the ministries concerned.
Similarly a prior consent was obtained from each patient involved in the survey after the whole
thing was explained to them.
These patients were assured that they would have a free supply of VIPROX during and after the
survey.
The total cost of transport expenses and daily allowance was guaranteed for the patients selected
for the survey.
The publishing of the findings of the survey was subject to the approval of the Medical Ethics
Committee.
7. Difficulties Encountered:
Difficulties related to:
- sampling
The number of patients in each site raised many problems. As a matter of fact, in recruiting
patients with CD4 above 150, it was necessary to test more than 100 patients per site, which the
18
initial budget did not provide for. And as a result the survey could not take off according
schedule and the beginning of the intake of the products was in three stages.
- duration of the survey
The duration of the survey was extended on account of the different periods when the patients
started taking the products.
The failure of patient to turn up for the laboratory tests.
8. FINDINDS
Kodjoviakope Site
a) General Health Status of Patient:
This was assessed with respect to the following variables (weight, temperature and blood
pressure).
We observed a net increase in the average weight of the patients as they took the products
(66.8kg to 67.5kg).
The average temperature of the patients was within the norms (37.3 ° to 37.6°).
The average blood pressure of the patients was within the norms (85% of the patients regained
their normal blood pressure after three months’ treatment).
From these we could conclude that the general health status of the patients was normal.
b) Function of the Body Defence System
After the patients had taking the product for 3 months, a net increase was observed in the
average CD4 (ranging from 347 to 359).
However, there was a slight fall in the number of red corpuscles resulting in a slight anaemia
with an average rate of haemoglobin ranging from 11. 6% to 11.1%.
A further slight increase was found at the leucocytes side ranging from 4,770 to 4,855 with an
average lymphocyte percentage rise ranging from 55.4% to 57%.
It was found that an improvement of the patients’ body defence system was under way.
c) Function of the Hepatic System
The average transaminases and SGOT and average SGPT decreased in number indicating an
improvement of this variable ( 50.4 IU/L to 40.8 IU/L).
The median glycaemia was falling showing an improvement from 0.9g/l to 0.87 g/l.
The triglycerides also were falling from 0.9g/l to 0.7g/l.
19
There was also a fall in the blood cholesterol level from 1.6g/l to 1.5g/l.
It was found that the hepatic system was getting normal.
d) Function of the Kidney System
The average creatinine dropped from 9.7mg/l to 9.1mg/l.
The kidney system reached normal values (7mg/l – 12mg/l).
CONCLUSION
One could conclude that the patients’ general health status had improved as there was an
improvement in their hepatic, kidney and defence systems.
The Agou Site
a) General Health Status of the Patients:
As a net increase in the patients’ average weight was observed in the case of the Kodjoviakope
site, there was a net increase in the patients’ average weight (54 kg to 56.9 kg) as they took the
products.
The patients’ average temperatures reached normal values (36.7° to 36.8°).
The average blood pressure also reached normal values.
After three months’ treatment the patients’ weight increased considerably.
As a matter of fact, after three months’ treatment the initial average weight which was 55kg,
reached nearly 57kg.
It was found that the patients’ general health status was normal.
b) Function of the Body Defence System
After the patients had taken the products for three months, there was a change in the average
CD4 (from 420 to 458 then to 374).
There was a slight fall in the number of red corpuscles resulting in a slight anaemia with an average
rate of haemoglobin ranging from 11.8% to 11.1%.
A further slight increase was found at the leucocytes side ranging 4,582 to 4,247 with an
average lymphocyte percentage rise ranging from 49.9% to 51.9%.
It was found that an improvement of the patients’ body defence system was under way.
20
c) Function of the Hepatic System
The average transaminases and SGOT and average SGPT decreased in number signalling an
improvement of this variable (30.4 IU/L to 24.1 IU/L).
The median glycaemia was falling showing an improvement from 0.9g/l to 0.87 g/l.
The triglycerides also reached normal values 0.6g/l to 0.7g/l.
There was also a fall in the blood cholesterol level from 1g/l to 09.0g/l.
It was found that the hepatic system was getting normal.
e) Function of the Kidney System
The average creatinine dropped from 9.4mg/l to 8.4mg/l.
The kidney system reached normal values (7mg/l – 12mg/l).
CONCLUSION
One could conclude that the patients’ general health status had improved.
There was an improvement in the patients’ hepatic, kidney and defence systems
The Kouve Site
a) General Health Status of the Patients:
This assessed with respect to the following variables: (weight, temperature, blood pressure).
There was an increase in the patients’ average weight as they took the products (54.42 kg to
58.26 kg).
The patients’ average temperatures reached normal values (36.9° to 37.02°).
The average blood pressure also reached normal values.
It was found that the patients’ general health status was normal.
b) Function of the Body Defence System
After the patients had taken the products for three months, the average CD4 increased
considerably (from 312 to 370).
However, there was a slight fall in the number of red corpuscles resulting in a slight anaemia with
an average haemoglobin rate ranging from 11.7% to 2.145%.
21
A further slight increase was observed at the leucocytes side ranging 5,853 to 5,932 with an
average lymphocyte percentage rise ranging from 36.34% to 44.70%.
It was found that an improvement of the patients’ body defence system was under way.
c) Function of the Hepatic System
The average transaminases and SGOT and average SGPT increased in number indicating a
change in this system( 34 IU/L to 40 IU/L).
The median glycaemia got stabilized.
The average triglycerides also dropped from1.5g/l to 0.82g/l.
There also a slight rise in the blood cholesterol level (from 0.95g/l to 1.38g/l.)
It was found that the hepatic system was getting slightly bad. It must be noted that that area is
known for the consumption of locally distilled alcohol.
d)Function of the Kidney System
The average creatinine went up slightly from 8.52mg/l to 9.09mg/l.
The kidney system reached normal values (7mg/l – 12mg/l).
CONCLUSION
In the case of Kouve site one could conclude that the patients’ general health status had
undergone a slight improvement; however, it is to be noted that the hepatic and kidney systems
had gone slightly bad. This may be due to regular consumption of locally distilled alcohol,
which characterizes the drinking habit of the local people.
22
9. GENERAL CONCLUSION
The comparative analysis of the data collected was made by the Levene and T-test to ensure
average equality.
The Levene variance equality test and the average equality T-test ensured the strength of the
comparisons of the biological constants levels during the three months’ treatment with active
product.
The analysis showed that the average constant variations of the functions of the patients’
general health status (Weight, T°, BP) representing a threshold of 99% was statistically
significant.
As regards the other functions of the kidney and body defence systems, it was further noticed
that there was a statistically significant difference between the months of treatment (M0 to M3)
according to the average equality T-test. Thus one can conclude without great risk (1%) that the
improvement is due to the treatments received by the patients.
Lome, 11th October 2007
Dr Kodjo Akpenyo ANTHONY M D; M P H
In-charge of the Survey
23
The findings of the survey are as follows:
I- Description of initial sample 2- Analysis of the findings per site and variables after three months’ treatment.
I- Initial Information Table 1 : Distribution of patients according to sites and age The patients used in survey are generally aged between 20 and 49 years (94.8% at Kodjoviakopé and 84.2% at Agou). This age group is the most sexually active.
LOMÉ COMMUNE
(Kodjoviakopé) PLATEAUX RÉGION (AGOU)ÄGE OF
PATIENTS
n % n %
18-19 years 1 2.6 0 0.0
20-29 years 7 17.9 7 18.4
30-39 years 24 61.5 15 39.5
40-49 years 6 15.4 10 26.3
50 years + 1 2.6 6 15.8
Total 39 100.0 38 100.0
Table 2 : Distribution of patients according to site and sex
25
At Agou 50% of the patients were men and women and at Kodjoviakope the per ratio of men to women was 18: 82.
SEX LOMÉ COMMUNE
(Kodjoviakope) PLATEAUX RÉGION (AGOU)
n % n %
MASCULINE 7 17.9 19 50.0
FÉMININE 32 82.1 19 50.0
Total 39 100.0 38 100.0
Tableau 3 : Distribution of patients according sites and occupations The majority of patients on both sites were traders.
OCCUPATION LOMÉ
COMMUNE (Kodjoviakope)
PLATEAUX RÉGION (AGOU)
OCCUPATION n % n %
TRADER 19 48.7 10 26.3
HAIR DRESSER /SEAMSTRESS 5 12.8 4 10.5
HOUSEWIFE 3 7.7 3 7.9
FARMER 0 0 4 10.5
DRIVER 0 0 4 10.5
LIBERAL PROFESSION 2 5.1 2 5.3
SALARIED MAN/WOMAN 5 12.8 3 7.9
THE UNEMPLOYED 4 10.3 8 21.1
Total 39 100.0 38 100.0
Table 4 : Distribution of patients according to site and matrimonial status The majority of the patients on either site were married (48.7% à Kodjoviakope and 65.8% at Agou).
LOMÉ COMMUNE (Kodjoviakope)
PLATEAU RÉGION (AGOU) MATRIMONIAL STATUS
n % n %
MARRIÉD 19 48.7 25 65.8
SINGLE 13 33.3 11 28.9
WIDOW/WIDOWER 7 17.9 2 5.3
Total 39 100.0 38 100.0
26
Table 5 : Distribution of patients according to site and educational standard The primary and secondary school educational standards of the patients were acceptable, 82% at Kodjoviakope and 94.7 at Agou.
LOMÉ COMMUNE (Kodjoviakope)
PLATEAU RÉGION ( AGOU)EDUCATIONAL STANDARD
n % n %
NONE 7 17.9 1 2.6
PRIMARY 16 41.0 17 44.7
SECONDARY 16 41.0 19 50.0
TERTIARY 0 0.0 1 2.6
Total 39 100.0 38 100.0
Table 6 : Distribution of patients according to site and temperature Patients with temperatures ranging from 37° et 37.4°: 28.2% at Kodjoviakope and 86.9% at Agou
LOMÉ COMMUNE (Kodjoviakope)
RÉGION PLATEAU ( AGOU) TEMPÉRATURE
n % n %
< 37°C 4 10.3 24 63.2
37°C-37.4°C 7 17.9 9 23.7
37.5°C+ 28 71.8 5 13.2
Total 39 100.0 38 100.0
27
Table 7: Distribution of patients according to site and weight The weights of the majority of the patients varied between 50kg et 79kg.
LOMÉ COMMUNE (Kodjoviakope)
PLATEAU RÉGION ( AGOU) WEIGHT
n % n %
< 50 KG 7 17.9 8 21.1
50-59 KG 8 20.5 16 42.1
60-69 KG 9 23.1 5 13.2
70-79 KG 5 12.8 7 18.4
80-89 KG 6 15.4 1 2.6
90 KG+ 4 10.3 1 2.6
Total 39 100.0 38 100.0
BIOLOGICAL CONSTANTS Table 8 : Distribution of patients according to transaminases The transaminases of the patients: SGOT : were within the norms, 65.8% at Agou and only 46.2% at Kodjoviakope ; SGPT : were normal, 65.8% at Agou and 12.8% at Kodjoviakope. SGPT1 TRANSAMINASES SGOT
LOMÉ COMMUNE (Kodjoviakope)
PLATEAU RÉGION (AGOU) TRANSAMINASES SGOT
n % n %
≤ 30 IU/L 18 46.2 25 65.8
>30 IU/L 21 53.8 13 34.2
Total 39 100.0 38 100.0
28
SGPT1 TRANSAMINASES SGPT
LOMÉ COMMUNE (Kodjoviakope)
PLATEAU RÉGION (AGOU) TRANSAMINASES SGPT
n % n %
≤30 IU/L 5 12.8 9 65.8
>30 IU/L 34 87.2 29 34.2
Total 39 100.0 38 100.0
Table 9 : Distribution of patients according to lymphocytes (%) Hyper lymphocytosis was noticed with 92.3% of the patients at Kodjoviakope and 78.9% at Agou.
LOMÉ COMMUNE (Kodjoviakope)
RÉGION PLATEAU ( AGOU) LYMPHOCYTE RATE
n % n %
20-40% 3 7.7 6 15.8
Over 40% 36 92.3 30 78.9
≤19% 0 0.0 2 5.3
Total 39 100.0 38 100.0
Table 10 : Distribution of patients according to site white corpuscles The leucocytosis was within the norms, 76.9% at Kodjoviakope and 60.5% at Agou.
LOMÉ COMMUNE (Kodjoviakope)
PLATEAU RÉGION ( AGOU)NUMBER OF WHITE CORPUSCLES
n % n %
4000-10000 30 76.9 23 60.5
≤3900 9 23.1 15 39.5
Total 39 100.0 38 100.0
29
Table 11 : Distribution of patients according to site and glycaemia The glycaemia rates were within the norms (0.7 g/l – 1g /l), 82.1% at Kodjoviakope and 97.4% at Agou.
LOMÉ COMMUNE (Kodjoviakope)
PLATEAU RÉGION ( AGOU) GLYCAÉMIA
n % n %
0.7-1 g/L.5 29 74.4 15 39.5
Over 1 g/l 7 17.9 1 2.6
< 0.7 g/l 3 7.7 22 57.9
Total 39 100.0 38 100.0
Table 12 : Distribution of patients according to site and cholesterol (g /l) The cholesterol was within the norms (1.5 g/l- 2.5g/l) ; 97.4% at Kodjoviakope and at Agou.
LOMÉ COMMUNE (Kodjoviakope)
PLATEAU RÉGION D ( AGOU) CHOLESTÉROL
n % n %
1.5 g/l- 2.5g/l 22 56.4 15 39.5
Over 2.5g/l 1 2.6 1 2.6
< 1.5g/l 16 41.0 22 57.9
Total 39 100.0 38 100.0
30
Table 13 : Distribution of patients according to site and red corpuscles The red corpuscles were within the norms (4-5 millions), 53.1% at Kodjoviakopé and 21.1% at Agou.
LOMÉ COMMUNE (Kodjoviakope)
PLATEAU RÉGION ( AGOU) NUMBER OF WOMEN’S RED
CORPUSCLES n % n %
4-5 millions 17 53.1 4 21.1
Over 5 millions 4 12.5 1 5.3
< 4 millions 11 34.4 14 73.7
Total 32 100.0 19 100.0
LOMÉ COMMUNE (Kodjoviakope)
PLATEAU RÉGION ( AGOU) NUMBER OF MEN’S RED
CORPUSCLES n % n %
4,5-5,5 millions 2 28.6 11 57.9
Over 5,5 millions 2 28.6 8 42.1
< 4,5 millions 3 42.9 0 0
Total 7 100.0 19 100.0
31
Table 14 : Distribution of patients according to site and creatinine (mg/l) The creatinine was within the norms (5 mg/l – 14 mg/l), 93.8% at Kodjoviakopé and 84.2% at Agou.
LOMÉ COMMUNE (Kodjoviakope)
PLATEAU RÉGION ( AGOU) WOMEN’S CRÉATININE
n % n %
5-12 30 93.8 16 84.2
Over 12 1 3.1 2 10.5
≤4 1 3.1 1 5.3
Total 32 100.0 19 100.0
LOMÉ COMMUNE (Kodjoviakope)
PLATEAU RÉGION ( AGOU) MEN’S CRÉATININE
n % n %
≤6 1 14.3 1 5.3
7-14 6 85.7 17 89.5
Over 14 0 0.0 1 5.3
Total 7 100.0 19 100.0
32
Table 15 : Distribution of patients according to site and triglycerides (g/l) The triglycerides were within the norms (0.3g/l – 1.4g/l), 81.3% at Kodjoviakope and 84.2% at Agou.
LOMÉ COMMUNE (Kodjoviakope)
PLATEAU RÉGION (AGOU) WOMEN’S TRIGLYCERIDES
n % n %
0.3g/l -1.4g/l 26 81.3 16 84.2
Over 1.4g/l
6 18.8 3 15.8
Total 32 100.0 19 100.0
LOMÉ COMMUNE (Kodjoviakope)
PLATEAU RÉGION (AGOU) MEN’S TRIGLYCERIDES
n % n %
0.40g/l - 1.50g/l 6 85.7 17 89.5
Over 1.5g/l 1 14.3 2 10.5
Total 7 100.0 19 100.0
33
RECAPILATION TABLES LOMÉ COMMUNE Table 16 Recapitulation of variables at Kodjoviakope
Average Median Mode Mark Gap Minimum Maximum Total Age 34.72 34 33(a) 6.794 18 52 1354Weight 66.5256 64 48.00(a) 16.68081 38 100.5 2594.5INITIAL TEMPERATURE 12.264 12.8 12.8 1.1913 10.5 14.9 478.3NUMBER OF CD4 373.23 345 151(a) 147.797 151 822 14556 Number of red corpuscles 4282820.51 4200000 3930000(a) 784326.559 2940000 6680000 167030000TRANSAMINASES SGOT 50.31 46 44 25.487 22 173 1962TRANSAMINASES SGPT 32.8205 33 19 14.20502 12 73 1280 Haemoglobin rate 11.3897 11.3 10.80(a) 2.00405 7.8 18.6 444.2 Number of white corpuscles 4956.41 4700 3800(a) 1366.862 2400 8900 193300Lymphocytes % 53.8205 55 60 9.22774 31 76 2099Creatinine 9.3308 9 9.00(a) 2.07962 0.9 13 363.9Glycaemia 0.9021 0.9 0.97 0.14311 0.61 1.21 35.18Triglycérides 1.0323 0.94 0.94 0.68902 0.34 4.48 40.26Cholesterol 1.5838 1.51 1.50(a) 0.49686 0.93 3.95 61.77
34
35
PLATEAU RÉGION Table 17 Recapitulation of variables at Agou
Average Median Mode Mark Gap Minimum Maximum
Age 38.0 35.5 41 10.89 22 68 Weight 59.5 55.5 55 13.31274 40 97 INITIAL TEMPERATURE 12.6 12.6 11.6 1.8242 9.5 18.8 NUMBER OF CD4 475.6 358 263 290.047 153 1185 Number of red corpuscles
3 877 289 3 965 000
2 900 000 847 694
2 095 000 5 200 000
TRANSAMINASES SGOT 42.9 41.5 24 14.644 16 78 TRANSAMINASES SGPT 29.1 23 13 16.65378 11 81 Haemoglobin rate 12.3 12.3 11.5 2.61628 8 17.1 Number of white corpuscles 4 773.7 4150 4100 2073.342 2000 9700 Lymphocytes % 47.6 48.5 42 14.70241 6.4 71 Creatinine 10.2 8.95 7.7 7.33099 0.65 51 Glycaemia 0.7 0.65 0.7 0.17209 0.2 1.47 Triglycerides 2.8 0.78 1.1 11.69846 0.44 73 Cholesterol 1.0 0.89 0.89 0.29821 0.47 1.87
THE FINDINGS FROM THE FIRST MONTH TO THE THIRD MONTH LOME COMMUNE (Kodjoviakope) General health status of the patients : This was assessed with respect to the following variables (Weight, T°, and B/P) A net improvement was noticed in the average weight of the patients as they took the products (66.8kg to 67.5kg). The patients’ average temperature was within the norms (37.3° to 37.6°) It may be concluded that the general health conditions are normal.
MOIS DE TRAITEMENT BIOLOGICAL CONSTANTS
STATISTICS MONTH 0 MONTH 1 MONTH 2 MOINTH 3AVERAGE 66.8 68.3 69.5025 70.4 MEDIAN 65 66 66.5 67.5
WEIGHT (kg) MARK GAP 18.5 17.3 18.3 18.2 AVERAGE 37.37 37.185 37.38 37.65 MEDIAN 37.5 37 37.5 38
TEMPERATURE MARK GAP 0.4 0.2 0.3 0.5 Changes in the blood pressure during the treatment period (Lome- Commune)
20
510
5
45
65 65
85
3530
25
10
0
10
20
30
40
50
60
70
80
90
MOIS 0 MOIS 1 MOIS 2 MOIS 3
MONTH OF TREATMENT
nu
mb
er
of
pa
tie
nts
(%)
> 12/8 12/8-10/8 < 12/8
The blood pressure showed a net improvement after 3 months’ treatment; patients with blood pressure ranging from 12/8 – 10/8 accounted for only 45% at the beginning of the treatment.
xxxvi
After 3 months’ treatment more than 85% of the patients regained their normal blood pressure. According to Levene Test, this change at the threshold of 99% was significant from statistical point of view. Defence function of the body After the patients had taken the products for 3 months, there was a net improvement in the average CD4 (from 347 to 359). However, there was a slight drop in the number of red corpuscles resulting in the patients having a slight anaemia with an average haemoglobin rate of 11.6% to 11.1%. A slight increase was also noticed in the number of leucocytes from (4770 to 4855 with an average percentage rise in the lymphocytes also, 55.4% to 57%. It may be concluded that an improvement in the patients’ body defence systems was under way. MONTH 0 MONTH 1 MONTH 2 MONTH 3
AVERAGE 347.15 327.5 327.55 359.25 MEDIAN 313.5 286.5 279 290.5
CD4 MARK GAP 154.4 177.3 160.1 180.0 AVERAGE 4434500 4380500 4398000 4409500 MEDIAN 4375000 4275000 4370000 4370000 Number of red
corpuscles MARK GAP 934 009.3 852 102.5 933 632.4 927 217.0 AVERAGE 11.61 11.33 11.17 11.11 MEDIAN 11.25 11.05 11.3 11.4
Haemoglobin rate MARK GAP 2.1 1.9 1.8 1.4 AVERAGE 4770 4620 4975 4855 MEDIAN 4550 4250 4350 4400 Number of white
corpuscles MARK GAP 1 249.0 1 346.2 2 108.1 1 621.4 AVERAGE 55.45 56.55 49.9 57 MEDIAN 57 56.5 52.5 57.5
Lymphocytes % MARK GAP 9.4 9.0 8.3 10.7 Function of the hepatic system The average transaminases SGOT and SGPT decreased showing an improvement of this variable, 50.4 IU /L to 40.8 IU/L.
xxxvii
The patients’ median glycaemia dropped showing an improvement of this constant, from 0.9g/l to 0.87g/l). The average triglycerides also dropped, from 0.9g/l 0.7g/. The blood cholesterol level also dropped, from1g/l to 09.0g/l) It may be concluded that the hepatic system was getting normal. ********************************************************************************************* MONTH 0 MONTH 1 MONTH 2 MONTH 3
AVERAGE 50.4 44.75 44.45 40.8 MEDIAN 45 41.5 41 37.5 SGOT
TRANSAMINASES MARK GAP 32.2 25.4 20.4 13.4 AVERAGE 31.15 28.9 37.5 30.8 MEDIAN 29.5 24.5 26.5 29 SGPT
TRANSAMINASES MARK GAP 13.3 18.0 28.9 16.4 AVERAGE 0.959 0.952 0.8905 1.31 MEDIAN 0.92 0.975 0.89 0.875
GLYCAEMIA MARK GAP 0.3 0.1 0.1 1.8 AVERAGE 0.97 0.9065 0.8475 0.77 MEDIAN 0.725 0.8 0.765 0.725
TRIGLYCERIDES MARK GAP 0.9 0.5 0.4 0.3 AVERAGE 1.6175 1.5965 1.554 1.5115 MEDIAN 1.505 1.5 1.595 1.555
CHOLESTEROL MARK GAP 0.6 0.6 0.3 0.3 Function of the kidney system The average creatinine dropped from 9.7mg/l to 9.1mg/l The kidney system is within the norms (7mg/l – 12mg/l) MONTH 0 MONTH 1 MONTH 2 MONTH 3
AVERAGE 9.7 9.9 9.25 9.1 MEDIAN 10 9.5 8.5 9
CREATININE MARK GAP 1.2 2.4 2.5 1.3 CONCLUSION On the whole, it may be concluded that the patients general health conditions were getting improved. The patients’ hepatic, kidney and body defence system had improved.
xxxviii
AGOU General health status of the patients : This was assessed with respect to the following variables (Weight, T°, and B/P) A net improvement was noticed in the average weight of the patients as they took the products (66.8kg to 67.5kg). The patients’ average temperature was within the norms (37.3° to 37.6°) The average blood pressure was also within the norms. It may be concluded that the general health conditions were normal.
MONTHS OF TREATMENT BIOLOGICAL CONSTANTS
STATISTICS MONTH 0 MONTH 1 MONTH 2 MOINTH 3AVERAGE 54.8 55.2 56.1 56.9 MEDIAN 55.0 55.0 56.0 57.0
WEIGHT (kg) MARK GAP 10.8 10.6 10.9 10.6 AVERAGE 36.7 37.0 36.9 36.8 MEDIAN 36.8 37.0 37.0 37.0
TEMPERATURE MARK GAP 0.5 0.6 0.7 0.5 BLOOD PRESURE AVERAGE 12.7 12.0 12.2 12.5 MEDIAN 12.6 11.5 11.5 12.6 MARK GAP 2.1 2.3 2.7 2.1
xxxix
Changes in the patients’ weights during the treatment period
54,8
55,2
56,1
56,9
54
54
55
55
56
56
57
57
58
MOIS 0 MOIS 2 MOIS 2 MOIS 3
AVERAGE WEIGHT OF PATIENTS
MONTH OF TREATMENT
After 3 months’ treatment there was a net increase in the patients’ weights from an initial average weight of 55kg to nearly 57kg. Defence function of the body After the patients had taken the products for 3 months, there was a net improvement in the average CD4 (from 420 to 458 then to 374). However, there was a slight drop in the number of red corpuscles resulting in the patients having a slight anaemia with an average haemoglobin rate of 11.8% to 11.1%. A slight increase was also noticed in the number of leucocytes from (4582 to 4247 with an average percentage rise in the lymphocytes also, 49.9% to 51.9%.
xl
It may be concluded that an improvement in the patients’ body defence systems was under way. MONTH 0 MONTH 1 MONTH 2 MONTH 3
AVERAGE 420 345 458 374 MEDIAN 42.0 32.0 36.0 34.0
CD4 MARK GAP 13.7 10.6 31.9 15.3
AVERAGE 3695 588.2 3465823.5 3173294.1
3533 823.5
MEDIAN 3700 000.0 3461000.0 3346000.0
3585 000.0 Number of red
corpuscles MARK GAP 903223.0 553629.2 1028878.7 723631.1 AVERAGE 1.8 11.0 9.8 11.2 MEDIAN 11.5 11.3 10.2 11.5
Haemoglobin rate MARK GAP 2.6 1.8 3.4 2.5 AVERAGE 4582.4 4758.8 4158.8 4247.1 MEDIAN 4200.0 4600.0 4100.0 4300.0 Number of white
corpuscles MARK GAP 1933.7 1749.7 1741.4 649.2 AVERAGE 49.5 42.9 45.6 51.9 MEDIAN 48.0 40.0 48.0 52.0
Lymphocytes % MARK GAP 13.4 12.4 17.8 10.6
xli
Function of the hepatic system The average transaminases SGOT and SGPT decreased showing an improvement of this variable, 30.4 IU /L to 24.1 IU/L. The patients’ median glycaemia dropped showing an improvement of this constant, from 0.9g/l to 0.87g/l). The average triglycerides were within the norms 0.6g/l 0.7g/l. The blood cholesterol level also dropped, from1g/l to 09.0g/l) It may be concluded that the hepatic system was getting normal. MONTH 0 MONTH 1 MONTH 2 MONTH 3
AVERAGE 30.4 24.4 32.4 24.1 MEDIAN 20.0 24.0 22.5 23.0 SGOT
TRANSAMINASES MARK GAP 17.9 8.8 23.2 7.8 AVERAGE 436.2 337.6 389.0 378.1 MEDIAN 345.0 267.0 292.0 306.0 SGPT
TRANSAMINASES MARK GAP 291.3 261.6 296.2 291.0 AVERAGE 0.6 0.6 0.7 0.7 MEDIAN 0.6 0.6 0.7 0.7
GLYCAEMIA MARK GAP 0.1 0.1 0.1 0.1 AVERAGE 1.0 1.0 0.6 0.8 MEDIAN 0.7 0.8 0.6 0.7
TRIGLYCERIDES MARK GAP 0.5 0.3 0.3 0.4 AVERAGE 1.0 0.8 1.1 0.9 MEDIAN 0.9 0.8 1.1 0.8
CHOLESTEROL MARK GAP 0.3 0.3 0.3 0.3 Function of the kidney system The average creatinine dropped from 9.4mg/l to 8.4mg/l The kidney system was within the norms (7mg/l – 12mg/l) MONTH 0 MONTH 1 MONTH 2 MONTH 3
AVERAGE 9.4 11.3 9.2 8.4 MEDIAN 8.7 8.2 8.2 7.9
CREATININE MARK GAP 2.2 8.9 2.5 2.1
xlii
CONCLUSION On the whole, it may be concluded that the patients’ general health conditions were getting improved. The patients’ hepatic, kidney and body defence systems had improved. RECAPITULATION OF DATA ANALYSIS AFTER THE TREATMENT
AGOU MONTH 0 MONTH 1 MONTH 2 MONTH 3 WEIGHT N % N % N % N % < 50 KG 6 35.3 6 35 6 35 6 35.3 50-59 KG 8 47.1 7 41 5 29 6 35.3 60-69 KG 1 5.88 1 5.9 3 18 2 11.8 70-79 KG 2 11.8 2 12 2 12 2 11.8 80-89 KG 0 0 1 5.9 1 5.9 1 5.9 TEMPERATURE < 37°C 10 58.8 5 29 8 47 8 47.1 37°C-37.4°C 5 29.4 6 35 4 24 7 41.2 37.5°C+ 2 11.8 6 35 5 29 2 11.8 MONTH 0 MONTH 1 MONTH 2 MONTH 3 SGOT TRANSAMINASES ≤ 30 IU/L 5 29.4 8 47 6 35 6 35.3 >30 UI/L 12 70.6 9 53 11 65 11 64.7 SGPT TRANSAMINASES ≤ 30 IU/L 10 58.8 13 76 9 56 15 88.2 >30 IU/L 7 41.2 4 24 7 44 2 11.8 CHOLESTEROL 1.5 g/l -2.5g/l 1 5.88 0 0 1 5.9 1 5.9 < 1.5g/l 16 94.1 17 100 16 94 16 94.1 GLYCAEMIA < 1.5g/l 17 100 17 100 17 100 17 100.0 LYMPHOCYTES 20-40% 2 11.8 9 53 4 24 3 17.6 OVER 40% 15 88.2 8 47 12 71 14 82.4 ≤ 19% 0 0 0 0 1 5.9 0 - LEUCOCYTES 4000-10000 11 64.7 12 71 10 59 11 64.7 ≤ 3900 6 35.3 5 29 7 41 6 35.3
xliii
0 1 2 3 N % N % N % N % RED CORPUSCLES (WOMEN) 4-5 millions 0 0 0 0 1 9.1 2 18.2 OVER 5 millions 1 9.09 0 0 0 0 0 - < 4 millions 10 90.9 11 100 10 91 9 81.8
TRIGLYRERIDES (WOMEN)
0.3g/l-1.4g/l 8 72.7 9 82 11 100 10 90.9 OVER 1.4 3 27.3 2 18 0 0 1 9.1 CREATININE (WOMEN) 5mg/l -12mg/l 10 90.9 10 91 9 82 9 81.8 OVER 12mg/l 1 9.09 1 9.1 1 9.1 0 - ≤ 4mg/l 0 0 0 0 1 9.1 0 -
4.2 0 0 0 0 0 0 1 9.1 4.8 0 0 0 0 0 0 1 9.1
MONTH 0 MONTH 1 MONTH 2 MONTH 3
N % N % N % N % RED CORPUSCLES (MEN) 4,5 - 5,5 millions 4 66.7 0 0 1 17 0 - < 4,5 millions 2 33.3 6 100 5 83 6 100.0 TRIGLYRERIDES (MEN)
0.40g/l -1.50g/l 6 100 5 83 6 100 4 66.7 ove 1.5g/l 0 0 1 17 0 0 0 - < 0.40g/l 0 0 0 0 0 0 2 33.3 CREATININE (MEN) 7-13mg/l 6 100 6 100 6 100 6 100.0
xliv
LOME COMMUNE Patients’ general health conditions MONTH 0 MONTH 1 MONTH 2 MONTH 3 WEIGHT N % N % N % N % < 50 KG 5 25 3 15 4 20 3 15 50-59 KG 3 15 4 20 3 15 3 15 60-69 KG 3 15 5 25 4 20 4 20 70-79 KG 3 15 2 10 1 5 2 10 80-89 KG 4 20 3 15 4 20 4 20 90 KG+ 2 10 3 15 4 20 4 20 TEMPERATURE < 37°C 2 10 0 0 0 0 0 0 37°C-37.4°C 6 30 14 70 9 45 7 35 37.5°C+ 12 60 6 30 11 55 13 65 Function of the hepatic system MONTH 0 MONTH 1 MONTH 2 MONTH 3 SGOT TRANSAMINASES ≤ 30 IU/L 4 20 4 20 6 30 5 25 >30 IU/L 16 80 16 80 14 70 15 75 SGPT TRANSAMINASES ≤30 IU/L 10 50 11 55 11 55 12 60 >30 IU/L 10 50 9 45 9 45 8 40 CHOLESTEROL 1.5g/l - 2.5g/l 11 55 8 40 13 65 11 55 OVER 2.5g/l 1 5 2 10 0 0 0 0 < 1.5g/l 8 40 10 50 7 35 9 45 GLYCAEMIA 1.5g/l - 2.5g/l 1 5 0 0 0 0 0 0 OVER 2.5 0 0 0 0 0 0 1 5 < 1.5g/l 19 95 20 100 20 100 19 95 The body’s defence system LYMPHOCYTES 20-40% 1 5 2 10 3 15 0 0 OVER 40% 19 95 18 90 17 85 20 100 LEUCOCYTES 4000-10000 16 80 12 60 12 60 14 70 OVER 10000 0 0 0 0 1 5 0 0 ≤ 3900 4 20 8 40 7 35 6 30 MONTH 0 MONTH 1 MONTH 2 MONTH 3 RED CORPUSCLES (WOMEN) N % N % N % N % 4-5 millions 9 56.25 7 43.8 8 50 6 37.5 OVER 5 millions 2 12.5 2 12.5 2 13 3 18.8
xlv
5 31.25 7 43.8 6 38 7 43.8 TRIGLYRERIDES (WOMEN) 0.3g/l - 1.4g/L 14 87.5 13 81.3 14 88 16 100 PLUS DE 1.4g/L 2 12.5 3 18.8 2 13 0 0 CREATININE(WOMEN) 5mg/l – 12mg/L 16 100 14 87.5 15 94 16 100 OVER 12mg/l 0 0 2 12.5 1 6.3 0 0
MONTH 0 MONTH 1 MONTH 2 MONTH 3 N % N % N % N % RED CORPUSCLES (MEN) 4,5 - 5,5 millions 1 25 1 25 2 50 0 0 OVER 5,5 millions 2 50 0 0 0 0 0 0
< 4,5 millions 1 25 1 25 1 25 2 50 TRIGLYRERIDES (MEN) 0.40g/l - 1.50g/l 4 100 3 75 4 100 4 100 OVER 1.5g/l 0 0 1 25 0 0 0 0 Function of the kidney systeml MONTH 0 MONTH 1 MONTH 2 MONTH 3 CREATININE (MEN) 7mg/l- 13mg/l 4 100 3 75 2 50 4 100 OVER 13mg/l 0 0 1 25 1 25 0 0 ≤ 6mg/l 0 0 0 0 1 25 0 0
KOUVE
General Health Status of the Patients:
This was assessed with respect to the following variables: (weight, temperature, blood
pressure).
There was an increase in the patients’ average weight as they took the products (54.42 kg to
58.26 kg).
The patients’ average temperatures reached normal values (36.9° to 37.02°).
The average blood pressure also reached normal values.
It was found that the patients’ general health status was normal.
xlvi
MONTHS OF TREATMENT BIOLOGICALCONSTANTS
STATISTICS MONTH 0 MONTH 1 MONTH 2 MONTH 3 AVERAGE 54.42 56.77 58.08 58.26 MEDIAN 56.00 56.00 58.00 58.50
WEIGHT (kg) MARK GAP 7.50 8.72 8.36 9.04 AVERAGE 36.98 37.25 37.01 37.02 MEDIAN 36.90 37.20 36.90 37.00
TEMPERATURE MARK GAP .40 .40 .37 .41
Function of the Body Defence System
After the patients had taken the products for three months, the average CD4 increased
considerably (from 312 to 370).
However, there was a slight fall in the number of red corpuscles resulting in a slight anaemia with
an average haemoglobin rate ranging from 11.7% to 2.145%.
A further slight increase was observed at the leucocytes side ranging 5,853 to 5,932 with an
average lymphocyte percentage rise ranging from 35.34% to 44.70%.
It was found that an improvement of the patients’ body defence system was under way.
xlvii
MONTH 0 MONTH 1 MONTH 2 MONTH 3
AVERAGE 312 301 331 370 MEDIAN 312 267 302 363
CD4 MARK GAP 78 141 150 153 AVERAGE 4543684 4493158 4740526 4286842 MEDIAN 4460000 4300000 4750000 3930000
Number of red corpuscles MARK GAP 597143 721881 802132 664505
AVERAGE 11.71 11.66 11.77 12.45 MEDIAN 11.50 11.40 11.50 12.20 Haemoglobin rate
MARK GAP 1.97 1.81 1.91 1.97 AVERAGE 5853 6042 6426 5932 MEDIAN 5400 6100 6100 6200 Number of white
corpuscles MARK GAP 1799 1763 2397 2405 AVERAGE 35.34 44.57 49.13 44.70 MEDIAN 33.80 44.20 48.40 45.60
Lymphocytes % MARK GAP 12.37 6.54 9.00 13.04
xlviii
Function of the Hepatic System
The average transaminases and SGOT and average SGPT increased in number indicating a
change in this system( 34 IU/L to 40 IU/L).
The median glycaemia got stabilized.
The average triglycerides also dropped from1.5g/l to 0.82g/l.
There also a slight rise in the blood cholesterol level (from 0.95g/l to 1.38g/l.)
It was found that the hepatic system was getting slightly bad.
It must be noted that that area is known for the consumption of locally distilled alcohol.
MONTH 0 MONTH 1 MONTH 2 MONTH 3
AVERAGE 36.42 44.53 47.37 42.42 MEDIAN 34.00 39.00 46.00 40.00 SGOT
TRANSAMINASES MARK GAP 11.98 14.91 20.55 17.30 AVERAGE 25.79 29.63 28.58 28.05 MEDIAN 25.00 29.00 29.00 29.00
SGPT TRANSAMINASES MARK GAP 8.98 10.01 7.76 11.68
AVERAGE .75 .75 .75 .73 MEDIAN .74 .71 .72 .80 GLYCAEMIA
MARK GAP .12 .10 .11 .12 AVERAGE 1.50 .65 .74 .82 MEDIAN 1.36 .58 .72 .80 TRIGLYCERIDES
MARK GAP .98 .25 .25 .27 AVERAGE .95 1.28 1.41 1.38 MEDIAN 1.01 1.32 1.47 1.50
CHOLESTEROL MARK GAP .36 .49 .44 .41
xlix
Function of the kidney system The average creatinine slightly rose from 8.52mg/l to 9.09mg/l The kidney system was within the norms (7mg/l – 12mg/l) MONTH 0 MONTH 1 MONTH 2 MONTH 3
AVERAGE 8.52 8.57 8.56 9.09 MEDIAN 8.50 8.20 8.70 9.30
CREATININE AVERAGE 1.69 1.68 2.58 1.65 RECAPITULATION OF DATA ANALYSIS AFTER TREATMENT
MONTH 0 MONTH 1 MONTH 2 MONTH 3 OVER ALL N % N % N % N % N %
WEIGHT < 50 KG 4 21.1 4 21.1 4 21.1 4 21.1 16 21.1 50-59 KG 11 57.9 7 36.8 7 36.8 6 31.6 31 40.8 60-69 KG 4 21.1 7 36.8 8 42.1 7 36.8 26 34.2 70-79 KG 0 - 1 5.3 0 - 2 10.5 3 3.9 TEMPERATURE < 37°C 10 52.6 3 15.8 10 52.6 3 15.8 26 34.2 37°C-37.4°C 6 31.6 10 52.6 6 31.6 14 73.7 36 47.4 37.5°C+ 3 15.8 6 31.6 3 15.8 2 10.5 14 18.4 TOTAL 19 100.0 19 100.0 19 100.0 19 100.0 76 100.0 Function of the hepatic system
MONTHS OF TREATMENT OVER ALL MONTH 0 MONTH 1 MONTH 2 MONTH 3
N % N % N % N % N %
<=30 IU/L
7 36.8 3 15.8 5 26.3 5 26.3 20 26.3SGOT TRANSAMINASES
>30 IU/L
12 63.2 16 84.2 14 73.7 14 73.7 56 73.7
<=30 IU/L
12 63.2 10 52.6 11 57.9 14 73.7 47 61.8SGPT TRANSAMINASES
>30 IU/L
7 36.8 9 47.4 8 42.1 5 26.3 29 38.2
1.5-2.5
0 .0 5 26.3 9 47.4 10 52.6 24 31.6CHOLESTEROL
< 1.5 19 100.0 14 73.7 10 52.6 9 47.4 52 68.4GLYCAEMIA < 1.5 19 100.0 19 100.0 19 100.0 19 100.0 76 100.0TOTAL 19 100.0% 19 100.0 19 100.0 19 100.0 76 100.0 Body defence system
l
MONTHS OF TREATMENT OVER ALL 0 1 2 3 N %
N % N % N % N %
20-40% 12 63.2 3 15.8 3 15.8 3 15.8 21 27.6OVER 40%
6 31.6 16 84.2 16 84.2 15 78.9 53 69.7
LYMPHOCYTES
<=19% 1 5.3 0 .0 0 .0 1 5.3 2 2.6 4000-10000
16 84.2 16 84.2 16 84.2 13 68.4 61 80.3
OVER 10000
1 5.3 1 5.3 1 5.3 1 5.3 4 5.3
LEUCOCYTES
<=3900 2 10.5 2 10.5 2 10.5 5 26.3 11 14.5TOTAL 19 100.0 19 100.0 19 100.0 19 100.0 76 100.0
li
Function of the kidney system
MONTHS OF TREATMENT OVER ALL MONTH 0 MONTH 1 MONTH 2 MONTH 3 N % N % N % N % N %
4-5 millions
13 68.4 10 52.6 11 57.9 7 36.8 41 53.9 RED CORPUSCLES (WOMEN)
OVER 5 millions
4 21.1 5 26.3 5 26.3 2 10.5 16 21.1
< 4 millions
2 10.5 4 21.1 3 15.8 10 52.6 19 25.0
0.3-1.4 10 52.6 18 94.7 19 100.0 19 100.0 66 86.8 OVER 1.4 8 42.1 0 .0 0 .0 0 .0 8 10.5
TRIGLYRERIDES WOMEN)
< 0.3 1 5.3 1 5.3 0 .0 0 .0 2 2.6 5-12 19 100.0 19 100.0 16 84.2 18 94.7 72 94.7 OVER 12 0 .0 0 .0 2 10.5 1 5.3 3 3.9
CREATININE (WOMEN)
<=4 0 .0 0 .0 1 5.3 0 .0 1 1.3
TOTAL 19 100.0 19 100.0 19 100.0 19 100.0 76 100.0
MONTHS OF TREATMENT OVER ALL MONTH 0 MONTH 1 MONTH 2 MONTH 3 N %
N % N % N % N %
0.40-1.50 10 52.6 17 89.5 19 100.0 18 94.7 64 84.2 OVER 1.5 7 36.8 0 .0 0 .0 0 .0 7 9.2
TRIGLYRERIDES (MEN)
< 0.40 2 10.5 2 10.5 0 .0 1 5.3 5 6.6
4,5-5,5 millions
6 31.6 5 26.3 7 36.8 7 36.8 25 32.9
OVER 5,5 millions
1 5.3 2 10.5 4 21.1 1 5.3 8 10.5
RED CORPUSCLES (MEN) < 4,5 millions 12 63.2 12 63.2 8 42.1 11 57.9 43 56.6
<=6 4 21.1 3 15.8 3 15.8 3 15.8 13 17.1 CREATININE (MEN)
7-14 15 78.9 16 84.2 16 84.2 16 84.2 63 82.9
TOTAL 19 100.0 19 100.0 19 100.0 19 100.0 76 100.0 LÉGEND: Color ash = variables within the norms Red color = pathological
lii
Progression of Weight according to the center and the period
Progression of CD4 according to the centre and the period
Evolution du CD4 selon les sites et la période
347,15
420
312327,5
345
301327,5
458
331359,25
374 370
0
50
100
150
200
250
300
350
400
450
500
KODJOVIAKOPE BETHESDA KOUVE
Sites
CD4 moyen
M0 M1 M2 M3
Evolution du poids selon les sites et la période
68,8
54,8 54,4
68,3
55,2 56,7
69,5
56,1 58
70,4
56,9 58,26
0
10
20
30
40
50
60
70
80
KODJOVIAKOPE BETHESDA KOUVE
Sites
Po
ids m
oyen
M0 M1 M2 M3
liii
Progression of Transaminases according to the centre and the period
Progression of Cholesterol according to the centre and the period
Evolution du taux de cholestérole selon les sites et la période
1,62
10,95
1,59
0,8
1,28
1,55
1,1
1,411,51
0,9
1,38
0
0,2
0,4
0,6
0,8
1
1,2
1,4
1,6
1,8
KODJOVIAKOPE BETHESDA KOUVE
Sites
Taux moyen de
cholesterole
M0 M1 M2 M3
Evolution de la transaminase (SGOT) selon les sites et la période
50,4
30,4
36,42
44,75
24,4
44,5344,45
32,4
47,37
40,8
24,1
42,42
0
10
20
30
40
50
60
KODJOVIAKOPE BETHESDA KOUVE
Sites
Taux moyen de transa
(SGOT)
M0 M1 M2 M3
liv
Progression of Creatinine according to the centre and the period
Evolution du taux de créatinine selon les sites et la période
9,7 9,4
8,52
9,9
11,3
8,579,25 9,2
8,569,1
8,49
0
2
4
6
8
10
12
KODJOVIAKOPE BETHESDA KOUVE
Sites
Taux moyen de créatinine
M0 M1 M2 M3
lv
American Journal of Clinical Nutrition, Vol 64, 524S-532S, 1996
BBiiooeelleeccttrriiccaall iimmppeeddaannccee aannaallyyssiiss iinn bbooddyy ccoommppoossiittiioonn mmeeaassuurreemmeenntt::
National Institutes of Health Technology Assessment Conference
Statement
The objective of this conference was to provide physicians with a responsible assessment of bioelectrical impedance analysis (BIA) technology for body composition measurements.
The panel concluded that BIA provides a reliable estimate of total body water under most conditions. It can be a useful technique for body composition analysis in healthy individuals and in those with a number of chronic conditions such as mild-to-moderate obesity, diabetes mellitus, and other medical conditions in which major disturbances of water distribution are not prominent.
Therefore, the panel recommends that a committee of appropriate scientific experts and instrument manufacturers be formed with the goal of setting instrument standards and procedural methods.
64
American Journal of Clinical Nutrition, 77: 331-340, 2003
DDeevveellooppmmeenntt ooff bbiiooeelleeccttrriiccaall iimmppeeddaannccee aannaallyyssiiss pprreeddiiccttiioonn eeqquuaattiioonn ffoorr bbooddyy ccoommppoossiittiioonn wwiitthh tthhee uussee ooff aa mmuullttiiccoommppoonneenntt mmooddeell ffoorr uussee iinn eeppiiddeemmiioollooggiicc ssuurrvveeyyss 11,,33,,44 Shumei S Sun, W Cameron Chumlea, Steven B Heymsfield, Henry C Lukaski, Dale Schoeller, Karl Friedl, Robert J Kuczmarski,
Katherine M Flegal, Clifford L Johnson and Van S Hubbard 1 From the Department of Community Health, Wright State University School of Medicine, Dayton, OH (SSS and WCC); the Obesity Research Center, St Lukes–Roosevelt Hospital, Columbia University, New York (SBH); the US Department of Agriculture, Agricultural Research Service, Grand Forks Human Nutrition Research Center, Grand Forks, ND (HCL); Nutritional Sciences, University of Wisconsin, Madison (DS); the Military Operational Medicine Program, Military Medical Research and Materiel Command, Frederick, MD (KF); the National Institutes of Health, Division of Digestive Diseases and Nutrition (RJK) and the Division of Nutrition Research (VSH), National Institute of Diabetes and Digestive and Kidney Diseases, Bethesda, MD; and the Centers for Disease Control and Prevention, National Center for Health Statistics, Division of Health Examination Statistics, Hyattsville, MD (KMF and CLJ). Background: Previous studies to develop and validate bioelectrical impedance analysis (BIA) equations to predict body composition were limited by small sample sizes, sex specificity, and reliance on reference methods that use a 2-component model. Conclusion: These equations have excellent precision and are recommended for use in epidemiological studies to describe normal levels of body composition.
65
J Acquir Immune Defic Syndr Hum Retrovirol. 1995 May 1;9(1):20-5. Bioelectrical impedance analysis as a predictor of survival in patients with human immunodeficiency virus infection. Ott M, Fischer H, Polat H, Helm EB, Frenz M, Caspary WF, Lembcke B Division of Gastroenterology, University Hospital, Johann Wolfgang Goethe University, Frankfurt, Germany. In patients with AIDS, short-term survival has been related to body weight, body composition, and serum nutritional parameters, but their prognostic impact at earlier stages of the HIV infection is not known. With an individual follow-up period of 1,000 days, we investigated the prognostic relevance of electrical tissue conductivity [resistance R, reactance Xc, phase angle alpha, extracellular mass (ECM), body cell mass (BCM)] measured by bioelectrical impedance analysis, of the CD4+ cell count, and of serum parameters indicating malnutrition in 75 HIV-infected male patients at Walter Reed stages 3-5. After initial recording, 29 patients (38.7%) died from AIDS during this period. Among 12 parameters estimated with a semiparametric Cox regression model adjusted for therapy (pentamidine, azidothymidine), the phase angle alpha (parameter estimate: -1.043, 95% confidence interval of -0.61 to -1.47; p < or = 0.0001), the ECM/BCM ratio, Xc, BCM, serum cholesterol, number of CD4+ cells, and serum albumin had significant prognostic influence on survival, whereas age, body weight, body mass index, resistance, serum protein, and serum triglycerides did not. In a model with four covariates (CD4+ cells, phase angle, pentamidine, azidothymidine), the prognostic impact of the CD4+ cell count (parameter estimate: -0.549) was lower compared with the phase angle alpha (parameter estimate: -0.799; p < or = 0.0001) and did not gain statistical significance (p = 0.0626). The phase angle alpha was the best single predictive factor for survival among all 12 parameters (comparison of the respective Cox models with the likelihood ratio test).
66
Am J Clin Nutr. 2000 Aug;72(2):496-501. PPhhaassee aannggllee ffrroomm bbiiooeelleeccttrriiccaall iimmppeeddaannccee aannaallyyssiiss rreemmaaiinnss aann iinnddeeppeennddeenntt pprreeddiiccttiivvee mmaarrkkeerr iinn HHIIVV--iinnffeecctteedd ppaattiieennttss iinn tthhee eerraa ooff hhiigghhllyy aaccttiivvee aannttiirreettrroovviirraall ttrreeaattmmeenntt.. Schwenk A, Beisenherz A, Römer K, Kremer G, Salzberger B, Elia M. Klinik I für Innere Medizin der Universität zu Köln, Cologne, Germany. BACKGROUND: Highly active antiretroviral treatment (HAART) reduces the risk of wasting in HIV infection and may alter the prognostic weight of wasting. The phase angle from bioelectrical impedance analysis (BIA) can be interpreted as a surrogate marker for the catabolic reaction to chronic HIV infection and opportunistic disease. OBJECTIVE: Our objective was to assess the prognostic ability of the phase angle in HIV-infected patients in the era of HAART. DESIGN: Two cross-sectional observation studies were conducted in 1996 and 1997 at a German university outpatient HIV clinic. In the 1996 and 1997 cohorts, HAART was prescribed to 17 of 212 and 168 of 257 patients at baseline and to 179 of 212 and 234 of 257 patients during observation, respectively. Whole-body BIA was assessed at 50 KHz. Time to clinical progression and survival were calculated by using Cox proportional hazard models with time-dependent covariates. Median observation times were 1000 and 515 d for the 1996 and 1997 cohorts, respectively. RESULTS: Higher phase angle was associated with a lower relative mortality risk, adjusted for viral load and CD4(+) cell count, of 0.49 (95% CI: 0.30, 0.81) per degree in 1996 and of 0.33 (95% CI: 0.18, 0.61) in 1997. The influence of phase angle on time to clinical progression, adjusted for viral load and CD4(+) cell count, was not significant in 1996 but the relative risk was 0.58 (0.36, 0.83) in 1997. CONCLUSION: Despite the favorable effects of HAART on the nutritional status of HIV-infected persons, low phase angle remains an independent adverse prognostic marker of clinical progression and survival.
67
68
J Nutr. 2001 Nov;131(11):2843-7. Severity of human immunodeficiency virus infection is associated with decreased phase angle, fat mass and body cell mass in adults with pulmonary tuberculosis infection in Uganda. Shah S., Whalen C., , Kotler DP., , Mayanja H., Namale A., Melikian G,, Mugerwa R, Semba RD. The Children's Hospital of Philadelphia, University of Pennsylvania, Philadelphia, PA, USA. Although coinfection with tuberculosis and human immunodeficiency virus (HIV) is emerging as a major problem in many developing countries, nutritional status has not been well characterized in adults with tuberculosis and HIV infection. We compared nutritional status between 261 HIV-positive and 278 HIV-negative adults with pulmonary tuberculosis in Kampala, Uganda, using anthropometry and bioelectrical impedance analysis. Among 163 HIV-positive and 199 HIV-negative men, intracellular water-to-extracellular water (ICW:ECW) ratio was 1.48 +/- 0.26 and 1.59 +/- 0.48 (P = 0.006) and phase angle was 5.42 +/- 1.05 and 5.76 +/- 1.30 (P = 0.009), respectively. Among 98 HIV-positive and 79 HIV-negative women, ICW:ECW was 1.19 +/- 0.16 and 1.23 +/- 0.15 (P = 0.11) and phase angle was 5.35 +/- 1.27 and 5.43 +/- 0.93 (P = 0.61), respectively. There were no significant differences in BMI, body cell mass, fat mass or fat-free mass between HIV-positive and HIV-negative adults. Among HIV-positive subjects, BMI, ICW:ECW, body cell mass, fat mass and phase angle were significantly lower among those with CD4(+) lymphocytes < or = 200 cells/microL compared with those who had > 200 cells/microL. In sub-Saharan Africa, coinfection with pulmonary tuberculosis and HIV is associated with smaller body cell mass and intracellular water, but not fat-free mass, and by large differences in ICW:ECW and phase angle alpha.
BIA
TE
ST
KO
DJA
VIA
KO
PE
FIN
AL
Tes
t D
ate
Tes
t T
ime
Las
t N
ame
Fir
st N
ame
Su
bje
ct ID
Ag
eG
end
erH
eig
ht
Wei
gh
tA
ctiv
ity
Lev
elR
esis
tan
ceR
eact
ance
Imp
edan
ceF
ram
e S
ize
Tar
get
W
eig
ht
BM
IB
MR
DE
EP
has
e A
ng
leF
at w
tF
FM
wt
TB
W
liter
sF
at %
o
f w
tF
FM
%
of
wt
TB
W %
o
f w
t
30/0
4/20
0711
:25:
49S
OH
OIN
AB
LAV
IC
SK
1 00
145
Fem
ale
140
cm47
kgS
ome
exer
cise
625
7262
9.1
Sm
all
34.
323
.98
1146
1720
6.6
16.
8 3
0.2
23.
2 3
5.8
64.
2 4
9.3
07/0
5/20
0711
:25:
49S
OH
OIN
AB
LAV
IC
SK
1 00
145
Fem
ale
140
cm47
kgS
ome
exer
cise
650
7565
4.3
Sm
all
34.
323
.98
1146
1720
6.6
17.
2 2
9.8
22.
6 3
6.7
63.
3 4
8.1
14/0
5/20
0711
:25:
49S
OH
OIN
AB
LAV
IC
SK
1 00
145
Fem
ale
140
cm47
kgS
ome
exer
cise
656
7866
0.6
Sm
all
34.
323
.98
1146
1720
6.8
17.
3 2
9.7
22.
5 3
6.9
63.
1 4
7.9
30/0
4/20
0711
:25:
49A
DJE
AK
OU
AC
SK
1 00
229
Fem
ale
160
cm79
kgS
ome
exer
cise
677
7868
1.5
Med
ium
34.
330
.86
1565
2347
6.6
38.
1 4
0.9
29.
7 4
8.2
51
.8 3
7.6
07/0
5/20
0711
:25:
49A
DJE
AK
OU
AC
SK
1 00
229
Fem
ale
160
cm80
kgS
ome
exer
cise
677
7668
1.3
Med
ium
34.
331
.25
1574
2362
6.4
38.
9 4
1.1
29.
8 4
8.7
51
.3 3
7.3
14/0
5/20
0711
:25:
49A
DJE
AK
OU
AC
SK
1 00
229
Fem
ale
160
cm81
kgS
ome
exer
cise
650
7165
3.9
Med
ium
34.
331
.64
1584
2376
6.2
39.
1 4
1.9
30.
6 4
8.3
51
.7 3
7.8
30/0
4/20
0711
:44:
11T
OS
SO
UK
PE
KO
KO
UC
SK
1 00
333
Mal
e18
0cm
101
kgM
oder
ate
exer
c53
464
537.
8La
rge
34.
331
.17
2135
3631
6.8
37.
6 6
3.4
46.
2 3
7.3
62.
7 4
5.8
07/0
5/20
0711
:44:
47T
OS
SO
UK
PE
KO
KO
UC
SK
1 00
333
Fem
ale
180
cm10
2kg
Som
e ex
erci
se51
664
520.
0La
rge
34.
331
.48
1803
2704
7.1
42.
4 5
9.6
43.
5 4
1.6
58.
4 4
2.7
14/0
5/20
0711
:44:
47T
OS
SO
UK
PE
KO
KO
UC
SK
1 00
333
Fem
ale
180
cm10
3kg
Som
e ex
erci
se50
760
510.
5La
rge
34.
331
.79
1812
2719
6.7
42.
6 6
0.4
44.
1 4
1.4
58.
6 4
2.9
07/0
5/20
0711
:51:
22D
e S
OU
ZA
AF
IAV
IC
SK
1 00
433
Fem
ale
180
cm66
kgS
ome
exer
cise
744
8474
8.7
Sm
all
34.
320
.37
1457
2186
6.4
22.
2 4
3.8
30.
8 3
3.7
66.
3 4
6.7
14/0
5/20
0711
:51:
22D
e S
OU
ZA
AF
IAV
IC
SK
1 00
433
Fem
ale
180
cm66
kgS
ome
exer
cise
752
8375
6.6
Sm
all
34.
320
.37
1457
2186
6.3
22.
4 4
3.6
30.
6 3
4.0
66.
0 4
6.4
30/0
4/20
0711
:57:
51A
MO
UZ
OU
ER
NE
ST
INE
CS
K1
005
52F
emal
e15
1cm
81kg
Som
e ex
erci
se51
048
512.
3La
rge
34.
335
.52
1460
2190
5.4
37.
6 4
3.4
33.
0 4
6.5
53.
5 4
0.8
07/0
5/20
0711
:58:
55A
MO
UZ
OU
ER
NE
ST
INE
CS
K1
005
52F
emal
e15
1cm
83kg
Som
e ex
erci
se51
748
519.
2La
rge
34.
336
.40
1479
2218
5.3
39.
6 4
3.4
33.
0 4
7.7
52.
3 3
9.7
14/0
5/20
0711
:58:
55A
MO
UZ
OU
ER
NE
ST
INE
CS
K1
005
52F
emal
e15
1cm
84kg
Som
e ex
erci
se50
044
501.
9La
rge
34.
336
.84
1488
2233
5.0
39.
7 4
4.3
33.
8 4
7.2
52.
8 4
0.2
30/0
4/20
0711
:58:
55G
NA
DIO
PA
SC
ALI
NE
CS
K1
006
33F
emal
e16
0cm
52kg
Som
e ex
erci
se68
974
693.
0M
ediu
m 3
4.3
20.3
112
8719
30 6
.1 1
5.9
36.
1 2
6.3
30.
6 6
9.4
50.
7
07/0
5/20
0711
:58:
55G
NA
DIO
PA
SC
ALI
NE
CS
K1
006
33F
emal
e16
0cm
53kg
Som
e ex
erci
se71
277
716.
2M
ediu
m 3
4.3
20.7
012
9619
45 6
.2 1
7.2
35.
8 2
5.9
32.
5 6
7.5
48.
9
14/0
5/20
0711
:58:
55G
NA
DIO
PA
SC
ALI
NE
CS
K1
006
52F
emal
e16
0cm
50kg
Som
e ex
erci
se74
080
744.
3M
ediu
m 3
4.3
19.5
311
7817
68 6
.2 1
5.2
34.
8 2
5.0
30.
4 6
9.6
49.
9
30/0
4/20
0711
:58:
55A
KP
AK
LIK
OS
SIW
AC
SK
1 00
738
Fem
ale
158
cm62
kgS
ome
exer
cise
592
5959
4.9
Sm
all
34.
324
.84
1356
2034
5.7
22.
3 3
9.7
29.
7 3
6.0
64.
0 4
8.0
07/0
5/20
0711
:58:
55A
KP
AK
LIK
OS
SIW
AC
SK
1 00
738
Fem
ale
158
cm63
kgS
ome
exer
cise
581
6058
4.1
Sm
all
34.
325
.24
1365
2048
5.9
22.
7 4
0.3
30.
2 3
6.1
63.
9 4
7.9
14/0
5/20
0711
:58:
55A
KP
AK
LIK
OS
SIW
AC
SK
1 00
738
Fem
ale
158
cm63
kgS
ome
exer
cise
644
6864
7.6
Sm
all
34.
325
.24
1365
2048
6.0
24.
7 3
8.3
28.
3 3
9.1
60.
9 4
4.9
30/0
4/20
0713
:11:
05A
GB
AN
AA
MA
VI
CS
K1
008
35F
emal
e16
0cm
58kg
Som
e ex
erci
se65
963
662.
0S
mal
l 3
4.3
22.6
613
3520
03 5
.5 2
0.2
37.
8 2
7.8
34.
8 6
5.2
47.
9
07/0
5/20
0713
:11:
42A
GB
AN
AA
MA
VI
CS
K1
008
35F
emal
e16
0cm
58kg
Mod
erat
e ex
erc
692
7069
5.5
Med
ium
34.
322
.66
1335
2136
5.8
21.
0 3
7.0
26.
9 3
6.1
63.
9 4
6.5
14/0
5/20
0713
:11:
42A
GB
AN
AA
MA
VI
CS
K1
008
35F
emal
e16
0cm
58kg
Som
e ex
erci
se67
265
675.
1S
mal
l 3
4.3
22.6
613
3520
03 5
.5 2
0.5
37.
5 2
7.4
35.
4 6
4.6
47.
3
30/0
4/20
0713
:21:
14E
VE
NY
OA
DJO
CS
K1
010
31F
emal
e16
0cm
67kg
Som
e ex
erci
se69
775
701.
0M
ediu
m 3
4.3
26.1
714
4021
60 6
.1 2
8.6
38.
4 2
7.8
42.
6 5
7.4
41.
6
07/0
5/20
073:
55:4
4E
VE
NY
OA
DJO
CS
K1
010
31F
emal
e16
0cm
67kg
Som
e ex
erci
se69
477
698.
3M
ediu
m 5
2.1
26.1
714
4021
60 6
.3 2
8.5
38.
5 2
7.9
42.
5 5
7.5
41.
7
14/0
5/20
073:
55:4
4E
VE
NY
OA
DJO
CS
K1
010
31F
emal
e16
0cm
68kg
Som
e ex
erci
se66
573
669.
0M
ediu
m 5
2.1
26.5
614
5021
75 6
.3 2
8.7
39.
3 2
8.8
42.
2 5
7.8
42.
3
30/0
4/20
073:
55:4
4A
PE
ZO
UM
ON
AD
JOC
SK
1 01
130
Fem
ale
160
cm68
kgS
ome
exer
cise
538
5354
0.6
Larg
e 5
2.1
26.5
614
5421
82 5
.6 2
4.4
43.
6 3
2.8
35.
9 6
4.1
48.
3
07/0
5/20
073:
55:4
4A
PE
ZO
UM
ON
AD
JOC
SK
1 01
130
Fem
ale
160
cm69
kgS
ome
exer
cise
564
5856
7.0
Larg
e 5
2.1
26.9
514
6421
96 5
.9 2
6.3
42.
7 3
2.0
38.
1 6
1.9
46.
3
14/0
5/20
073:
55:4
4A
PE
ZO
UM
ON
AD
JOC
SK
1 01
130
Fem
ale
160
cm69
kgS
ome
exer
cise
577
6158
0.2
Larg
e 5
2.1
26.9
514
6421
96 6
.0 2
6.8
42.
2 3
1.5
38.
9 6
1.1
45.
7
07/0
5/20
074:
07:4
8K
AT
AK
OU
BE
NE
DIC
TE
CS
K1
012
35F
emal
e16
2cm
77kg
Som
e ex
erci
se54
757
550.
0S
mal
l 5
2.1
29.3
415
2122
82 5
.9 3
1.4
45.
6 3
4.0
40
.8 5
9.2
44.
2
14/0
5/20
074:
07:4
8K
AT
AK
OU
BE
NE
DIC
TE
CS
K1
012
35F
emal
e16
2cm
77kg
Som
e ex
erci
se52
147
523.
1S
mal
l 5
2.1
29.3
415
2122
82 5
.2 3
0.2
46.
8 3
5.1
39
.2 6
0.8
45.
6
30/0
4/20
074:
07:4
8K
AT
AK
OU
BE
NE
DIC
TE
CS
K1
012
35F
emal
e16
2cm
78kg
Som
e ex
erci
se51
648
518.
2S
mal
l 5
2.1
29.7
215
3122
96 5
.3 3
0.8
47.
2 3
5.4
39
.4 6
0.6
45.
4
30/0
4/20
074:
20:4
9A
GB
EN
OU
TA
NIA
CS
K1
013
20F
emal
e17
0cm
55kg
Som
e ex
erci
se74
058
742.
3S
mal
l 5
2.1
19.0
313
9520
92 4
.5 1
6.3
38.
7 2
7.5
29.
6 7
0.4
50.
1
07/0
5/20
074:
21:2
9A
GB
EN
OU
TA
NIA
CS
K1
013
20F
emal
e17
0cm
55kg
Som
e ex
erci
se79
760
799.
3S
mal
l 5
2.1
19.0
313
9520
92 4
.3 1
7.3
37.
7 2
6.3
31.
5 6
8.5
47.
8
14/0
5/20
074:
21:2
9A
GB
EN
OU
TA
NIA
CS
K1
013
20F
emal
e17
0cm
55kg
Som
e ex
erci
se84
164
843.
4S
mal
l 5
2.1
19.0
313
9520
92 4
.4 1
7.9
37.
1 2
5.4
32.
6 6
7.4
46.
2
30/0
4/20
074:
21:2
9Y
OV
OG
AN
AT
SO
UP
IC
SK
1 01
438
Fem
ale
160
cm46
kgS
ome
exer
cise
754
7875
8.0
Sm
all
52.
117
.97
1206
1809
5.9
12.
1 3
3.9
24.
2 2
6.3
73.
7 5
2.7
07/0
5/20
074:
32:2
7Y
OV
OG
AN
AT
SO
UP
IC
SK
1 01
438
Fem
ale
160
cm45
kgS
ome
exer
cise
756
7675
9.8
Sm
all
52.
117
.58
1196
1794
5.7
11.
3 3
3.7
24.
1 2
5.1
74.
9 5
3.5
14/0
5/20
074:
32:2
7Y
OV
OG
AN
AT
SO
UP
IC
SK
1 01
438
Fem
ale
160
cm46
kgS
ome
exer
cise
740
7274
3.5
Sm
all
52.
117
.97
1206
1809
5.6
11.
9 3
4.1
24.
5 2
5.8
74.
2 5
3.3
30/0
4/20
074:
32:2
7S
OK
PO
AD
JOA
VI
CS
K1
015
29F
emal
e15
0cm
62kg
Som
e ex
erci
se54
649
548.
2M
ediu
m 5
2.1
27.5
613
8420
76 5
.1 2
3.7
38.
3 2
9.3
38.
2 6
1.8
47.
3
07/0
5/20
074:
32:2
7S
OK
PO
AD
JOA
VI
CS
K1
015
29F
emal
e15
0cm
62kg
Som
e ex
erci
se53
047
532.
1M
ediu
m 5
2.1
27.5
613
8420
76 5
.1 2
3.1
38.
9 2
9.9
37.
2 6
2.8
48.
2
14/0
5/20
074:
32:2
7S
OK
PO
AD
JOA
VI
CS
K1
015
29F
emal
e15
0cm
62kg
Som
e ex
erci
se53
750
539.
3M
ediu
m 5
2.1
27.5
613
8420
76 5
.3 2
3.4
38.
6 2
9.6
37.
7 6
2.3
47.
8
30/0
4/20
074:
32:2
7A
DO
ME
LIA
NE
CS
K1
016
23F
emal
e15
0cm
45kg
Som
e ex
erci
se60
767
610.
7M
ediu
m 5
2.1
20.0
012
4918
73 6
.3 1
1.5
33.
5 2
5.5
25.
5 7
4.5
56.
7
07/0
5/20
074:
47:1
6A
DO
ME
LIA
NE
CS
K1
016
23F
emal
e15
0cm
47kg
Som
e ex
erci
se62
468
627.
7M
ediu
m 5
2.1
20.8
912
6819
02 6
.2 1
3.6
33.
4 2
5.3
28.
8 7
1.2
53.
8
14/0
5/20
074:
47:1
6A
DO
ME
LIA
NE
CS
K1
016
23F
emal
e15
0cm
46kg
Som
e ex
erci
se62
771
631.
0M
ediu
m 5
2.1
20.4
412
5818
87 6
.5 1
2.8
33.
2 2
5.1
27.
8 7
2.2
54.
6
30/0
4/20
075:
02:0
9A
NIG
LOK
EN
OU
CS
K1
018
38M
ale
183
cm57
kgS
ome
exer
cise
644
4064
5.2
Sm
all
80.
917
.02
1509
2415
3.6
9.2
47.
8 3
4.6
16.
1 8
3.9
60.
7
07/0
5/20
075:
02:5
7A
NIG
LOK
EN
OU
CS
K1
018
38M
ale
183
cm58
kgS
ome
exer
cise
606
3660
7.1
Sm
all
80.
917
.32
1523
2437
3.4
8.4
49.
6 3
6.2
14.
4 8
5.6
62.
5
14/0
5/20
075:
02:5
7A
NIG
LOK
EN
OU
CS
K1
018
38M
ale
183
cm59
kgS
ome
exer
cise
612
3761
3.1
Sm
all
80.
917
.62
1537
2459
3.5
9.4
49.
6 3
6.2
15.
9 8
4.1
61.
3
1B
IA T
ES
T K
OD
JOV
IAK
OP
E F
INA
L F
inal
F 2
.xls
BIA
TE
ST
KO
DJA
VIA
KO
PE
FIN
AL
Tes
t D
ate
Tes
t T
ime
Las
t N
ame
Fir
st N
ame
Su
bje
ct ID
Ag
eG
end
erH
eig
ht
Wei
gh
tA
ctiv
ity
Lev
elR
esis
tan
ceR
eact
ance
Imp
edan
ceF
ram
e S
ize
Tar
get
W
eig
ht
BM
IB
MR
DE
EP
has
e A
ng
leF
at w
tF
FM
wt
TB
W
liter
sF
at %
o
f w
tF
FM
%
of
wt
TB
W %
o
f w
t
30/0
4/20
075:
02:5
7A
ME
GA
NC
HA
RLO
TT
EC
SK
1 01
937
Fem
ale
150
cm54
kgS
ome
exer
cise
637
7764
1.6
Med
ium
80.
924
.00
1269
1904
6.9
19.
7 3
4.3
25.
7 3
6.4
63.
6 4
7.7
07/0
5/20
075:
02:5
7A
ME
GA
NC
HA
RLO
TT
EC
SK
1 01
937
Fem
ale
150
cm56
kgS
ome
exer
cise
614
7361
8.3
Med
ium
80.
924
.89
1288
1933
6.8
20.
8 3
5.2
26.
6 3
7.1
62.
9 4
7.4
14/0
5/20
075:
02:5
7A
ME
GA
NC
HA
RLO
TT
EC
SK
1 01
937
Fem
ale
150
cm55
kgS
ome
exer
cise
610
6961
3.9
Med
ium
80.
924
.44
1279
1918
6.5
19.
9 3
5.1
26.
6 3
6.1
63.
9 4
8.3
30/0
4/20
075:
02:5
7T
ET
TE
KP
OE
KA
NG
NI
CS
K1
020
37M
ale
160
cm51
kgS
ome
exer
cise
629
6663
2.5
Med
ium
80.
919
.92
1318
2109
6.0
12.
3 3
8.7
28.
5 2
4.2
75.
8 5
5.8
07/0
5/20
075:
02:5
7T
ET
TE
KP
OE
KA
NG
NI
CS
K1
020
37M
ale
160
cm54
kgS
ome
exer
cise
552
5555
4.7
Med
ium
80.
921
.09
1360
2176
5.7
12.
0 4
2.0
31.
5 2
2.2
77.
8 5
8.4
14/0
5/20
075:
02:5
7T
ET
TE
KP
OE
KA
NG
NI
CS
K1
020
37M
ale
160
cm53
kgS
ome
exer
cise
634
6863
7.6
Med
ium
80.
920
.70
1346
2154
6.1
14.
0 3
9.0
28.
7 2
6.3
73.
7 5
4.1
30/0
4/20
075:
02:5
7LA
WS
ON
NA
DO
UC
SK
1 02
134
Fem
ale
165
cm90
kgS
ome
exer
cise
426
5442
9.4
Med
ium
80.
933
.06
1656
2484
7.2
33.
1 5
6.9
42.
7 3
6.8
63.
2 4
7.4
07/0
5/20
075:
02:5
7LA
WS
ON
NA
DO
UC
SK
1 02
134
Fem
ale
165
cm89
kgS
ome
exer
cise
421
5442
4.4
Med
ium
80.
932
.69
1646
2470
7.3
31.
8 5
7.2
42.
9 3
5.8
64.
2 4
8.2
14/0
5/20
075:
02:5
7LA
WS
ON
NA
DO
UC
SK
1 02
134
Fem
ale
165
cm92
kgS
ome
exer
cise
410
5341
3.4
Med
ium
80.
933
.79
1675
2513
7.4
33.
3 5
8.7
44.
0 3
6.2
63.
8 4
7.9
07/0
5/20
075:
58:2
3B
AY
OR
FA
TI
CS
K1
022
33F
emal
e17
0cm
98kg
Som
e ex
erci
se49
253
494.
8La
rge
80.
933
.91
1746
2620
6.1
42.
3 5
5.7
41.
3 4
3.2
56.
8 4
2.1
14/0
5/20
075:
58:2
3B
AY
OR
FA
TI
CS
K1
022
33F
emal
e17
0cm
98kg
Som
e ex
erci
se50
852
510.
7La
rge
80.
933
.91
1746
2620
5.8
43.
3 5
4.7
40.
4 4
4.2
55.
8 4
1.2
30/0
4/20
075:
58:2
3B
AY
OR
FA
TI
CS
K1
022
33F
emal
e17
0cm
98kg
Som
e ex
erci
se48
451
486.
7La
rge
80.
933
.91
1746
2620
6.0
41.
8 5
6.2
41.
7 4
2.6
57.
4 4
2.5
30/0
4/20
076:
06:2
2Y
OV
OG
AN
AM
IVI
CS
K1
023
46F
emal
e17
0cm
84kg
Som
e ex
erci
se57
245
573.
8S
mal
l 8
0.9
29.0
715
5123
26 4
.5 3
5.1
48.
9 3
6.0
41.
8 5
8.2
42.
8
07/0
5/20
076:
07:0
0Y
OV
OG
AN
AM
IVI
CS
K1
023
46F
emal
e17
0cm
85kg
Som
e ex
erci
se60
347
604.
8S
mal
l 8
0.9
29.4
115
6023
41 4
.5 3
7.2
47.
8 3
4.9
43.
8 5
6.2
41.
1
14/0
5/20
076:
07:0
0Y
OV
OG
AN
AM
IVI
CS
K1
023
46F
emal
e17
0cm
85kg
Som
e ex
erci
se59
945
600.
7S
mal
l 8
0.9
29.4
115
6023
41 4
.3 3
7.1
47.
9 3
5.1
43.
6 5
6.4
41.
3
30/0
4/20
076:
07:0
0LA
WS
ON
KO
KO
VI
CS
K1
024
41F
emal
e15
0cm
63kg
Som
e ex
erci
se56
264
565.
6S
mal
l 8
0.9
28.0
013
3720
05 6
.5 2
5.1
37.
9 2
8.9
39.
8 6
0.2
45.
8
07/0
5/20
076:
07:0
0LA
WS
ON
KO
KO
VI
CS
K1
024
41F
emal
e15
0cm
63kg
Som
e ex
erci
se57
664
579.
5S
mal
l 8
0.9
28.0
013
3720
05 6
.3 2
5.5
37.
5 2
8.4
40.
5 5
9.5
45.
1
14/0
5/20
076:
07:0
0LA
WS
ON
KO
KO
VI
CS
K1
024
41F
emal
e15
0cm
63kg
Som
e ex
erci
se57
666
579.
8S
mal
l 8
0.9
28.0
013
3720
05 6
.5 2
5.5
37.
5 2
8.4
40.
5 5
9.5
45.
1
30/0
4/20
076:
21:2
1D
OV
ID
OP
EC
SK
1 02
530
Fem
ale
165
cm56
kgS
ome
exer
cise
604
7460
8.5
Sm
all
56.
620
.57
1348
2023
7.0
15.
1 4
0.9
30.
4 2
6.9
73.
1 5
4.2
07/0
5/20
076:
21:2
1D
OV
ID
OP
EC
SK
1 02
530
Fem
ale
165
cm57
kgS
ome
exer
cise
614
7961
9.1
Sm
all
56.
620
.94
1358
2037
7.3
16.
3 4
0.7
30.
1 2
8.5
71.
5 5
2.9
14/0
5/20
076:
21:2
1D
OV
ID
OP
EC
SK
1 02
530
Fem
ale
165
cm57
kgS
ome
exer
cise
612
7261
6.2
Sm
all
56.
620
.94
1358
2037
6.7
16.
2 4
0.8
30.
2 2
8.4
71.
6 5
3.0
30/0
4/20
076:
30:0
2A
PE
DE
ME
GN
MA
SS
AN
CS
K1
026
33F
emal
e16
6cm
90kg
Som
e ex
erci
se52
160
524.
4La
rge
56.
632
.66
1662
2494
6.6
39.
3 5
0.7
37.
7 4
3.6
56.
4 4
1.9
14/0
5/20
076:
40:3
4A
PE
DE
ME
GN
MA
SS
AN
CS
K1
026
33F
emal
e16
6cm
91kg
Som
e ex
erci
se54
266
546.
0La
rge
56.
633
.02
1672
2508
6.9
41.
2 4
9.8
36.
9 4
5.3
54.
7 4
0.6
30/0
4/20
076:
47:1
6G
NA
GA
NA
MA
CS
K1
027
38F
emal
e16
0cm
58kg
Som
e ex
erci
se55
041
551.
5S
mal
l 5
6.6
22.6
613
2119
81 4
.3 1
6.6
41.
4 3
1.2
28.
6 7
1.4
53.
9
07/0
5/20
076:
48:0
5G
NA
GA
NA
MA
CS
K1
027
38F
emal
e16
0cm
59kg
Som
e ex
erci
se50
240
503.
6S
mal
l 5
6.6
23.0
513
3019
96 4
.6 1
5.1
43.
9 3
3.4
25.
6 7
4.4
56.
5
14/0
5/20
076:
48:0
5G
NA
GA
NA
MA
CS
K1
027
38F
emal
e16
0cm
58kg
Som
e ex
erci
se57
645
577.
8S
mal
l 5
6.6
22.6
613
2119
81 4
.5 1
7.6
40.
4 3
0.3
30.
4 6
9.6
52.
2
30/0
4/20
076:
56:0
0T
ET
EG
AN
DE
DE
CS
K1
028
38F
emal
e16
3cm
79kg
Som
e ex
erci
se59
961
602.
1M
ediu
m 5
6.6
29.7
315
2822
92 5
.8 3
4.8
44.
2 3
2.6
44.
1 5
5.9
41.
3
07/0
5/20
076:
56:2
8T
ET
EG
AN
DE
DE
CS
K1
028
38F
emal
e16
3cm
78kg
Som
e ex
erci
se54
871
552.
6M
ediu
m 5
6.6
29.3
615
1822
78 7
.4 3
1.9
46.
1 3
4.4
40.
9 5
9.1
44.
1
14/0
5/20
076:
56:2
8T
ET
EG
AN
DE
DE
CS
K1
028
38F
emal
e16
3cm
79kg
Som
e ex
erci
se53
267
536.
2M
ediu
m 5
6.6
29.7
315
2822
92 7
.2 3
2.0
47.
0 3
5.1
40.
5 5
9.5
44.
5
30/0
4/20
077:
00:3
8N
OM
ED
JIM
AR
CE
LIN
EC
SK
1 02
936
Fem
ale
160
cm62
kgS
ome
exer
cise
598
6160
1.1
Sm
all
56.
624
.22
1369
2053
5.8
21.
7 4
0.3
30.
0 3
5.1
64.
9 4
8.4
07/0
5/20
077:
00:3
8N
OM
ED
JIM
AR
CE
LIN
EC
SK
1 02
936
Fem
ale
160
cm62
kgS
ome
exer
cise
595
6059
8.0
Sm
all
56.
624
.22
1369
2053
5.8
21.
6 4
0.4
30.
1 3
4.9
65.
1 4
8.6
14/0
5/20
077:
00:3
8N
OM
ED
JIM
AR
CE
LIN
EC
SK
1 02
936
Fem
ale
160
cm62
kgS
ome
exer
cise
631
6663
4.4
Sm
all
56.
624
.22
1369
2053
6.0
22.
8 3
9.2
29.
0 3
6.7
63.
3 4
6.8
30/0
4/20
077:
00:3
8A
GB
AG
NO
NA
KO
UC
SK
1 03
031
Fem
ale
166
cm67
kgS
ome
exer
cise
547
5855
0.1
Med
ium
56.
624
.31
1451
2177
6.1
21.
5 4
5.5
34.
0 3
2.0
68.
0 5
0.7
07/0
5/20
077:
00:3
8A
GB
AG
NO
NA
KO
UC
SK
1 03
031
Fem
ale
166
cm66
kgS
ome
exer
cise
561
6256
4.4
Med
ium
56.
623
.95
1441
2162
6.3
21.
3 4
4.7
33.
3 3
2.2
67.
8 5
0.5
14/0
5/20
077:
18:0
3A
GB
AG
NO
NA
KO
UC
SK
1 03
031
Fem
ale
166
cm66
kgS
ome
exer
cise
538
6054
1.3
Med
ium
56.
623
.95
1441
2162
6.4
20.
2 4
5.8
34.
3 3
0.6
69.
4 5
1.9
30/0
4/20
077:
18:0
3M
OU
SS
AE
NY
ON
AM
CS
K1
031
28F
emal
e15
7cm
59kg
Mod
erat
e ex
erc
586
6358
9.4
Med
ium
56.
623
.94
1372
2196
6.1
20.
0 3
9.0
29.
3 3
3.8
66.
2 4
9.7
07/0
5/20
077:
18:0
3M
OU
SS
AE
NY
ON
AM
CS
K1
031
28F
emal
e15
7cm
59kg
Som
e ex
erci
se61
369
616.
9M
ediu
m 5
6.6
23.9
413
7220
58 6
.4 2
0.8
38.
2 2
8.5
35.
3 6
4.7
48.
3
14/0
5/20
077:
18:0
3M
OU
SS
AE
NY
ON
AM
CS
K1
031
28F
emal
e15
7cm
59kg
Som
e ex
erci
se64
575
649.
3M
ediu
m 5
6.6
23.9
413
7220
58 6
.6 2
1.7
37.
3 2
7.6
36.
8 6
3.2
46.
8
30/0
4/20
077:
35:4
6S
IMP
IA
TA
WA
CS
K1
032
42F
emal
e17
4cm
90kg
Som
e ex
erci
se62
560
627.
9S
mal
l 5
6.6
29.7
316
3424
52 5
.5 4
0.7
49.
3 3
5.7
45.
2 5
4.8
39.
7
07/0
5/20
077:
42:1
6S
IMP
IA
TA
WA
CS
K1
032
42F
emal
e17
4cm
90kg
Som
e ex
erci
se62
060
622.
9S
mal
l 5
6.6
29.7
316
3424
52 5
.5 4
0.5
49.
5 3
5.9
45.
0 5
5.0
39.
9
14/0
5/20
077:
42:1
6S
IMP
IA
TA
WA
CS
K1
032
42F
emal
e17
4cm
89kg
Som
e ex
erci
se62
459
626.
8S
mal
l 5
6.6
29.4
016
2524
37 5
.4 3
9.8
49.
2 3
5.6
44.
7 5
5.3
40.
0
30/0
4/20
077:
42:1
6B
ALO
KO
MLA
NC
SK
1 03
339
Mal
e17
0cm
80kg
Som
e ex
erci
se49
655
499.
0La
rge
56.
627
.68
1755
2808
6.3
24.
3 5
5.7
41.
4 3
0.4
69.
6 5
1.8
07/0
5/20
077:
42:1
6B
ALO
KO
MLA
NC
SK
1 03
339
Mal
e17
0cm
80kg
Som
e ex
erci
se54
264
545.
8La
rge
56.
627
.68
1755
2808
6.7
26.
8 5
3.2
39.
2 3
3.5
66.
5 4
9.0
14/0
5/20
077:
42:1
6B
ALO
KO
MLA
NC
SK
1 03
339
Mal
e17
0cm
81kg
Som
e ex
erci
se51
058
513.
3La
rge
56.
628
.03
1769
2830
6.5
25.
9 5
5.1
40.
9 3
1.9
68.
1 5
0.5
30/0
4/20
077:
42:1
6H
IAB
OU
AD
EA
RM
AN
DE
CS
K1
034
25M
ale
150
cm43
kgS
ome
exer
cise
687
7469
1.0
Sm
all
56.
619
.11
1239
1983
6.1
10.
8 3
2.2
23.
5 2
5.0
75.
0 5
4.6
07/0
5/20
077:
42:1
6H
IAB
OU
AD
EA
RM
AN
DE
CS
K1
034
25F
emal
e15
0cm
44kg
Som
e ex
erci
se67
670
679.
6S
mal
l 5
6.6
19.5
612
3018
45 5
.9 1
2.2
31.
8 2
3.7
27
.6 7
2.4
53.
9
14/0
5/20
077:
42:1
6H
IAB
OU
AD
EA
RM
AN
DE
CS
K1
034
25F
emal
e15
0cm
44kg
Som
e ex
erci
se72
580
729.
4S
mal
l 5
6.6
19.5
612
3018
45 6
.3 1
2.9
31.
1 2
2.7
29
.4 7
0.6
51.
6
2B
IA T
ES
T K
OD
JOV
IAK
OP
E F
INA
L F
inal
F 2
.xls
BIA
TE
ST
KO
DJA
VIA
KO
PE
FIN
AL
Tes
t D
ate
Tes
t T
ime
Las
t N
ame
Fir
st N
ame
Su
bje
ct ID
Ag
eG
end
erH
eig
ht
Wei
gh
tA
ctiv
ity
Lev
elR
esis
tan
ceR
eact
ance
Imp
edan
ceF
ram
e S
ize
Tar
get
W
eig
ht
BM
IB
MR
DE
EP
has
e A
ng
leF
at w
tF
FM
wt
TB
W
liter
sF
at %
o
f w
tF
FM
%
of
wt
TB
W %
o
f w
t
30/0
4/20
078:
05:3
7A
SS
EM
EM
ILIE
NN
EC
SK
1 03
538
Fem
ale
150
cm45
kgS
ome
exer
cise
646
6364
9.1
Sm
all
43.
220
.00
1178
1767
5.6
12.
4 3
2.6
24.
5 2
7.5
72.
5 5
4.5
07/0
5/20
078:
05:3
7A
SS
EM
EM
ILIE
NN
EC
SK
1 03
538
Fem
ale
150
cm45
kgS
ome
exer
cise
681
7168
4.7
Sm
all
43.
220
.00
1178
1767
6.0
13.
1 3
1.9
23.
7 2
9.1
70.
9 5
2.7
14/0
5/20
078:
05:3
7A
SS
EM
EM
ILIE
NN
EC
SK
1 03
538
Fem
ale
150
cm45
kgS
ome
exer
cise
708
7271
1.7
Sm
all
43.
220
.00
1178
1767
5.8
13.
5 3
1.5
23.
1 3
0.0
70.
0 5
1.4
30/0
4/20
078:
05:3
7A
DA
MA
DO
UK
OM
IC
SK
1 03
628
Mal
e19
0cm
83kg
Som
e ex
erci
se45
245
454.
2S
mal
l 4
3.2
22.9
919
7131
54 5
.7 1
3.1
69.
9 5
1.7
15.
8 8
4.2
62.
3
07/0
5/20
078:
11:2
4A
DA
MA
DO
UK
OM
IC
SK
1 03
628
Mal
e19
0cm
83kg
Som
e ex
erci
se44
446
446.
4S
mal
l 4
3.2
22.9
919
7131
54 5
.9 1
2.3
70.
7 5
2.3
14.
8 8
5.2
63.
0
14/0
5/20
078:
11:2
4A
DA
MA
DO
UK
OM
IC
SK
1 03
628
Mal
e19
0cm
82kg
Mod
erat
e ex
erc
472
4447
4.0
Med
ium
43.
222
.71
1957
3328
5.3
14.
2 6
7.8
50.
0 1
7.4
82.
6 6
0.9
30/0
4/20
078:
14:3
9Z
AN
KP
EA
MA
HC
SK
1 03
718
Fem
ale
150
cm50
kgS
ome
exer
cise
654
7265
8.0
Sm
all
43.
222
.22
1320
1980
6.3
16.
7 3
3.3
24.
9 3
3.4
66.
6 4
9.8
07/0
5/20
078:
17:0
7Z
AN
KP
EA
MA
HC
SK
1 03
718
Fem
ale
150
cm50
kgS
ome
exer
cise
652
7065
5.7
Sm
all
43.
222
.22
1320
1980
6.1
16.
7 3
3.3
24.
9 3
3.4
66.
6 4
9.9
14/0
5/20
078:
17:0
7Z
AN
KP
EA
MA
HC
SK
1 03
718
Fem
ale
150
cm50
kgS
ome
exer
cise
660
7066
3.7
Sm
all
43.
222
.22
1320
1980
6.1
16.
8 3
3.2
24.
7 3
3.7
66.
3 4
9.5
30/0
4/20
078:
17:0
7T
OS
SO
UK
PE
CH
RIS
TIN
EC
SK
1 03
835
Fem
ale
148
cm38
kgS
ome
exer
cise
646
6664
9.4
Sm
all
43.
217
.35
1121
1682
5.8
7.2
30.
8 2
3.3
19.
0 8
1.0
61.
3
07/0
5/20
078:
17:0
7T
OS
SO
UK
PE
CH
RIS
TIN
EC
SK
1 03
835
Fem
ale
148
cm38
kgS
ome
exer
cise
652
6965
5.6
Sm
all
43.
217
.35
1121
1682
6.0
7.3
30.
7 2
3.2
19.
3 8
0.7
60.
9
14/0
5/20
078:
17:0
7T
OS
SO
UK
PE
CH
RIS
TIN
EC
SK
1 03
835
Fem
ale
148
cm38
kgS
ome
exer
cise
677
7768
1.4
Sm
all
43.
217
.35
1121
1682
6.5
7.8
30.
2 2
2.6
20.
5 7
9.5
59.
5
30/0
4/20
078:
26:1
8A
GB
EG
NIN
OK
OK
OU
CS
K1
039
44M
ale
175
cm73
kgS
ome
exer
cise
489
5449
2.0
Sm
all
43.
223
.84
1649
2639
6.3
16.
4 5
6.6
42.
2 2
2.4
77.
6 5
7.8
07/0
5/20
078:
26:1
8A
GB
EG
NIN
OK
OK
OU
CS
K1
039
44M
ale
175
cm73
kgS
ome
exer
cise
496
5549
9.0
Sm
all
43.
223
.84
1649
2639
6.3
16.
9 5
6.1
41.
8 2
3.1
76.
9 5
7.2
14/0
5/20
078:
26:1
8A
GB
EG
NIN
OK
OK
OU
CS
K1
039
44M
ale
175
cm74
kgS
ome
exer
cise
516
6051
9.5
Sm
all
43.
224
.16
1663
2661
6.6
18.
9 5
5.1
40.
9 2
5.5
74.
5 5
5.2
30/0
4/20
079:
50:4
0G
UE
VO
NT
HE
RE
SE
CS
K1
017
33F
emal
e15
0cm
92kg
Som
e ex
erci
se49
858
501.
4La
rge
47.
540
.89
1653
2479
6.6
46.
7 4
5.3
34.
5 5
0.7
49.
3 3
7.5
07/0
5/20
079:
50:4
0G
UE
VO
NT
HE
RE
SE
CS
K1
017
33F
emal
e15
0cm
93kg
No
exer
cise
507
5951
0.4
Larg
e 4
7.5
41.3
316
6221
61 6
.6 4
7.9
45.
1 3
4.2
51.
5 4
8.5
36.
8
14/0
5/20
079:
50:4
0G
UE
VO
NT
HE
RE
SE
CS
K1
017
33F
emal
e15
0cm
93kg
Som
e ex
erci
se50
957
512.
2La
rge
47.
541
.33
1662
2494
6.4
48.
0 4
5.0
34.
1 5
1.6
48.
4 3
6.7
30/0
4/20
0711
:51:
22D
e S
OU
ZA
AF
IAV
IC
SK
1 00
433
Fem
ale
180
cm66
kgS
ome
exer
cise
705
7470
8.9
Sm
all
34.
320
.37
1457
2186
6.0
21.
2 4
4.8
31.
9 3
2.1
67.
9 4
8.3
30/0
4/20
0710
:00:
32K
AN
GN
IE
DO
HC
SK
1 00
928
Fem
ale
162
cm63
kgN
o ex
erci
se59
668
599.
9M
ediu
m 5
3.9
24.0
114
1918
45 6
.5 2
1.8
41.
2 3
0.7
34.
5 6
5.5
48.
7
07/0
5/20
0710
:00:
32K
AN
GN
IE
DO
HC
SK
1 00
928
Fem
ale
162
cm63
kgS
ome
exer
cise
570
6057
3.1
Med
ium
53.
924
.01
1419
2129
6.0
20.
8 4
2.2
31.
6 3
3.0
67.
0 5
0.1
14/0
5/20
0710
:00:
32K
AN
GN
IE
DO
HC
SK
1 00
928
Fem
ale
162
cm63
kgS
ome
exer
cise
565
6256
8.4
Med
ium
53.
924
.01
1419
2129
6.3
20.
6 4
2.4
31.
8 3
2.7
67.
3 5
0.4
21/0
5/20
0711
:25:
49S
OH
OIN
AB
LAV
IC
SK
1 00
145
Fem
ale
140
cm47
kgS
ome
exer
cise
638
8264
3.2
Sm
all
34.
323
.98
1146
1720
7.3
17.
0 3
0.0
22.
9 3
6.3
63.
7 4
8.7
29/0
5/20
0711
:25:
49S
OH
OIN
AB
LAV
IC
SK
1 00
145
Fem
ale
140
cm48
kgS
ome
exer
cise
577
7158
1.4
Sm
all
34.
324
.49
1156
1734
7.0
16.
6 3
1.4
24.
5 3
4.6
65.
4 5
1.0
04/0
6/20
0711
:25:
49S
OH
OIN
AB
LAV
IC
SK
1 00
145
Fem
ale
140
cm48
kgS
ome
exer
cise
572
6757
5.9
Sm
all
34.
324
.49
1156
1734
6.7
16.
5 3
1.5
24.
6 3
4.3
65.
7 5
1.2
11/0
6/20
0711
:25:
49S
OH
OIN
AB
LAV
IC
SK
1 00
145
Fem
ale
140
cm49
kgS
ome
exer
cise
547
6655
1.0
Sm
all
34.
325
.00
1166
1749
6.9
16.
6 3
2.4
25.
4 3
3.9
66.
1 5
1.9
25/0
6/20
0711
:25:
49S
OH
OIN
AB
LAV
IC
SK
1 00
145
Fem
ale
140
cm49
kgS
ome
exer
cise
563
6356
6.5
Sm
all
34.
325
.00
1166
1749
6.4
17.
1 3
1.9
25.
0 3
4.8
65.
2 5
0.9
02/0
7/20
0711
:25:
49S
OH
OIN
AB
LAV
IC
SK
1 00
145
Fem
ale
140
cm49
kgS
ome
exer
cise
635
8464
0.5
Sm
all
34.
325
.00
1166
1749
7.5
18.
7 3
0.3
23.
2 3
8.1
61.
9 4
7.3
09/0
7/20
0711
:25:
49S
OH
OIN
AB
LAV
IC
SK
1 00
145
Fem
ale
140
cm49
kgS
ome
exer
cise
622
7362
6.3
Sm
all
34.
325
.00
1166
1749
6.7
18.
4 3
0.6
23.
5 3
7.6
62.
4 4
7.9
13/0
7/20
0711
:25:
49S
OH
OIN
AB
LAV
IC
SK
1 00
145
Fem
ale
140
cm49
kgS
ome
exer
cise
636
8364
1.4
Sm
all
34.
325
.00
1166
1749
7.4
18.
7 3
0.3
23.
2 3
8.1
61.
9 4
7.2
21/0
5/20
0711
:25:
49A
DJE
AK
OU
AC
SK
1 00
229
Fem
ale
160
cm81
kgS
ome
exer
cise
662
7066
5.7
Med
ium
34.
331
.64
1584
2376
6.0
39.
4 4
1.6
30.
3 4
8.7
51
.3 3
7.4
29/0
5/20
0711
:25:
49A
DJE
AK
OU
AC
SK
1 00
229
Fem
ale
160
cm78
kgS
ome
exer
cise
699
8770
4.4
Med
ium
34.
330
.47
1555
2333
7.1
37.
8 4
0.2
29.
0 4
8.4
51
.6 3
7.2
04/0
6/20
0711
:25:
49A
DJE
AK
OU
AC
SK
1 00
229
Fem
ale
160
cm79
kgS
ome
exer
cise
665
7266
8.9
Med
ium
34.
330
.86
1565
2347
6.2
37.
8 4
1.2
30.
0 4
7.9
52
.1 3
8.0
11/0
6/20
0711
:25:
49A
DJE
AK
OU
AC
SK
1 00
229
Fem
ale
160
cm80
kgS
ome
exer
cise
636
6863
9.6
Med
ium
34.
331
.25
1574
2362
6.1
37.
9 4
2.1
30.
9 4
7.4
52
.6 3
8.6
25/0
6/20
0711
:25:
49A
DJE
AK
OU
AC
SK
1 00
229
Fem
ale
160
cm80
kgS
ome
exer
cise
643
7164
6.9
Med
ium
34.
331
.25
1574
2362
6.3
38.
1 4
1.9
30.
7 4
7.6
52
.4 3
8.4
02/0
7/20
0711
:25:
49A
DJE
AK
OU
AC
SK
1 00
229
Fem
ale
160
cm80
kgS
ome
exer
cise
659
7666
3.4
Med
ium
34.
331
.25
1574
2362
6.6
38.
5 4
1.5
30.
3 4
8.1
51
.9 3
7.8
09/0
7/20
0711
:25:
49A
DJE
AK
OU
AC
SK
1 00
229
Fem
ale
160
cm80
kgS
ome
exer
cise
620
6662
3.5
Med
ium
34.
331
.25
1574
2362
6.1
37.
4 4
2.6
31.
4 4
6.8
53
.2 3
9.2
13/0
7/20
0711
:25:
49A
DJE
AK
OU
AC
SK
1 00
229
Fem
ale
160
cm80
kgS
ome
exer
cise
620
6662
3.5
Med
ium
34.
331
.25
1574
2362
6.1
37.
4 4
2.6
31.
4 4
6.8
53
.2 3
9.2
21/0
5/20
0711
:44:
47T
OS
SO
UK
PE
KO
KO
UC
SK
1 00
333
Fem
ale
180
cm10
4kg
Som
e ex
erci
se52
161
524.
6La
rge
34.
332
.10
1822
2733
6.7
44.
4 5
9.6
43.
5 4
2.7
57.
3 4
1.8
29/0
5/20
0711
:44:
47T
OS
SO
UK
PE
KO
KO
UC
SK
1 00
333
Fem
ale
180
cm10
5kg
Som
e ex
erci
se52
865
532.
0La
rge
34.
332
.41
1832
2748
7.0
45.
7 5
9.3
43.
2 4
3.6
56.
4 4
1.2
04/0
6/20
0711
:44:
47T
OS
SO
UK
PE
KO
KO
UC
SK
1 00
333
Mal
e18
0cm
106
kgS
ome
exer
cise
488
6349
2.0
Larg
e 3
4.3
32.7
222
0435
27 7
.4 3
8.3
67.
7 4
9.7
36.
1 6
3.9
46.
9
11/0
6/20
0711
:44:
47T
OS
SO
UK
PE
KO
KO
UC
SK
1 00
333
Mal
e18
0cm
106
kgS
ome
exer
cise
465
5946
8.7
Larg
e 3
4.3
32.7
222
0435
27 7
.2 3
6.5
69.
5 5
1.1
34.
4 6
5.6
48.
2
25/0
6/20
0711
:44:
47T
OS
SO
UK
PE
KO
KO
UC
SK
1 00
333
Mal
e18
0cm
105
kgS
ome
exer
cise
483
6348
7.1
Larg
e 3
4.3
32.4
121
9135
05 7
.4 3
7.2
67.
8 4
9.8
35.
4 6
4.6
47.
4
02/0
7/20
0711
:44:
47T
OS
SO
UK
PE
KO
KO
UC
SK
1 00
333
Mal
e18
0cm
104
kgS
ome
exer
cise
467
6247
1.1
Larg
e 3
4.3
32.1
021
7734
83 7
.6 3
5.2
68.
8 5
0.7
33.
8 6
6.2
48.
7
09/0
7/20
0711
:44:
47T
OS
SO
UK
PE
KO
KO
UC
SK
1 00
333
Mal
e18
0cm
105
kgS
ome
exer
cise
514
6951
8.6
Larg
e 3
4.3
32.4
121
9135
05 7
.6 3
9.4
65.
6 4
8.0
37.
5 6
2.5
45.
7
13/0
7/20
0711
:44:
47T
OS
SO
UK
PE
KO
KO
UC
SK
1 00
333
Mal
e18
0cm
104
kgS
ome
exer
cise
510
6951
4.6
Larg
e 3
4.3
32.1
021
7734
83 7
.7 3
8.4
65.
6 4
8.0
36.
9 6
3.1
46.
2
21/0
5/20
0711
:51:
22D
e S
OU
ZA
AF
IAV
IC
SK
1 00
433
Fem
ale
180
cm67
kgS
ome
exer
cise
748
7975
2.2
Sm
all
34.
320
.68
1467
2200
6.0
23.
2 4
3.8
30.
8 3
4.6
65.
4 4
6.0
3B
IA T
ES
T K
OD
JOV
IAK
OP
E F
INA
L F
inal
F 2
.xls
BIA
TE
ST
KO
DJA
VIA
KO
PE
FIN
AL
Tes
t D
ate
Tes
t T
ime
Las
t N
ame
Fir
st N
ame
Su
bje
ct ID
Ag
eG
end
erH
eig
ht
Wei
gh
tA
ctiv
ity
Lev
elR
esis
tan
ceR
eact
ance
Imp
edan
ceF
ram
e S
ize
Tar
get
W
eig
ht
BM
IB
MR
DE
EP
has
e A
ng
leF
at w
tF
FM
wt
TB
W
liter
sF
at %
o
f w
tF
FM
%
of
wt
TB
W %
o
f w
t
29/0
5/20
0711
:51:
22D
e S
OU
ZA
AF
IAV
IC
SK
1 00
433
Fem
ale
180
cm67
kgS
ome
exer
cise
701
8270
5.8
Sm
all
34.
320
.68
1467
2200
6.7
21.
9 4
5.1
32.
1 3
2.7
67.
3 4
7.9
04/0
6/20
0711
:51:
22D
e S
OU
ZA
AF
IAV
IC
SK
1 00
433
Fem
ale
180
cm67
kgS
ome
exer
cise
695
7869
9.4
Sm
all
34.
320
.68
1467
2200
6.4
21.
7 4
5.3
32.
3 3
2.4
67.
6 4
8.2
11/0
6/20
0711
:51:
22D
e S
OU
ZA
AF
IAV
IC
SK
1 00
433
Fem
ale
180
cm68
kgS
ome
exer
cise
699
7770
3.2
Sm
all
34.
320
.99
1476
2215
6.3
22.
7 4
5.3
32.
3 3
3.3
66.
7 4
7.5
25/0
6/20
0711
:51:
22D
e S
OU
ZA
AF
IAV
IC
SK
1 00
433
Fem
ale
180
cm67
kgS
ome
exer
cise
714
8471
8.9
Sm
all
34.
320
.68
1467
2200
6.7
22.
3 4
4.7
31.
7 3
3.2
66.
8 4
7.4
02/0
7/20
0711
:51:
22D
e S
OU
ZA
AF
IAV
IC
SK
1 00
433
Fem
ale
180
cm67
kgS
ome
exer
cise
711
8371
5.8
Sm
all
34.
320
.68
1467
2200
6.7
22.
2 4
4.8
31.
8 3
3.1
66.
9 4
7.5
09/0
7/20
0711
:51:
22D
e S
OU
ZA
AF
IAV
IC
SK
1 00
433
Fem
ale
180
cm68
kgS
ome
exer
cise
741
8874
6.2
Sm
all
34.
320
.99
1476
2215
6.8
23.
8 4
4.2
31.
1 3
5.0
65.
0 4
5.7
13/0
7/20
0711
:51:
22D
e S
OU
ZA
AF
IAV
IC
SK
1 00
433
Fem
ale
180
cm67
kgS
ome
exer
cise
727
8373
1.7
Sm
all
34.
320
.68
1467
2200
6.5
22.
6 4
4.4
31.
4 3
3.8
66.
2 4
6.8
21/0
5/20
0711
:58:
55A
MO
UZ
OU
ER
NE
ST
INE
CS
K1
005
52F
emal
e15
1cm
85kg
Som
e ex
erci
se50
846
510.
1La
rge
34.
337
.28
1498
2247
5.2
40.
9 4
4.1
33.
5 4
8.1
51.
9 3
9.5
04/0
6/20
0711
:58:
55A
MO
UZ
OU
ER
NE
ST
INE
CS
K1
005
52F
emal
e15
1cm
86kg
Som
e ex
erci
se51
049
512.
3La
rge
34.
337
.72
1508
2262
5.5
41.
8 4
4.2
33.
6 4
8.6
51.
4 3
9.1
11/0
6/20
0711
:58:
55A
MO
UZ
OU
ER
NE
ST
INE
CS
K1
005
52F
emal
e15
1cm
86kg
Som
e ex
erci
se48
148
483.
4La
rge
34.
337
.72
1508
2262
5.7
40.
4 4
5.6
34.
8 4
7.0
53.
0 4
0.5
25/0
6/20
0711
:58:
55A
MO
UZ
OU
ER
NE
ST
INE
CS
K1
005
52F
emal
e15
1cm
86kg
Som
e ex
erci
se48
148
483.
4La
rge
34.
337
.72
1508
2262
5.7
40.
4 4
5.6
34.
8 4
7.0
53.
0 4
0.5
02/0
7/20
0711
:58:
55A
MO
UZ
OU
ER
NE
ST
INE
CS
K1
005
52F
emal
e15
1cm
86kg
Som
e ex
erci
se52
254
524.
8La
rge
34.
337
.72
1508
2262
5.9
42.
3 4
3.7
33.
1 4
9.2
50.
8 3
8.5
09/0
7/20
0711
:58:
55A
MO
UZ
OU
ER
NE
ST
INE
CS
K1
005
52F
emal
e15
1cm
85kg
Som
e ex
erci
se54
054
542.
7La
rge
34.
337
.28
1498
2247
5.7
42.
2 4
2.8
32.
4 4
9.7
50.
3 3
8.1
13/0
7/20
0711
:58:
55A
MO
UZ
OU
ER
NE
ST
INE
CS
K1
005
52F
emal
e15
1cm
86kg
Som
e ex
erci
se49
450
496.
5La
rge
34.
337
.72
1508
2262
5.8
41.
1 4
4.9
34.
2 4
7.7
52.
3 3
9.8
21/0
5/20
0711
:58:
55G
NA
DIO
PA
SC
ALI
NE
CS
K1
006
33F
emal
e16
0cm
51kg
Som
e ex
erci
se73
776
740.
9M
ediu
m 3
4.3
19.9
212
7719
16 5
.9 1
6.0
35.
0 2
5.1
31.
4 6
8.6
49.
3
29/0
5/20
0711
:58:
55G
NA
DIO
PA
SC
ALI
NE
CS
K1
006
52F
emal
e16
0cm
53kg
Som
e ex
erci
se67
672
679.
8M
ediu
m 3
4.3
20.7
012
0718
11 6
.1 1
6.5
36.
5 2
6.8
31.
0 6
9.0
50.
5
21/0
5/20
0711
:58:
55A
KP
AK
LIK
OS
SIW
AC
SK
1 00
738
Fem
ale
158
cm63
kgS
ome
exer
cise
615
6361
8.2
Sm
all
34.
325
.24
1365
2048
5.8
23.
9 3
9.1
29.
1 3
7.9
62.
1 4
6.2
29/0
5/20
0711
:58:
55A
KP
AK
LIK
OS
SIW
AC
SK
1 00
738
Fem
ale
158
cm64
kgS
ome
exer
cise
560
6256
3.4
Sm
all
34.
325
.64
1375
2062
6.3
22.
8 4
1.2
31.
0 3
5.6
64.
4 4
8.5
04/0
6/20
0711
:58:
55A
KP
AK
LIK
OS
SIW
AC
SK
1 00
738
Fem
ale
158
cm64
kgS
ome
exer
cise
578
6458
1.5
Sm
all
34.
325
.64
1375
2062
6.3
23.
5 4
0.5
30.
4 3
6.7
63.
3 4
7.5
11/0
6/20
0711
:58:
55A
KP
AK
LIK
OS
SIW
AC
SK
1 00
738
Fem
ale
158
cm64
kgS
ome
exer
cise
583
6758
6.8
Sm
all
34.
325
.64
1375
2062
6.6
23.
6 4
0.4
30.
2 3
6.9
63.
1 4
7.3
25/0
6/20
0711
:58:
55A
KP
AK
LIK
OS
SIW
AC
SK
1 00
738
Fem
ale
158
cm63
kgS
ome
exer
cise
556
6155
9.3
Sm
all
34.
325
.24
1365
2048
6.3
21.
8 4
1.2
31.
1 3
4.6
65.
4 4
9.3
02/0
7/20
0711
:58:
55A
KP
AK
LIK
OS
SIW
AC
SK
1 00
738
Fem
ale
158
cm63
kgS
ome
exer
cise
575
6757
8.9
Sm
all
34.
325
.24
1365
2048
6.6
22.
5 4
0.5
30.
4 3
5.8
64.
2 4
8.3
09/0
7/20
0711
:58:
55A
KP
AK
LIK
OS
SIW
AC
SK
1 00
738
Fem
ale
158
cm64
kgS
ome
exer
cise
597
6860
0.9
Sm
all
34.
325
.64
1375
2062
6.5
24.
1 3
9.9
29.
8 3
7.7
62.
3 4
6.6
13/0
7/20
0711
:58:
55A
KP
AK
LIK
OS
SIW
AC
SK
1 00
738
Fem
ale
158
cm64
kgS
ome
exer
cise
619
7362
3.3
Sm
all
34.
325
.64
1375
2062
6.7
24.
8 3
9.2
29.
1 3
8.8
61.
2 4
5.5
29/0
5/20
0713
:11:
42A
GB
AN
AA
MA
VI
CS
K1
008
35F
emal
e16
0cm
60kg
Som
e ex
erci
se61
361
616.
0S
mal
l 3
4.3
23.4
413
5420
31 5
.7 2
0.6
39.
4 2
9.3
34.
3 6
5.7
48.
9
21/0
5/20
0713
:11:
42A
GB
AN
AA
MA
VI
CS
K1
008
35F
emal
e16
0cm
58kg
Som
e ex
erci
se62
958
631.
7S
mal
l 3
4.3
22.6
613
3520
03 5
.3 1
9.4
38.
6 2
8.6
33.
4 6
6.6
49.
3
04/0
6/20
0713
:11:
42A
GB
AN
AA
MA
VI
CS
K1
008
35F
emal
e16
0cm
60kg
Som
e ex
erci
se61
458
616.
7S
mal
l 3
4.3
23.4
413
5420
31 5
.4 2
0.6
39.
4 2
9.3
34.
3 6
5.7
48.
8
11/0
6/20
0713
:11:
42A
GB
AN
AA
MA
VI
CS
K1
008
35F
emal
e16
0cm
59kg
Som
e ex
erci
se64
565
648.
3S
mal
l 3
4.3
23.0
513
4520
17 5
.8 2
0.7
38.
3 2
8.3
35.
0 6
5.0
47.
9
18/0
6/20
0713
:11:
42A
GB
AN
AA
MA
VI
CS
K1
008
35F
emal
e16
0cm
58kg
Som
e ex
erci
se64
065
643.
3S
mal
l 3
4.3
22.6
613
3520
03 5
.8 1
9.7
38.
3 2
8.3
34.
0 6
6.0
48.
8
02/0
7/20
0713
:11:
42A
GB
AN
AA
MA
VI
CS
K1
008
35F
emal
e16
0cm
58kg
Som
e ex
erci
se64
765
650.
3S
mal
l 3
4.3
22.6
613
3520
03 5
.7 1
9.9
38.
1 2
8.1
34.
3 6
5.7
48.
5
09/0
7/20
0713
:11:
42A
GB
AN
AA
MA
VI
CS
K1
008
35F
emal
e16
0cm
58kg
Som
e ex
erci
se62
561
628.
0S
mal
l 3
4.3
22.6
613
3520
03 5
.6 1
9.3
38.
7 2
8.7
33.
2 6
6.8
49.
5
13/0
7/20
0713
:11:
42A
GB
AN
AA
MA
VI
CS
K1
008
35F
emal
e16
0cm
59kg
Som
e ex
erci
se63
365
636.
3S
mal
l 3
4.3
23.0
513
4520
17 5
.9 2
0.3
38.
7 2
8.6
34.
5 6
5.5
48.
5
21/0
5/20
0710
:00:
32K
AN
GN
IE
DO
HC
SK
1 00
928
Fem
ale
162
cm64
kgS
ome
exer
cise
577
6258
0.3
Med
ium
53.
924
.39
1429
2144
6.1
21.
9 4
2.1
31.
4 3
4.2
65.
8 4
9.1
29/0
5/20
0710
:00:
32K
AN
GN
IE
DO
HC
SK
1 00
928
Fem
ale
162
cm66
kgS
ome
exer
cise
535
6553
8.9
Med
ium
53.
925
.15
1448
2173
6.9
21.
7 4
4.3
33.
3 3
2.9
67.
1 5
0.4
04/0
6/20
0710
:00:
32K
AN
GN
IE
DO
HC
SK
1 00
928
Fem
ale
162
cm66
kgS
ome
exer
cise
519
5652
2.0
Med
ium
53.
925
.15
1448
2173
6.2
20.
9 4
5.1
34.
0 3
1.7
68.
3 5
1.5
25/0
6/20
0710
:00:
32K
AN
GN
IE
DO
HC
SK
1 00
928
Fem
ale
162
cm66
kgS
ome
exer
cise
519
6152
2.6
Med
ium
53.
925
.15
1448
2173
6.7
20.
9 4
5.1
34.
0 3
1.7
68.
3 5
1.5
02/0
7/20
0710
:00:
32K
AN
GN
IE
DO
HC
SK
1 00
928
Fem
ale
162
cm65
kgS
ome
exer
cise
547
6855
1.2
Med
ium
53.
924
.77
1439
2158
7.1
21.
5 4
3.5
32.
7 3
3.0
67.
0 5
0.3
09/0
7/20
0710
:00:
32K
AN
GN
IE
DO
HC
SK
1 00
928
Fem
ale
162
cm65
kgS
ome
exer
cise
547
6455
0.7
Med
ium
53.
924
.77
1439
2158
6.7
21.
5 4
3.5
32.
7 3
3.0
67.
0 5
0.3
13/0
7/20
0710
:00:
32K
AN
GN
IE
DO
HC
SK
1 00
928
Fem
ale
162
cm65
kgS
ome
exer
cise
548
6855
2.2
Med
ium
53.
924
.77
1439
2158
7.1
21.
5 4
3.5
32.
6 3
3.1
66.
9 5
0.2
21/0
5/20
073:
55:4
4E
VE
NY
OA
DJO
CS
K1
010
31F
emal
e16
0cm
69kg
Som
e ex
erci
se71
476
718.
0M
ediu
m 5
2.1
26.9
514
5921
89 6
.1 3
0.6
38.
4 2
7.7
44.
3 5
5.7
40.
1
29/0
5/20
073:
55:4
4E
VE
NY
OA
DJO
CS
K1
010
31F
emal
e16
0cm
69kg
Som
e ex
erci
se61
280
617.
2M
ediu
m 5
2.1
26.9
514
5921
89 7
.4 2
8.0
41.
0 3
0.4
40.
6 5
9.4
44.
0
04/0
6/20
073:
55:4
4E
VE
NY
OA
DJO
CS
K1
010
31F
emal
e16
0cm
70kg
Som
e ex
erci
se62
068
623.
7M
ediu
m 5
2.1
27.3
414
6922
04 6
.3 2
9.1
40.
9 3
0.2
41.
6 5
8.4
43.
2
11/0
6/20
073:
55:4
4E
VE
NY
OA
DJO
CS
K1
010
31F
emal
e16
0cm
71kg
Som
e ex
erci
se67
577
679.
4M
ediu
m 5
2.1
27.7
314
7922
18 6
.5 3
1.4
39.
6 2
8.8
44.
2 5
5.8
40.
6
25/0
6/20
073:
55:4
4E
VE
NY
OA
DJO
CS
K1
010
31F
emal
e16
0cm
71kg
Som
e ex
erci
se61
973
623.
3M
ediu
m 5
2.1
27.7
314
7922
18 6
.7 2
9.9
41.
1 3
0.4
42.
1 5
7.9
42.
8
02/0
7/20
073:
55:4
4E
VE
NY
OA
DJO
CS
K1
010
31F
emal
e16
0cm
71kg
Som
e ex
erci
se62
875
632.
5M
ediu
m 5
2.1
27.7
314
7922
18 6
.8 3
0.2
40.
8 3
0.1
42.
5 5
7.5
42.
4
09/0
7/20
073:
55:4
4E
VE
NY
OA
DJO
CS
K1
010
31F
emal
e16
0cm
71kg
Som
e ex
erci
se69
081
694.
7M
ediu
m 5
2.1
27.7
314
7922
18 6
.7 3
1.7
39.
3 2
8.5
44.
7 5
5.3
40.
1
13/0
7/20
073:
55:4
4E
VE
NY
OA
DJO
CS
K1
010
31F
emal
e16
0cm
72kg
Som
e ex
erci
se67
982
683.
9M
ediu
m 5
2.1
28.1
214
8822
32 6
.9 3
2.3
39.
7 2
8.8
44.
9 5
5.1
40.
1
4B
IA T
ES
T K
OD
JOV
IAK
OP
E F
INA
L F
inal
F 2
.xls
BIA
TE
ST
KO
DJA
VIA
KO
PE
FIN
AL
Tes
t D
ate
Tes
t T
ime
Las
t N
ame
Fir
st N
ame
Su
bje
ct ID
Ag
eG
end
erH
eig
ht
Wei
gh
tA
ctiv
ity
Lev
elR
esis
tan
ceR
eact
ance
Imp
edan
ceF
ram
e S
ize
Tar
get
W
eig
ht
BM
IB
MR
DE
EP
has
e A
ng
leF
at w
tF
FM
wt
TB
W
liter
sF
at %
o
f w
tF
FM
%
of
wt
TB
W %
o
f w
t
21/0
5/20
073:
55:4
4A
PE
ZO
UM
ON
AD
JOC
SK
1 01
130
Fem
ale
160
cm71
kgS
ome
exer
cise
578
6058
1.1
Larg
e 5
2.1
27.7
314
8322
25 5
.9 2
8.5
42.
5 3
1.7
40.
2 5
9.8
44.
6
29/0
5/20
073:
55:4
4A
PE
ZO
UM
ON
AD
JOC
SK
1 01
130
Fem
ale
160
cm72
kgS
ome
exer
cise
554
6255
7.5
Larg
e 5
2.1
28.1
214
9322
39 6
.4 2
8.4
43.
6 3
2.7
39.
5 6
0.5
45.
4
11/0
6/20
073:
55:4
4A
PE
ZO
UM
ON
AD
JOC
SK
1 01
130
Fem
ale
160
cm72
kgS
ome
exer
cise
547
6455
0.7
Larg
e 5
2.1
28.1
214
9322
39 6
.7 2
8.1
43.
9 3
2.9
39.
0 6
1.0
45.
8
25/0
6/20
073:
55:4
4A
PE
ZO
UM
ON
AD
JOC
SK
1 01
130
Fem
ale
160
cm72
kgS
ome
exer
cise
528
5953
1.3
Larg
e 5
2.1
28.1
214
9322
39 6
.4 2
7.2
44.
8 3
3.7
37.
8 6
2.2
46.
8
02/0
7/20
073:
55:4
4A
PE
ZO
UM
ON
AD
JOC
SK
1 01
130
Fem
ale
160
cm72
kgS
ome
exer
cise
514
5751
7.2
Larg
e 5
2.1
28.1
214
9322
39 6
.3 2
6.5
45.
5 3
4.3
36.
9 6
3.1
47.
6
09/0
7/20
073:
55:4
4A
PE
ZO
UM
ON
AD
JOC
SK
1 01
130
Fem
ale
160
cm72
kgS
ome
exer
cise
527
5653
0.0
Larg
e 5
2.1
28.1
214
9322
39 6
.1 2
7.2
44.
8 3
3.7
37.
8 6
2.2
46.
9
13/0
7/20
073:
55:4
4A
PE
ZO
UM
ON
AD
JOC
SK
1 01
130
Fem
ale
160
cm73
kgS
ome
exer
cise
552
6555
5.8
Larg
e 5
2.1
28.5
215
0222
54 6
.7 2
9.2
43.
8 3
2.9
39.
9 6
0.1
45.
0
21/0
5/20
074:
07:4
8K
AT
AK
OU
BE
NE
DIC
TE
CS
K1
012
35F
emal
e16
2cm
78kg
Som
e ex
erci
se53
353
535.
6S
mal
l 5
2.1
29.7
215
3122
96 5
.7 3
1.6
46.
4 3
4.7
40
.5 5
9.5
44.
5
29/0
5/20
074:
07:4
8K
AT
AK
OU
BE
NE
DIC
TE
CS
K1
012
35F
emal
e16
2cm
78kg
Som
e ex
erci
se50
354
505.
9S
mal
l 5
2.1
29.7
215
3122
96 6
.1 3
0.1
47.
9 3
6.0
38
.5 6
1.5
46.
2
04/0
6/20
074:
07:4
8K
AT
AK
OU
BE
NE
DIC
TE
CS
K1
012
35F
emal
e16
2cm
73kg
Som
e ex
erci
se55
462
557.
5S
mal
l 5
2.1
27.8
214
8322
24 6
.4 2
8.4
44.
6 3
3.3
38
.9 6
1.1
45.
6
11/0
6/20
074:
07:4
8K
AT
AK
OU
BE
NE
DIC
TE
CS
K1
012
35F
emal
e16
2cm
73kg
Som
e ex
erci
se58
062
583.
3S
mal
l 5
2.1
27.8
214
8322
24 6
.1 2
9.5
43.
5 3
2.4
40
.4 5
9.6
44.
3
25/0
6/20
074:
07:4
8K
AT
AK
OU
BE
NE
DIC
TE
CS
K1
012
35F
emal
e16
2cm
71kg
Som
e ex
erci
se58
260
585.
1S
mal
l 5
2.1
27.0
514
6321
95 5
.9 2
7.9
43.
1 3
2.1
39
.3 6
0.7
45.
2
02/0
7/20
074:
07:4
8K
AT
AK
OU
BE
NE
DIC
TE
CS
K1
012
35F
emal
e16
2cm
72kg
Som
e ex
erci
se51
950
521.
4S
mal
l 5
2.1
27.4
314
7322
10 5
.5 2
5.9
46.
1 3
4.6
36
.0 6
4.0
48.
1
09/0
7/20
074:
07:4
8K
AT
AK
OU
BE
NE
DIC
TE
CS
K1
012
35F
emal
e16
2cm
70kg
Som
e ex
erci
se58
760
590.
1S
mal
l 5
2.1
26.6
714
5421
81 5
.8 2
7.3
42.
7 3
1.8
38
.9 6
1.1
45.
4
13/0
7/20
074:
07:4
8K
AT
AK
OU
BE
NE
DIC
TE
CS
K1
012
35F
emal
e16
2cm
72kg
Som
e ex
erci
se53
854
540.
7S
mal
l 5
2.1
27.4
314
7322
10 5
.7 2
6.9
45.
1 3
3.8
37
.3 6
2.7
47.
0
21/0
5/20
074:
21:2
9A
GB
EN
OU
TA
NIA
CS
K1
013
20F
emal
e17
0cm
55kg
Som
e ex
erci
se87
270
874.
8S
mal
l 5
2.1
19.0
313
9520
92 4
.6 1
8.3
36.
7 2
4.9
33.
2 6
6.8
45.
2
29/0
5/20
074:
21:2
9A
GB
EN
OU
TA
NIA
CS
K1
013
20F
emal
e17
0cm
55kg
Som
e ex
erci
se82
472
827.
1S
mal
l 5
2.1
19.0
313
9520
92 5
.0 1
7.7
37.
3 2
5.7
32.
2 6
7.8
46.
8
04/0
6/20
074:
21:2
9A
GB
EN
OU
TA
NIA
CS
K1
013
20F
emal
e17
0cm
56kg
Som
e ex
erci
se80
769
809.
9S
mal
l 5
2.1
19.3
814
0421
07 4
.9 1
8.3
37.
7 2
6.2
32.
7 6
7.3
46.
8
11/0
6/20
074:
21:2
9A
GB
EN
OU
TA
NIA
CS
K1
013
20F
emal
e17
0cm
56kg
Som
e ex
erci
se77
069
773.
1S
mal
l 5
2.1
19.3
814
0421
07 5
.1 1
7.7
38.
3 2
7.0
31.
6 6
8.4
48.
2
25/0
6/20
074:
21:2
9A
GB
EN
OU
TA
NIA
CS
K1
013
20F
emal
e17
0cm
57kg
Som
e ex
erci
se71
765
719.
9S
mal
l 5
2.1
19.7
214
1421
21 5
.2 1
7.4
39.
6 2
8.3
30.
6 6
9.4
49.
7
02/0
7/20
074:
21:2
9A
GB
EN
OU
TA
NIA
CS
K1
013
20F
emal
e17
0cm
59kg
Som
e ex
erci
se73
369
736.
2S
mal
l 5
2.1
20.4
214
3321
50 5
.4 1
9.4
39.
6 2
8.2
33.
0 6
7.0
47.
7
09/0
7/20
074:
21:2
9A
GB
EN
OU
TA
NIA
CS
K1
013
20F
emal
e17
0cm
58kg
Som
e ex
erci
se80
378
806.
8S
mal
l 5
2.1
20.0
714
2321
35 5
.5 1
9.9
38.
1 2
6.5
34.
3 6
5.7
45.
7
13/0
7/20
074:
21:2
9A
GB
EN
OU
TA
NIA
CS
K1
013
20F
emal
e17
0cm
57kg
Som
e ex
erci
se75
571
758.
3S
mal
l 5
2.1
19.7
214
1421
21 5
.4 1
8.2
38.
8 2
7.4
32.
0 6
8.0
48.
1
21/0
5/20
074:
32:2
7Y
OV
OG
AN
AT
SO
UP
IC
SK
1 01
438
Fem
ale
160
cm47
kgS
ome
exer
cise
722
7372
5.7
Sm
all
52.
118
.36
1215
1823
5.8
12.
4 3
4.6
25.
0 2
6.4
73.
6 5
3.2
29/0
5/20
074:
32:2
7Y
OV
OG
AN
AT
SO
UP
IC
SK
1 01
438
Fem
ale
160
cm47
kgS
ome
exer
cise
722
7172
5.5
Sm
all
52.
118
.36
1215
1823
5.6
12.
4 3
4.6
25.
0 2
6.4
73.
6 5
3.2
04/0
6/20
074:
32:2
7Y
OV
OG
AN
AT
SO
UP
IC
SK
1 01
438
Fem
ale
160
cm48
kgS
ome
exer
cise
697
7470
0.9
Sm
all
52.
118
.75
1225
1837
6.1
12.
7 3
5.3
25.
7 2
6.6
73.
4 5
3.5
11/0
6/20
074:
32:2
7Y
OV
OG
AN
AT
SO
UP
IC
SK
1 01
438
Fem
ale
160
cm50
kgS
ome
exer
cise
677
7268
0.8
Sm
all
52.
119
.53
1244
1866
6.1
14.
0 3
6.0
26.
4 2
8.0
72.
0 5
2.8
25/0
6/20
074:
32:2
7Y
OV
OG
AN
AT
SO
UP
IC
SK
1 01
438
Fem
ale
160
cm49
kgS
ome
exer
cise
652
6665
5.3
Sm
all
52.
119
.14
1234
1852
5.8
12.
5 3
6.5
27.
0 2
5.6
74.
4 5
5.0
02/0
7/20
074:
32:2
7Y
OV
OG
AN
AT
SO
UP
IC
SK
1 01
438
Fem
ale
160
cm49
kgS
ome
exer
cise
722
7972
6.3
Sm
all
52.
119
.14
1234
1852
6.2
14.
1 3
4.9
25.
2 2
8.7
71.
3 5
1.5
09/0
7/20
074:
32:2
7Y
OV
OG
AN
AT
SO
UP
IC
SK
1 01
438
Fem
ale
160
cm49
kgS
ome
exer
cise
715
7871
9.2
Sm
all
52.
119
.14
1234
1852
6.2
13.
9 3
5.1
25.
4 2
8.4
71.
6 5
1.8
13/0
7/20
074:
32:2
7Y
OV
OG
AN
AT
SO
UP
IC
SK
1 01
438
Fem
ale
160
cm49
kgS
ome
exer
cise
717
8272
1.7
Sm
all
52.
119
.14
1234
1852
6.5
14.
0 3
5.0
25.
4 2
8.5
71.
5 5
1.7
21/0
5/20
074:
32:2
7S
OK
PO
AD
JOA
VI
CS
K1
015
29F
emal
e15
0cm
63kg
Som
e ex
erci
se57
655
578.
6M
ediu
m 5
2.1
28.0
013
9320
90 5
.5 2
5.5
37.
5 2
8.4
40.
5 5
9.5
45.
1
29/0
5/20
074:
32:2
7S
OK
PO
AD
JOA
VI
CS
K1
015
29F
emal
e15
0cm
64kg
Som
e ex
erci
se56
855
570.
7M
ediu
m 5
2.1
28.4
414
0321
04 5
.5 2
6.1
37.
9 2
8.8
40.
8 5
9.2
45.
0
04/0
6/20
074:
32:2
7S
OK
PO
AD
JOA
VI
CS
K1
015
29F
emal
e15
0cm
64kg
Som
e ex
erci
se55
554
557.
6M
ediu
m 5
2.1
28.4
414
0321
04 5
.6 2
5.7
38.
3 2
9.2
40.
1 5
9.9
45.
7
11/0
6/20
074:
32:2
7S
OK
PO
AD
JOA
VI
CS
K1
015
29F
emal
e15
0cm
64kg
Som
e ex
erci
se53
354
535.
7M
ediu
m 5
2.1
28.4
414
0321
04 5
.8 2
4.9
39.
1 3
0.0
38.
9 6
1.1
46.
8
25/0
6/20
074:
32:2
7S
OK
PO
AD
JOA
VI
CS
K1
015
29F
emal
e15
0cm
62kg
Som
e ex
erci
se55
757
559.
9M
ediu
m 5
2.1
27.5
613
8420
76 5
.8 2
4.1
37.
9 2
8.9
38.
8 6
1.2
46.
7
02/0
7/20
074:
32:2
7S
OK
PO
AD
JOA
VI
CS
K1
015
29F
emal
e15
0cm
62kg
Som
e ex
erci
se56
162
564.
4M
ediu
m 5
2.1
27.5
613
8420
76 6
.3 2
4.2
37.
8 2
8.8
39.
1 6
0.9
46.
5
21/0
5/20
074:
47:1
6A
DO
ME
LIA
NE
CS
K1
016
23F
emal
e15
0cm
46kg
Som
e ex
erci
se68
674
690.
0M
ediu
m 5
2.1
20.4
412
5818
87 6
.2 1
4.0
32.
0 2
3.7
30.
4 6
9.6
51.
5
29/0
5/20
074:
47:1
6A
DO
ME
LIA
NE
CS
K1
016
23F
emal
e15
0cm
47kg
Som
e ex
erci
se59
666
599.
6M
ediu
m 5
2.1
20.8
912
6819
02 6
.3 1
2.8
34.
2 2
6.0
27.
3 7
2.7
55.
4
04/0
6/20
074:
47:1
6A
DO
ME
LIA
NE
CS
K1
016
23F
emal
e15
0cm
47kg
Som
e ex
erci
se58
766
590.
7M
ediu
m 5
2.1
20.8
912
6819
02 6
.4 1
2.6
34.
4 2
6.3
26.
7 7
3.3
56.
0
11/0
6/20
074:
47:1
6A
DO
ME
LIA
NE
CS
K1
016
23F
emal
e15
0cm
47kg
Som
e ex
erci
se58
065
583.
6M
ediu
m 5
2.1
20.8
912
6819
02 6
.4 1
2.4
34.
6 2
6.5
26.
3 7
3.7
56.
4
25/0
6/20
074:
47:1
6A
DO
ME
LIA
NE
CS
K1
016
23F
emal
e15
0cm
48kg
Som
e ex
erci
se58
065
583.
6M
ediu
m 5
2.1
21.3
312
7719
16 6
.4 1
3.2
34.
8 2
6.6
27.
5 7
2.5
55.
5
02/0
7/20
074:
47:1
6A
DO
ME
LIA
NE
CS
K1
016
23F
emal
e15
0cm
47kg
Som
e ex
erci
se59
070
594.
1M
ediu
m 5
2.1
20.8
912
6819
02 6
.8 1
2.7
34.
3 2
6.2
26.
9 7
3.1
55.
8
09/0
7/20
074:
47:1
6A
DO
ME
LIA
NE
CS
K1
016
23F
emal
e15
0cm
48kg
Som
e ex
erci
se61
271
616.
1M
ediu
m 5
2.1
21.3
312
7719
16 6
.6 1
4.1
33.
9 2
5.7
29.
3 7
0.7
53.
6
13/0
7/20
074:
47:1
6A
DO
ME
LIA
NE
CS
K1
016
23F
emal
e15
0cm
50kg
Som
e ex
erci
se58
970
593.
1M
ediu
m 5
2.1
22.2
212
9719
45 6
.8 1
5.1
34.
9 2
6.6
30.
2 6
9.8
53.
2
21/0
5/20
079:
50:4
0G
UE
VO
NT
HE
RE
SE
CS
K1
017
33F
emal
e15
0cm
94kg
Som
e ex
erci
se50
757
510.
2La
rge
47.
541
.78
1672
2508
6.4
48.
7 4
5.3
34.
3 5
1.8
48.
2 3
6.5
29/0
5/20
079:
50:4
0G
UE
VO
NT
HE
RE
SE
CS
K1
017
33F
emal
e15
0cm
94kg
Som
e ex
erci
se46
958
472.
6La
rge
47.
541
.78
1672
2508
7.0
46.
8 4
7.2
36.
0 4
9.8
50.
2 3
8.3
5B
IA T
ES
T K
OD
JOV
IAK
OP
E F
INA
L F
inal
F 2
.xls
BIA
TE
ST
KO
DJA
VIA
KO
PE
FIN
AL
Tes
t D
ate
Tes
t T
ime
Las
t N
ame
Fir
st N
ame
Su
bje
ct ID
Ag
eG
end
erH
eig
ht
Wei
gh
tA
ctiv
ity
Lev
elR
esis
tan
ceR
eact
ance
Imp
edan
ceF
ram
e S
ize
Tar
get
W
eig
ht
BM
IB
MR
DE
EP
has
e A
ng
leF
at w
tF
FM
wt
TB
W
liter
sF
at %
o
f w
tF
FM
%
of
wt
TB
W %
o
f w
t
04/0
6/20
079:
50:4
0G
UE
VO
NT
HE
RE
SE
CS
K1
017
33F
emal
e15
0cm
94kg
Som
e ex
erci
se45
254
455.
2La
rge
47.
541
.78
1672
2508
6.8
45.
9 4
8.1
36.
8 4
8.8
51.
2 3
9.1
11/0
6/20
079:
50:4
0G
UE
VO
NT
HE
RE
SE
CS
K1
017
33F
emal
e15
0cm
94kg
Som
e ex
erci
se48
062
484.
0La
rge
47.
541
.78
1672
2508
7.4
47.
4 4
6.6
35.
5 5
0.5
49.
5 3
7.7
25/0
6/20
079:
50:4
0G
UE
VO
NT
HE
RE
SE
CS
K1
017
33F
emal
e15
0cm
94kg
Som
e ex
erci
se44
851
450.
9La
rge
47.
541
.78
1672
2508
6.5
45.
6 4
8.4
37.
0 4
8.5
51.
5 3
9.3
02/0
7/20
079:
50:4
0G
UE
VO
NT
HE
RE
SE
CS
K1
017
33F
emal
e15
0cm
95kg
Som
e ex
erci
se46
960
472.
8La
rge
47.
542
.22
1682
2523
7.3
47.
7 4
7.3
36.
1 5
0.2
49.
8 3
8.0
13/0
7/20
079:
50:4
0G
UE
VO
NT
HE
RE
SE
CS
K1
017
33F
emal
e15
0cm
95kg
Som
e ex
erci
se45
757
460.
5La
rge
47.
542
.22
1682
2523
7.1
47.
0 4
8.0
36.
6 4
9.5
50.
5 3
8.6
21/0
5/20
075:
02:5
7A
ME
GA
NC
HA
RLO
TT
EC
SK
1 01
937
Fem
ale
150
cm56
kgS
ome
exer
cise
602
6660
5.6
Med
ium
80.
924
.89
1288
1933
6.3
20.
5 3
5.5
26.
9 3
6.6
63.
4 4
8.0
29/0
5/20
075:
02:5
7A
ME
GA
NC
HA
RLO
TT
EC
SK
1 01
937
Fem
ale
150
cm55
kgS
ome
exer
cise
587
7359
1.5
Med
ium
80.
924
.44
1279
1918
7.1
19.
2 3
5.8
27.
2 3
4.9
65.
1 4
9.5
04/0
6/20
075:
02:5
7A
ME
GA
NC
HA
RLO
TT
EC
SK
1 01
937
Fem
ale
150
cm56
kgS
ome
exer
cise
585
7058
9.2
Med
ium
80.
924
.89
1288
1933
6.8
20.
0 3
6.0
27.
4 3
5.7
64.
3 4
8.9
11/0
6/20
075:
02:5
7A
ME
GA
NC
HA
RLO
TT
EC
SK
1 01
937
Fem
ale
150
cm56
kgS
ome
exer
cise
587
7459
1.6
Med
ium
80.
924
.89
1288
1933
7.2
20.
1 3
5.9
27.
3 3
5.8
64.
2 4
8.8
25/0
6/20
075:
02:5
7A
ME
GA
NC
HA
RLO
TT
EC
SK
1 01
937
Fem
ale
150
cm56
kgS
ome
exer
cise
602
7860
7.0
Med
ium
80.
924
.89
1288
1933
7.4
20.
5 3
5.5
26.
9 3
6.6
63.
4 4
8.0
02/0
7/20
075:
02:5
7A
ME
GA
NC
HA
RLO
TT
EC
SK
1 01
937
Fem
ale
150
cm56
kgS
ome
exer
cise
591
7659
5.9
Med
ium
80.
924
.89
1288
1933
7.3
20.
2 3
5.8
27.
2 3
6.0
64.
0 4
8.6
09/0
7/20
075:
02:5
7A
ME
GA
NC
HA
RLO
TT
EC
SK
1 01
937
Fem
ale
150
cm56
kgS
ome
exer
cise
631
7963
5.9
Med
ium
80.
924
.89
1288
1933
7.1
21.
2 3
4.8
26.
1 3
7.9
62.
1 4
6.6
13/0
7/20
075:
02:5
7A
ME
GA
NC
HA
RLO
TT
EC
SK
1 01
937
Fem
ale
150
cm56
kgS
ome
exer
cise
631
7963
5.9
Med
ium
80.
924
.89
1288
1933
7.1
21.
2 3
4.8
26.
1 3
7.9
62.
1 4
6.6
21/0
5/20
075:
02:5
7T
ET
TE
KP
OE
KA
NG
NI
CS
K1
020
37M
ale
160
cm54
kgS
ome
exer
cise
630
6763
3.6
Med
ium
80.
921
.09
1360
2176
6.1
14.
6 3
9.4
29.
0 2
7.0
73.
0 5
3.6
29/0
5/20
075:
02:5
7T
ET
TE
KP
OE
KA
NG
NI
CS
K1
020
37M
ale
160
cm54
kgS
ome
exer
cise
584
6958
8.1
Med
ium
80.
921
.09
1360
2176
6.7
13.
2 4
0.8
30.
4 2
4.4
75.
6 5
6.3
04/0
6/20
075:
02:5
7T
ET
TE
KP
OE
KA
NG
NI
CS
K1
020
37M
ale
160
cm54
kgS
ome
exer
cise
555
6155
8.3
Med
ium
80.
921
.09
1360
2176
6.3
12.
1 4
1.9
31.
4 2
2.5
77.
5 5
8.2
11/0
6/20
075:
02:5
7T
ET
TE
KP
OE
KA
NG
NI
CS
K1
020
37M
ale
160
cm54
kgS
ome
exer
cise
590
7159
4.3
Med
ium
80.
921
.09
1360
2176
6.9
13.
4 4
0.6
30.
2 2
4.8
75.
2 5
5.9
25/0
6/20
075:
02:5
7T
ET
TE
KP
OE
KA
NG
NI
CS
K1
020
37M
ale
160
cm54
kgS
ome
exer
cise
581
7358
5.6
Med
ium
80.
921
.09
1360
2176
7.2
13.
1 4
0.9
30.
5 2
4.2
75.
8 5
6.5
02/0
7/20
075:
02:5
7T
ET
TE
KP
OE
KA
NG
NI
CS
K1
020
37M
ale
160
cm54
kgS
ome
exer
cise
566
6757
0.0
Med
ium
80.
921
.09
1360
2176
6.8
12.
6 4
1.4
31.
0 2
3.2
76.
8 5
7.4
09/0
7/20
075:
02:5
7T
ET
TE
KP
OE
KA
NG
NI
CS
K1
020
37M
ale
160
cm54
kgS
ome
exer
cise
595
7059
9.1
Med
ium
80.
921
.09
1360
2176
6.7
13.
6 4
0.4
30.
0 2
5.1
74.
9 5
5.6
13/0
7/20
075:
02:5
7T
ET
TE
KP
OE
KA
NG
NI
CS
K1
020
37M
ale
160
cm54
kgS
ome
exer
cise
569
7057
3.3
Med
ium
80.
921
.09
1360
2176
7.0
12.
7 4
1.3
30.
9 2
3.4
76.
6 5
7.2
21/0
5/20
075:
02:5
7LA
WS
ON
NA
DO
UC
SK
1 02
134
Fem
ale
165
cm92
kgS
ome
exer
cise
424
5342
7.3
Med
ium
80.
933
.79
1675
2513
7.1
34.
6 5
7.4
43.
0 3
7.6
62.
4 4
6.8
29/0
5/20
075:
02:5
7LA
WS
ON
NA
DO
UC
SK
1 02
134
Fem
ale
165
cm92
kgS
ome
exer
cise
388
6239
2.9
Med
ium
80.
933
.79
1675
2513
9.1
31.
0 6
1.0
45.
7 3
3.7
66.
3 4
9.7
04/0
6/20
075:
02:5
7LA
WS
ON
NA
DO
UC
SK
1 02
134
Fem
ale
165
cm92
kgS
ome
exer
cise
426
6243
0.5
Med
ium
80.
933
.79
1675
2513
8.3
34.
8 5
7.2
42.
9 3
7.8
62.
2 4
6.6
11/0
6/20
075:
02:5
7LA
WS
ON
NA
DO
UC
SK
1 02
134
Fem
ale
165
cm91
kgS
ome
exer
cise
432
6543
6.9
Med
ium
80.
933
.43
1665
2498
8.6
34.
5 5
6.5
42.
4 3
7.9
62.
1 4
6.6
25/0
6/20
075:
02:5
7LA
WS
ON
NA
DO
UC
SK
1 02
134
Fem
ale
165
cm92
kgS
ome
exer
cise
450
6545
4.7
Med
ium
80.
933
.79
1675
2513
8.2
36.
8 5
5.2
41.
4 4
0.0
60.
0 4
5.0
02/0
7/20
075:
02:5
7LA
WS
ON
NA
DO
UC
SK
1 02
134
Fem
ale
165
cm92
kgS
ome
exer
cise
433
6543
7.9
Med
ium
80.
933
.79
1675
2513
8.5
35.
4 5
6.6
42.
4 3
8.5
61.
5 4
6.1
09/0
7/20
075:
02:5
7LA
WS
ON
NA
DO
UC
SK
1 02
134
Fem
ale
165
cm92
kgS
ome
exer
cise
432
6443
6.7
Med
ium
80.
933
.79
1675
2513
8.4
35.
3 5
6.7
42.
5 3
8.4
61.
6 4
6.2
13/0
7/20
075:
02:5
7LA
WS
ON
NA
DO
UC
SK
1 02
134
Fem
ale
165
cm92
kgS
ome
exer
cise
410
5741
3.9
Med
ium
80.
933
.79
1675
2513
7.9
33.
3 5
8.7
44.
0 3
6.2
63.
8 4
7.9
21/0
5/20
075:
58:2
3B
AY
OR
FA
TI
CS
K1
022
33F
emal
e17
0cm
99kg
Som
e ex
erci
se50
254
504.
9La
rge
80.
934
.26
1756
2634
6.1
43.
8 5
5.2
40.
8 4
4.2
55.
8 4
1.3
29/0
5/20
075:
58:2
3B
AY
OR
FA
TI
CS
K1
022
33F
emal
e17
0cm
99kg
Som
e ex
erci
se48
255
485.
1La
rge
80.
934
.26
1756
2634
6.5
42.
5 5
6.5
41.
9 4
2.9
57.
1 4
2.3
04/0
6/20
075:
58:2
3B
AY
OR
FA
TI
CS
K1
022
33F
emal
e17
0cm
100
kgS
ome
exer
cise
464
5046
6.7
Larg
e 8
0.9
34.6
017
6626
49 6
.2 4
2.0
58.
0 4
3.1
42.
0 5
8.0
43.
1
11/0
6/20
075:
58:2
3B
AY
OR
FA
TI
CS
K1
022
33F
emal
e17
0cm
100
kgS
ome
exer
cise
479
5348
1.9
Larg
e 8
0.9
34.6
017
6626
49 6
.3 4
3.1
56.
9 4
2.2
43.
1 5
6.9
42.
2
25/0
6/20
075:
58:2
3B
AY
OR
FA
TI
CS
K1
022
33F
emal
e17
0cm
98kg
Som
e ex
erci
se44
750
449.
8La
rge
80.
933
.91
1746
2620
6.4
38.
9 5
9.1
43.
9 3
9.7
60.
3 4
4.8
02/0
7/20
075:
58:2
3B
AY
OR
FA
TI
CS
K1
022
33F
emal
e17
0cm
98kg
Som
e ex
erci
se48
257
485.
4La
rge
80.
933
.91
1746
2620
6.7
41.
6 5
6.4
41.
8 4
2.5
57.
5 4
2.7
09/0
7/20
075:
58:2
3B
AY
OR
FA
TI
CS
K1
022
33F
emal
e17
0cm
100
kgS
ome
exer
cise
489
5549
2.1
Larg
e 8
0.9
34.6
017
6626
49 6
.4 4
3.8
56.
2 4
1.6
43.
8 5
6.2
41.
6
13/0
7/20
075:
58:2
3B
AY
OR
FA
TI
CS
K1
022
33F
emal
e17
0cm
100
kgS
ome
exer
cise
464
5646
7.4
Larg
e 8
0.9
34.6
017
6626
49 6
.9 4
2.0
58.
0 4
3.1
42.
0 5
8.0
43.
1
21/0
5/20
076:
07:0
0Y
OV
OG
AN
AM
IVI
CS
K1
023
46F
emal
e17
0cm
85kg
Som
e ex
erci
se60
748
608.
9S
mal
l 8
0.9
29.4
115
6023
41 4
.5 3
7.4
47.
6 3
4.8
44.
0 5
6.0
40.
9
29/0
5/20
076:
07:0
0Y
OV
OG
AN
AM
IVI
CS
K1
023
46F
emal
e17
0cm
85kg
Som
e ex
erci
se58
749
589.
0S
mal
l 8
0.9
29.4
115
6023
41 4
.8 3
6.6
48.
4 3
5.5
43.
0 5
7.0
41.
8
04/0
6/20
076:
07:0
0Y
OV
OG
AN
AM
IVI
CS
K1
023
46F
emal
e17
0cm
85kg
Som
e ex
erci
se59
751
599.
2S
mal
l 8
0.9
29.4
115
6023
41 4
.9 3
7.0
48.
0 3
5.1
43.
5 5
6.5
41.
3
11/0
6/20
076:
07:0
0Y
OV
OG
AN
AM
IVI
CS
K1
023
46F
emal
e17
0cm
86kg
Som
e ex
erci
se56
549
567.
1S
mal
l 8
0.9
29.7
615
7023
55 5
.0 3
6.4
49.
6 3
6.5
42.
4 5
7.6
42.
4
25/0
6/20
076:
07:0
0Y
OV
OG
AN
AM
IVI
CS
K1
023
46F
emal
e17
0cm
88kg
Som
e ex
erci
se56
947
570.
9S
mal
l 8
0.9
30.4
515
8923
84 4
.7 3
8.3
49.
7 3
6.5
43.
5 5
6.5
41.
5
02/0
7/20
076:
07:0
0Y
OV
OG
AN
AM
IVI
CS
K1
023
46F
emal
e17
0cm
87kg
Som
e ex
erci
se57
851
580.
2S
mal
l 8
0.9
30.1
015
8023
70 5
.0 3
7.9
49.
1 3
6.1
43.
5 5
6.5
41.
5
09/0
7/20
076:
07:0
0Y
OV
OG
AN
AM
IVI
CS
K1
023
46F
emal
e17
0cm
88kg
Som
e ex
erci
se58
552
587.
3S
mal
l 8
0.9
30.4
515
8923
84 5
.1 3
9.0
49.
0 3
5.9
44.
3 5
5.7
40.
8
13/0
7/20
076:
07:0
0Y
OV
OG
AN
AM
IVI
CS
K1
023
46F
emal
e17
0cm
88kg
Som
e ex
erci
se60
754
609.
4S
mal
l 8
0.9
30.4
515
8923
84 5
.1 3
9.9
48.
1 3
5.1
45.
3 5
4.7
39.
9
21/0
5/20
076:
07:0
0LA
WS
ON
KO
KO
VI
CS
K1
024
41F
emal
e15
0cm
64kg
Som
e ex
erci
se60
666
609.
6S
mal
l 8
0.9
28.4
413
4620
20 6
.2 2
7.2
36.
8 2
7.7
42.
6 5
7.4
43.
3
29/0
5/20
076:
07:0
0LA
WS
ON
KO
KO
VI
CS
K1
024
41F
emal
e15
0cm
65kg
Som
e ex
erci
se56
466
567.
8S
mal
l 8
0.9
28.8
913
5620
34 6
.7 2
6.8
38.
2 2
9.0
41.
3 5
8.7
44.
7
6B
IA T
ES
T K
OD
JOV
IAK
OP
E F
INA
L F
inal
F 2
.xls
BIA
TE
ST
KO
DJA
VIA
KO
PE
FIN
AL
Tes
t D
ate
Tes
t T
ime
Las
t N
ame
Fir
st N
ame
Su
bje
ct ID
Ag
eG
end
erH
eig
ht
Wei
gh
tA
ctiv
ity
Lev
elR
esis
tan
ceR
eact
ance
Imp
edan
ceF
ram
e S
ize
Tar
get
W
eig
ht
BM
IB
MR
DE
EP
has
e A
ng
leF
at w
tF
FM
wt
TB
W
liter
sF
at %
o
f w
tF
FM
%
of
wt
TB
W %
o
f w
t
04/0
6/20
076:
07:0
0LA
WS
ON
KO
KO
VI
CS
K1
024
41F
emal
e15
0cm
65kg
Som
e ex
erci
se58
171
585.
3S
mal
l 8
0.9
28.8
913
5620
34 7
.0 2
7.4
37.
6 2
8.5
42.
1 5
7.9
43.
9
11/0
6/20
076:
07:0
0LA
WS
ON
KO
KO
VI
CS
K1
024
41F
emal
e15
0cm
65kg
Som
e ex
erci
se53
862
541.
6S
mal
l 8
0.9
28.8
913
5620
34 6
.6 2
5.9
39.
1 2
9.9
39.
8 6
0.2
46.
0
25/0
6/20
076:
07:0
0LA
WS
ON
KO
KO
VI
CS
K1
024
41F
emal
e15
0cm
64kg
Som
e ex
erci
se53
862
541.
6S
mal
l 8
0.9
28.4
413
4620
20 6
.6 2
5.1
38.
9 2
9.8
39.
2 6
0.8
46.
6
02/0
7/20
076:
07:0
0LA
WS
ON
KO
KO
VI
CS
K1
024
41F
emal
e15
0cm
66kg
Som
e ex
erci
se54
868
552.
2S
mal
l 8
0.9
29.3
313
6620
49 7
.1 2
7.1
38.
9 2
9.7
41.
1 5
8.9
45.
0
09/0
7/20
076:
07:0
0LA
WS
ON
KO
KO
VI
CS
K1
024
41F
emal
e15
0cm
66kg
Som
e ex
erci
se58
969
593.
0S
mal
l 8
0.9
29.3
313
6620
49 6
.7 2
8.4
37.
6 2
8.4
43.
1 5
6.9
43.
0
13/0
7/20
0713
:12:
09LA
WS
ON
KO
KO
VI
CS
K1
024
41F
emal
e15
0cm
66kg
Som
e ex
erci
se57
576
580.
0S
mal
l 8
0.9
29.3
313
6620
49 7
.5 2
8.0
38.
0 2
8.8
42.
4 5
7.6
43.
7
21/0
5/20
076:
21:2
1D
OV
ID
OP
EC
SK
1 02
530
Fem
ale
165
cm58
kgS
ome
exer
cise
613
7461
7.5
Sm
all
56.
621
.30
1367
2051
6.9
17.
1 4
0.9
30.
3 2
9.4
70.
6 5
2.2
29/0
5/20
076:
21:2
1D
OV
ID
OP
EC
SK
1 02
530
Fem
ale
165
cm58
kgS
ome
exer
cise
603
7860
8.0
Sm
all
56.
621
.30
1367
2051
7.4
16.
7 4
1.3
30.
6 2
8.8
71.
2 5
2.8
04/0
6/20
076:
21:2
1D
OV
ID
OP
EC
SK
1 02
530
Fem
ale
165
cm58
kgS
ome
exer
cise
591
7559
5.7
Sm
all
56.
621
.30
1367
2051
7.2
16.
3 4
1.7
31.
0 2
8.0
72.
0 5
3.5
11/0
6/20
076:
21:2
1D
OV
ID
OP
EC
SK
1 02
530
Fem
ale
165
cm59
kgS
ome
exer
cise
568
7257
2.5
Sm
all
56.
621
.67
1377
2066
7.2
16.
2 4
2.8
32.
0 2
7.4
72.
6 5
4.2
25/0
6/20
076:
21:2
1D
OV
ID
OP
EC
SK
1 02
530
Fem
ale
165
cm58
kgS
ome
exer
cise
598
8260
3.6
Sm
all
56.
621
.30
1367
2051
7.8
16.
5 4
1.5
30.
8 2
8.5
71.
5 5
3.1
02/0
7/20
076:
21:2
1D
OV
ID
OP
EC
SK
1 02
530
Fem
ale
165
cm58
kgS
ome
exer
cise
584
7758
9.1
Sm
all
56.
621
.30
1367
2051
7.5
16.
0 4
2.0
31.
3 2
7.6
72.
4 5
3.9
09/0
7/20
076:
21:2
1D
OV
ID
OP
EC
SK
1 02
530
Fem
ale
165
cm58
kgS
ome
exer
cise
614
7961
9.1
Sm
all
56.
621
.30
1367
2051
7.3
17.
1 4
0.9
30.
3 2
9.5
70.
5 5
2.2
13/0
7/20
076:
21:2
1D
OV
ID
OP
EC
SK
1 02
530
Fem
ale
165
cm58
kgS
ome
exer
cise
615
8462
0.7
Sm
all
56.
621
.30
1367
2051
7.8
17.
1 4
0.9
30.
2 2
9.5
70.
5 5
2.1
21/0
5/20
076:
40:3
4A
PE
DE
ME
GN
MA
SS
AN
CS
K1
026
33F
emal
e16
6cm
93kg
Som
e ex
erci
se53
362
536.
6La
rge
56.
633
.75
1691
2537
6.6
42.
4 5
0.6
37.
5 4
5.6
54.
4 4
0.3
29/0
5/20
076:
40:3
4A
PE
DE
ME
GN
MA
SS
AN
CS
K1
026
33F
emal
e16
6cm
93kg
Som
e ex
erci
se53
362
536.
6La
rge
56.
633
.75
1691
2537
6.6
42.
4 5
0.6
37.
5 4
5.6
54.
4 4
0.3
04/0
6/20
076:
40:3
4A
PE
DE
ME
GN
MA
SS
AN
CS
K1
026
33F
emal
e16
6cm
94kg
Som
e ex
erci
se51
560
518.
5La
rge
56.
634
.11
1701
2551
6.6
42.
3 5
1.7
38.
4 4
5.0
55.
0 4
0.9
11/0
6/20
076:
40:3
4A
PE
DE
ME
GN
MA
SS
AN
CS
K1
026
33F
emal
e16
6cm
94kg
Som
e ex
erci
se50
360
506.
6La
rge
56.
634
.11
1701
2551
6.8
41.
6 5
2.4
39.
0 4
4.2
55.
8 4
1.5
25/0
6/20
076:
40:3
4A
PE
DE
ME
GN
MA
SS
AN
CS
K1
026
33F
emal
e16
6cm
93kg
Som
e ex
erci
se52
964
532.
9La
rge
56.
633
.75
1691
2537
6.9
42.
2 5
0.8
37.
7 4
5.4
54.
6 4
0.5
02/0
7/20
076:
40:3
4A
PE
DE
ME
GN
MA
SS
AN
CS
K1
026
33F
emal
e16
6cm
93kg
Som
e ex
erci
se50
563
508.
9La
rge
56.
633
.75
1691
2537
7.1
40.
8 5
2.2
38.
8 4
3.9
56.
1 4
1.7
09/0
7/20
076:
40:3
4A
PE
DE
ME
GN
MA
SS
AN
CS
K1
026
33F
emal
e16
6cm
93kg
Som
e ex
erci
se50
063
504.
0La
rge
56.
633
.75
1691
2537
7.2
40.
5 5
2.5
39.
1 4
3.6
56.
4 4
2.0
13/0
7/20
076:
40:3
4A
PE
DE
ME
GN
MA
SS
AN
CS
K1
026
33F
emal
e16
6cm
92kg
Som
e ex
erci
se53
268
536.
3La
rge
56.
633
.39
1682
2523
7.3
41.
5 5
0.5
37.
5 4
5.1
54.
9 4
0.7
07/0
5/20
076:
40:3
4A
PE
DE
ME
GN
MA
SS
AN
CS
K1
026
33F
emal
e16
6cm
92kg
Som
e ex
erci
se51
660
519.
5La
rge
56.
633
.39
1682
2523
6.6
40.
6 5
1.4
38.
2 4
4.2
55.
8 4
1.5
21/0
5/20
076:
48:0
5G
NA
GA
NA
MA
CS
K1
027
38F
emal
e16
0cm
59kg
Som
e ex
erci
se57
443
575.
6S
mal
l 5
6.6
23.0
513
3019
96 4
.3 1
8.4
40.
6 3
0.5
31.
2 6
8.8
51.
7
29/0
5/20
076:
48:0
5G
NA
GA
NA
MA
CS
K1
027
38F
emal
e16
0cm
59kg
Som
e ex
erci
se54
949
551.
2S
mal
l 5
6.6
23.0
513
3019
96 5
.1 1
7.4
41.
6 3
1.4
29.
5 7
0.5
53.
2
04/0
6/20
076:
48:0
5G
NA
GA
NA
MA
CS
K1
027
38F
emal
e16
0cm
60kg
Som
e ex
erci
se53
942
540.
6S
mal
l 5
6.6
23.4
413
4020
10 4
.5 1
7.8
42.
2 3
1.9
29.
6 7
0.4
53.
2
11/0
6/20
076:
48:0
5G
NA
GA
NA
MA
CS
K1
027
38F
emal
e16
0cm
60kg
Som
e ex
erci
se53
746
539.
0S
mal
l 5
6.6
23.4
413
4020
10 4
.9 1
7.7
42.
3 3
2.0
29.
5 7
0.5
53.
3
25/0
6/20
076:
48:0
5G
NA
GA
NA
MA
CS
K1
027
38F
emal
e16
0cm
59kg
Som
e ex
erci
se49
844
499.
9S
mal
l 5
6.6
23.0
513
3019
96 5
.0 1
4.9
44.
1 3
3.5
25.
2 7
4.8
56.
9
02/0
7/20
076:
48:0
5G
NA
GA
NA
MA
CS
K1
027
38F
emal
e16
0cm
59kg
Som
e ex
erci
se57
052
572.
4S
mal
l 5
6.6
23.0
513
3019
96 5
.2 1
8.2
40.
8 3
0.6
30.
9 6
9.1
51.
9
09/0
7/20
076:
48:0
5G
NA
GA
NA
MA
CS
K1
027
38F
emal
e16
0cm
59kg
Som
e ex
erci
se54
242
543.
6S
mal
l 5
6.6
23.0
513
3019
96 4
.4 1
7.1
41.
9 3
1.7
28.
9 7
1.1
53.
7
13/0
7/20
076:
48:0
5G
NA
GA
NA
MA
CS
K1
027
38F
emal
e16
0cm
61kg
Som
e ex
erci
se51
942
520.
7S
mal
l 5
6.6
23.8
313
5020
25 4
.6 1
7.6
43.
4 3
2.8
28.
9 7
1.1
53.
8
21/0
5/20
076:
56:2
8T
ET
EG
AN
DE
DE
CS
K1
028
38F
emal
e16
3cm
79kg
Som
e ex
erci
se53
767
541.
2M
ediu
m 5
6.6
29.7
315
2822
92 7
.1 3
2.2
46.
8 3
4.9
40.
8 5
9.2
44.
2
29/0
5/20
076:
56:2
8T
ET
EG
AN
DE
DE
CS
K1
028
38F
emal
e16
3cm
79kg
Som
e ex
erci
se51
468
518.
5M
ediu
m 5
6.6
29.7
315
2822
92 7
.5 3
1.1
47.
9 3
5.9
39.
3 6
0.7
45.
5
04/0
6/20
076:
56:2
8T
ET
EG
AN
DE
DE
CS
K1
028
38F
emal
e16
3cm
78kg
Som
e ex
erci
se57
464
577.
6M
ediu
m 5
6.6
29.3
615
1822
78 6
.4 3
3.0
45.
0 3
3.4
42.
3 5
7.7
42.
8
11/0
6/20
076:
56:2
8T
ET
EG
AN
DE
DE
CS
K1
028
38F
emal
e16
3cm
80kg
Som
e ex
erci
se55
264
555.
7M
ediu
m 5
6.6
30.1
115
3723
06 6
.6 3
3.8
46.
2 3
4.4
42.
2 5
7.8
43.
1
25/0
6/20
076:
56:2
8T
ET
EG
AN
DE
DE
CS
K1
028
38F
emal
e16
3cm
81kg
Som
e ex
erci
se48
561
488.
8M
ediu
m 5
6.6
30.4
915
4723
21 7
.2 3
1.0
50.
0 3
7.6
38.
3 6
1.7
46.
4
02/0
7/20
076:
56:2
8T
ET
EG
AN
DE
DE
CS
K1
028
38F
emal
e16
3cm
81kg
Som
e ex
erci
se53
372
537.
8M
ediu
m 5
6.6
30.4
915
4723
21 7
.7 3
3.7
47.
3 3
5.3
41.
6 5
8.4
43.
6
09/0
7/20
076:
56:2
8T
ET
EG
AN
DE
DE
CS
K1
028
38F
emal
e16
3cm
81kg
Som
e ex
erci
se52
469
528.
5M
ediu
m 5
6.6
30.4
915
4723
21 7
.5 3
3.2
47.
8 3
5.7
41.
0 5
9.0
44.
1
13/0
7/20
076:
56:2
8T
ET
EG
AN
DE
DE
CS
K1
028
38F
emal
e16
3cm
81kg
Som
e ex
erci
se52
270
526.
7M
ediu
m 5
6.6
30.4
915
4723
21 7
.6 3
3.1
47.
9 3
5.8
40.
9 5
9.1
44.
2
21/0
5/20
077:
00:3
8N
OM
ED
JIM
AR
CE
LIN
EC
SK
1 02
936
Fem
ale
160
cm63
kgS
ome
exer
cise
577
5657
9.7
Sm
all
56.
624
.61
1378
2068
5.5
21.
8 4
1.2
30.
8 3
4.7
65.
3 4
8.9
29/0
5/20
077:
00:3
8N
OM
ED
JIM
AR
CE
LIN
EC
SK
1 02
936
Fem
ale
160
cm64
kgS
ome
exer
cise
568
6257
1.4
Sm
all
56.
625
.00
1388
2082
6.2
22.
3 4
1.7
31.
3 3
4.9
65.
1 4
8.8
04/0
6/20
077:
00:3
8N
OM
ED
JIM
AR
CE
LIN
EC
SK
1 02
936
Fem
ale
160
cm63
kgS
ome
exer
cise
545
5754
8.0
Sm
all
56.
624
.61
1378
2068
6.0
20.
5 4
2.5
32.
0 3
2.6
67.
4 5
0.8
11/0
6/20
077:
00:3
8N
OM
ED
JIM
AR
CE
LIN
EC
SK
1 02
936
Fem
ale
160
cm64
kgS
ome
exer
cise
552
6055
5.3
Sm
all
56.
625
.00
1388
2082
6.2
21.
7 4
2.3
31.
8 3
3.9
66.
1 4
9.8
25/0
6/20
077:
00:3
8N
OM
ED
JIM
AR
CE
LIN
EC
SK
1 02
936
Fem
ale
160
cm64
kgS
ome
exer
cise
564
6256
7.4
Sm
all
56.
625
.00
1388
2082
6.3
22.
2 4
1.8
31.
4 3
4.6
65.
4 4
9.1
02/0
7/20
077:
00:3
8N
OM
ED
JIM
AR
CE
LIN
EC
SK
1 02
936
Fem
ale
160
cm64
kgS
ome
exer
cise
610
7661
4.7
Sm
all
56.
625
.00
1388
2082
7.1
23.
8 4
0.2
29.
9 3
7.2
62.
8 4
6.7
09/0
7/20
077:
00:3
8N
OM
ED
JIM
AR
CE
LIN
EC
SK
1 02
936
Fem
ale
160
cm64
kgS
ome
exer
cise
571
6357
4.5
Sm
all
56.
625
.00
1388
2082
6.3
22.
4 4
1.6
31.
2 3
5.1
64.
9 4
8.7
13/0
7/20
077:
00:3
8N
OM
ED
JIM
AR
CE
LIN
EC
SK
1 02
936
Fem
ale
160
cm64
kgS
ome
exer
cise
577
6758
0.9
Sm
all
56.
625
.00
1388
2082
6.6
22.
7 4
1.3
30.
9 3
5.4
64.
6 4
8.4
7B
IA T
ES
T K
OD
JOV
IAK
OP
E F
INA
L F
inal
F 2
.xls
BIA
TE
ST
KO
DJA
VIA
KO
PE
FIN
AL
Tes
t D
ate
Tes
t T
ime
Las
t N
ame
Fir
st N
ame
Su
bje
ct ID
Ag
eG
end
erH
eig
ht
Wei
gh
tA
ctiv
ity
Lev
elR
esis
tan
ceR
eact
ance
Imp
edan
ceF
ram
e S
ize
Tar
get
W
eig
ht
BM
IB
MR
DE
EP
has
e A
ng
leF
at w
tF
FM
wt
TB
W
liter
sF
at %
o
f w
tF
FM
%
of
wt
TB
W %
o
f w
t
29/0
5/20
077:
18:0
3A
GB
AG
NO
NA
KO
UC
SK
1 03
031
Fem
ale
166
cm68
kgS
ome
exer
cise
547
5855
0.1
Med
ium
56.
624
.68
1461
2191
6.1
22.
3 4
5.7
34.
1 3
2.8
67.
2 5
0.1
04/0
6/20
077:
18:0
3A
GB
AG
NO
NA
KO
UC
SK
1 03
031
Fem
ale
166
cm69
kgS
ome
exer
cise
512
5751
5.2
Med
ium
56.
625
.04
1470
2205
6.4
21.
3 4
7.7
35.
8 3
0.8
69.
2 5
1.8
11/0
6/20
077:
18:0
3A
GB
AG
NO
NA
KO
UC
SK
1 03
031
Fem
ale
166
cm69
kgS
ome
exer
cise
532
6053
5.4
Med
ium
56.
625
.04
1470
2205
6.4
22.
4 4
6.6
34.
9 3
2.4
67.
6 5
0.5
25/0
6/20
077:
18:0
3A
GB
AG
NO
NA
KO
UC
SK
1 03
031
Fem
ale
166
cm69
kgS
ome
exer
cise
541
6754
5.1
Med
ium
56.
625
.04
1470
2205
7.1
22.
8 4
6.2
34.
5 3
3.1
66.
9 4
9.9
02/0
7/20
077:
18:0
3A
GB
AG
NO
NA
KO
UC
SK
1 03
031
Fem
ale
166
cm70
kgS
ome
exer
cise
521
6152
4.6
Med
ium
56.
625
.40
1480
2220
6.7
22.
6 4
7.4
35.
5 3
2.3
67.
7 5
0.7
09/0
7/20
077:
18:0
3A
GB
AG
NO
NA
KO
UC
SK
1 03
031
Fem
ale
166
cm70
kgS
ome
exer
cise
536
6053
9.3
Med
ium
56.
625
.40
1480
2220
6.4
23.
4 4
6.6
34.
8 3
3.4
66.
6 4
9.7
13/0
7/20
077:
18:0
3A
GB
AG
NO
NA
KO
UC
SK
1 03
031
Fem
ale
166
cm70
kgS
ome
exer
cise
527
6353
0.8
Med
ium
56.
625
.40
1480
2220
6.8
22.
9 4
7.1
35.
2 3
2.8
67.
2 5
0.3
21/0
5/20
077:
18:0
3A
GB
AG
NO
NA
KO
UC
SK
1 03
031
Fem
ale
166
cm70
kgS
ome
exer
cise
527
6153
0.5
Med
ium
56.
625
.40
1480
2220
6.6
22.
9 4
7.1
35.
2 3
2.8
67.
2 5
0.3
21/0
5/20
077:
18:0
3M
OU
SS
AE
NY
ON
AM
CS
K1
031
28F
emal
e15
7cm
60kg
Som
e ex
erci
se63
572
639.
1M
ediu
m 5
6.6
24.3
413
8220
73 6
.5 2
2.3
37.
7 2
8.0
37.
1 6
2.9
46.
7
29/0
5/20
077:
18:0
3M
OU
SS
AE
NY
ON
AM
CS
K1
031
28F
emal
e15
7cm
61kg
Som
e ex
erci
se67
872
681.
8M
ediu
m 5
6.6
24.7
513
9120
87 6
.1 2
4.1
36.
9 2
7.0
39.
6 6
0.4
44.
3
04/0
6/20
077:
18:0
3M
OU
SS
AE
NY
ON
AM
CS
K1
031
28F
emal
e15
7cm
61kg
Som
e ex
erci
se55
866
561.
9M
ediu
m 5
6.6
24.7
513
9120
87 6
.7 2
0.6
40.
4 3
0.5
33.
8 6
6.2
50.
0
11/0
6/20
077:
18:0
3M
OU
SS
AE
NY
ON
AM
CS
K1
031
28F
emal
e15
7cm
61kg
Som
e ex
erci
se60
074
604.
5M
ediu
m 5
6.6
24.7
513
9120
87 7
.0 2
2.1
38.
9 2
9.1
36.
2 6
3.8
47.
7
25/0
6/20
077:
18:0
3M
OU
SS
AE
NY
ON
AM
CS
K1
031
28F
emal
e15
7cm
59kg
Som
e ex
erci
se60
074
604.
5M
ediu
m 5
6.6
23.9
413
7220
58 7
.0 2
0.4
38.
6 2
8.9
34.
6 6
5.4
49.
0
09/0
7/20
077:
18:0
3M
OU
SS
AE
NY
ON
AM
CS
K1
031
28F
emal
e15
7cm
58kg
Som
e ex
erci
se61
270
616.
0M
ediu
m 5
6.6
23.5
313
6220
44 6
.5 2
0.0
38.
0 2
8.4
34.
4 6
5.6
49.
0
13/0
7/20
077:
18:0
3M
OU
SS
AE
NY
ON
AM
CS
K1
031
28F
emal
e15
7cm
58kg
Som
e ex
erci
se61
976
623.
6M
ediu
m 5
6.6
23.5
313
6220
44 7
.0 2
0.2
37.
8 2
8.2
34.
8 6
5.2
48.
7
02/0
7/20
077:
18:0
3M
OU
SS
AE
NY
ON
AM
CS
K1
031
28F
emal
e15
7cm
58kg
Som
e ex
erci
se63
179
635.
9M
ediu
m 5
6.6
23.5
313
6220
44 7
.1 2
0.5
37.
5 2
7.9
35.
3 6
4.7
48.
1
21/0
5/20
077:
42:1
6S
IMP
IA
TA
WA
CS
K1
032
42F
emal
e17
4cm
90kg
Som
e ex
erci
se61
858
620.
7S
mal
l 5
6.6
29.7
316
3424
52 5
.4 4
0.4
49.
6 3
6.0
44.
9 5
5.1
40.
0
29/0
5/20
077:
42:1
6S
IMP
IA
TA
WA
CS
K1
032
42F
emal
e17
4cm
90kg
Som
e ex
erci
se64
164
644.
2S
mal
l 5
6.6
29.7
316
3424
52 5
.7 4
1.3
48.
7 3
5.2
45.
9 5
4.1
39.
1
04/0
6/20
077:
42:1
6S
IMP
IA
TA
WA
CS
K1
032
42F
emal
e17
4cm
91kg
Som
e ex
erci
se67
957
681.
4S
mal
l 5
6.6
30.0
616
4424
66 4
.8 4
3.3
47.
7 3
4.1
47.
6 5
2.4
37.
5
11/0
6/20
077:
42:1
6S
IMP
IA
TA
WA
CS
K1
032
42F
emal
e17
4cm
91kg
Som
e ex
erci
se60
061
603.
1S
mal
l 5
6.6
30.0
616
4424
66 5
.8 4
0.5
50.
5 3
6.7
44.
5 5
5.5
40.
4
25/0
6/20
077:
42:1
6S
IMP
IA
TA
WA
CS
K1
032
42F
emal
e17
4cm
91kg
Som
e ex
erci
se60
962
612.
1S
mal
l 5
6.6
30.0
616
4424
66 5
.8 4
0.9
50.
1 3
6.4
44.
9 5
5.1
40.
0
02/0
7/20
077:
42:1
6S
IMP
IA
TA
WA
CS
K1
032
42F
emal
e17
4cm
92kg
Som
e ex
erci
se61
166
614.
6S
mal
l 5
6.6
30.3
916
5424
81 6
.2 4
1.8
50.
2 3
6.4
45.
4 5
4.6
39.
6
09/0
7/20
077:
42:1
6S
IMP
IA
TA
WA
CS
K1
032
42F
emal
e17
4cm
91kg
Som
e ex
erci
se67
967
682.
3S
mal
l 5
6.6
30.0
616
4424
66 5
.6 4
3.3
47.
7 3
4.1
47.
6 5
2.4
37.
5
13/0
7/20
077:
42:1
6S
IMP
IA
TA
WA
CS
K1
032
42F
emal
e17
4cm
91kg
Som
e ex
erci
se61
766
620.
5S
mal
l 5
6.6
30.0
616
4424
66 6
.1 4
1.2
49.
8 3
6.1
45.
3 5
4.7
39.
7
21/0
5/20
077:
42:1
6B
ALO
KO
MLA
NC
SK
1 03
339
Mal
e17
0cm
82kg
Som
e ex
erci
se50
458
507.
3La
rge
56.
628
.37
1782
2852
6.6
26.
2 5
5.8
41.
4 3
2.0
68.
0 5
0.5
29/0
5/20
077:
42:1
6B
ALO
KO
MLA
NC
SK
1 03
339
Mal
e17
0cm
83kg
Som
e ex
erci
se50
957
512.
2La
rge
56.
628
.72
1796
2874
6.4
27.
3 5
5.7
41.
3 3
2.9
67.
1 4
9.8
04/0
6/20
077:
42:1
6B
ALO
KO
MLA
NC
SK
1 03
339
Mal
e17
0cm
83kg
Som
e ex
erci
se44
554
448.
3La
rge
56.
628
.72
1796
2874
6.9
22.
9 6
0.1
45.
0 2
7.6
72.
4 5
4.2
11/0
6/20
077:
42:1
6B
ALO
KO
MLA
NC
SK
1 03
339
Mal
e17
0cm
82kg
Som
e ex
erci
se46
456
467.
4La
rge
56.
628
.37
1782
2852
6.9
23.
6 5
8.4
43.
6 2
8.8
71.
2 5
3.2
25/0
6/20
077:
42:1
6B
ALO
KO
MLA
NC
SK
1 03
339
Mal
e17
0cm
82kg
Som
e ex
erci
se48
058
483.
5La
rge
56.
628
.37
1782
2852
6.9
24.
7 5
7.3
42.
7 3
0.2
69.
8 5
2.0
02/0
7/20
077:
42:1
6B
ALO
KO
MLA
NC
SK
1 03
339
Mal
e17
0cm
82kg
Som
e ex
erci
se48
159
484.
6La
rge
56.
628
.37
1782
2852
7.0
24.
8 5
7.2
42.
6 3
0.2
69.
8 5
2.0
09/0
7/20
077:
42:1
6B
ALO
KO
MLA
NC
SK
1 03
339
Mal
e17
0cm
83kg
Som
e ex
erci
se46
456
467.
4La
rge
56.
628
.72
1796
2874
6.9
24.
4 5
8.6
43.
8 2
9.4
70.
6 5
2.7
13/0
7/20
077:
42:1
6B
ALO
KO
MLA
NC
SK
1 03
339
Mal
e17
0cm
84kg
Som
e ex
erci
se45
756
460.
4La
rge
56.
629
.07
1810
2896
7.0
24.
6 5
9.4
44.
4 2
9.3
70.
7 5
2.8
21/0
5/20
077:
42:1
6H
IAB
OU
AD
EA
RM
AN
DE
CS
K1
034
25F
emal
e15
0cm
45kg
Som
e ex
erci
se64
660
648.
8S
mal
l 5
6.6
20.0
012
3918
59 5
.3 1
2.4
32.
6 2
4.5
27
.5 7
2.5
54.
5
29/0
5/20
077:
42:1
6H
IAB
OU
AD
EA
RM
AN
DE
CS
K1
034
25F
emal
e15
0cm
44kg
Som
e ex
erci
se70
882
712.
7S
mal
l 5
6.6
19.5
612
3018
45 6
.6 1
2.7
31.
3 2
3.0
28
.8 7
1.2
52.
3
04/0
6/20
077:
42:1
6H
IAB
OU
AD
EA
RM
AN
DE
CS
K1
034
25F
emal
e15
0cm
45kg
Som
e ex
erci
se65
775
661.
3S
mal
l 5
6.6
20.0
012
3918
59 6
.5 1
2.6
32.
4 2
4.2
28
.0 7
2.0
53.
9
11/0
6/20
077:
42:1
6H
IAB
OU
AD
EA
RM
AN
DE
CS
K1
034
25F
emal
e15
0cm
45kg
Som
e ex
erci
se69
883
702.
9S
mal
l 5
6.6
20.0
012
3918
59 6
.8 1
3.4
31.
6 2
3.3
29
.7 7
0.3
51.
9
25/0
6/20
077:
42:1
6H
IAB
OU
AD
EA
RM
AN
DE
CS
K1
034
25F
emal
e15
0cm
44kg
Som
e ex
erci
se68
280
686.
7S
mal
l 5
6.6
19.5
612
3018
45 6
.7 1
2.3
31.
7 2
3.6
27
.9 7
2.1
53.
6
02/0
7/20
077:
42:1
6H
IAB
OU
AD
EA
RM
AN
DE
CS
K1
034
25F
emal
e15
0cm
45kg
Som
e ex
erci
se65
576
659.
4S
mal
l 5
6.6
20.0
012
3918
59 6
.6 1
2.6
32.
4 2
4.3
28
.0 7
2.0
54.
0
09/0
7/20
077:
42:1
6H
IAB
OU
AD
EA
RM
AN
DE
CS
K1
034
25F
emal
e15
0cm
45kg
Som
e ex
erci
se67
280
676.
7S
mal
l 5
6.6
20.0
012
3918
59 6
.8 1
2.9
32.
1 2
3.9
28
.7 7
1.3
53.
1
13/0
7/20
077:
42:1
6H
IAB
OU
AD
EA
RM
AN
DE
CS
K1
034
25F
emal
e15
0cm
45kg
Som
e ex
erci
se68
380
687.
7S
mal
l 5
6.6
20.0
012
3918
59 6
.7 1
3.1
31.
9 2
3.7
29
.1 7
0.9
52.
6
21/0
5/20
078:
05:3
7A
SS
EM
EM
ILIE
NN
EC
SK
1 03
538
Fem
ale
150
cm46
kgS
ome
exer
cise
653
6365
6.0
Sm
all
43.
220
.44
1188
1782
5.5
13.
4 3
2.6
24.
5 2
9.1
70.
9 5
3.2
29/0
5/20
078:
05:3
7A
SS
EM
EM
ILIE
NN
EC
SK
1 03
538
Fem
ale
150
cm46
kgS
ome
exer
cise
697
7770
1.2
Sm
all
43.
220
.44
1188
1782
6.3
14.
2 3
1.8
23.
5 3
0.8
69.
2 5
1.0
04/0
6/20
078:
05:3
7A
SS
EM
EM
ILIE
NN
EC
SK
1 03
538
Fem
ale
150
cm47
kgS
ome
exer
cise
637
6764
0.5
Sm
all
43.
220
.89
1197
1796
6.0
13.
9 3
3.1
25.
0 2
9.5
70.
5 5
3.1
11/0
6/20
078:
05:3
7A
SS
EM
EM
ILIE
NN
EC
SK
1 03
538
Fem
ale
150
cm47
kgS
ome
exer
cise
621
6862
4.7
Sm
all
43.
220
.89
1197
1796
6.2
13.
5 3
3.5
25.
4 2
8.7
71.
3 5
4.0
25/0
6/20
078:
05:3
7A
SS
EM
EM
ILIE
NN
EC
SK
1 03
538
Fem
ale
150
cm46
kgS
ome
exer
cise
645
7064
8.8
Sm
all
43.
220
.44
1188
1782
6.2
13.
2 3
2.8
24.
6 2
8.7
71.
3 5
3.6
02/0
7/20
078:
05:3
7A
SS
EM
EM
ILIE
NN
EC
SK
1 03
538
Fem
ale
150
cm46
kgS
ome
exer
cise
642
6764
5.5
Sm
all
43.
220
.44
1188
1782
6.0
13.
1 3
2.9
24.
7 2
8.6
71.
4 5
3.7
09/0
7/20
078:
05:3
7A
SS
EM
EM
ILIE
NN
EC
SK
1 03
538
Fem
ale
150
cm46
kgS
ome
exer
cise
626
6762
9.6
Sm
all
43.
220
.44
1188
1782
6.1
12.
8 3
3.2
25.
1 2
7.8
72.
2 5
4.6
8B
IA T
ES
T K
OD
JOV
IAK
OP
E F
INA
L F
inal
F 2
.xls
BIA
TE
ST
KO
DJA
VIA
KO
PE
FIN
AL
Tes
t D
ate
Tes
t T
ime
Las
t N
ame
Fir
st N
ame
Su
bje
ct ID
Ag
eG
end
erH
eig
ht
Wei
gh
tA
ctiv
ity
Lev
elR
esis
tan
ceR
eact
ance
Imp
edan
ceF
ram
e S
ize
Tar
get
W
eig
ht
BM
IB
MR
DE
EP
has
e A
ng
leF
at w
tF
FM
wt
TB
W
liter
sF
at %
o
f w
tF
FM
%
of
wt
TB
W %
o
f w
t
13/0
7/20
078:
05:3
7A
SS
EM
EM
ILIE
NN
EC
SK
1 03
538
Fem
ale
150
cm46
kgS
ome
exer
cise
673
7067
6.6
Sm
all
43.
220
.44
1188
1782
5.9
13.
8 3
2.2
24.
0 2
9.9
70.
1 5
2.2
21/0
5/20
078:
11:2
4A
DA
MA
DO
UK
OM
IC
SK
1 03
628
Mal
e19
0cm
83kg
Som
e ex
erci
se44
744
449.
2S
mal
l 4
3.2
22.9
919
7131
54 5
.6 1
2.6
70.
4 5
2.1
15.
1 8
4.9
62.
7
29/0
5/20
078:
11:2
4A
DA
MA
DO
UK
OM
IC
SK
1 03
628
Mal
e19
0cm
84kg
Som
e ex
erci
se43
645
438.
3S
mal
l 4
3.2
23.2
719
8531
76 5
.9 1
2.1
71.
9 5
3.2
14.
5 8
5.5
63.
3
04/0
6/20
078:
11:2
4A
DA
MA
DO
UK
OM
IC
SK
1 03
628
Mal
e19
0cm
84kg
Som
e ex
erci
se43
146
433.
4S
mal
l 4
3.2
23.2
719
8531
76 6
.1 1
1.6
72.
4 5
3.6
13.
8 8
6.2
63.
8
11/0
6/20
078:
11:2
4A
DA
MA
DO
UK
OM
IC
SK
1 03
628
Mal
e19
0cm
79kg
Som
e ex
erci
se53
165
535.
0S
mal
l 4
3.2
21.8
819
1630
66 7
.0 1
6.7
62.
3 4
5.6
21.
1 7
8.9
57.
8
25/0
6/20
078:
11:2
4A
DA
MA
DO
UK
OM
IC
SK
1 03
628
Mal
e19
0cm
81kg
Som
e ex
erci
se44
247
444.
5S
mal
l 4
3.2
22.4
419
4331
10 6
.1 1
0.6
70.
4 5
2.1
13.
1 8
6.9
64.
4
02/0
7/20
078:
11:2
4A
DA
MA
DO
UK
OM
IC
SK
1 03
628
Mal
e19
0cm
82kg
Som
e ex
erci
se44
649
448.
7S
mal
l 4
3.2
22.7
119
5731
32 6
.3 1
1.7
70.
3 5
2.0
14.
3 8
5.7
63.
4
09/0
7/20
078:
11:2
4A
DA
MA
DO
UK
OM
IC
SK
1 03
628
Mal
e19
0cm
81kg
Som
e ex
erci
se48
150
483.
6S
mal
l 4
3.2
22.4
419
4331
10 5
.9 1
4.3
66.
7 4
9.2
17.
7 8
2.3
60.
7
13/0
7/20
078:
11:2
4A
DA
MA
DO
UK
OM
IC
SK
1 03
628
Mal
e19
0cm
82kg
Som
e ex
erci
se46
150
463.
7S
mal
l 4
3.2
22.7
119
5731
32 6
.2 1
3.2
68.
8 5
0.8
16.
1 8
3.9
61.
9
21/0
5/20
078:
17:0
7Z
AN
KP
EA
MA
HC
SK
1 03
718
Fem
ale
150
cm50
kgS
ome
exer
cise
701
7570
5.0
Sm
all
43.
222
.22
1320
1980
6.1
17.
6 3
2.4
23.
8 3
5.1
64.
9 4
7.7
29/0
5/20
078:
17:0
7Z
AN
KP
EA
MA
HC
SK
1 03
718
Fem
ale
150
cm51
kgS
ome
exer
cise
668
7667
2.3
Sm
all
43.
222
.67
1330
1995
6.5
17.
8 3
3.2
24.
7 3
5.0
65.
0 4
8.4
04/0
6/20
078:
17:0
7Z
AN
KP
EA
MA
HC
SK
1 03
718
Fem
ale
150
cm49
kgS
ome
exer
cise
629
6663
2.5
Sm
all
43.
221
.78
1310
1966
6.0
15.
3 3
3.7
25.
4 3
1.3
68.
7 5
1.8
11/0
6/20
078:
17:0
7Z
AN
KP
EA
MA
HC
SK
1 03
718
Fem
ale
150
cm49
kgS
ome
exer
cise
595
5759
7.7
Sm
all
43.
221
.78
1310
1966
5.5
14.
5 3
4.5
26.
3 2
9.5
70.
5 5
3.7
25/0
6/20
078:
17:0
7Z
AN
KP
EA
MA
HC
SK
1 03
718
Fem
ale
150
cm48
kgS
ome
exer
cise
629
6463
2.2
Sm
all
43.
221
.33
1301
1951
5.8
14.
5 3
3.5
25.
3 3
0.2
69.
8 5
2.6
02/0
7/20
078:
17:0
7Z
AN
KP
EA
MA
HC
SK
1 03
718
Fem
ale
150
cm48
kgS
ome
exer
cise
648
7265
2.0
Sm
all
43.
221
.33
1301
1951
6.3
14.
9 3
3.1
24.
8 3
1.1
68.
9 5
1.7
09/0
7/20
078:
17:0
7Z
AN
KP
EA
MA
HC
SK
1 03
718
Fem
ale
150
cm50
kgS
ome
exer
cise
643
6964
6.7
Sm
all
43.
222
.22
1320
1980
6.1
16.
5 3
3.5
25.
1 3
3.0
67.
0 5
0.3
13/0
7/20
078:
17:0
7Z
AN
KP
EA
MA
HC
SK
1 03
718
Fem
ale
150
cm50
kgS
ome
exer
cise
621
6762
4.6
Sm
all
43.
222
.22
1320
1980
6.2
16.
0 3
4.0
25.
7 3
2.0
68.
0 5
1.4
21/0
5/20
078:
17:0
7T
OS
SO
UK
PE
CH
RIS
TIN
EC
SK
1 03
835
Fem
ale
148
cm38
kgS
ome
exer
cise
688
7469
2.0
Sm
all
43.
217
.35
1121
1682
6.1
8.0
30.
0 2
2.4
21.
0 7
9.0
58.
9
29/0
5/20
078:
17:0
7T
OS
SO
UK
PE
CH
RIS
TIN
EC
SK
1 03
835
Fem
ale
148
cm39
kgS
ome
exer
cise
696
7369
9.8
Sm
all
43.
217
.80
1131
1697
6.0
8.9
30.
1 2
2.3
22.
9 7
7.1
57.
2
04/0
6/20
078:
17:0
7T
OS
SO
UK
PE
CH
RIS
TIN
EC
SK
1 03
835
Fem
ale
148
cm39
kgS
ome
exer
cise
664
7266
7.9
Sm
all
43.
217
.80
1131
1697
6.2
8.4
30.
6 2
3.0
21.
5 7
8.5
59.
0
11/0
6/20
078:
17:0
7T
OS
SO
UK
PE
CH
RIS
TIN
EC
SK
1 03
835
Fem
ale
148
cm39
kgS
ome
exer
cise
632
7263
6.1
Sm
all
43.
217
.80
1131
1697
6.5
7.7
31.
3 2
3.8
19.
9 8
0.1
60.
9
25/0
6/20
078:
17:0
7T
OS
SO
UK
PE
CH
RIS
TIN
EC
SK
1 03
835
Fem
ale
148
cm39
kgS
ome
exer
cise
634
6863
7.6
Sm
all
43.
217
.80
1131
1697
6.1
7.8
31.
2 2
3.7
20.
0 8
0.0
60.
8
02/0
7/20
078:
17:0
7T
OS
SO
UK
PE
CH
RIS
TIN
EC
SK
1 03
835
Fem
ale
148
cm38
kgS
ome
exer
cise
658
7866
2.6
Sm
all
43.
217
.35
1121
1682
6.8
7.4
30.
6 2
3.0
19.
6 8
0.4
60.
6
09/0
7/20
078:
17:0
7T
OS
SO
UK
PE
CH
RIS
TIN
EC
SK
1 03
835
Fem
ale
148
cm38
kgS
ome
exer
cise
658
7666
2.4
Sm
all
43.
217
.35
1121
1682
6.6
7.4
30.
6 2
3.0
19.
6 8
0.4
60.
6
13/0
7/20
078:
17:0
7T
OS
SO
UK
PE
CH
RIS
TIN
EC
SK
1 03
835
Fem
ale
148
cm38
kgS
ome
exer
cise
661
8366
6.2
Sm
all
43.
217
.35
1121
1682
7.2
7.5
30.
5 2
3.0
19.
8 8
0.2
60.
4
21/0
5/20
078:
26:1
8A
GB
EG
NIN
OK
OK
OU
CS
K1
039
44M
ale
175
cm74
kgS
ome
exer
cise
537
6354
0.7
Sm
all
43.
224
.16
1663
2661
6.7
20.
1 5
3.9
39.
8 2
7.1
72.
9 5
3.8
29/0
5/20
078:
26:1
8A
GB
EG
NIN
OK
OK
OU
CS
K1
039
44M
ale
175
cm76
kgS
ome
exer
cise
470
5447
3.1
Sm
all
43.
224
.82
1691
2705
6.6
17.
2 5
8.8
43.
8 2
2.7
77.
3 5
7.7
04/0
6/20
078:
26:1
8A
GB
EG
NIN
OK
OK
OU
CS
K1
039
44M
ale
175
cm77
kgS
ome
exer
cise
470
5647
3.3
Sm
all
43.
225
.14
1704
2727
6.8
18.
0 5
9.0
44.
0 2
3.3
76.
7 5
7.2
11/0
6/20
078:
26:1
8A
GB
EG
NIN
OK
OK
OU
CS
K1
039
44M
ale
175
cm77
kgS
ome
exer
cise
489
6049
2.7
Sm
all
43.
225
.14
1704
2727
7.0
19.
3 5
7.7
42.
9 2
5.1
74.
9 5
5.7
25/0
6/20
078:
26:1
8A
GB
EG
NIN
OK
OK
OU
CS
K1
039
44M
ale
175
cm77
kgS
ome
exer
cise
465
5646
8.4
Sm
all
43.
225
.14
1704
2727
6.9
17.
6 5
9.4
44.
3 2
2.8
77.
2 5
7.6
02/0
7/20
078:
26:1
8A
GB
EG
NIN
OK
OK
OU
CS
K1
039
44M
ale
175
cm76
kgS
ome
exer
cise
483
6148
6.8
Sm
all
43.
224
.82
1691
2705
7.2
18.
2 5
7.8
43.
0 2
3.9
76.
1 5
6.6
09/0
7/20
078:
26:1
8A
GB
EG
NIN
OK
OK
OU
CS
K1
039
44M
ale
175
cm79
kgS
ome
exer
cise
469
5347
2.0
Sm
all
43.
225
.80
1732
2772
6.4
19.
4 5
9.6
44.
4 2
4.5
75.
5 5
6.2
13/0
7/20
078:
26:1
8A
GB
EG
NIN
OK
OK
OU
CS
K1
039
44M
ale
175
cm79
kgS
ome
exer
cise
498
6150
1.7
Sm
all
43.
225
.80
1732
2772
7.0
21.
4 5
7.6
42.
7 2
7.1
72.
9 5
4.1
09/0
7/20
079:
50:4
0G
UE
VO
NT
HE
RE
SE
CS
K1
017
33F
emal
e15
0cm
95kg
Som
e ex
erci
se47
960
482.
7La
rge
47.
542
.22
1682
2523
7.1
48.
2 4
6.8
35.
6 5
0.7
49.
3 3
7.5
29/0
5/20
0711
:58:
55A
MO
UZ
OU
ER
NE
ST
INE
CS
K1
005
52F
emal
e15
1cm
86kg
Som
e ex
erci
se52
450
526.
4La
rge
34.
337
.72
1508
2262
5.5
42.
4 4
3.6
33.
0 4
9.3
50.
7 3
8.4
11/0
6/20
0710
:00:
32K
AN
GN
IE
DO
HC
SK
1 00
928
Fem
ale
162
cm66
kgS
ome
exer
cise
546
6655
0.0
Med
ium
53.
925
.15
1448
2173
6.9
22.
3 4
3.7
32.
8 3
3.7
66.
3 4
9.7
9B
IA T
ES
T K
OD
JOV
IAK
OP
E F
INA
L F
inal
F 2
.xls
BIA
TE
ST
AG
OU
FIN
AL
Tes
t D
ate
Tes
t T
ime
Las
t N
ame
Fir
st
Nam
eS
ub
ject
IDA
ge
Gen
der
Hei
gh
tW
eig
ht
Act
ivit
y L
eve
Res
ista
nce
Rea
ctan
ceIm
ped
ance
Fra
me
Siz
eT
arg
et
Wei
gh
tB
MI
BM
RD
EE
Ph
ase
An
gle
Fat
wt
FF
M w
tT
BW
lit
ers
Fat
%
of
wt
FF
M %
o
f w
tT
BW
%
of
wt
16/0
4/20
073:
07:2
8K
PO
GO
KO
FF
IH
BA
1 00
152
Mal
e16
8cm
55kg
Mod
erat
e ex
e41
948
421.
7M
ediu
m 6
4.8
19.4
913
1122
30 6
.5 1
.1 5
3.9
41.
1 1
.9 9
8.1
74.
8
23/0
4/20
073:
13:3
2K
PO
GO
KO
FF
IH
BA
1 00
152
Mal
e16
8cm
58kg
Mod
erat
e ex
e42
248
424.
7M
ediu
m 6
4.8
20.5
513
5323
00 6
.5 3
.5 5
4.5
41.
4 6
.1 9
3.9
71.
4
30/0
4/20
073:
13:3
2K
PO
GO
KO
FF
IH
BA
1 00
152
Mal
e16
8cm
59kg
Mod
erat
e ex
e41
046
412.
6M
ediu
m 6
4.8
20.9
013
6723
24 6
.4 3
.2 5
5.8
42.
5 5
.4 9
4.6
72.
0
07/0
5/20
073:
13:3
2K
PO
GO
KO
FF
IH
BA
1 00
152
Mal
e16
8cm
60kg
Mod
erat
e ex
e30
965
315.
8M
ediu
m 6
4.8
21.2
613
8023
47 1
1.9
-9.
2 6
9.2
52.
8-1
5.4
115.
4 8
8.0
04/0
4/20
073:
13:3
2G
AS
SO
UY
AW
AH
BA
1 00
241
Fem
ale
159
cm63
kgM
oder
ate
exe
582
6858
6.0
Med
ium
64.
824
.92
1353
2165
6.7
22.
4 4
0.6
30.
4 3
5.6
64.
4 4
8.3
11/0
4/20
073:
13:3
2G
AS
SO
UY
AW
AH
BA
1 00
241
Fem
ale
159
cm62
kgM
oder
ate
exe
570
6657
3.8
Med
ium
64.
824
.52
1343
2150
6.6
21.
1 4
0.9
30.
7 3
4.1
65.
9 4
9.5
18/0
4/20
073:
13:3
2G
AS
SO
UY
AW
AH
BA
1 00
241
Fem
ale
159
cm63
kgM
oder
ate
exe
557
7156
1.5
Med
ium
64.
824
.92
1353
2165
7.3
21.
4 4
1.6
31.
3 3
4.0
66.
0 4
9.7
25/0
4/20
073:
13:3
2G
AS
SO
UY
AW
AH
BA
1 00
241
Fem
ale
159
cm63
kgM
oder
ate
exe
547
6955
1.3
Med
ium
64.
824
.92
1353
2165
7.2
21.
0 4
2.0
31.
7 3
3.4
66.
6 5
0.3
02/0
5/20
073:
13:3
2G
AS
SO
UY
AW
AH
BA
1 00
241
Fem
ale
159
cm65
kgM
oder
ate
exe
510
8451
6.9
Med
ium
64.
825
.71
1372
2196
9.4
20.
9 4
4.1
33.
4 3
2.2
67.
8 5
1.4
11/0
4/20
074:
12:5
1E
DO
HK
OD
ZO
HB
A1
003
47M
ale
177
cm55
kgM
oder
ate
exe
534
6053
7.4
Sm
all
64.
817
.56
1390
2364
6.4
5.0
50.
0 3
7.2
9.1
90.
9 6
7.7
18/0
4/20
074:
12:5
1E
DO
HK
OD
ZO
HB
A1
003
47M
ale
177
cm56
kgM
oder
ate
exe
525
6052
8.4
Sm
all
64.
817
.87
1404
2387
6.5
5.2
50.
8 3
7.9
9.3
90.
7 6
7.6
25/0
4/20
074:
20:5
9E
DO
HK
OD
ZO
HB
A1
003
47M
ale
177
cm59
kgM
oder
ate
exe
493
5449
5.9
Sm
all
64.
818
.83
1446
2458
6.3
5.4
53.
6 4
0.1
9.1
90.
9 6
8.0
02/0
5/20
074:
21:3
3E
DO
HK
OD
ZO
HB
A1
003
47M
ale
177
cm58
kgM
oder
ate
exe
545
6754
9.1
Sm
all
64.
818
.51
1432
2434
7.0
7.8
50.
2 3
7.2
13.
5 8
6.5
64
.2
11/0
4/20
074:
44:4
5A
KA
KP
OM
AW
UN
YOH
BA
1 00
537
Fem
ale
163
cm70
kgM
oder
ate
exe
620
6562
3.4
Med
ium
64.
826
.35
1446
2314
6.0
28.
0 4
2.0
30.
9 4
0.0
60.
0 4
4.2
18/0
4/20
074:
44:4
5A
KA
KP
OM
AW
UN
YOH
BA
1 00
537
Fem
ale
163
cm69
kgM
oder
ate
exe
624
7562
8.5
Med
ium
64.
825
.97
1437
2299
6.9
27.
3 4
1.7
30.
7 3
9.6
60.
4 4
4.5
25/0
4/20
074:
44:4
5A
KA
KP
OM
AW
UN
YOH
BA
1 00
537
Fem
ale
163
cm70
kgM
oder
ate
exe
639
7164
2.9
Med
ium
64.
826
.35
1446
2314
6.3
28.
6 4
1.4
30.
4 4
0.9
59.
1 4
3.4
02/0
5/20
074:
44:4
5A
KA
KP
OM
AW
UN
YOH
BA
1 00
537
Fem
ale
163
cm69
kgM
oder
ate
exe
623
6962
6.8
Med
ium
64.
825
.97
1437
2299
6.3
27.
3 4
1.7
30.
7 3
9.5
60.
5 4
4.5
11/0
4/20
074:
51:3
6A
GB
ON
ON
YA
WO
VI P
HB
A1
006
68M
ale
164
cm62
kgM
oder
ate
exe
528
5253
0.6
Med
ium
64.
823
.05
1279
2175
5.6
15.
3 4
6.7
35.
0 2
4.7
75.
3 5
6.4
04/0
4/20
074:
56:1
4A
GB
ON
ON
YA
WO
VI P
HB
A1
006
68M
ale
164
cm63
kgM
oder
ate
exe
505
4850
7.3
Med
ium
64.
823
.42
1293
2198
5.4
14.
9 4
8.1
36.
2 2
3.6
76.
4 5
7.5
18/0
4/20
074:
58:3
1A
GB
ON
ON
YA
WO
VI P
HB
A1
006
68M
ale
164
cm62
kgM
oder
ate
exe
493
5149
5.6
Med
ium
64.
823
.05
1279
2175
5.9
13.
5 4
8.5
36.
6 2
1.7
78.
3 5
9.0
25/0
4/20
075:
02:0
2A
GB
ON
ON
YA
WO
VI P
HB
A1
006
68M
ale
164
cm64
kgM
oder
ate
exe
505
5250
7.7
Med
ium
64.
823
.80
1307
2222
5.9
15.
6 4
8.4
36.
4 2
4.4
75.
6 5
6.8
02/0
5/20
075:
02:0
2A
GB
ON
ON
YA
WO
VI P
HB
A1
006
68M
ale
164
cm63
kgM
oder
ate
exe
509
5151
1.5
Med
ium
64.
823
.42
1293
2198
5.7
15.
1 4
7.9
36.
0 2
3.9
76.
1 5
7.2
16/0
4/20
075:
08:5
0T
OS
SIN
YA
DK
OF
FI
HB
A1
007
65M
ale
175
cm55
kgM
oder
ate
exe
607
5460
9.4
Med
ium
64.
817
.96
1258
2139
5.1
9.3
45.
7 3
3.5
16.
9 8
3.1
61.
0
23/0
4/20
075:
09:1
6T
OS
SIN
YA
DK
OF
FI
HB
A1
007
65M
ale
175
cm57
kgM
oder
ate
exe
622
5862
4.7
Med
ium
64.
818
.61
1286
2186
5.3
11.
3 4
5.7
33.
3 1
9.8
80.
2 5
8.5
30/0
4/20
075:
10:5
2T
OS
SIN
YA
DK
OF
FI
HB
A1
007
65M
ale
175
cm60
kgM
oder
ate
exe
586
5658
8.7
Med
ium
64.
819
.59
1327
2256
5.5
12.
1 4
7.9
35.
2 2
0.2
79.
8 5
8.7
07/0
5/20
075:
12:4
5T
OS
SIN
YA
DK
OF
FI
HB
A1
007
65M
ale
175
cm60
kgM
oder
ate
exe
428
8143
5.6
Med
ium
64.
819
.59
1327
2256
10.
7 1
.9 5
8.1
43.
9 3
.1 9
6.9
73.
2
04/0
4/20
075:
19:3
3P
AN
IZI
BE
BE
HB
A1
008
23F
emal
e17
2cm
51kg
Mod
erat
e ex
e70
165
704.
0M
ediu
m 6
4.8
17.2
413
4621
53 5
.3 1
1.4
39.
6 2
8.5
22.
3 7
7.7
55.
9
11/0
4/20
075:
19:3
3P
AN
IZI
BE
BE
HB
A1
008
23F
emal
e17
2cm
51kg
Mod
erat
e ex
e68
764
690.
0M
ediu
m 6
4.8
17.2
413
4621
53 5
.3 1
1.0
40.
0 2
8.9
21.
6 7
8.4
56.
6
18/0
4/20
075:
19:3
3P
AN
IZI
BE
BE
HB
A1
008
23F
emal
e17
2cm
52kg
Mod
erat
e ex
e64
961
651.
9M
ediu
m 6
4.8
17.5
813
5521
69 5
.4 1
0.7
41.
3 3
0.1
20.
5 7
9.5
58.
0
25/0
4/20
075:
19:3
3P
AN
IZI
BE
BE
HB
A1
008
23F
emal
e17
2cm
51kg
Mod
erat
e ex
e68
175
685.
1M
ediu
m 6
4.8
17.2
413
4621
53 6
.3 1
0.8
40.
2 2
9.1
21.
2 7
8.8
57.
0
02/0
5/20
075:
28:2
3P
AN
IZI
BE
BE
HB
A1
008
23F
emal
e17
2cm
52kg
Mod
erat
e ex
e65
559
657.
7M
ediu
m 6
4.8
17.5
813
5521
69 5
.1 1
0.9
41.
1 2
9.9
20.
9 7
9.1
57.
6
04/0
4/20
075:
37:5
3A
TT
IKP
OY
AW
AH
BA
1 00
930
Fem
ale
160
cm48
kgM
oder
ate
exe
573
6157
6.2
Sm
all
64.
818
.75
1262
2020
6.1
9.2
38.
8 2
9.3
19.
2 8
0.8
61.
0
11/0
4/20
075:
37:5
3A
TT
IKP
OY
AW
AH
BA
1 00
930
Fem
ale
160
cm48
kgM
oder
ate
exe
570
6157
3.3
Sm
all
64.
818
.75
1262
2020
6.1
9.1
38.
9 2
9.4
18.
9 8
1.1
61.
2
18/0
4/20
075:
37:5
3A
TT
IKP
OY
AW
AH
BA
1 00
930
Fem
ale
160
cm49
kgM
oder
ate
exe
550
5955
3.2
Sm
all
64.
819
.14
1272
2036
6.1
9.1
39.
9 3
0.2
18.
6 8
1.4
61.
7
25/0
4/20
075:
37:5
3A
TT
IKP
OY
AW
AH
BA
1 00
930
Fem
ale
160
cm50
kgM
oder
ate
exe
572
6757
5.9
Sm
all
64.
819
.53
1282
2051
6.7
10.
8 3
9.2
29.
5 2
1.7
78.
3 5
9.1
02/0
5/20
075:
37:5
3A
TT
IKP
OY
AW
AH
BA
1 00
930
Fem
ale
160
cm51
kgM
oder
ate
exe
595
6659
8.6
Sm
all
64.
819
.92
1291
2066
6.3
12.
5 3
8.5
28.
9 2
4.5
75.
5 5
6.6
16/0
4/20
075:
46:5
7S
EW
OA
DA
EN
YO
VI
HB
A1
010
25F
emal
e15
8cm
55kg
Mod
erat
e ex
e48
051
482.
7M
ediu
m 6
4.8
22.0
313
5021
60 6
.1 1
1.4
43.
6 3
3.4
20.
7 7
9.3
60.
7
23/0
4/20
075:
46:5
7S
EW
OA
DA
EN
YO
VI
HB
A1
010
25F
emal
e15
8cm
56kg
Mod
erat
e ex
e54
864
551.
7M
ediu
m 6
4.8
22.4
313
5921
75 6
.7 1
5.6
40.
4 3
0.6
27.
9 7
2.1
54.
6
30/0
4/20
075:
46:5
7S
EW
OA
DA
EN
YO
VI
HB
A1
010
25F
emal
e15
8cm
58kg
Mod
erat
e ex
e50
758
510.
3M
ediu
m 6
4.8
23.2
313
7822
06 6
.5 1
5.4
42.
6 3
2.5
26.
6 7
3.4
56.
0
07/0
5/20
075:
49:2
4S
EW
OA
DA
EN
YO
VI
HB
A1
010
25F
emal
e15
8cm
60kg
Mod
erat
e ex
e52
060
523.
5M
ediu
m 6
4.8
24.0
313
9822
36 6
.6 1
7.7
42.
3 3
2.1
29.
5 7
0.5
53.
6
04/0
4/20
075:
57:3
1A
YIK
OE
AY
OK
OH
BA
1 01
135
Fem
ale
168
cm40
kgM
oder
ate
exe
852
6585
4.5
Sm
all
64.
814
.17
1177
1883
4.4
6.1
33.
9 2
3.2
15.
3 8
4.7
57.
9
11/0
4/20
076:
01:4
0A
YIK
OE
AY
OK
OH
BA
1 01
135
Fem
ale
168
cm42
kgM
oder
ate
exe
772
5777
4.1
Sm
all
64.
814
.88
1196
1913
4.2
6.7
35.
3 2
4.9
15.
9 8
4.1
59.
4
18/0
4/20
076:
01:4
0A
YIK
OE
AY
OK
OH
BA
1 01
135
Fem
ale
168
cm43
kgM
oder
ate
exe
747
6374
9.7
Sm
all
64.
815
.24
1205
1929
4.8
7.1
35.
9 2
5.6
16.
4 8
3.6
59.
6
25/0
4/20
076:
03:3
7A
YIK
OE
AY
OK
OH
BA
1 01
135
Fem
ale
168
cm43
kgM
oder
ate
exe
745
6474
7.7
Sm
all
64.
815
.24
1205
1929
4.9
7.0
36.
0 2
5.7
16.
3 8
3.7
59.
7
02/0
5/20
076:
10:2
1A
YIK
OE
AY
OK
OH
BA
1 01
135
Fem
ale
168
cm44
kgM
oder
ate
exe
746
6674
8.9
Sm
all
64.
815
.59
1215
1944
5.1
7.9
36.
1 2
5.7
17.
9 8
2.1
58.
5
16/0
4/20
076:
14:5
0D
UM
AH
EK
OD
ZO
HB
A1
012
56M
ale
167
cm58
kgM
oder
ate
exe
473
4947
5.5
Sm
all
64.
820
.80
1321
2245
5.9
7.9
50.
1 3
7.9
13.
7 8
6.3
65.
3
30/0
4/20
076:
17:5
1D
UM
AH
EK
OD
ZO
HB
A1
012
56M
ale
167
cm59
kgM
oder
ate
exe
497
5349
9.8
Sm
all
64.
821
.16
1334
2269
6.1
10.
2 4
8.8
36.
8 1
7.3
82.
7 6
2.3
07/0
5/20
076:
17:5
1D
UM
AH
EK
OD
ZO
HB
A1
012
56M
ale
167
cm60
kgM
oder
ate
exe
356
7736
4.2
Sm
all
64.
821
.51
1348
2292
12.
2 -
1.5
61.
5 4
6.9
-2.
410
2.4
78.
2
23/0
4/20
076:
17:5
1D
UM
AH
EK
OD
ZO
HB
A1
012
56M
ale
167
cm57
kgM
oder
ate
exe
498
5350
0.8
Sm
all
64.
820
.44
1307
2222
6.1
8.8
48.
2 3
6.4
15.
4 8
4.6
63.
8
1B
IA T
ES
T A
GO
U F
INA
L F
inal
F 2
.xls
BIA
TE
ST
AG
OU
FIN
AL
Tes
t D
ate
Tes
t T
ime
Las
t N
ame
Fir
st
Nam
eS
ub
ject
IDA
ge
Gen
der
Hei
gh
tW
eig
ht
Act
ivit
y L
eve
Res
ista
nce
Rea
ctan
ceIm
ped
ance
Fra
me
Siz
eT
arg
et
Wei
gh
tB
MI
BM
RD
EE
Ph
ase
An
gle
Fat
wt
FF
M w
tT
BW
lit
ers
Fat
%
of
wt
FF
M %
o
f w
tT
BW
%
of
wt
04/0
4/20
076:
28:0
2Y
AB
EA
NA
AF
FIT
EY
HB
A1
013
30M
ale
176
cm78
kgM
oder
ate
exe
425
5542
8.5
Med
ium
64.
825
.18
1818
3092
7.4
14.
3 6
3.7
47.
7 1
8.4
81.
6 6
1.1
11/0
4/20
076:
28:0
2Y
AB
EA
NA
AF
FIT
EY
HB
A1
013
30M
ale
176
cm78
kgM
oder
ate
exe
425
5842
8.9
Med
ium
64.
825
.18
1818
3092
7.8
14.
3 6
3.7
47.
7 1
8.4
81.
6 6
1.1
18/0
4/20
076:
28:0
2Y
AB
EA
NA
AF
FIT
EY
HB
A1
013
30M
ale
176
cm76
kgM
oder
ate
exe
450
6645
4.8
Med
ium
64.
824
.54
1791
3045
8.3
15.
1 6
0.9
45.
5 1
9.9
80.
1 5
9.9
25/0
4/20
076:
28:0
2Y
AB
EA
NA
AF
FIT
EY
HB
A1
013
30M
ale
176
cm73
kgM
oder
ate
exe
429
6143
3.3
Med
ium
64.
823
.57
1749
2974
8.1
11.
0 6
2.0
46.
5 1
5.1
84.
9 6
3.7
02/0
5/20
076:
40:1
1Y
AB
EA
NA
AF
FIT
EY
HB
A1
013
30M
ale
176
cm75
kgM
oder
ate
exe
459
6346
3.3
Med
ium
64.
824
.21
1777
3021
7.8
15.
1 5
9.9
44.
7 2
0.2
79.
8 5
9.6
04/0
4/20
076:
44:1
6D
AC
HI
KO
FF
I ED
OHB
A1
014
43M
ale
165
cm45
kgM
oder
ate
exe
610
4061
1.3
Sm
all
64.
816
.53
1220
2074
3.8
5.6
39.
4 2
9.2
12.
5 8
7.5
64.
8
11/0
4/20
076:
44:1
6D
AC
HI
KO
FF
I ED
OHB
A1
014
43M
ale
165
cm45
kgM
oder
ate
exe
559
3756
0.2
Sm
all
64.
816
.53
1220
2074
3.8
3.7
41.
3 3
1.0
8.3
91.
7 6
8.9
18/0
4/20
076:
44:1
6D
AC
HI
KO
FF
I ED
OHB
A1
014
43M
ale
165
cm47
kgM
oder
ate
exe
569
3757
0.2
Sm
all
64.
817
.26
1247
2121
3.7
5.6
41.
4 3
1.0
12.
0 8
8.0
65.
9
25/0
4/20
076:
44:1
6D
AC
HI
KO
FF
I ED
OHB
A1
014
43M
ale
165
cm47
kgM
oder
ate
exe
585
4158
6.4
Sm
all
64.
817
.26
1247
2121
4.0
6.2
40.
8 3
0.4
13.
3 8
6.7
64.
6
02/0
5/20
076:
44:1
6D
AC
HI
KO
FF
I ED
OHB
A1
014
43M
ale
165
cm48
kgM
oder
ate
exe
627
4562
8.6
Sm
all
64.
817
.63
1261
2144
4.1
8.4
39.
6 2
9.1
17.
5 8
2.5
60.
7
16/0
4/20
076:
44:1
6A
ZIA
GB
ED
EK
OF
FI
HB
A1
015
30M
ale
182
cm74
kgM
oder
ate
exe
575
6757
8.9
Med
ium
64.
822
.34
1793
3049
6.6
19.
1 5
4.9
40.
1 2
5.8
74.
2 5
4.2
16/0
4/20
077:
12:4
0A
DO
NK
OK
OD
ZO
HB
A1
016
32M
ale
177
cm73
kgM
oder
ate
exe
431
4543
3.3
Med
ium
64.
823
.30
1741
2960
6.0
10.
7 6
2.3
46.
7 1
4.6
85.
4 6
4.0
23/0
4/20
077:
12:4
0A
DO
NK
OK
OD
ZO
HB
A1
016
32M
ale
177
cm72
kgM
oder
ate
exe
456
4845
8.5
Med
ium
64.
822
.98
1727
2936
6.0
12.
2 5
9.8
44.
7 1
6.9
83.
1 6
2.1
30/0
4/20
077:
12:4
0A
DO
NK
OK
OD
ZO
HB
A1
016
32M
ale
177
cm73
kgM
oder
ate
exe
505
6150
8.7
Med
ium
64.
823
.30
1741
2960
6.9
16.
5 5
6.5
41.
9 2
2.6
77.
4 5
7.4
07/0
5/20
077:
12:4
0A
DO
NK
OK
OD
ZO
HB
A1
016
32M
ale
177
cm74
kgM
oder
ate
exe
478
5648
1.3
Med
ium
64.
823
.62
1755
2983
6.7
15.
4 5
8.6
43.
7 2
0.8
79.
2 5
9.0
16/0
4/20
077:
18:4
2K
PIN
IK
UD
ZO
HB
A1
017
35M
ale
168
cm69
kgM
oder
ate
exe
440
5644
3.5
Med
ium
64.
824
.45
1620
2755
7.3
13.
2 5
5.8
42.
1 1
9.1
80.
9 6
1.1
23/0
4/20
079:
29:1
2K
PIN
IK
UD
ZO
HB
A1
017
35M
ale
168
cm70
kgM
oder
ate
exe
454
6145
8.1
Med
ium
64.
824
.80
1634
2778
7.7
15.
0 5
5.0
41.
4 2
1.4
78.
6 5
9.2
30/0
4/20
079:
29:1
2K
PIN
IK
UD
ZO
HB
A1
017
35M
ale
168
cm73
kgM
oder
ate
exe
419
5742
2.9
Med
ium
64.
825
.86
1675
2849
7.7
14.
3 5
8.7
44.
3 1
9.7
80.
3 6
0.7
07/0
5/20
079:
29:1
2K
PIN
IK
UD
ZO
HB
A1
017
35M
ale
168
cm73
kgM
oder
ate
exe
439
6144
3.2
Med
ium
64.
825
.86
1675
2849
7.9
16.
0 5
7.0
42.
9 2
2.0
78.
0 5
8.8
04/0
4/20
079:
29:1
2A
GB
OK
OM
LAH
BA
1 01
849
Mal
e17
7cm
84kg
Mod
erat
e ex
e44
458
447.
8M
ediu
m 6
4.8
26.8
117
7730
21 7
.4 2
0.0
64.
0 4
7.7
23.
8 7
6.2
56.
7
11/0
4/20
079:
29:1
2A
GB
OK
OM
LAH
BA
1 01
849
Mal
e17
7cm
83kg
Mod
erat
e ex
e47
266
476.
6M
ediu
m 6
4.8
26.4
917
6329
98 8
.0 2
1.6
61.
4 4
5.6
26.
0 7
4.0
55.
0
18/0
4/20
079:
29:1
2A
GB
OK
OM
LAH
BA
1 01
849
Mal
e17
7cm
82kg
Mod
erat
e ex
e42
761
431.
3M
ediu
m 6
4.8
26.1
717
4929
74 8
.1 1
7.0
65.
0 4
8.6
20.
7 7
9.3
59.
2
25/0
4/20
079:
29:1
2A
GB
OK
OM
LAH
BA
1 01
849
Mal
e17
7cm
83kg
Mod
erat
e ex
e44
966
453.
8M
ediu
m 6
4.8
26.4
917
6329
98 8
.4 1
9.7
63.
3 4
7.1
23.
7 7
6.3
56.
8
02/0
5/20
079:
29:1
2A
GB
OK
OM
LAH
BA
1 01
849
Mal
e17
7cm
84kg
Mod
erat
e ex
e43
556
438.
6M
ediu
m 6
4.8
26.8
117
7730
21 7
.3 1
9.2
64.
8 4
8.3
22.
8 7
7.2
57.
5
04/0
4/20
079:
29:1
2A
GB
OD
JAN
KE
KE
LIH
BA
1 01
928
Fem
ale
164
cm50
kgM
oder
ate
exe
651
6465
4.1
Med
ium
64.
818
.59
1298
2077
5.6
12.
0 3
8.0
28.
0 2
3.9
76.
1 5
6.0
11/0
4/20
079:
29:1
2A
GB
OD
JAN
KE
KE
LIH
BA
1 01
928
Fem
ale
164
cm50
kgM
oder
ate
exe
614
6161
7.0
Med
ium
64.
818
.59
1298
2077
5.7
10.
8 3
9.2
29.
1 2
1.6
78.
4 5
8.2
18/0
4/20
079:
29:1
2A
GB
OD
JAN
KE
KE
LIH
BA
1 01
928
Fem
ale
164
cm50
kgM
oder
ate
exe
606
6760
9.7
Med
ium
64.
818
.59
1298
2077
6.3
10.
5 3
9.5
29.
4 2
1.1
78.
9 5
8.7
25/0
4/20
079:
29:1
2A
GB
OD
JAN
KE
KE
LIH
BA
1 01
928
Fem
ale
164
cm52
kgM
oder
ate
exe
636
7164
0.0
Med
ium
64.
819
.33
1317
2108
6.4
13.
2 3
8.8
28.
7 2
5.4
74.
6 5
5.1
02/0
5/20
079:
51:4
2A
GB
OD
JAN
KE
KE
LIH
BA
1 01
928
Fem
ale
164
cm51
kgM
oder
ate
exe
659
6966
2.6
Med
ium
64.
818
.96
1308
2093
6.0
13.
0 3
8.0
27.
9 2
5.5
74.
5 5
4.7
04/0
4/20
079:
56:4
1T
OM
EK
PE
KO
FF
IH
BA
1 02
032
Mal
e16
8cm
67kg
Mod
erat
e ex
e53
071
534.
7M
ediu
m 6
4.8
23.7
416
1327
42 7
.6 1
7.5
49.
5 3
6.9
26.
0 7
4.0
55.
1
11/0
4/20
079:
56:4
1T
OM
EK
PE
KO
FF
IH
BA
1 02
032
Mal
e16
8cm
68kg
Mod
erat
e ex
e52
066
524.
2M
ediu
m 6
4.8
24.0
916
2727
66 7
.2 1
7.7
50.
3 3
7.5
26.
0 7
4.0
55.
2
18/0
4/20
079:
56:4
1T
OM
EK
PE
KO
FF
IH
BA
1 02
032
Mal
e16
8cm
69kg
Mod
erat
e ex
e48
372
488.
3M
ediu
m 6
4.8
24.4
516
4127
89 8
.5 1
6.3
52.
7 3
9.6
23.
6 7
6.4
57.
4
25/0
4/20
079:
56:4
1T
OM
EK
PE
KO
FF
IH
BA
1 02
032
Mal
e16
8cm
69kg
Mod
erat
e ex
e54
071
544.
6M
ediu
m 6
4.8
24.4
516
4127
89 7
.5 1
9.4
49.
6 3
6.8
28.
1 7
1.9
53.
4
02/0
5/20
079:
56:4
1T
OM
EK
PE
KO
FF
IH
BA
1 02
032
Mal
e16
8cm
70kg
Mod
erat
e ex
e50
566
509.
3M
ediu
m 6
4.8
24.8
016
5428
13 7
.4 1
8.3
51.
7 3
8.6
26.
2 7
3.8
55.
2
04/0
4/20
0710
:04:
12A
GB
OA
DZ
OH
BA
1 02
128
Fem
ale
155
cm44
kgM
oder
ate
exe
647
7065
0.8
Med
ium
64.
818
.31
1224
1959
6.2
9.9
34.
1 2
5.4
22.
6 7
7.4
57.
8
11/0
4/20
0710
:04:
12A
GB
OA
DZ
OH
BA
1 02
128
Fem
ale
155
cm45
kgM
oder
ate
exe
564
5356
6.5
Med
ium
64.
818
.73
1234
1975
5.4
8.3
36.
7 2
8.0
18.
4 8
1.6
62.
2
18/0
4/20
0710
:04:
12A
GB
OA
DZ
OH
BA
1 02
128
Fem
ale
155
cm45
kgM
oder
ate
exe
624
6562
7.4
Med
ium
64.
818
.73
1234
1975
5.9
10.
2 3
4.8
26.
2 2
2.6
77.
4 5
8.1
25/0
4/20
0710
:04:
12A
GB
OA
DZ
OH
BA
1 02
128
Fem
ale
155
cm45
kgM
oder
ate
exe
606
6460
9.4
Med
ium
64.
818
.73
1234
1975
6.0
9.7
35.
3 2
6.7
21.
5 7
8.5
59.
3
02/0
5/20
0710
:04:
12A
GB
OA
DZ
OH
BA
1 02
128
Fem
ale
155
cm46
kgM
oder
ate
exe
608
6561
1.5
Med
ium
64.
819
.15
1244
1990
6.1
10.
6 3
5.4
26.
7 2
3.0
77.
0 5
8.1
04/0
4/20
0710
:12:
14A
HA
VI
ELI
HB
A1
022
33M
ale
168
cm44
kgM
oder
ate
exe
500
5950
3.5
Sm
all
64.
815
.59
1289
2191
6.7
-1.
2 4
5.2
34.
3 -
2.6
102.
6 7
7.9
11/0
4/20
0710
:12:
53A
HA
VI
ELI
HB
A1
022
33M
ale
168
cm55
kgM
oder
ate
exe
528
6653
2.1
Sm
all
64.
819
.49
1441
2449
7.1
8.5
46.
5 3
4.9
15.
4 8
4.6
63
.4
18/0
4/20
0710
:16:
09A
HA
VI
ELI
HB
A1
022
33M
ale
168
cm54
kgM
oder
ate
exe
504
6950
8.7
Sm
all
64.
819
.13
1427
2426
7.8
6.5
47.
5 3
5.9
12.
0 8
8.0
66
.4
25/0
4/20
0710
:16:
09A
HA
VI
ELI
HB
A1
022
33M
ale
168
cm55
kgM
oder
ate
exe
495
7049
9.9
Sm
all
64.
819
.49
1441
2449
8.0
6.7
48.
3 3
6.5
12.
1 8
7.9
66
.3
02/0
5/20
0710
:16:
09A
HA
VI
ELI
HB
A1
022
33M
ale
168
cm55
kgM
oder
ate
exe
525
6452
8.9
Sm
all
64.
819
.49
1441
2449
7.0
8.3
46.
7 3
5.0
15.
2 8
4.8
63
.7
16/0
4/20
0710
:20:
39E
PP
RE
HK
OF
FI
HB
A1
023
36M
ale
174
cm55
kgM
oder
ate
exe
494
4449
6.0
Sm
all
64.
818
.17
1450
2466
5.1
3.9
51.
1 3
8.4
7.1
92.
9 6
9.8
23/0
4/20
0710
:21:
32E
PP
RE
HK
OF
FI
HB
A1
023
36M
ale
174
cm52
kgM
oder
ate
exe
515
5151
7.5
Sm
all
64.
817
.18
1409
2395
5.7
3.0
49.
0 3
6.8
5.8
94.
2 7
0.7
30/0
4/20
0710
:21:
32E
PP
RE
HK
OF
FI
HB
A1
023
36M
ale
174
cm54
kgM
oder
ate
exe
521
5752
4.1
Sm
all
64.
817
.84
1436
2442
6.2
4.8
49.
2 3
6.8
8.9
91.
1 6
8.1
07/0
5/20
0710
:21:
32E
PP
RE
HK
OF
FI
HB
A1
023
36M
ale
174
cm55
kgM
oder
ate
exe
502
5250
4.7
Sm
all
64.
818
.17
1450
2466
5.9
4.4
50.
6 3
8.0
8.0
92.
0 6
9.0
04/0
4/20
0710
:21:
32T
OM
EK
PE
AK
UH
BA
1 02
441
Fem
ale
160
cm51
kgM
oder
ate
exe
542
5454
4.7
Sm
all
64.
819
.92
1240
1984
5.7
10.
4 4
0.6
30.
8 2
0.4
79.
6 6
0.3
2B
IA T
ES
T A
GO
U F
INA
L F
inal
F 2
.xls
BIA
TE
ST
AG
OU
FIN
AL
Tes
t D
ate
Tes
t T
ime
Las
t N
ame
Fir
st
Nam
eS
ub
ject
IDA
ge
Gen
der
Hei
gh
tW
eig
ht
Act
ivit
y L
eve
Res
ista
nce
Rea
ctan
ceIm
ped
ance
Fra
me
Siz
eT
arg
et
Wei
gh
tB
MI
BM
RD
EE
Ph
ase
An
gle
Fat
wt
FF
M w
tT
BW
lit
ers
Fat
%
of
wt
FF
M %
o
f w
tT
BW
%
of
wt
11/0
4/20
0710
:21:
32T
OM
EK
PE
AK
UH
BA
1 02
441
Fem
ale
160
cm50
kgM
oder
ate
exe
557
5755
9.9
Sm
all
64.
819
.53
1230
1968
5.8
10.
2 3
9.8
30.
1 2
0.5
79.
5 6
0.2
18/0
4/20
0710
:21:
32T
OM
EK
PE
AK
UH
BA
1 02
441
Fem
ale
160
cm50
kgM
oder
ate
exe
560
6656
3.9
Sm
all
64.
819
.53
1230
1968
6.7
10.
4 3
9.6
30.
0 2
0.7
79.
3 5
9.9
25/0
4/20
0710
:21:
32T
OM
EK
PE
AK
UH
BA
1 02
441
Fem
ale
160
cm52
kgM
oder
ate
exe
528
5753
1.1
Sm
all
64.
820
.31
1249
1999
6.2
10.
6 4
1.4
31.
4 2
0.4
79.
6 6
0.5
02/0
5/20
0710
:21:
32T
OM
EK
PE
AK
UH
BA
1 02
441
Fem
ale
160
cm52
kgM
oder
ate
exe
559
6756
3.0
Sm
all
64.
820
.31
1249
1999
6.8
12.
0 4
0.0
30.
2 2
3.0
77.
0 5
8.1
04/0
4/20
0710
:21:
32D
ZIM
AS
SE
AT
AW
AH
BA
1 02
540
Fem
ale
157
cm59
kgM
oder
ate
exe
603
5960
5.9
Sm
all
64.
823
.94
1316
2105
5.6
20.
5 3
8.5
28.
8 3
4.8
65.
2 4
8.8
11/0
4/20
0710
:21:
32D
ZIM
AS
SE
AT
AW
AH
BA
1 02
540
Fem
ale
157
cm59
kgM
oder
ate
exe
564
5556
6.7
Sm
all
64.
823
.94
1316
2105
5.6
19.
2 3
9.8
30.
1 3
2.5
67.
5 5
1.0
18/0
4/20
0710
:21:
32D
ZIM
AS
SE
AT
AW
AH
BA
1 02
540
Fem
ale
157
cm58
kgM
oder
ate
exe
594
6259
7.2
Sm
all
64.
823
.53
1306
2090
6.0
19.
4 3
8.6
29.
0 3
3.4
66.
6 5
0.0
25/0
4/20
0710
:21:
32D
ZIM
AS
SE
AT
AW
AH
BA
1 02
540
Fem
ale
157
cm59
kgM
oder
ate
exe
581
5958
4.0
Sm
all
64.
823
.94
1316
2105
5.8
19.
8 3
9.2
29.
5 3
3.5
66.
5 5
0.0
02/0
5/20
0710
:21:
32D
ZIM
AS
SE
AT
AW
AH
BA
1 02
540
Fem
ale
157
cm60
kgM
oder
ate
exe
606
6360
9.3
Sm
all
64.
824
.34
1325
2121
5.9
21.
4 3
8.6
28.
8 3
5.7
64.
3 4
8.1
04/0
4/20
0710
:21:
32N
YO
NA
TO
RA
DZ
OH
BA
1 02
652
Fem
ale
157
cm45
kgM
oder
ate
exe
592
5059
4.1
Sm
all
64.
818
.26
1125
1800
4.8
8.5
36.
5 2
7.6
18.
9 8
1.1
61.
3
11/0
4/20
0710
:21:
32N
YO
NA
TO
RA
DZ
OH
BA
1 02
652
Fem
ale
157
cm45
kgM
oder
ate
exe
574
5257
6.4
Sm
all
64.
818
.26
1125
1800
5.2
7.9
37.
1 2
8.2
17.
5 8
2.5
62.
6
18/0
4/20
0710
:45:
29N
YO
NA
TO
RA
DZ
OH
BA
1 02
652
Fem
ale
157
cm45
kgM
oder
ate
exe
598
5460
0.4
Sm
all
64.
818
.26
1125
1800
5.2
8.7
36.
3 2
7.4
19.
4 8
0.6
60.
8
25/0
4/20
0710
:45:
29N
YO
NA
TO
RA
DZ
OH
BA
1 02
652
Fem
ale
157
cm45
kgM
oder
ate
exe
584
5458
6.5
Sm
all
64.
818
.26
1125
1800
5.3
8.2
36.
8 2
7.8
18.
3 8
1.7
61.
8
02/0
5/20
0710
:50:
11N
YO
NA
TO
RA
DZ
OH
BA
1 02
652
Fem
ale
157
cm46
kgM
oder
ate
exe
552
4955
4.2
Sm
all
64.
818
.66
1134
1815
5.1
7.9
38.
1 2
9.0
17.
2 8
2.8
63.
1
16/0
4/20
0710
:53:
21T
SO
NY
AY
AW
OH
BA
1 02
745
Mal
e16
2cm
54kg
Mod
erat
e ex
e52
160
524.
4M
ediu
m 6
4.8
20.5
813
1522
36 6
.6 9
.9 4
4.1
33.
3 1
8.3
81.
7 6
1.7
23/0
4/20
0710
:53:
21T
SO
NY
AY
AW
OH
BA
1 02
745
Mal
e16
2cm
53kg
Mod
erat
e ex
e51
159
514.
4M
ediu
m 6
4.8
20.2
013
0122
13 6
.6 8
.6 4
4.4
33.
6 1
6.3
83.
7 6
3.4
30/0
4/20
0710
:57:
12T
SO
NY
AY
AW
OH
BA
1 02
745
Mal
e16
2cm
56kg
Mod
erat
e ex
e51
862
521.
7M
ediu
m 6
4.8
21.3
413
4322
83 6
.8 1
1.2
44.
8 3
3.8
20.
0 8
0.0
60.
4
07/0
5/20
0710
:57:
12T
SO
NY
AY
AW
OH
BA
1 02
745
Mal
e16
2cm
56kg
Mod
erat
e ex
e52
666
530.
1M
ediu
m 6
4.8
21.3
413
4322
83 7
.2 1
1.6
44.
4 3
3.5
20.
7 7
9.3
59.
8
04/0
4/20
0710
:57:
12S
AN
KA
RB
OA
KO
UV
IH
BA
1 02
823
Fem
ale
155
cm57
kgM
oder
ate
exe
629
7463
3.3
Med
ium
64.
823
.73
1373
2197
6.7
20.
3 3
6.7
27.
4 3
5.6
64.
4 4
8.0
11/0
4/20
0710
:57:
12S
AN
KA
RB
OA
KO
UV
IH
BA
1 02
823
Fem
ale
155
cm57
kgM
oder
ate
exe
626
7263
0.1
Med
ium
64.
823
.73
1373
2197
6.6
20.
2 3
6.8
27.
5 3
5.5
64.
5 4
8.2
18/0
4/20
0710
:57:
12S
AN
KA
RB
OA
KO
UV
IH
BA
1 02
823
Fem
ale
155
cm57
kgM
oder
ate
exe
629
7863
3.8
Med
ium
64.
823
.73
1373
2197
7.1
20.
3 3
6.7
27.
4 3
5.6
64.
4 4
8.0
25/0
4/20
0710
:57:
12S
AN
KA
RB
OA
KO
UV
IH
BA
1 02
823
Fem
ale
155
cm56
kgM
oder
ate
exe
629
7563
3.5
Med
ium
64.
823
.31
1363
2181
6.8
19.
5 3
6.5
27.
3 3
4.8
65.
2 4
8.7
02/0
5/20
0710
:57:
12S
AN
KA
RB
OA
KO
UV
IH
BA
1 02
823
Fem
ale
155
cm58
kgM
oder
ate
exe
647
8665
2.7
Med
ium
64.
824
.14
1382
2212
7.6
21.
6 3
6.4
27.
0 3
7.2
62.
8 4
6.6
04/0
4/20
0711
:28:
21T
SE
VI
KO
MI W
OLH
BA
1 03
034
Mal
e16
7cm
75kg
Mod
erat
e ex
e42
652
429.
2M
ediu
m 6
4.8
26.8
917
0528
99 7
.0 1
7.0
58.
0 4
3.8
22.
6 7
7.4
58.
4
11/0
4/20
0711
:29:
19T
SE
VI
KO
MI W
OLH
BA
1 03
034
Mal
e16
7cm
75kg
Mod
erat
e ex
e41
250
415.
0M
ediu
m 6
4.8
26.8
917
0528
99 6
.9 1
5.7
59.
3 4
4.8
21.
0 7
9.0
59.
7
18/0
4/20
0711
:29:
19T
SE
VI
KO
MI W
OLH
BA
1 03
034
Mal
e16
7cm
74kg
Mod
erat
e ex
e39
466
399.
5M
ediu
m 6
4.8
26.5
316
9128
75 9
.5 1
3.2
60.
8 4
6.0
17.
9 8
2.1
62.
2
25/0
4/20
0711
:29:
19T
SE
VI
KO
MI W
OLH
BA
1 03
034
Mal
e16
7cm
71kg
Mod
erat
e ex
e42
253
425.
3M
ediu
m 6
4.8
25.4
616
5028
05 7
.2 1
3.7
57.
3 4
3.4
19.
2 8
0.8
61.
1
02/0
5/20
0711
:29:
19T
SE
VI
KO
MI W
OLH
BA
1 03
034
Mal
e16
7cm
70kg
Mod
erat
e ex
e41
653
419.
4M
ediu
m 6
4.8
25.1
016
3627
81 7
.3 1
2.4
57.
6 4
3.6
17.
7 8
2.3
62.
3
26/0
4/20
0711
:29:
19K
OS
SIG
AN
KO
KO
UH
BA
1 03
157
Mal
e17
1cm
78kg
Mod
erat
e ex
e39
744
399.
4M
ediu
m 6
4.8
26.6
716
1027
37 6
.3 1
4.3
63.
7 4
8.0
18.
3 8
1.7
61.
5
03/0
5/20
0711
:36:
43K
OS
SIG
AN
KO
KO
UH
BA
1 03
157
Mal
e17
1cm
78kg
Mod
erat
e ex
e41
647
418.
6M
ediu
m 6
4.8
26.6
716
1027
37 6
.4 1
6.2
61.
8 4
6.5
20.
7 7
9.3
59.
6
04/0
4/20
0711
:38:
58S
AM
TO
UD
ZIG
BO
DIH
BA
1 03
233
Fem
ale
164
cm45
kgM
oder
ate
exe
746
5174
7.7
Med
ium
64.
816
.73
1227
1963
3.9
9.9
35.
1 2
5.1
22.
1 7
7.9
55.
7
11/0
4/20
0711
:47:
31S
AM
TO
UD
ZIG
BO
DIH
BA
1 03
233
Fem
ale
164
cm45
kgM
oder
ate
exe
666
4266
7.3
Med
ium
64.
816
.73
1227
1963
3.6
8.2
36.
8 2
7.0
18.
2 8
1.8
60.
0
18/0
4/20
0711
:47:
31S
AM
TO
UD
ZIG
BO
DIH
BA
1 03
233
Fem
ale
164
cm46
kgM
oder
ate
exe
622
6562
5.4
Med
ium
64.
817
.10
1236
1978
6.0
7.8
38.
2 2
8.4
16.
9 8
3.1
61.
7
25/0
4/20
0711
:47:
31S
AM
TO
UD
ZIG
BO
DIH
BA
1 03
233
Fem
ale
164
cm47
kgM
oder
ate
exe
637
5063
9.0
Med
ium
64.
817
.47
1246
1994
4.5
9.1
37.
9 2
8.1
19.
3 8
0.7
59.
7
02/0
5/20
0711
:47:
31S
AM
TO
UD
ZIG
BO
DIH
BA
1 03
233
Fem
ale
164
cm45
kgM
oder
ate
exe
634
4663
5.7
Med
ium
64.
816
.73
1227
1963
4.1
7.3
37.
7 2
7.9
16.
2 8
3.8
62.
0
04/0
4/20
0711
:47:
31M
ISS
IAM
EN
MA
GU
YH
BA
1 03
331
Fem
ale
152
cm43
kgM
oder
ate
exe
768
5977
0.3
Med
ium
64.
818
.61
1195
1913
4.4
12.
1 3
0.9
22.
1 2
8.1
71.
9 5
1.5
11/0
4/20
0711
:47:
31M
ISS
IAM
EN
MA
GU
YH
BA
1 03
331
Fem
ale
152
cm42
kgM
oder
ate
exe
709
5671
1.2
Med
ium
64.
818
.18
1186
1897
4.5
10.
4 3
1.6
23.
2 2
4.9
75.
1 5
5.1
18/0
4/20
0711
:47:
31M
ISS
IAM
EN
MA
GU
YH
BA
1 03
331
Fem
ale
152
cm43
kgM
oder
ate
exe
699
5470
1.1
Med
ium
64.
818
.61
1195
1913
4.4
11.
1 3
1.9
23.
5 2
5.9
74.
1 5
4.6
25/0
4/20
0711
:47:
31M
ISS
IAM
EN
MA
GU
YH
BA
1 03
331
Fem
ale
152
cm42
kgM
oder
ate
exe
724
6172
6.6
Med
ium
64.
818
.18
1186
1897
4.8
10.
7 3
1.3
22.
9 2
5.4
74.
6 5
4.4
02/0
5/20
0711
:47:
31M
ISS
IAM
EN
MA
GU
YH
BA
1 03
331
Fem
ale
152
cm41
kgM
oder
ate
exe
756
6675
8.9
Med
ium
64.
817
.75
1176
1882
5.0
10.
3 3
0.7
22.
1 2
5.1
74.
9 5
4.0
04/0
4/20
0711
:47:
31A
GB
ON
ON
AF
IH
BA
1 03
441
Fem
ale
169
cm76
kgM
oder
ate
exe
576
5857
8.9
Med
ium
64.
826
.61
1496
2393
5.7
29.
0 4
7.0
34.
6 3
8.2
61
.8 4
5.6
11/0
4/20
0711
:47:
31A
GB
ON
ON
AF
IH
BA
1 03
441
Fem
ale
169
cm75
kgM
oder
ate
exe
556
5655
8.8
Med
ium
64.
826
.26
1486
2378
5.8
27.
3 4
7.7
35.
3 3
6.4
63
.6 4
7.1
18/0
4/20
0712
:08:
12A
GB
ON
ON
AF
IH
BA
1 03
441
Fem
ale
169
cm76
kgM
oder
ate
exe
534
5653
6.9
Med
ium
64.
826
.61
1496
2393
6.0
27.
0 4
9.0
36.
4 3
5.5
64
.5 4
7.9
25/0
4/20
0712
:08:
12A
GB
ON
ON
AF
IH
BA
1 03
441
Fem
ale
169
cm77
kgM
oder
ate
exe
532
5753
5.0
Med
ium
64.
826
.96
1505
2409
6.1
27.
7 4
9.3
36.
6 3
6.0
64
.0 4
7.5
02/0
5/20
0712
:13:
17A
GB
ON
ON
AF
IH
BA
1 03
441
Fem
ale
169
cm80
kgM
oder
ate
exe
487
4748
9.3
Med
ium
64.
828
.01
1534
2455
5.5
27.
5 5
2.5
39.
2 3
4.3
65
.7 4
9.0
04/0
4/20
0712
:13:
17D
A S
ILV
EIR
AD
JELE
HB
A1
035
22F
emal
e14
9cm
45kg
Mod
erat
e ex
e60
257
604.
7M
ediu
m 6
4.8
20.2
712
5120
03 5
.4 1
1.7
33.
3 2
5.4
25.
9 7
4.1
56.
5
11/0
4/20
0712
:23:
20D
A S
ILV
EIR
AD
JELE
HB
A1
035
22F
emal
e14
9cm
45kg
Mod
erat
e ex
e62
361
626.
0M
ediu
m 6
4.8
20.2
712
5120
03 5
.6 1
2.2
32.
8 2
4.9
27.
1 7
2.9
55.
3
18/0
4/20
0712
:23:
20D
A S
ILV
EIR
AD
JELE
HB
A1
035
22F
emal
e14
9cm
45kg
Mod
erat
e ex
e57
758
579.
9M
ediu
m 6
4.8
20.2
712
5120
03 5
.7 1
1.0
34.
0 2
6.1
24.
3 7
5.7
58.
1
25/0
4/20
0712
:23:
20D
A S
ILV
EIR
AD
JELE
HB
A1
035
22F
emal
e14
9cm
46kg
Mod
erat
e ex
e59
262
595.
2M
ediu
m 6
4.8
20.7
212
6120
18 6
.0 1
2.2
33.
8 2
5.8
26.
6 7
3.4
56.
1
3B
IA T
ES
T A
GO
U F
INA
L F
inal
F 2
.xls
BIA
TE
ST
AG
OU
FIN
AL
Tes
t D
ate
Tes
t T
ime
Las
t N
ame
Fir
st
Nam
eS
ub
ject
IDA
ge
Gen
der
Hei
gh
tW
eig
ht
Act
ivit
y L
eve
Res
ista
nce
Rea
ctan
ceIm
ped
ance
Fra
me
Siz
eT
arg
et
Wei
gh
tB
MI
BM
RD
EE
Ph
ase
An
gle
Fat
wt
FF
M w
tT
BW
lit
ers
Fat
%
of
wt
FF
M %
o
f w
tT
BW
%
of
wt
02/0
5/20
0712
:23:
20D
A S
ILV
EIR
AD
JELE
HB
A1
035
22F
emal
e14
9cm
45kg
Mod
erat
e ex
e63
070
633.
9M
ediu
m 6
4.8
20.2
712
5120
03 6
.3 1
2.4
32.
6 2
4.7
27.
5 7
2.5
54.
9
04/0
4/20
0712
:27:
39K
OB
AR
AA
TH
AN
AS
HB
A1
036
41F
emal
e17
0cm
58kg
Mod
erat
e ex
e59
464
597.
4M
ediu
m 6
4.8
20.0
713
2521
20 6
.1 1
4.4
43.
6 3
2.2
24.
9 7
5.1
55.
5
11/0
4/20
0712
:27:
39K
OB
AR
AA
TH
AN
AS
HB
A1
036
41M
ale
170
cm58
kgM
oder
ate
exe
563
6256
6.4
Med
ium
64.
820
.07
1438
2444
6.3
11.
6 4
6.4
34.
5 1
9.9
80.
1 5
9.4
18/0
4/20
0712
:27:
39K
OB
AR
AA
TH
AN
AS
HB
A1
036
41M
ale
170
cm58
kgM
oder
ate
exe
585
6558
8.6
Med
ium
64.
820
.07
1438
2444
6.3
12.
5 4
5.5
33.
6 2
1.5
78.
5 5
7.9
25/0
4/20
0712
:27:
39K
OB
AR
AA
TH
AN
AS
HB
A1
036
41M
ale
170
cm59
kgM
oder
ate
exe
564
6856
8.1
Med
ium
64.
820
.42
1451
2468
6.9
12.
4 4
6.6
34.
6 2
0.9
79.
1 5
8.6
02/0
5/20
0712
:27:
39K
OB
AR
AA
TH
AN
AS
HB
A1
036
41M
ale
170
cm58
kgM
oder
ate
exe
561
6156
4.3
Med
ium
64.
820
.07
1438
2444
6.2
11.
5 4
6.5
34.
5 1
9.8
80.
2 5
9.6
04/0
4/20
0712
:27:
39D
OH
AK
OF
AH
BA
1 03
722
Fem
ale
163
cm43
kgM
oder
ate
exe
705
5770
7.3
Med
ium
64.
816
.18
1257
2012
4.6
7.8
35.
2 2
5.6
18.
1 8
1.9
59.
5
11/0
4/20
0712
:27:
39D
OH
AK
OF
AH
BA
1 03
722
Fem
ale
163
cm43
kgM
oder
ate
exe
684
5268
6.0
Med
ium
64.
816
.18
1257
2012
4.3
7.3
35.
7 2
6.1
17.
0 8
3.0
60.
7
18/0
4/20
0712
:27:
39D
OH
AK
OF
AH
BA
1 03
722
Fem
ale
163
cm43
kgM
oder
ate
exe
680
5368
2.1
Med
ium
64.
816
.18
1257
2012
4.5
7.2
35.
8 2
6.2
16.
8 8
3.2
60.
9
25/0
4/20
0712
:27:
39D
OH
AK
OF
AH
BA
1 03
722
Fem
ale
163
cm44
kgM
oder
ate
exe
671
5667
3.3
Med
ium
64.
816
.56
1267
2028
4.8
7.8
36.
2 2
6.5
17.
8 8
2.2
60.
3
02/0
5/20
0712
:27:
39D
OH
AK
OF
AH
BA
1 03
722
Fem
ale
163
cm44
kgM
oder
ate
exe
709
6671
2.1
Med
ium
64.
816
.56
1267
2028
5.3
8.7
35.
3 2
5.6
19.
8 8
0.2
58.
1
04/0
4/20
0712
:27:
39E
TS
EK
OM
LAH
BA
1 03
839
Mal
e17
3cm
56kg
Mod
erat
e ex
e50
749
509.
4S
mal
l 6
4.8
18.7
114
3924
46 5
.5 5
.9 5
0.1
37.
6 1
0.6
89.
4 6
7.1
11/0
4/20
0712
:27:
39E
TS
EK
OM
LAH
BA
1 03
839
Mal
e17
3cm
55kg
Mod
erat
e ex
e59
059
592.
9S
mal
l 6
4.8
18.3
814
2524
23 5
.7 9
.3 4
5.7
33.
7 1
7.0
83.
0 6
1.2
18/0
4/20
0712
:27:
39E
TS
EK
OM
LAH
BA
1 03
839
Mal
e17
3cm
55kg
Mod
erat
e ex
e60
968
612.
8S
mal
l 6
4.8
18.3
814
2524
23 6
.4 1
0.1
44.
9 3
2.9
18.
3 8
1.7
59.
9
23/0
4/20
076:
44:1
6A
ZIA
GB
ED
EK
OF
FI
HB
A1
015
30M
ale
182
cm73
kgM
oder
ate
exe
596
7060
0.1
Med
ium
64.
822
.04
1779
3025
6.7
19.
4 5
3.6
39.
0 2
6.5
73.
5 5
3.4
30/0
4/20
076:
44:1
6A
ZIA
GB
ED
EK
OF
FI
HB
A1
015
30M
ale
182
cm73
kgM
oder
ate
exe
594
6859
7.9
Med
ium
64.
822
.04
1779
3025
6.5
19.
3 5
3.7
39.
1 2
6.4
73.
6 5
3.5
07/0
5/20
076:
44:1
6A
ZIA
GB
ED
EK
OF
FI
HB
A1
015
30M
ale
182
cm74
kgM
oder
ate
exe
551
8355
7.2
Med
ium
64.
822
.34
1793
3049
8.6
17.
8 5
6.2
41.
2 2
4.1
75.
9 5
5.7
14/0
5/20
073:
13:3
2K
PO
GO
KO
FF
IH
BA
1 00
152
Mal
e16
8cm
60kg
Mod
erat
e ex
e41
250
415.
0M
ediu
m 6
4.8
21.2
613
8023
47 6
.9 4
.1 5
5.9
42.
5 6
.9 9
3.1
70.
9
21/0
5/20
073:
13:3
2K
PO
GO
KO
FF
IH
BA
1 00
152
Mal
e16
8cm
60kg
Mod
erat
e ex
e42
051
423.
1M
ediu
m 6
4.8
21.2
613
8023
47 6
.9 4
.8 5
5.2
41.
9 8
.1 9
1.9
69.
9
28/0
5/20
073:
13:3
2K
PO
GO
KO
FF
IH
BA
1 00
152
Mal
e16
8cm
60kg
Mod
erat
e ex
e43
057
433.
8M
ediu
m 6
4.8
21.2
613
8023
47 7
.6 5
.7 5
4.3
41.
2 9
.5 9
0.5
68.
7
04/0
6/20
073:
13:3
2K
PO
GO
KO
FF
IH
BA
1 00
152
Mal
e16
8cm
60kg
Mod
erat
e ex
e42
150
424.
0M
ediu
m 6
4.8
21.2
613
8023
47 6
.8 4
.9 5
5.1
41.
9 8
.2 9
1.8
69.
8
11/0
6/20
073:
13:3
2K
PO
GO
KO
FF
IH
BA
1 00
152
Mal
e16
8cm
61kg
Mod
erat
e ex
e42
052
423.
2M
ediu
m 6
4.8
21.6
113
9423
70 7
.1 5
.6 5
5.4
42.
1 9
.2 9
0.8
69.
0
18/0
6/20
073:
13:3
2K
PO
GO
KO
FF
IH
BA
1 00
152
Mal
e16
8cm
60kg
Mod
erat
e ex
e44
452
447.
0M
ediu
m 6
4.8
21.2
613
8023
47 6
.7 6
.9 5
3.1
40.
3 1
1.4
88.
6 6
7.2
09/0
5/20
073:
13:3
2G
AS
SO
UY
AW
AH
BA
1 00
241
Fem
ale
159
cm65
kgM
oder
ate
exe
530
8053
6.0
Med
ium
64.
825
.71
1372
2196
8.6
21.
9 4
3.1
32.
6 3
3.7
66.
3 5
0.1
16/0
5/20
073:
13:3
2G
AS
SO
UY
AW
AH
BA
1 00
241
Fem
ale
159
cm65
kgM
oder
ate
exe
518
8152
4.3
Med
ium
64.
825
.71
1372
2196
8.9
21.
4 4
3.6
33.
1 3
2.9
67.
1 5
0.9
23/0
5/20
073:
13:3
2G
AS
SO
UY
AW
AH
BA
1 00
241
Fem
ale
159
cm65
kgM
oder
ate
exe
487
8249
3.9
Med
ium
64.
825
.71
1372
2196
9.6
19.
7 4
5.3
34.
5 3
0.3
69.
7 5
3.0
30/0
5/20
073:
13:3
2G
AS
SO
UY
AW
AH
BA
1 00
241
Fem
ale
159
cm65
kgM
oder
ate
exe
565
6756
9.0
Med
ium
64.
825
.71
1372
2196
6.8
23.
4 4
1.6
31.
2 3
6.0
64.
0 4
8.0
09/0
5/20
074:
21:3
3E
DO
HK
OD
ZO
HB
A1
003
47M
ale
177
cm57
kgM
oder
ate
exe
561
7156
5.5
Sm
all
64.
818
.19
1418
2411
7.2
7.9
49.
1 3
6.3
13.
9 8
6.1
63
.7
16/0
5/20
074:
21:3
3E
DO
HK
OD
ZO
HB
A1
003
47M
ale
177
cm59
kgM
oder
ate
exe
497
5850
0.4
Sm
all
64.
818
.83
1446
2458
6.7
5.7
53.
3 3
9.9
9.6
90.
4 6
7.6
23/0
5/20
074:
21:3
3E
DO
HK
OD
ZO
HB
A1
003
47M
ale
177
cm59
kgM
oder
ate
exe
501
5650
4.1
Sm
all
64.
818
.83
1446
2458
6.4
5.9
53.
1 3
9.7
10.
1 8
9.9
67
.2
30/0
5/20
074:
21:3
3E
DO
HK
OD
ZO
HB
A1
003
47M
ale
177
cm59
kgM
oder
ate
exe
543
6154
6.4
Sm
all
64.
818
.83
1446
2458
6.4
8.5
50.
5 3
7.5
14.
3 8
5.7
63
.5
04/0
4/20
074:
44:4
5A
KA
KP
OM
AW
UN
YOH
BA
1 00
537
Fem
ale
163
cm70
kgM
oder
ate
exe
640
6764
3.5
Med
ium
64.
826
.35
1446
2314
6.0
28.
6 4
1.4
30.
3 4
0.9
59.
1 4
3.3
09/0
5/20
074:
44:4
5A
KA
KP
OM
AW
UN
YOH
BA
1 00
537
Fem
ale
163
cm70
kgM
oder
ate
exe
605
7160
9.2
Med
ium
64.
826
.35
1446
2314
6.7
27.
5 4
2.5
31.
4 3
9.3
60.
7 4
4.9
16/0
5/20
074:
44:4
5A
KA
KP
OM
AW
UN
YOH
BA
1 00
537
Fem
ale
163
cm70
kgM
oder
ate
exe
636
6963
9.7
Med
ium
64.
826
.35
1446
2314
6.2
28.
5 4
1.5
30.
5 4
0.7
59.
3 4
3.5
23/0
5/20
0717
:16:
54A
KA
KP
OM
AW
UN
YOH
BA
1 00
537
Fem
ale
163
cm73
kgM
oder
ate
exe
641
7164
4.9
Med
ium
64.
827
.48
1475
2360
6.3
31.
2 4
1.8
30.
6 4
2.7
57.
3 4
2.0
30/0
5/20
0717
:16:
54A
KA
KP
OM
AW
UN
YOH
BA
1 00
537
Fem
ale
163
cm72
kgM
oder
ate
exe
621
6862
4.7
Med
ium
64.
827
.10
1465
2345
6.2
29.
7 4
2.3
31.
1 4
1.3
58.
7 4
3.2
09/0
5/20
075:
02:0
2A
GB
ON
ON
YA
WO
VI P
HB
A1
006
68M
ale
164
cm63
kgM
oder
ate
exe
511
5551
4.0
Med
ium
64.
823
.42
1293
2198
6.1
15.
2 4
7.8
35.
9 2
4.1
75.
9 5
7.0
16/0
5/20
075:
02:0
2A
GB
ON
ON
YA
WO
VI P
HB
A1
006
68M
ale
164
cm65
kgM
oder
ate
exe
494
5549
7.1
Med
ium
64.
824
.17
1321
2245
6.4
15.
7 4
9.3
37.
1 2
4.2
75.
8 5
7.1
23/0
5/20
075:
02:0
2A
GB
ON
ON
YA
WO
VI P
HB
A1
006
68M
ale
164
cm65
kgM
oder
ate
exe
529
5853
2.2
Med
ium
64.
824
.17
1321
2245
6.3
17.
6 4
7.4
35.
5 2
7.0
73.
0 5
4.6
30/0
5/20
075:
02:0
2A
GB
ON
ON
YA
WO
VI P
HB
A1
006
68M
ale
164
cm65
kgM
oder
ate
exe
516
5651
9.0
Med
ium
64.
824
.17
1321
2245
6.2
16.
9 4
8.1
36.
0 2
6.0
74.
0 5
5.5
14/0
5/20
075:
12:4
5T
OS
SIN
YA
DK
OF
FI
HB
A1
007
65M
ale
175
cm60
kgM
oder
ate
exe
612
5961
4.8
Med
ium
64.
819
.59
1327
2256
5.5
13.
2 4
6.8
34.
2 2
1.9
78.
1 5
7.1
21/0
5/20
075:
12:4
5T
OS
SIN
YA
DK
OF
FI
HB
A1
007
65M
ale
175
cm60
kgM
oder
ate
exe
624
5962
6.8
Med
ium
64.
819
.59
1327
2256
5.4
13.
6 4
6.4
33.
8 2
2.7
77.
3 5
6.3
28/0
5/20
075:
12:4
5T
OS
SIN
YA
DK
OF
FI
HB
A1
007
65M
ale
175
cm60
kgM
oder
ate
exe
597
5759
9.7
Med
ium
64.
819
.59
1327
2256
5.5
12.
6 4
7.4
34.
8 2
0.9
79.
1 5
8.0
04/0
6/20
075:
12:4
5T
OS
SIN
YA
DK
OF
FI
HB
A1
007
65M
ale
175
cm61
kgM
oder
ate
exe
571
5857
3.9
Med
ium
64.
819
.92
1341
2280
5.8
12.
2 4
8.8
36.
0 1
9.9
80.
1 5
9.1
11/0
6/20
075:
12:4
5T
OS
SIN
YA
DK
OF
FI
HB
A1
007
65M
ale
175
cm60
kgM
oder
ate
exe
584
5558
6.6
Med
ium
64.
819
.59
1327
2256
5.4
12.
0 4
8.0
35.
3 2
0.0
80.
0 5
8.8
18/0
6/20
075:
12:4
5T
OS
SIN
YA
DK
OF
FI
HB
A1
007
65M
ale
175
cm60
kgM
oder
ate
exe
613
5961
5.8
Med
ium
64.
819
.59
1327
2256
5.5
13.
2 4
6.8
34.
2 2
2.0
78.
0 5
7.0
09/0
5/20
075:
28:2
3P
AN
IZI
BE
BE
HB
A1
008
23F
emal
e17
2cm
52kg
Mod
erat
e ex
e64
360
645.
8M
ediu
m 6
4.8
17.5
813
5521
69 5
.3 1
0.5
41.
5 3
0.3
20.
2 7
9.8
58.
3
16/0
5/20
075:
28:2
3P
AN
IZI
BE
BE
HB
A1
008
23F
emal
e17
2cm
52kg
Mod
erat
e ex
e64
362
646.
0M
ediu
m 6
4.8
17.5
813
5521
69 5
.5 1
0.5
41.
5 3
0.3
20.
2 7
9.8
58.
3
23/0
5/20
075:
28:2
3P
AN
IZI
BE
BE
HB
A1
008
23F
emal
e17
2cm
51kg
Mod
erat
e ex
e71
070
713.
4M
ediu
m 6
4.8
17.2
413
4621
53 5
.6 1
1.6
39.
4 2
8.3
22.
7 7
7.3
55.
4
4B
IA T
ES
T A
GO
U F
INA
L F
inal
F 2
.xls
BIA
TE
ST
AG
OU
FIN
AL
Tes
t D
ate
Tes
t T
ime
Las
t N
ame
Fir
st
Nam
eS
ub
ject
IDA
ge
Gen
der
Hei
gh
tW
eig
ht
Act
ivit
y L
eve
Res
ista
nce
Rea
ctan
ceIm
ped
ance
Fra
me
Siz
eT
arg
et
Wei
gh
tB
MI
BM
RD
EE
Ph
ase
An
gle
Fat
wt
FF
M w
tT
BW
lit
ers
Fat
%
of
wt
FF
M %
o
f w
tT
BW
%
of
wt
30/0
5/20
075:
28:2
3P
AN
IZI
BE
BE
HB
A1
008
23F
emal
e17
2cm
52kg
Mod
erat
e ex
e65
062
653.
0M
ediu
m 6
4.8
17.5
813
5521
69 5
.4 1
0.7
41.
3 3
0.1
20.
6 7
9.4
57.
9
09/0
5/20
075:
37:5
3A
TT
IKP
OY
AW
AH
BA
1 00
930
Fem
ale
160
cm51
kgM
oder
ate
exe
543
5954
6.2
Sm
all
64.
819
.92
1291
2066
6.2
10.
5 4
0.5
30.
7 2
0.5
79.
5 6
0.2
16/0
5/20
075:
37:5
3A
TT
IKP
OY
AW
AH
BA
1 00
930
Fem
ale
160
cm52
kgM
oder
ate
exe
539
6354
2.7
Sm
all
64.
820
.31
1301
2082
6.7
11.
1 4
0.9
31.
0 2
1.4
78.
6 5
9.6
23/0
5/20
075:
37:5
3A
TT
IKP
OY
AW
AH
BA
1 00
930
Fem
ale
160
cm50
kgM
oder
ate
exe
549
5955
2.2
Sm
all
64.
819
.53
1282
2051
6.1
9.9
40.
1 3
0.4
19.
8 8
0.2
60.
8
30/0
5/20
075:
37:5
3A
TT
IKP
OY
AW
AH
BA
1 00
930
Fem
ale
160
cm50
kgM
oder
ate
exe
599
6860
2.8
Sm
all
64.
819
.53
1282
2051
6.5
11.
8 3
8.2
28.
6 2
3.6
76.
4 5
7.3
14/0
5/20
075:
49:2
4S
EW
OA
DA
EN
YO
VI
HB
A1
010
25F
emal
e15
8cm
60kg
Mod
erat
e ex
e52
957
532.
1M
ediu
m 6
4.8
24.0
313
9822
36 6
.1 1
8.1
41.
9 3
1.8
30.
2 6
9.8
52.
9
21/0
5/20
075:
49:2
4S
EW
OA
DA
EN
YO
VI
HB
A1
010
25F
emal
e15
8cm
60kg
Mod
erat
e ex
e53
861
541.
4M
ediu
m 6
4.8
24.0
313
9822
36 6
.5 1
8.5
41.
5 3
1.4
30.
9 6
9.1
52.
3
28/0
5/20
075:
49:2
4S
EW
OA
DA
EN
YO
VI
HB
A1
010
25F
emal
e15
8cm
60kg
Mod
erat
e ex
e55
670
560.
4M
ediu
m 6
4.8
24.0
313
9822
36 7
.2 1
9.3
40.
7 3
0.7
32.
2 6
7.8
51.
2
04/0
6/20
075:
49:2
4S
EW
OA
DA
EN
YO
VI
HB
A1
010
25F
emal
e15
8cm
61kg
Mod
erat
e ex
e53
665
539.
9M
ediu
m 6
4.8
24.4
414
0722
52 6
.9 1
9.3
41.
7 3
1.6
31.
6 6
8.4
51.
8
11/0
6/20
075:
49:2
4S
EW
OA
DA
EN
YO
VI
HB
A1
010
25F
emal
e15
8cm
60kg
Mod
erat
e ex
e53
159
534.
3M
ediu
m 6
4.8
24.0
313
9822
36 6
.3 1
8.2
41.
8 3
1.7
30.
4 6
9.6
52.
8
18/0
6/20
075:
49:2
4S
EW
OA
DA
EN
YO
VI
HB
A1
010
25F
emal
e15
8cm
60kg
Mod
erat
e ex
e55
063
553.
6M
ediu
m 6
4.8
24.0
313
9822
36 6
.5 1
9.1
40.
9 3
1.0
31.
8 6
8.2
51.
6
09/0
5/20
076:
10:2
1A
YIK
OE
AY
OK
OH
BA
1 01
135
Fem
ale
168
cm43
kgM
oder
ate
exe
774
6377
6.6
Sm
all
64.
815
.24
1205
1929
4.7
7.5
35.
5 2
5.0
17.
5 8
2.5
58.
2
16/0
5/20
076:
10:2
1A
YIK
OE
AY
OK
OH
BA
1 01
135
Fem
ale
168
cm44
kgM
oder
ate
exe
757
6776
0.0
Sm
all
64.
815
.59
1215
1944
5.1
8.1
35.
9 2
5.5
18.
4 8
1.6
57.
9
23/0
5/20
076:
10:2
1A
YIK
OE
AY
OK
OH
BA
1 01
135
Fem
ale
168
cm43
kgM
oder
ate
exe
780
6678
2.8
Sm
all
64.
815
.24
1205
1929
4.8
7.6
35.
4 2
4.9
17.
8 8
2.2
57.
9
30/0
5/20
076:
10:2
1A
YIK
OE
AY
OK
OH
BA
1 01
135
Fem
ale
168
cm45
kgM
oder
ate
exe
745
6974
8.2
Sm
all
64.
815
.94
1225
1960
5.3
8.7
36.
3 2
5.9
19.
3 8
0.7
57.
5
14/0
5/20
076:
17:5
1D
UM
AH
EK
OD
ZO
HB
A1
012
56M
ale
167
cm59
kgM
oder
ate
exe
499
5550
2.0
Sm
all
64.
821
.16
1334
2269
6.3
10.
3 4
8.7
36.
7 1
7.4
82.
6 6
2.2
21/0
5/20
076:
17:5
1D
UM
AH
EK
OD
ZO
HB
A1
012
56M
ale
167
cm59
kgM
oder
ate
exe
505
5950
8.4
Sm
all
64.
821
.16
1334
2269
6.7
10.
6 4
8.4
36.
4 1
8.0
82.
0 6
1.7
28/0
5/20
076:
17:5
1D
UM
AH
EK
OD
ZO
HB
A1
012
56M
ale
167
cm59
kgM
oder
ate
exe
478
5548
1.2
Sm
all
64.
821
.16
1334
2269
6.6
9.0
50.
0 3
7.8
15.
3 8
4.7
64.
0
04/0
6/20
076:
17:5
1D
UM
AH
EK
OD
ZO
HB
A1
012
56M
ale
167
cm59
kgM
oder
ate
exe
490
6449
4.2
Sm
all
64.
821
.16
1334
2269
7.4
9.8
49.
2 3
7.1
16.
5 8
3.5
63.
0
11/0
6/20
076:
17:5
1D
UM
AH
EK
OD
ZO
HB
A1
012
56M
ale
167
cm59
kgM
oder
ate
exe
480
5248
2.8
Sm
all
64.
821
.16
1334
2269
6.2
9.1
49.
9 3
7.7
15.
5 8
4.5
63.
9
18/0
6/20
076:
17:5
1D
UM
AH
EK
OD
ZO
HB
A1
012
56M
ale
167
cm58
kgM
oder
ate
exe
481
5448
4.0
Sm
all
64.
820
.80
1321
2245
6.4
8.5
49.
5 3
7.4
14.
6 8
5.4
64.
6
16/0
5/20
076:
40:1
1Y
AB
EA
NA
AF
FIT
EY
HB
A1
013
30M
ale
176
cm75
kgM
oder
ate
exe
458
6746
2.9
Med
ium
64.
824
.21
1777
3021
8.3
15.
1 5
9.9
44.
8 2
0.1
79.
9 5
9.7
23/0
5/20
076:
40:1
1Y
AB
EA
NA
AF
FIT
EY
HB
A1
013
30M
ale
176
cm75
kgM
oder
ate
exe
452
6645
6.8
Med
ium
64.
824
.21
1777
3021
8.3
14.
6 6
0.4
45.
2 1
9.4
80.
6 6
0.2
30/0
5/20
076:
40:1
1Y
AB
EA
NA
AF
FIT
EY
HB
A1
013
30M
ale
176
cm75
kgM
oder
ate
exe
412
5941
6.2
Med
ium
64.
824
.21
1777
3021
8.1
10.
8 6
4.2
48.
2 1
4.4
85.
6 6
4.2
09/0
5/20
076:
44:1
6D
AC
HI
KO
FF
I ED
OHB
A1
014
43M
ale
165
cm49
kgM
oder
ate
exe
568
4456
9.7
Sm
all
64.
818
.00
1275
2168
4.4
7.1
41.
9 3
1.3
14.
4 8
5.6
64.
0
16/0
5/20
076:
44:1
6D
AC
HI
KO
FF
I ED
OHB
A1
014
43M
ale
165
cm50
kgM
oder
ate
exe
633
5363
5.2
Sm
all
64.
818
.37
1289
2191
4.8
10.
0 4
0.0
29.
3 2
0.1
79.
9 5
8.6
23/0
5/20
076:
44:1
6D
AC
HI
KO
FF
I ED
OHB
A1
014
43M
ale
165
cm49
kgM
oder
ate
exe
634
5063
6.0
Sm
all
64.
818
.00
1275
2168
4.5
9.3
39.
7 2
9.1
19.
0 8
1.0
59.
4
30/0
5/20
076:
44:1
6D
AC
HI
KO
FF
I ED
OHB
A1
014
43M
ale
165
cm50
kgM
oder
ate
exe
591
4759
2.9
Sm
all
64.
818
.37
1289
2191
4.5
8.7
41.
3 3
0.7
17.
4 8
2.6
61.
4
14/0
5/20
076:
44:1
6A
ZIA
GB
ED
EK
OF
FI
HB
A1
015
30M
ale
182
cm75
kgM
oder
ate
exe
599
6960
3.0
Med
ium
64.
822
.64
1807
3072
6.6
21.
0 5
4.0
39.
2 2
8.0
72.
0 5
2.3
21/0
5/20
076:
44:1
6A
ZIA
GB
ED
EK
OF
FI
HB
A1
015
30M
ale
182
cm75
kgM
oder
ate
exe
575
6957
9.1
Med
ium
64.
822
.64
1807
3072
6.8
19.
8 5
5.2
40.
3 2
6.5
73.
5 5
3.7
28/0
5/20
076:
44:1
6A
ZIA
GB
ED
EK
OF
FI
HB
A1
015
30M
ale
182
cm75
kgM
oder
ate
exe
566
6656
9.8
Med
ium
64.
822
.64
1807
3072
6.7
19.
4 5
5.6
40.
7 2
5.8
74.
2 5
4.2
04/0
6/20
076:
44:1
6A
ZIA
GB
ED
EK
OF
FI
HB
A1
015
30M
ale
182
cm75
kgM
oder
ate
exe
580
6658
3.7
Med
ium
64.
822
.64
1807
3072
6.5
20.
1 5
4.9
40.
0 2
6.8
73.
2 5
3.4
11/0
6/20
076:
44:1
6A
ZIA
GB
ED
EK
OF
FI
HB
A1
015
30M
ale
182
cm75
kgM
oder
ate
exe
606
7461
0.5
Med
ium
64.
822
.64
1807
3072
7.0
21.
3 5
3.7
38.
9 2
8.4
71.
6 5
1.9
18/0
6/20
076:
44:1
6A
ZIA
GB
ED
EK
OF
FI
HB
A1
015
30M
ale
182
cm76
kgM
oder
ate
exe
578
7158
2.3
Med
ium
64.
822
.94
1821
3096
7.0
20.
7 5
5.3
40.
3 2
7.3
72.
7 5
3.0
14/0
5/20
077:
12:4
0A
DO
NK
OK
OD
ZO
HB
A1
016
32M
ale
177
cm73
kgM
oder
ate
exe
471
5847
4.6
Med
ium
64.
823
.30
1741
2960
7.0
14.
1 5
8.9
43.
9 1
9.3
80.
7 6
0.2
21/0
5/20
077:
12:4
0A
DO
NK
OK
OD
ZO
HB
A1
016
32M
ale
177
cm74
kgM
oder
ate
exe
486
5748
9.3
Med
ium
64.
823
.62
1755
2983
6.7
16.
0 5
8.0
43.
2 2
1.6
78.
4 5
8.3
28/0
5/20
077:
12:4
0A
DO
NK
OK
OD
ZO
HB
A1
016
32M
ale
177
cm75
kgM
oder
ate
exe
423
4842
5.7
Med
ium
64.
823
.94
1768
3007
6.5
11.
4 6
3.6
47.
7 1
5.2
84.
8 6
3.5
04/0
6/20
077:
12:4
0A
DO
NK
OK
OD
ZO
HB
A1
016
32M
ale
177
cm75
kgM
oder
ate
exe
446
5444
9.3
Med
ium
64.
823
.94
1768
3007
6.9
13.
5 6
1.5
45.
9 1
8.1
81.
9 6
1.3
11/0
6/20
077:
12:4
0A
DO
NK
OK
OD
ZO
HB
A1
016
32M
ale
177
cm74
kgM
oder
ate
exe
468
5847
1.6
Med
ium
64.
823
.62
1755
2983
7.1
14.
6 5
9.4
44.
3 1
9.8
80.
2 5
9.8
18/0
6/20
077:
12:4
0A
DO
NK
OK
OD
ZO
HB
A1
016
32M
ale
177
cm74
kgM
oder
ate
exe
476
6248
0.0
Med
ium
64.
823
.62
1755
2983
7.4
15.
2 5
8.8
43.
8 2
0.6
79.
4 5
9.2
14/0
5/20
079:
29:1
2K
PIN
IK
UD
ZO
HB
A1
017
35M
ale
168
cm75
kgM
oder
ate
exe
438
5944
2.0
Med
ium
64.
826
.57
1703
2895
7.7
17.
4 5
7.6
43.
3 2
3.3
76.
7 5
7.8
21/0
5/20
079:
29:1
2K
PIN
IK
UD
ZO
HB
A1
017
35M
ale
168
cm75
kgM
oder
ate
exe
475
6447
9.3
Med
ium
64.
826
.57
1703
2895
7.7
20.
2 5
4.8
41.
1 2
6.9
73.
1 5
4.8
28/0
5/20
079:
29:1
2K
PIN
IK
UD
ZO
HB
A1
017
35M
ale
168
cm75
kgM
oder
ate
exe
478
6548
2.4
Med
ium
64.
826
.57
1703
2895
7.7
20.
4 5
4.6
40.
9 2
7.1
72.
9 5
4.6
04/0
6/20
079:
29:1
2K
PIN
IK
UD
ZO
HB
A1
017
35M
ale
168
cm75
kgM
oder
ate
exe
446
6345
0.4
Med
ium
64.
826
.57
1703
2895
8.0
18.
1 5
6.9
42.
8 2
4.1
75.
9 5
7.1
11/0
6/20
079:
29:1
2K
PIN
IK
UD
ZO
HB
A1
017
35M
ale
168
cm75
kgM
oder
ate
exe
437
5544
0.4
Med
ium
64.
826
.57
1703
2895
7.2
17.
4 5
7.6
43.
4 2
3.2
76.
8 5
7.9
18/0
6/20
079:
29:1
2K
PIN
IK
UD
ZO
HB
A1
017
35M
ale
168
cm75
kgM
oder
ate
exe
449
5745
2.6
Med
ium
64.
826
.57
1703
2895
7.2
18.
3 5
6.7
42.
6 2
4.4
75.
6 5
6.8
09/0
5/20
079:
29:1
2A
GB
OK
OM
LAH
BA
1 01
849
Mal
e17
7cm
83kg
Mod
erat
e ex
e43
860
442.
1M
ediu
m 6
4.8
26.4
917
6329
98 7
.8 1
8.7
64.
3 4
7.9
22.
6 7
7.4
57.
7
16/0
5/20
079:
29:1
2A
GB
OK
OM
LAH
BA
1 01
849
Mal
e17
7cm
83kg
Mod
erat
e ex
e44
458
447.
8M
ediu
m 6
4.8
26.4
917
6329
98 7
.4 1
9.3
63.
7 4
7.5
23.
2 7
6.8
57.
2
23/0
5/20
079:
29:1
2A
GB
OK
OM
LAH
BA
1 01
849
Mal
e17
7cm
83kg
Mod
erat
e ex
e44
560
449.
0M
ediu
m 6
4.8
26.4
917
6329
98 7
.7 1
9.4
63.
6 4
7.4
23.
3 7
6.7
57.
1
5B
IA T
ES
T A
GO
U F
INA
L F
inal
F 2
.xls
BIA
TE
ST
AG
OU
FIN
AL
Tes
t D
ate
Tes
t T
ime
Las
t N
ame
Fir
st
Nam
eS
ub
ject
IDA
ge
Gen
der
Hei
gh
tW
eig
ht
Act
ivit
y L
eve
Res
ista
nce
Rea
ctan
ceIm
ped
ance
Fra
me
Siz
eT
arg
et
Wei
gh
tB
MI
BM
RD
EE
Ph
ase
An
gle
Fat
wt
FF
M w
tT
BW
lit
ers
Fat
%
of
wt
FF
M %
o
f w
tT
BW
%
of
wt
30/0
5/20
079:
29:1
2A
GB
OK
OM
LAH
BA
1 01
849
Mal
e17
7cm
83kg
Mod
erat
e ex
e43
959
442.
9M
ediu
m 6
4.8
26.4
917
6329
98 7
.7 1
8.8
64.
2 4
7.9
22.
7 7
7.3
57.
7
09/0
5/20
079:
51:4
2A
GB
OD
JAN
KE
KE
LIH
BA
1 01
928
Fem
ale
164
cm50
kgM
oder
ate
exe
656
7265
9.9
Med
ium
64.
818
.59
1298
2077
6.3
12.
1 3
7.9
27.
8 2
4.2
75.
8 5
5.7
16/0
5/20
079:
51:4
2A
GB
OD
JAN
KE
KE
LIH
BA
1 01
928
Fem
ale
164
cm52
kgM
oder
ate
exe
629
6763
2.6
Med
ium
64.
819
.33
1317
2108
6.1
13.
0 3
9.0
28.
9 2
4.9
75.
1 5
5.5
23/0
5/20
079:
51:4
2A
GB
OD
JAN
KE
KE
LIH
BA
1 01
928
Fem
ale
164
cm52
kgM
oder
ate
exe
646
7465
0.2
Med
ium
64.
819
.33
1317
2108
6.5
13.
5 3
8.5
28.
4 2
5.9
74.
1 5
4.5
30/0
5/20
079:
51:4
2A
GB
OD
JAN
KE
KE
LIH
BA
1 01
928
Fem
ale
164
cm53
kgM
oder
ate
exe
618
7262
2.2
Med
ium
64.
819
.71
1327
2124
6.6
13.
4 3
9.6
29.
3 2
5.4
74.
6 5
5.3
09/0
5/20
079:
56:4
1T
OM
EK
PE
KO
FF
IH
BA
1 02
032
Mal
e16
8cm
70kg
Mod
erat
e ex
e49
562
498.
9M
ediu
m 6
4.8
24.8
016
5428
13 7
.1 1
7.7
52.
3 3
9.1
25.
3 7
4.7
55.
9
16/0
5/20
079:
56:4
1T
OM
EK
PE
KO
FF
IH
BA
1 02
032
Mal
e16
8cm
70kg
Mod
erat
e ex
e52
065
524.
0M
ediu
m 6
4.8
24.8
016
5428
13 7
.1 1
9.1
50.
9 3
7.9
27.
4 7
2.6
54.
1
23/0
5/20
079:
56:4
1T
OM
EK
PE
KO
FF
IH
BA
1 02
032
Mal
e16
8cm
70kg
Mod
erat
e ex
e51
567
519.
3M
ediu
m 6
4.8
24.8
016
5428
13 7
.4 1
8.9
51.
1 3
8.1
27.
0 7
3.0
54.
5
30/0
5/20
079:
56:4
1T
OM
EK
PE
KO
FF
IH
BA
1 02
032
Mal
e16
8cm
70kg
Mod
erat
e ex
e49
863
502.
0M
ediu
m 6
4.8
24.8
016
5428
13 7
.2 1
7.9
52.
1 3
9.0
25.
6 7
4.4
55.
7
09/0
5/20
0710
:04:
12A
GB
OA
DZ
OH
BA
1 02
128
Fem
ale
155
cm46
kgM
oder
ate
exe
619
7662
3.6
Med
ium
64.
819
.15
1244
1990
7.0
10.
9 3
5.1
26.
4 2
3.7
76.
3 5
7.4
16/0
5/20
0710
:04:
12A
GB
OA
DZ
OH
BA
1 02
128
Fem
ale
155
cm47
kgM
oder
ate
exe
586
7659
0.9
Med
ium
64.
819
.56
1253
2005
7.4
10.
7 3
6.3
27.
5 2
2.8
77.
2 5
8.5
23/0
5/20
0710
:04:
12A
GB
OA
DZ
OH
BA
1 02
128
Fem
ale
155
cm47
kgM
oder
ate
exe
589
6259
2.3
Med
ium
64.
819
.56
1253
2005
6.0
10.
8 3
6.2
27.
4 2
3.0
77.
0 5
8.3
30/0
5/20
0710
:04:
12A
GB
OA
DZ
OH
BA
1 02
128
Fem
ale
155
cm46
kgM
oder
ate
exe
602
6660
5.6
Med
ium
64.
819
.15
1244
1990
6.3
10.
4 3
5.6
26.
9 2
2.6
77.
4 5
8.5
09/0
5/20
0710
:16:
09A
HA
VI
ELI
HB
A1
022
33M
ale
168
cm55
kgM
oder
ate
exe
521
6552
5.0
Sm
all
64.
819
.49
1441
2449
7.1
8.1
46.
9 3
5.2
14.
8 8
5.2
64
.0
16/0
5/20
0710
:16:
09A
HA
VI
ELI
HB
A1
022
33M
ale
168
cm55
kgM
oder
ate
exe
508
6451
2.0
Sm
all
64.
819
.49
1441
2449
7.2
7.4
47.
6 3
5.8
13.
5 8
6.5
65
.1
23/0
5/20
0710
:16:
09A
HA
VI
ELI
HB
A1
022
33M
ale
168
cm55
kgM
oder
ate
exe
501
6350
4.9
Sm
all
64.
819
.49
1441
2449
7.2
7.0
48.
0 3
6.2
12.
8 8
7.2
65
.8
30/0
5/20
0710
:16:
09A
HA
VI
ELI
HB
A1
022
33M
ale
168
cm56
kgM
oder
ate
exe
460
5546
3.3
Sm
all
64.
819
.84
1454
2473
6.8
5.1
50.
9 3
8.6
9.1
90.
9 6
8.9
14/0
5/20
0710
:21:
32E
PP
RE
HK
OF
FI
HB
A1
023
36M
ale
174
cm55
kgM
oder
ate
exe
523
5552
5.9
Sm
all
64.
818
.17
1450
2466
6.0
5.7
49.
3 3
6.9
10.
3 8
9.7
67.
0
21/0
5/20
0710
:21:
32E
PP
RE
HK
OF
FI
HB
A1
023
36M
ale
174
cm53
kgM
oder
ate
exe
637
6964
0.7
Sm
all
64.
817
.51
1423
2419
6.2
9.2
43.
8 3
1.9
17.
4 8
2.6
60.
1
28/0
5/20
0710
:21:
32E
PP
RE
HK
OF
FI
HB
A1
023
36M
ale
174
cm53
kgM
oder
ate
exe
536
6153
9.5
Sm
all
64.
817
.51
1423
2419
6.5
4.9
48.
1 3
5.9
9.3
90.
7 6
7.7
04/0
6/20
0710
:21:
32E
PP
RE
HK
OF
FI
HB
A1
023
36M
ale
174
cm53
kgM
oder
ate
exe
530
5053
2.4
Sm
all
64.
817
.51
1423
2419
5.4
4.6
48.
4 3
6.2
8.7
91.
3 6
8.3
11/0
6/20
0710
:21:
32E
PP
RE
HK
OF
FI
HB
A1
023
36M
ale
174
cm54
kgM
oder
ate
exe
488
4749
0.3
Sm
all
64.
817
.84
1436
2442
5.5
2.8
51.
2 3
8.6
5.1
94.
9 7
1.4
18/0
6/20
0710
:21:
32E
PP
RE
HK
OF
FI
HB
A1
023
36M
ale
174
cm53
kgM
oder
ate
exe
572
6057
5.1
Sm
all
64.
817
.51
1423
2419
6.0
6.7
46.
3 3
4.3
12.
6 8
7.4
64.
7
09/0
5/20
0710
:21:
32T
OM
EK
PE
AK
UH
BA
1 02
441
Fem
ale
160
cm53
kgM
oder
ate
exe
535
6153
8.5
Sm
all
64.
820
.70
1259
2014
6.5
11.
8 4
1.2
31.
3 2
2.2
77.
8 5
9.0
16/0
5/20
0710
:21:
32T
OM
EK
PE
AK
UH
BA
1 02
441
Fem
ale
160
cm54
kgM
oder
ate
exe
533
6053
6.4
Sm
all
64.
821
.09
1268
2030
6.4
12.
5 4
1.5
31.
5 2
3.1
76.
9 5
8.3
23/0
5/20
0710
:21:
32T
OM
EK
PE
AK
UH
BA
1 02
441
Fem
ale
160
cm55
kgM
oder
ate
exe
531
6253
4.6
Sm
all
64.
821
.48
1278
2045
6.7
13.
2 4
1.8
31.
7 2
4.1
75.
9 5
7.6
30/0
5/20
0710
:21:
32T
OM
EK
PE
AK
UH
BA
1 02
441
Fem
ale
160
cm55
kgM
oder
ate
exe
539
5954
2.2
Sm
all
64.
821
.48
1278
2045
6.2
13.
6 4
1.4
31.
3 2
4.7
75.
3 5
7.0
09/0
5/20
0710
:21:
32D
ZIM
AS
SE
AT
AW
AH
BA
1 02
540
Fem
ale
157
cm60
kgM
oder
ate
exe
583
6258
6.3
Sm
all
64.
824
.34
1325
2121
6.1
20.
7 3
9.3
29.
6 3
4.5
65.
5 4
9.3
16/0
5/20
0710
:21:
32D
ZIM
AS
SE
AT
AW
AH
BA
1 02
540
Fem
ale
157
cm60
kgM
oder
ate
exe
569
6257
2.4
Sm
all
64.
824
.34
1325
2121
6.2
20.
2 3
9.8
30.
0 3
3.7
66.
3 5
0.0
23/0
5/20
0710
:21:
32D
ZIM
AS
SE
AT
AW
AH
BA
1 02
540
Fem
ale
157
cm60
kgM
oder
ate
exe
596
6259
9.2
Sm
all
64.
824
.34
1325
2121
5.9
21.
1 3
8.9
29.
1 3
5.2
64.
8 4
8.6
30/0
5/20
0710
:21:
32D
ZIM
AS
SE
AT
AW
AH
BA
1 02
540
Fem
ale
157
cm60
kgM
oder
ate
exe
593
6359
6.3
Sm
all
64.
824
.34
1325
2121
6.1
21.
0 3
9.0
29.
2 3
5.1
64.
9 4
8.7
09/0
5/20
0710
:50:
11N
YO
NA
TO
RA
DZ
OH
BA
1 02
652
Fem
ale
157
cm44
kgM
oder
ate
exe
624
6462
7.3
Sm
all
64.
817
.85
1115
1785
5.9
8.7
35.
3 2
6.5
19.
7 8
0.3
60.
2
16/0
5/20
0710
:50:
11N
YO
NA
TO
RA
DZ
OH
BA
1 02
652
Fem
ale
157
cm44
kgM
oder
ate
exe
614
5961
6.8
Sm
all
64.
817
.85
1115
1785
5.5
8.4
35.
6 2
6.8
19.
0 8
1.0
60.
9
23/0
5/20
0710
:50:
11N
YO
NA
TO
RA
DZ
OH
BA
1 02
652
Fem
ale
157
cm45
kgM
oder
ate
exe
560
4956
2.1
Sm
all
64.
818
.26
1125
1800
5.0
7.4
37.
6 2
8.6
16.
4 8
3.6
63.
6
30/0
5/20
0710
:50:
11N
YO
NA
TO
RA
DZ
OH
BA
1 02
652
Fem
ale
157
cm44
kgM
oder
ate
exe
630
5963
2.8
Sm
all
64.
817
.85
1115
1785
5.4
8.8
35.
2 2
6.3
20.
1 7
9.9
59.
8
14/0
5/20
0710
:57:
12T
SO
NY
AY
AW
OH
BA
1 02
745
Mal
e16
2cm
56kg
Mod
erat
e ex
e53
163
534.
7M
ediu
m 6
4.8
21.3
413
4322
83 6
.8 1
1.8
44.
2 3
3.3
21.
1 7
8.9
59.
4
21/0
5/20
0710
:57:
12T
SO
NY
AY
AW
OH
BA
1 02
745
Mal
e16
2cm
55kg
Mod
erat
e ex
e54
966
553.
0M
ediu
m 6
4.8
20.9
613
2922
60 6
.9 1
1.9
43.
1 3
2.3
21.
6 7
8.4
58.
8
28/0
5/20
0710
:57:
12T
SO
NY
AY
AW
OH
BA
1 02
745
Mal
e16
2cm
57kg
Mod
erat
e ex
e50
757
510.
2M
ediu
m 6
4.8
21.7
213
5723
07 6
.4 1
1.4
45.
6 3
4.5
20.
0 8
0.0
60.
5
04/0
6/20
0710
:57:
12T
SO
NY
AY
AW
OH
BA
1 02
745
Mal
e16
2cm
57kg
Mod
erat
e ex
e50
661
509.
7M
ediu
m 6
4.8
21.7
213
5723
07 6
.9 1
1.3
45.
7 3
4.5
19.
9 8
0.1
60.
6
11/0
6/20
0710
:57:
12T
SO
NY
AY
AW
OH
BA
1 02
745
Mal
e16
2cm
55kg
Mod
erat
e ex
e51
058
513.
3M
ediu
m 6
4.8
20.9
613
2922
60 6
.5 1
0.1
44.
9 3
4.0
18.
3 8
1.7
61.
8
18/0
6/20
0710
:57:
12T
SO
NY
AY
AW
OH
BA
1 02
745
Mal
e16
2cm
57kg
Mod
erat
e ex
e44
857
451.
6M
ediu
m 6
4.8
21.7
213
5723
07 7
.3 7
.8 4
9.2
37.
5 1
3.7
86.
3 6
5.9
09/0
5/20
0710
:57:
12S
AN
KA
RB
OA
KO
UV
IH
BA
1 02
823
Fem
ale
155
cm57
kgM
oder
ate
exe
640
8264
5.2
Med
ium
64.
823
.73
1373
2197
7.3
20.
6 3
6.4
27.
1 3
6.1
63.
9 4
7.5
16/0
5/20
0710
:57:
12S
AN
KA
RB
OA
KO
UV
IH
BA
1 02
823
Fem
ale
155
cm58
kgM
oder
ate
exe
638
7764
2.6
Med
ium
64.
824
.14
1382
2212
6.9
21.
4 3
6.6
27.
2 3
6.8
63.
2 4
7.0
23/0
5/20
0710
:57:
12S
AN
KA
RB
OA
KO
UV
IH
BA
1 02
823
Fem
ale
155
cm58
kgM
oder
ate
exe
635
7763
9.7
Med
ium
64.
824
.14
1382
2212
6.9
21.
3 3
6.7
27.
3 3
6.7
63.
3 4
7.1
30/0
5/20
0710
:57:
12S
AN
KA
RB
OA
KO
UV
IH
BA
1 02
823
Fem
ale
155
cm58
kgM
oder
ate
exe
648
8665
3.7
Med
ium
64.
824
.14
1382
2212
7.6
21.
6 3
6.4
27.
0 3
7.3
62.
7 4
6.5
09/0
5/20
0711
:29:
19T
SE
VI
KO
MI W
OLH
BA
1 03
034
Mal
e16
7cm
73kg
Mod
erat
e ex
e41
751
420.
1M
ediu
m 6
4.8
26.1
816
7728
52 7
.0 1
4.7
58.
3 4
4.1
20.
1 7
9.9
60.
4
16/0
5/20
0711
:29:
19T
SE
VI
KO
MI W
OLH
BA
1 03
034
Mal
e16
7cm
73kg
Mod
erat
e ex
e43
857
441.
7M
ediu
m 6
4.8
26.1
816
7728
52 7
.4 1
6.5
56.
5 4
2.6
22.
6 7
7.4
58.
4
23/0
5/20
0711
:29:
19T
SE
VI
KO
MI W
OLH
BA
1 03
034
Mal
e16
7cm
73kg
Mod
erat
e ex
e43
556
438.
6M
ediu
m 6
4.8
26.1
816
7728
52 7
.3 1
6.2
56.
8 4
2.8
22.
2 7
7.8
58.
7
30/0
5/20
0711
:29:
19T
SE
VI
KO
MI W
OLH
BA
1 03
034
Mal
e16
7cm
74kg
Mod
erat
e ex
e44
555
448.
4M
ediu
m 6
4.8
26.5
316
9128
75 7
.0 1
7.8
56.
2 4
2.4
24.
0 7
6.0
57.
3
6B
IA T
ES
T A
GO
U F
INA
L F
inal
F 2
.xls
BIA
TE
ST
AG
OU
FIN
AL
Tes
t D
ate
Tes
t T
ime
Las
t N
ame
Fir
st
Nam
eS
ub
ject
IDA
ge
Gen
der
Hei
gh
tW
eig
ht
Act
ivit
y L
eve
Res
ista
nce
Rea
ctan
ceIm
ped
ance
Fra
me
Siz
eT
arg
et
Wei
gh
tB
MI
BM
RD
EE
Ph
ase
An
gle
Fat
wt
FF
M w
tT
BW
lit
ers
Fat
%
of
wt
FF
M %
o
f w
tT
BW
%
of
wt
10/0
5/20
0711
:36:
43K
OS
SIG
AN
KO
KO
UH
BA
1 03
157
Mal
e17
1cm
79kg
Mod
erat
e ex
e40
645
408.
5M
ediu
m 6
4.8
27.0
216
2427
60 6
.3 1
5.9
63.
1 4
7.4
20.
2 7
9.8
60.
1
17/0
5/20
0711
:36:
43K
OS
SIG
AN
KO
KO
UH
BA
1 03
157
Mal
e17
1cm
80kg
Mod
erat
e ex
e39
844
400.
4M
ediu
m 6
4.8
27.3
616
3727
84 6
.3 1
5.8
64.
2 4
8.3
19.
8 8
0.2
60.
3
24/0
5/20
0711
:36:
43K
OS
SIG
AN
KO
KO
UH
BA
1 03
157
Mal
e17
1cm
80kg
Mod
erat
e ex
e39
444
396.
4M
ediu
m 6
4.8
27.3
616
3727
84 6
.4 1
5.4
64.
6 4
8.6
19.
3 8
0.7
60.
8
31/0
5/20
0711
:36:
43K
OS
SIG
AN
KO
KO
UH
BA
1 03
157
Mal
e17
1cm
79kg
Mod
erat
e ex
e44
052
443.
1M
ediu
m 6
4.8
27.0
216
2427
60 6
.7 1
9.1
59.
9 4
4.9
24.
1 7
5.9
56.
9
07/0
6/20
0711
:36:
43K
OS
SIG
AN
KO
KO
UH
BA
1 03
157
Mal
e17
1cm
80kg
Mod
erat
e ex
e43
853
441.
2M
ediu
m 6
4.8
27.3
616
3727
84 6
.9 1
9.6
60.
4 4
5.3
24.
5 7
5.5
56.
6
14/0
6/20
0711
:36:
43K
OS
SIG
AN
KO
KO
UH
BA
1 03
157
Mal
e17
1cm
80kg
Mod
erat
e ex
e42
763
431.
6M
ediu
m 6
4.8
27.3
616
3727
84 8
.4 1
8.7
61.
3 4
6.0
23.
3 7
6.7
57.
5
09/0
5/20
0711
:47:
31S
AM
TO
UD
ZIG
BO
DIH
BA
1 03
233
Fem
ale
164
cm46
kgM
oder
ate
exe
674
5467
6.2
Med
ium
64.
817
.10
1236
1978
4.6
9.2
36.
8 2
6.9
20.
1 7
9.9
58.
5
16/0
5/20
0711
:47:
31S
AM
TO
UD
ZIG
BO
DIH
BA
1 03
233
Fem
ale
164
cm46
kgM
oder
ate
exe
659
5166
1.0
Med
ium
64.
817
.10
1236
1978
4.4
8.9
37.
1 2
7.3
19.
2 8
0.8
59.
4
23/0
5/20
0711
:47:
31S
AM
TO
UD
ZIG
BO
DIH
BA
1 03
233
Fem
ale
164
cm47
kgM
oder
ate
exe
608
4860
9.9
Med
ium
64.
817
.47
1246
1994
4.5
8.1
38.
9 2
9.0
17.
3 8
2.7
61.
6
30/0
5/20
0711
:47:
31S
AM
TO
UD
ZIG
BO
DIH
BA
1 03
233
Fem
ale
164
cm49
kgM
oder
ate
exe
643
4564
4.6
Med
ium
64.
818
.22
1265
2024
4.0
10.
9 3
8.1
28.
1 2
2.2
77.
8 5
7.4
09/0
5/20
0711
:47:
31M
ISS
IAM
EN
MA
GU
YH
BA
1 03
331
Fem
ale
152
cm41
kgM
oder
ate
exe
798
6780
0.8
Med
ium
64.
817
.75
1176
1882
4.8
10.
7 3
0.3
21.
4 2
6.2
73.
8 5
2.2
16/0
5/20
0711
:47:
31M
ISS
IAM
EN
MA
GU
YH
BA
1 03
331
Fem
ale
152
cm42
kgM
oder
ate
exe
803
7680
6.6
Med
ium
64.
818
.18
1186
1897
5.4
11.
6 3
0.4
21.
4 2
7.6
72.
4 5
1.0
23/0
5/20
0711
:47:
31M
ISS
IAM
EN
MA
GU
YH
BA
1 03
331
Fem
ale
152
cm44
kgM
oder
ate
exe
734
5973
6.4
Med
ium
64.
819
.04
1205
1928
4.6
12.
5 3
1.5
22.
9 2
8.4
71.
6 5
2.0
30/0
5/20
0711
:47:
31M
ISS
IAM
EN
MA
GU
YH
BA
1 03
331
Fem
ale
152
cm43
kgM
oder
ate
exe
745
7374
8.6
Med
ium
64.
818
.61
1195
1913
5.6
11.
8 3
1.2
22.
6 2
7.4
72.
6 5
2.5
09/0
5/20
0712
:13:
17A
GB
ON
ON
AF
IH
BA
1 03
441
Fem
ale
169
cm77
kgM
oder
ate
exe
577
6258
0.3
Med
ium
64.
826
.96
1505
2409
6.1
29.
9 4
7.1
34.
7 3
8.8
61
.2 4
5.1
16/0
5/20
0712
:13:
17A
GB
ON
ON
AF
IH
BA
1 03
441
Fem
ale
169
cm78
kgM
oder
ate
exe
552
5655
4.8
Med
ium
64.
827
.31
1515
2424
5.8
29.
6 4
8.4
35.
8 3
7.9
62
.1 4
6.0
23/0
5/20
0712
:13:
17A
GB
ON
ON
AF
IH
BA
1 03
441
Fem
ale
169
cm80
kgM
oder
ate
exe
569
6457
2.6
Med
ium
64.
828
.01
1534
2455
6.4
32.
0 4
8.0
35.
4 4
0.1
59
.9 4
4.2
30/0
5/20
0712
:13:
17A
GB
ON
ON
AF
IH
BA
1 03
441
Fem
ale
169
cm78
kgM
oder
ate
exe
555
6155
8.3
Med
ium
64.
827
.31
1515
2424
6.3
29.
7 4
8.3
35.
7 3
8.1
61
.9 4
5.8
09/0
5/20
0712
:23:
20D
A S
ILV
EIR
AD
JELE
HB
A1
035
22F
emal
e14
9cm
44kg
Mod
erat
e ex
e64
373
647.
1M
ediu
m 6
4.8
19.8
212
4219
87 6
.5 1
1.8
32.
2 2
4.3
26.
9 7
3.1
55.
1
16/0
5/20
0712
:23:
20D
A S
ILV
EIR
AD
JELE
HB
A1
035
22F
emal
e14
9cm
43kg
Mod
erat
e ex
e70
683
710.
9M
ediu
m 6
4.8
19.3
712
3219
72 6
.7 1
2.1
30.
9 2
2.8
28.
2 7
1.8
52.
9
23/0
5/20
0712
:23:
20D
A S
ILV
EIR
AD
JELE
HB
A1
035
22F
emal
e14
9cm
44kg
Mod
erat
e ex
e63
972
643.
0M
ediu
m 6
4.8
19.8
212
4219
87 6
.4 1
1.7
32.
3 2
4.4
26.
7 7
3.3
55.
3
30/0
5/20
0712
:23:
20D
A S
ILV
EIR
AD
JELE
HB
A1
035
22F
emal
e14
9cm
45kg
Mod
erat
e ex
e65
379
657.
8M
ediu
m 6
4.8
20.2
712
5120
03 6
.9 1
2.9
32.
1 2
4.1
28.
6 7
1.4
53.
6
09/0
5/20
0712
:27:
39K
OB
AR
AA
TH
AN
AS
HB
A1
036
41M
ale
170
cm58
kgM
oder
ate
exe
561
6256
4.4
Med
ium
64.
820
.07
1438
2444
6.3
11.
5 4
6.5
34.
5 1
9.8
80.
2 5
9.6
16/0
5/20
0712
:27:
39K
OB
AR
AA
TH
AN
AS
HB
A1
036
41M
ale
170
cm58
kgM
oder
ate
exe
563
6356
6.5
Med
ium
64.
820
.07
1438
2444
6.4
11.
6 4
6.4
34.
5 1
9.9
80.
1 5
9.4
23/0
5/20
0712
:27:
39K
OB
AR
AA
TH
AN
AS
HB
A1
036
41M
ale
170
cm59
kgM
oder
ate
exe
561
6256
4.4
Med
ium
64.
820
.42
1451
2468
6.3
12.
2 4
6.8
34.
7 2
0.7
79.
3 5
8.8
30/0
5/20
0712
:27:
39K
OB
AR
AA
TH
AN
AS
HB
A1
036
41M
ale
170
cm59
kgM
oder
ate
exe
566
6256
9.4
Med
ium
64.
820
.42
1451
2468
6.3
12.
4 4
6.6
34.
5 2
1.1
78.
9 5
8.5
09/0
5/20
0712
:27:
39D
OH
AK
OF
AH
BA
1 03
722
Fem
ale
163
cm42
kgM
oder
ate
exe
674
5567
6.2
Med
ium
64.
815
.81
1248
1997
4.7
6.3
35.
7 2
6.2
14.
9 8
5.1
62.
5
16/0
5/20
0712
:27:
39D
OH
AK
OF
AH
BA
1 03
722
Fem
ale
163
cm43
kgM
oder
ate
exe
710
6171
2.6
Med
ium
64.
816
.18
1257
2012
4.9
7.9
35.
1 2
5.4
18.
4 8
1.6
59.
2
23/0
5/20
0712
:27:
39D
OH
AK
OF
AH
BA
1 03
722
Fem
ale
163
cm41
kgM
oder
ate
exe
728
6473
0.8
Med
ium
64.
815
.43
1238
1981
5.0
6.6
34.
4 2
4.8
16.
1 8
3.9
60.
5
30/0
5/20
0712
:27:
39D
OH
AK
OF
AH
BA
1 03
722
Fem
ale
163
cm42
kgM
oder
ate
exe
762
6676
4.9
Med
ium
64.
815
.81
1248
1997
5.0
8.0
34.
0 2
4.2
19.
1 8
0.9
57.
6
09/0
5/20
076:
40:1
1Y
AB
EA
NA
AF
FIT
EY
HB
A1
013
30M
ale
176
cm75
kgM
oder
ate
exe
441
6644
5.9
Med
ium
64.
824
.21
1777
3021
8.5
13.
6 6
1.4
45.
9 1
8.2
81.
8 6
1.3
04/0
4/20
0720
:57:
49M
ON
GA
AM
AH
BA
1 02
944
Fem
ale
166
cm55
kgM
oder
ate
exe
632
6163
4.9
Med
ium
64.
819
.96
1275
2040
5.5
14.
8 4
0.2
29.
6 2
7.0
73.
0 5
3.8
11/0
4/20
0720
:58:
48M
ON
GA
AM
AH
BA
1 02
944
Fem
ale
166
cm54
kgM
oder
ate
exe
610
6161
3.0
Med
ium
64.
819
.60
1265
2024
5.7
13.
3 4
0.7
30.
2 2
4.5
75.
5 5
5.9
18/0
4/20
0720
:58:
48M
ON
GA
AM
AH
BA
1 02
944
Fem
ale
166
cm55
kgM
oder
ate
exe
621
6962
4.8
Med
ium
64.
819
.96
1275
2040
6.3
14.
5 4
0.5
29.
9 2
6.3
73.
7 5
4.4
25/0
4/20
0720
:58:
48M
ON
GA
AM
AH
BA
1 02
944
Fem
ale
166
cm55
kgM
oder
ate
exe
575
6157
8.2
Med
ium
64.
819
.96
1275
2040
6.1
12.
7 4
2.3
31.
5 2
3.2
76.
8 5
7.3
02/0
5/20
0720
:58:
48M
ON
GA
AM
AH
BA
1 02
944
Fem
ale
166
cm56
kgM
oder
ate
exe
619
6362
2.2
Med
ium
64.
820
.32
1284
2055
5.8
15.
2 4
0.8
30.
1 2
7.2
72.
8 5
3.8
09/0
5/20
0720
:58:
48M
ON
GA
AM
AH
BA
1 02
944
Fem
ale
166
cm56
kgM
oder
ate
exe
589
6659
2.7
Med
ium
64.
820
.32
1284
2055
6.4
14.
1 4
1.9
31.
1 2
5.2
74.
8 5
5.6
16/0
5/20
0720
:58:
48M
ON
GA
AM
AH
BA
1 02
944
Fem
ale
166
cm57
kgM
oder
ate
exe
570
6257
3.4
Med
ium
64.
820
.69
1294
2070
6.2
14.
2 4
2.8
31.
9 2
4.9
75.
1 5
6.0
23/0
5/20
0720
:58:
48M
ON
GA
AM
AH
BA
1 02
944
Fem
ale
166
cm57
kgM
oder
ate
exe
569
5657
1.7
Med
ium
64.
820
.69
1294
2070
5.6
14.
1 4
2.9
32.
0 2
4.8
75.
2 5
6.1
30/0
5/20
0720
:58:
48M
ON
GA
AM
AH
BA
1 02
944
Fem
ale
166
cm57
kgM
oder
ate
exe
620
6862
3.7
Med
ium
64.
820
.69
1294
2070
6.3
16.
1 4
0.9
30.
2 2
8.2
71.
8 5
3.0
04/0
4/20
0721
:52:
52A
ZIA
DO
UV
OAN
NA
HB
A1
004
33F
emal
e16
6cm
57kg
Mod
erat
e ex
e57
056
572.
7M
ediu
m 6
4.8
20.6
913
4621
53 5
.6 1
4.2
42.
8 3
1.9
24.
9 7
5.1
56.
0
11/0
4/20
0721
:52:
52A
ZIA
DO
UV
OAN
NA
HB
A1
004
33F
emal
e16
6cm
57kg
Mod
erat
e ex
e60
566
608.
6M
ediu
m 6
4.8
20.6
913
4621
53 6
.2 1
5.6
41.
4 3
0.7
27.
3 7
2.7
53.
8
18/0
4/20
0721
:52:
52A
ZIA
DO
UV
OAN
NA
HB
A1
004
33F
emal
e16
6cm
57kg
Mod
erat
e ex
e56
363
566.
5M
ediu
m 6
4.8
20.6
913
4621
53 6
.4 1
3.9
43.
1 3
2.2
24.
3 7
5.7
56.
5
25/0
4/20
0721
:52:
52A
ZIA
DO
UV
OAN
NA
HB
A1
004
33F
emal
e16
6cm
57kg
Mod
erat
e ex
e57
565
578.
7M
ediu
m 6
4.8
20.6
913
4621
53 6
.4 1
4.4
42.
6 3
1.8
25.
3 7
4.7
55.
7
02/0
5/20
0721
:52:
52A
ZIA
DO
UV
OAN
NA
HB
A1
004
33F
emal
e16
6cm
56kg
Mod
erat
e ex
e65
175
655.
3M
ediu
m 6
4.8
20.3
213
3621
38 6
.6 1
6.2
39.
8 2
9.1
29.
0 7
1.0
52.
0
09/0
5/20
0721
:52:
52A
ZIA
DO
UV
OAN
NA
HB
A1
004
33F
emal
e16
6cm
57kg
Mod
erat
e ex
e60
372
607.
3M
ediu
m 6
4.8
20.6
913
4621
53 6
.8 1
5.5
41.
5 3
0.8
27.
2 7
2.8
54.
0
16/0
5/20
0721
:52:
52A
ZIA
DO
UV
OAN
NA
HB
A1
004
33F
emal
e16
6cm
57kg
Mod
erat
e ex
e59
574
599.
6M
ediu
m 6
4.8
20.6
913
4621
53 7
.1 1
5.2
41.
8 3
1.0
26.
7 7
3.3
54.
4
23/0
5/20
0721
:52:
52A
ZIA
DO
UV
OAN
NA
HB
A1
004
33F
emal
e16
6cm
57kg
Mod
erat
e ex
e69
965
702.
0M
ediu
m 6
4.8
20.6
913
4621
53 5
.3 1
8.3
38.
7 2
7.9
32.
2 6
7.8
49.
0
30/0
5/20
0721
:52:
52A
ZIA
DO
UV
OAN
NA
HB
A1
004
33F
emal
e16
6cm
59kg
Mod
erat
e ex
e59
764
600.
4M
ediu
m 6
4.8
21.4
113
6521
84 6
.1 1
6.9
42.
1 3
1.2
28.
7 7
1.3
52.
9
7B
IA T
ES
T A
GO
U F
INA
L F
inal
F 2
.xls
BIA
TE
ST
KO
UV
É F
INA
L
Tes
t D
ate
Tes
t T
ime
Las
t N
ame
Fir
st N
ame
Su
bje
ct ID
Ag
eG
end
erH
eig
ht
Wei
gh
tA
ctiv
ity
Lev
elR
esis
tan
ceR
eact
ance
Imp
edan
ceF
ram
e S
ize
Tar
get
W
eig
ht
BM
IB
MR
DE
EP
has
e A
ng
leF
at
wt
FF
M w
tT
BW
lit
ers
Fat
%
of
wt
FF
M %
o
f w
tT
BW
%
of
wt
05/0
6/20
0712
:25:
14A
FA
VI
VIC
TO
RIN
EC
MS
K1
001
33F
emal
e15
2cm
55kg
Som
e ex
er
592
6159
5.1
Larg
e 4
9.5
23.8
113
0119
52 5
.9 1
8.7
36.
3 2
7.5
33.
9 6
6.1
50.
0
12/0
6/20
0712
:25:
14A
FA
VI
VIC
TO
RIN
EC
MS
K1
001
33F
emal
e15
2cm
55kg
Som
e ex
er
587
6159
0.2
Larg
e 4
9.5
23.8
113
0119
52 5
.9 1
8.5
36.
5 2
7.7
33.
6 6
6.4
50.
3
19/0
6/20
0712
:25:
14A
FA
VI
VIC
TO
RIN
EC
MS
K1
001
33F
emal
e15
2cm
55kg
Som
e ex
er
614
6761
7.6
Larg
e 4
9.5
23.8
113
0119
52 6
.2 1
9.3
35.
7 2
6.9
35.
0 6
5.0
48.
9
26/0
6/20
0712
:25:
14A
FA
VI
VIC
TO
RIN
EC
MS
K1
001
33F
emal
e15
2cm
53kg
Som
e ex
er
627
6963
0.8
Larg
e 4
9.5
22.9
412
8219
23 6
.3 1
7.9
35.
1 2
6.3
33.
9 6
6.1
49.
7
03/0
7/20
0712
:25:
14A
FA
VI
VIC
TO
RIN
EC
MS
K1
001
33F
emal
e15
2cm
55kg
Som
e ex
er
585
6358
8.4
Larg
e 4
9.5
23.8
113
0119
52 6
.1 1
8.4
36.
6 2
7.7
33.
5 6
6.5
50.
4
11/0
7/20
0712
:25:
14A
FA
VI
VIC
TO
RIN
EC
MS
K1
001
33F
emal
e15
2cm
55kg
Som
e ex
er
583
6358
6.4
Larg
e 4
9.5
23.8
113
0119
52 6
.2 1
8.4
36.
6 2
7.8
33.
4 6
6.6
50.
5
18/0
7/20
0712
:25:
14A
FA
VI
VIC
TO
RIN
EC
MS
K1
001
33F
emal
e15
2cm
55kg
Som
e ex
er
567
6457
0.6
Larg
e 4
9.5
23.8
113
0119
52 6
.4 1
7.9
37.
1 2
8.3
32.
5 6
7.5
51.
5
25/0
7/20
0712
:25:
14A
FA
VI
VIC
TO
RIN
EC
MS
K1
001
33F
emal
e15
2cm
55kg
Som
e ex
er
601
6860
4.8
Larg
e 4
9.5
23.8
113
0119
52 6
.5 1
8.9
36.
1 2
7.3
34.
4 6
5.6
49.
6
01/0
8/20
0712
:25:
14A
FA
VI
VIC
TO
RIN
EC
MS
K1
001
33F
emal
e15
2cm
56kg
Som
e ex
er
573
6057
6.1
Larg
e 4
9.5
24.2
413
1119
66 6
.0 1
8.9
37.
1 2
8.2
33.
7 6
6.3
50.
4
05/0
6/20
0712
:43:
45A
BO
TS
IA
MA
DA
YO
VCM
SK
1 00
225
Fem
ale
167
cm55
kgS
ome
exe
r69
562
697.
8S
mal
l 5
2.6
19.7
213
6620
49 5
.1 1
6.2
38.
8 2
8.0
29.
5 7
0.5
50.
9
12/0
6/20
0712
:43:
45A
BO
TS
IA
MA
DA
YO
VCM
SK
1 00
225
Fem
ale
167
cm55
kgS
ome
exe
r71
261
714.
6S
mal
l 5
2.6
19.7
213
6620
49 4
.9 1
6.6
38.
4 2
7.6
30.
2 6
9.8
50.
2
19/0
6/20
0712
:43:
45A
BO
TS
IA
MA
DA
YO
VCM
SK
1 00
225
Fem
ale
167
cm54
kgS
ome
exe
r66
855
670.
3S
mal
l 5
2.6
19.3
613
5620
34 4
.7 1
4.7
39.
3 2
8.6
27.
2 7
2.8
53.
0
26/0
6/20
0712
:43:
45A
BO
TS
IA
MA
DA
YO
VCM
SK
1 00
225
Fem
ale
167
cm51
kgS
ome
exe
r84
389
847.
7S
mal
l 5
2.6
18.2
913
2719
91 6
.0 1
5.4
35.
6 2
4.4
30.
3 6
9.7
47.
8
10/0
7/20
0712
:43:
45A
BO
TS
IA
MA
DA
YO
VCM
SK
1 00
225
Fem
ale
167
cm53
kgS
ome
exe
r66
662
668.
9S
mal
l 5
2.6
19.0
013
4720
20 5
.3 1
3.8
39.
2 2
8.6
26.
1 7
3.9
53.
9
03/0
7/20
0712
:43:
45A
BO
TS
IA
MA
DA
YO
VCM
SK
1 00
225
Fem
ale
167
cm55
kgS
ome
exe
r58
548
587.
0S
mal
l 5
2.6
19.7
213
6620
49 4
.7 1
2.7
42.
3 3
1.4
23.
2 7
6.8
57.
1
18/0
7/20
0712
:43:
45A
BO
TS
IA
MA
DA
YO
VCM
SK
1 00
225
Fem
ale
167
cm55
kgS
ome
exe
r64
059
642.
7S
mal
l 5
2.6
19.7
213
6620
49 5
.3 1
4.7
40.
3 2
9.6
26.
8 7
3.2
53.
8
25/0
7/20
0712
:43:
45A
BO
TS
IA
MA
DA
YO
VCM
SK
1 00
225
Fem
ale
167
cm56
kgS
ome
exe
r64
257
644.
5S
mal
l 5
2.6
20.0
813
7520
63 5
.1 1
5.6
40.
4 2
9.6
27.
9 7
2.1
52.
9
01/0
8/20
0712
:43:
45A
BO
TS
IA
MA
DA
YO
VCM
SK
1 00
225
Fem
ale
167
cm56
kgS
ome
exe
r65
359
655.
7S
mal
l 5
2.6
20.0
813
7520
63 5
.2 1
5.9
40.
1 2
9.3
28.
5 7
1.5
52.
3
05/0
6/20
0712
:58:
07A
FA
TO
WO
UA
KO
SS
IWA
SC
MS
K1
003
32F
emal
e16
1cm
52kg
Som
e ex
er
590
6059
3.0
Med
ium
53.
020
.06
1293
1940
5.8
12.
8 3
9.2
29.
4 2
4.6
75.
4 5
6.5
12/0
6/20
0712
:58:
07A
FA
TO
WO
UA
KO
SS
IWA
SC
MS
K1
003
32F
emal
e16
1cm
52kg
Som
e ex
er
616
6161
9.0
Med
ium
53.
020
.06
1293
1940
5.7
13.
6 3
8.4
28.
6 2
6.2
73.
8 5
4.9
19/0
6/20
0712
:58:
07A
FA
TO
WO
UA
KO
SS
IWA
SC
MS
K1
003
32F
emal
e16
1cm
49kg
Som
e ex
er
619
6362
2.2
Med
ium
53.
018
.90
1264
1897
5.8
11.
2 3
7.8
28.
1 2
3.0
77.
0 5
7.4
26/0
6/20
0712
:58:
07A
FA
TO
WO
UA
KO
SS
IWA
SC
MS
K1
003
32F
emal
e16
1cm
47kg
Som
e ex
er
629
6663
2.5
Med
ium
53.
018
.13
1245
1868
6.0
9.9
37.
1 2
7.6
21.
0 7
9.0
58.
7
03/0
7/20
0712
:58:
07A
FA
TO
WO
UA
KO
SS
IWA
SC
MS
K1
003
32F
emal
e16
1cm
49kg
Som
e ex
er
642
6864
5.6
Med
ium
53.
018
.90
1264
1897
6.0
11.
9 3
7.1
27.
5 2
4.3
75.
7 5
6.0
10/0
7/20
0712
:58:
07A
FA
TO
WO
UA
KO
SS
IWA
SC
MS
K1
003
32F
emal
e16
1cm
47kg
Som
e ex
er
609
5961
1.9
Med
ium
53.
018
.13
1245
1868
5.5
9.3
37.
7 2
8.2
19.
7 8
0.3
60.
0
18/0
7/20
0712
:58:
07A
FA
TO
WO
UA
KO
SS
IWA
SC
MS
K1
003
32F
emal
e16
1cm
50kg
Som
e ex
er
622
6562
5.4
Med
ium
53.
019
.29
1274
1911
6.0
12.
2 3
7.8
28.
2 2
4.3
75.
7 5
6.3
25/0
7/20
0712
:58:
07A
FA
TO
WO
UA
KO
SS
IWA
SC
MS
K1
003
32F
emal
e16
1cm
51kg
Som
e ex
er
619
6562
2.4
Med
ium
53.
019
.68
1284
1926
6.0
12.
9 3
8.1
28.
4 2
5.3
74.
7 5
5.6
01/0
8/20
0712
:58:
07A
FA
TO
WO
UA
KO
SS
IWA
SC
MS
K1
003
32F
emal
e16
1cm
50kg
Som
e ex
er
550
5355
2.5
Med
ium
53.
019
.29
1274
1911
5.5
9.5
40.
5 3
0.6
19.
1 8
0.9
61.
2
05/0
6/20
0713
:22:
27K
ON
VI
ME
DO
NU
INA
CM
SK
1 00
441
Fem
ale
158
cm60
kgS
ome
exe
r66
364
666.
1La
rge
55.
424
.03
1322
1984
5.5
22.
6 3
7.4
27.
5 3
7.7
62.
3 4
5.8
12/0
6/20
0713
:22:
27K
ON
VI
ME
DO
NU
INA
CM
SK
1 00
441
Fem
ale
158
cm60
kgS
ome
exe
r64
258
644.
6La
rge
55.
424
.03
1322
1984
5.2
22.
1 3
7.9
28.
0 3
6.9
63.
1 4
6.7
19/0
6/20
0713
:22:
27K
ON
VI
ME
DO
NU
INA
CM
SK
1 00
441
Fem
ale
158
cm60
kgS
ome
exe
r69
466
697.
1La
rge
55.
424
.03
1322
1984
5.4
23.
3 3
6.7
26.
7 3
8.8
61.
2 4
4.5
26/0
6/20
0713
:22:
27K
ON
VI
ME
DO
NU
INA
CM
SK
1 00
441
Fem
ale
158
cm60
kgS
ome
exe
r64
757
649.
5La
rge
55.
424
.03
1322
1984
5.0
22.
2 3
7.8
27.
9 3
7.1
62.
9 4
6.5
03/0
7/20
0713
:22:
27K
ON
VI
ME
DO
NU
INA
CM
SK
1 00
441
Fem
ale
158
cm60
kgS
ome
exe
r67
668
679.
4La
rge
55.
424
.03
1322
1984
5.7
22.
9 3
7.1
27.
1 3
8.2
61.
8 4
5.2
11/0
7/20
0713
:22:
27K
ON
VI
ME
DO
NU
INA
CM
SK
1 00
441
Fem
ale
158
cm57
kgS
ome
exe
r65
662
658.
9La
rge
55.
422
.83
1294
1941
5.4
20.
0 3
7.0
27.
3 3
5.0
65.
0 4
7.9
18/0
7/20
0713
:22:
27K
ON
VI
ME
DO
NU
INA
CM
SK
1 00
441
Fem
ale
158
cm57
kgS
ome
exe
r70
571
708.
6La
rge
55.
422
.83
1294
1941
5.8
21.
0 3
6.0
26.
1 3
6.9
63.
1 4
5.8
25/0
7/20
0713
:22:
27K
ON
VI
ME
DO
NU
INA
CM
SK
1 00
441
Fem
ale
158
cm59
kgS
ome
exe
r65
153
653.
2La
rge
55.
423
.63
1313
1969
4.7
21.
5 3
7.5
27.
7 3
6.5
63.
5 4
6.9
01/0
8/20
0713
:22:
27K
ON
VI
ME
DO
NU
INA
CM
SK
1 00
441
Fem
ale
158
cm59
kgS
ome
exe
r67
566
678.
2La
rge
55.
423
.63
1313
1969
5.6
22.
1 3
6.9
27.
1 3
7.4
62.
6 4
5.9
05/0
6/20
0713
:34:
37K
PA
MA
AD
JOW
A M
AC
MS
K1
005
41F
emal
e16
9cm
69kg
Som
e ex
er
609
6461
2.4
Med
ium
60.
224
.16
1429
2143
6.0
24.
6 4
4.4
32.
6 3
5.6
64.
4 4
7.3
12/0
6/20
0713
:34:
37K
PA
MA
AD
JOW
A M
AC
MS
K1
005
41F
emal
e16
9cm
69kg
Som
e ex
er
582
5758
4.8
Med
ium
60.
224
.16
1429
2143
5.6
23.
5 4
5.5
33.
6 3
4.0
66.
0 4
8.7
19/0
6/20
0713
:34:
37K
PA
MA
AD
JOW
A M
AC
MS
K1
005
41F
emal
e16
9cm
70kg
Som
e ex
er
592
6059
5.0
Med
ium
60.
224
.51
1438
2157
5.8
24.
7 4
5.3
33.
4 3
5.3
64.
7 4
7.7
26/0
6/20
0713
:34:
37K
PA
MA
AD
JOW
A M
AC
MS
K1
005
41F
emal
e16
9cm
72kg
Som
e ex
er
597
6360
0.3
Med
ium
60.
225
.21
1457
2186
6.0
26.
6 4
5.4
33.
4 3
6.9
63.
1 4
6.4
03/0
7/20
0713
:34:
37K
PA
MA
AD
JOW
A M
AC
MS
K1
005
41F
emal
e16
9cm
72kg
Som
e ex
er
579
6058
2.1
Med
ium
60.
225
.21
1457
2186
5.9
25.
8 4
6.2
34.
1 3
5.9
64.
1 4
7.3
11/0
7/20
0713
:34:
37K
PA
MA
AD
JOW
A M
AC
MS
K1
005
41F
emal
e16
9cm
70kg
Som
e ex
er
629
6363
2.1
Med
ium
60.
224
.51
1438
2157
5.7
26.
1 4
3.9
32.
1 3
7.3
62.
7 4
5.8
18/0
7/20
0713
:34:
37K
PA
MA
AD
JOW
A M
AC
MS
K1
005
41F
emal
e16
9cm
70kg
Som
e ex
er
574
6357
7.4
Med
ium
60.
224
.51
1438
2157
6.3
24.
0 4
6.0
34.
0 3
4.2
65.
8 4
8.6
25/0
7/20
0713
:34:
37K
PA
MA
AD
JOW
A M
AC
MS
K1
005
41F
emal
e16
9cm
69kg
Som
e ex
er
620
7762
4.8
Med
ium
60.
224
.16
1429
2143
7.1
25.
0 4
4.0
32.
3 3
6.2
63.
8 4
6.8
01/0
8/20
0713
:34:
37K
PA
MA
AD
JOW
A M
AC
MS
K1
005
41F
emal
e16
9cm
71kg
Som
e ex
er
622
6862
5.7
Med
ium
60.
224
.86
1448
2172
6.2
26.
7 4
4.3
32.
4 3
7.6
62.
4 4
5.7
05/0
6/20
0718
:01:
43Z
IAF
OM
AR
IE M
AD
ECM
SK
1 00
634
Fem
ale
147
cm44
kgS
ome
exe
r66
071
663.
8M
ediu
m 4
0.5
20.3
611
8217
73 6
.1 1
2.8
31.
2 2
3.5
29.
1 7
0.9
53.
3
12/0
6/20
0718
:01:
43Z
IAF
OM
AR
IE M
AD
ECM
SK
1 00
634
Fem
ale
147
cm44
kgS
ome
exe
r65
369
656.
6M
ediu
m 4
0.5
20.3
611
8217
73 6
.0 1
2.7
31.
3 2
3.6
28.
8 7
1.2
53.
7
19/0
6/20
0718
:01:
43Z
IAF
OM
AR
IE M
AD
ECM
SK
1 00
634
Fem
ale
147
cm47
kgS
ome
exe
r64
670
649.
8M
ediu
m 4
0.5
21.7
512
1118
16 6
.2 1
5.0
32.
0 2
4.1
31.
9 6
8.1
51.
3
1D
:\BIA
TE
ST
KO
UV
E F
INA
L F
inal
F 2
.xls
BIA
TE
ST
KO
UV
É F
INA
L
Tes
t D
ate
Tes
t T
ime
Las
t N
ame
Fir
st N
ame
Su
bje
ct ID
Ag
eG
end
erH
eig
ht
Wei
gh
tA
ctiv
ity
Lev
elR
esis
tan
ceR
eact
ance
Imp
edan
ceF
ram
e S
ize
Tar
get
W
eig
ht
BM
IB
MR
DE
EP
has
e A
ng
leF
at
wt
FF
M w
tT
BW
lit
ers
Fat
%
of
wt
FF
M %
o
f w
tT
BW
%
of
wt
26/0
6/20
0718
:01:
43Z
IAF
OM
AR
IE M
AD
ECM
SK
1 00
634
Fem
ale
147
cm45
kgS
ome
exe
r61
368
616.
8M
ediu
m 4
0.5
20.8
211
9117
87 6
.3 1
2.6
32.
4 2
4.7
28.
1 7
1.9
54.
9
03/0
7/20
0718
:01:
43Z
IAF
OM
AR
IE M
AD
ECM
SK
1 00
634
Fem
ale
147
cm46
kgS
ome
exe
r67
276
676.
3M
ediu
m 4
0.5
21.2
912
0118
02 6
.5 1
4.7
31.
3 2
3.4
31.
9 6
8.1
50.
9
11/0
7/20
0718
:01:
43Z
IAF
OM
AR
IE M
AD
ECM
SK
1 00
634
Fem
ale
147
cm46
kgS
ome
exe
r64
966
652.
3M
ediu
m 4
0.5
21.2
912
0118
02 5
.8 1
4.2
31.
8 2
3.9
31.
0 6
9.0
52.
0
18/0
7/20
0718
:01:
43Z
IAF
OM
AR
IE M
AD
ECM
SK
1 00
634
Fem
ale
147
cm47
kgS
ome
exe
r61
563
618.
2M
ediu
m 4
0.5
21.7
512
1118
16 5
.8 1
4.3
32.
7 2
4.9
30.
5 6
9.5
52.
9
25/0
7/20
0718
:01:
43Z
IAF
OM
AR
IE M
AD
ECM
SK
1 00
634
Fem
ale
147
cm48
kgS
ome
exe
r65
372
657.
0M
ediu
m 4
0.5
22.2
112
2018
31 6
.3 1
6.0
32.
0 2
4.1
33.
3 6
6.7
50.
1
01/0
8/20
0718
:01:
43Z
IAF
OM
AR
IE M
AD
ECM
SK
1 00
634
Fem
ale
147
cm47
kgS
ome
exe
r60
864
611.
4M
ediu
m 4
0.5
21.7
512
1118
16 6
.0 1
4.2
32.
8 2
5.1
30.
1 6
9.9
53.
3
05/0
6/20
0718
:11:
44A
VO
GN
ON
AD
JO A
NG
EC
MS
K1
007
32F
emal
e15
6cm
47kg
Som
e ex
er
647
6765
0.5
Med
ium
48.
619
.31
1236
1855
5.9
12.
1 3
4.9
26.
0 2
5.7
74.
3 5
5.3
12/0
6/20
0718
:11:
44A
VO
GN
ON
AD
JO A
NG
EC
MS
K1
007
32F
emal
e15
6cm
47kg
Som
e ex
er
631
6063
3.8
Med
ium
48.
619
.31
1236
1855
5.4
11.
7 3
5.3
26.
4 2
4.9
75.
1 5
6.2
19/0
6/20
0718
:11:
44A
VO
GN
ON
AD
JO A
NG
EC
MS
K1
007
32F
emal
e15
6cm
49kg
Som
e ex
er
621
6362
4.2
Med
ium
48.
620
.13
1255
1883
5.8
13.
1 3
5.9
26.
9 2
6.7
73.
3 5
4.9
26/0
6/20
0718
:11:
44A
VO
GN
ON
AD
JO A
NG
EC
MS
K1
007
32F
emal
e15
6cm
48kg
Som
e ex
er
645
6764
8.5
Med
ium
48.
619
.72
1246
1869
5.9
12.
9 3
5.1
26.
1 2
6.8
73.
2 5
4.5
03/0
7/20
0718
:11:
44A
VO
GN
ON
AD
JO A
NG
EC
MS
K1
007
32F
emal
e15
6cm
49kg
Som
e ex
er
632
6663
5.4
Med
ium
48.
620
.13
1255
1883
6.0
13.
4 3
5.6
26.
6 2
7.3
72.
7 5
4.3
11/0
7/20
0718
:11:
44A
VO
GN
ON
AD
JO A
NG
EC
MS
K1
007
32F
emal
e15
6cm
47kg
Som
e ex
er
609
6061
1.9
Med
ium
48.
619
.31
1236
1855
5.6
11.
1 3
5.9
27.
0 2
3.6
76.
4 5
7.5
18/0
7/20
0718
:11:
44A
VO
GN
ON
AD
JO A
NG
EC
MS
K1
007
32F
emal
e15
6cm
49kg
Som
e ex
er
602
6060
5.0
Med
ium
48.
620
.13
1255
1883
5.7
12.
5 3
6.5
27.
5 2
5.6
74.
4 5
6.1
25/0
7/20
0718
:11:
44A
VO
GN
ON
AD
JO A
NG
EC
MS
K1
007
32F
emal
e15
6cm
50kg
Som
e ex
er
625
6562
8.4
Med
ium
48.
620
.55
1265
1898
5.9
14.
0 3
6.0
26.
9 2
8.1
71.
9 5
3.8
01/0
8/20
0718
:11:
44A
VO
GN
ON
AD
JO A
NG
EC
MS
K1
007
32F
emal
e15
6cm
49kg
Som
e ex
er
607
4960
9.0
Med
ium
48.
620
.13
1255
1883
4.6
12.
7 3
6.3
27.
3 2
5.9
74.
1 5
5.8
05/0
6/20
0718
:34:
26K
OU
AY
IJU
LIE
TT
EC
MS
K1
008
35F
emal
e16
0cm
60kg
Som
e ex
er
570
6357
3.5
Med
ium
52.
123
.44
1354
2031
6.3
19.
1 4
0.9
30.
7 3
1.8
68.
2 5
1.2
12/0
6/20
0718
:34:
26K
OU
AY
IJU
LIE
TT
EC
MS
K1
008
35F
emal
e16
0cm
60kg
Som
e ex
er
582
6258
5.3
Med
ium
52.
123
.44
1354
2031
6.1
19.
5 4
0.5
30.
3 3
2.5
67.
5 5
0.5
19/0
6/20
0718
:34:
26K
OU
AY
IJU
LIE
TT
EC
MS
K1
008
35F
emal
e16
0cm
61kg
Som
e ex
er
550
5555
2.7
Med
ium
52.
123
.83
1364
2046
5.7
19.
1 4
1.9
31.
6 3
1.3
68.
7 5
1.8
26/0
6/20
0718
:34:
26K
OU
AY
IJU
LIE
TT
EC
MS
K1
008
35F
emal
e16
0cm
61kg
Som
e ex
er
548
5855
1.1
Med
ium
52.
123
.83
1364
2046
6.0
19.
0 4
2.0
31.
7 3
1.1
68.
9 5
1.9
03/0
7/20
0718
:34:
26K
OU
AY
IJU
LIE
TT
EC
MS
K1
008
35F
emal
e16
0cm
62kg
Som
e ex
er
594
6759
7.8
Med
ium
52.
124
.22
1373
2060
6.4
21.
6 4
0.4
30.
1 3
4.9
65.
1 4
8.6
11/0
7/20
0718
:34:
26K
OU
AY
IJU
LIE
TT
EC
MS
K1
008
35F
emal
e16
0cm
61kg
Som
e ex
er
575
6057
8.1
Med
ium
52.
123
.83
1364
2046
6.0
20.
1 4
0.9
30.
7 3
2.9
67.
1 5
0.3
18/0
7/20
0718
:34:
26K
OU
AY
IJU
LIE
TT
EC
MS
K1
008
35F
emal
e16
0cm
60kg
Som
e ex
er
544
5854
7.1
Med
ium
52.
123
.44
1354
2031
6.1
18.
0 4
2.0
31.
7 3
0.0
70.
0 5
2.8
25/0
7/20
0718
:34:
26K
OU
AY
IJU
LIE
TT
EC
MS
K1
008
35F
emal
e16
0cm
62kg
Som
e ex
er
526
5552
8.9
Med
ium
52.
124
.22
1373
2060
6.0
18.
8 4
3.2
32.
7 3
0.4
69.
6 5
2.7
01/0
8/20
0718
:34:
26K
OU
AY
IJU
LIE
TT
EC
MS
K1
008
35F
emal
e16
0cm
60kg
Som
e ex
er
582
6358
5.4
Med
ium
52.
123
.44
1354
2031
6.2
19.
5 4
0.5
30.
3 3
2.5
67.
5 5
0.5
12/0
6/20
0718
:53:
20T
OK
UIB
OU
PA
OLA
CM
SK
1 00
935
Fem
ale
155
cm50
kgS
ome
exe
r60
070
604.
1S
mal
l 4
2.9
20.8
112
4918
74 6
.7 1
3.7
36.
3 2
7.4
27.
3 7
2.7
54.
8
19/0
6/20
0718
:53:
20T
OK
UIB
OU
PA
OLA
CM
SK
1 00
935
Fem
ale
155
cm52
kgS
ome
exe
r63
978
643.
7S
mal
l 4
2.9
21.6
412
6819
03 7
.0 1
6.4
35.
6 2
6.5
31.
5 6
8.5
51.
0
26/0
6/20
0718
:53:
20T
OK
UIB
OU
PA
OLA
CM
SK
1 00
935
Fem
ale
155
cm52
kgS
ome
exe
r61
674
620.
4S
mal
l 4
2.9
21.6
412
6819
03 6
.9 1
5.8
36.
2 2
7.2
30.
4 6
9.6
52.
3
03/0
7/20
0718
:53:
20T
OK
UIB
OU
PA
OLA
CM
SK
1 00
935
Fem
ale
155
cm54
kgS
ome
exe
r56
073
564.
7S
mal
l 4
2.9
22.4
812
8819
32 7
.4 1
5.6
38.
4 2
9.2
29.
0 7
1.0
54.
0
11/0
7/20
0718
:53:
20T
OK
UIB
OU
PA
OLA
CM
SK
1 00
935
Fem
ale
155
cm52
kgS
ome
exe
r61
573
619.
3S
mal
l 4
2.9
21.6
412
6819
03 6
.8 1
5.8
36.
2 2
7.2
30.
3 6
9.7
52.
3
18/0
7/20
0718
:53:
20T
OK
UIB
OU
PA
OLA
CM
SK
1 00
935
Fem
ale
155
cm51
kgS
ome
exe
r63
675
640.
4S
mal
l 4
2.9
21.2
312
5918
88 6
.7 1
5.5
35.
5 2
6.5
30.
4 6
9.6
52.
0
25/0
7/20
0718
:53:
20T
OK
UIB
OU
PA
OLA
CM
SK
1 00
935
Fem
ale
155
cm53
kgS
ome
exe
r59
471
598.
2S
mal
l 4
2.9
22.0
612
7819
17 6
.8 1
6.0
37.
0 2
7.9
30.
1 6
9.9
52.
7
01/0
8/20
0718
:53:
20T
OK
UIB
OU
PA
OLA
CM
SK
1 00
935
Fem
ale
155
cm50
kgS
ome
exe
r59
969
603.
0S
mal
l 4
2.9
20.8
112
4918
74 6
.6 1
3.6
36.
4 2
7.4
27.
3 7
2.7
54.
9
05/0
6/20
0719
:13:
19D
JAG
OE
LIS
EC
MS
K1
010
25F
emal
e15
9cm
44kg
Som
e ex
er
632
5763
4.6
Sm
all
46.
117
.40
1246
1869
5.2
8.2
35.
8 2
6.7
18.
6 8
1.4
60.
7
12/0
6/20
0719
:13:
19D
JAG
OE
LIS
EC
MS
K1
010
25F
emal
e15
9cm
44kg
Som
e ex
er
649
6265
2.0
Sm
all
46.
117
.40
1246
1869
5.5
8.6
35.
4 2
6.2
19.
6 8
0.4
59.
7
19/0
6/20
0719
:13:
19D
JAG
OE
LIS
EC
MS
K1
010
25F
emal
e15
9cm
44kg
Som
e ex
er
651
6265
3.9
Sm
all
46.
117
.40
1246
1869
5.4
8.7
35.
3 2
6.2
19.
8 8
0.2
59.
5
26/0
6/20
0719
:13:
19D
JAG
OE
LIS
EC
MS
K1
010
25F
emal
e15
9cm
45kg
Som
e ex
er
597
5359
9.3
Sm
all
46.
117
.80
1255
1883
5.1
7.9
37.
1 2
7.9
17.
7 8
2.3
62.
0
03/0
7/20
0719
:13:
19D
JAG
OE
LIS
EC
MS
K1
010
25F
emal
e15
9cm
46kg
Som
e ex
er
623
6062
5.9
Sm
all
46.
118
.20
1265
1898
5.5
9.6
36.
4 2
7.2
20.
8 7
9.2
59.
1
11/0
7/20
0719
:13:
19D
JAG
OE
LIS
EC
MS
K1
010
25F
emal
e15
9cm
45kg
Som
e ex
er
603
5960
5.9
Sm
all
46.
117
.80
1255
1883
5.6
8.1
36.
9 2
7.7
18.
1 8
1.9
61.
6
18/0
7/20
0719
:13:
19D
JAG
OE
LIS
EC
MS
K1
010
25F
emal
e15
9cm
45kg
Som
e ex
er
618
5862
0.7
Sm
all
46.
117
.80
1255
1883
5.4
8.6
36.
4 2
7.2
19.
1 8
0.9
60.
5
25/0
7/20
0719
:13:
19D
JAG
OE
LIS
EC
MS
K1
010
25F
emal
e15
9cm
48kg
Som
e ex
er
550
5055
2.3
Sm
all
46.
118
.99
1284
1926
5.2
8.7
39.
3 2
9.9
18.
1 8
1.9
62.
2
01/0
8/20
0719
:13:
19D
JAG
OE
LIS
EC
MS
K1
010
25F
emal
e15
9cm
46kg
Som
e ex
er
602
6360
5.3
Sm
all
46.
118
.20
1265
1898
6.0
8.9
37.
1 2
7.8
19.
4 8
0.6
60.
5
05/0
6/20
078:
44:1
3B
ALO
VI
A L
UC
IEC
MS
K1
011
52F
emal
e15
0cm
51kg
Som
e ex
er
570
5757
2.8
Larg
e 4
7.5
22.6
711
7017
55 5
.7 1
5.4
35.
6 2
7.3
30.
1 6
9.9
53.
5
12/0
6/20
078:
44:1
3B
ALO
VI
A L
UC
IEC
MS
K1
011
52F
emal
e15
0cm
51kg
Som
e ex
er
584
6258
7.3
Larg
e 4
7.5
22.6
711
7017
55 6
.1 1
5.8
35.
2 2
6.8
31.
0 6
9.0
52.
6
19/0
6/20
078:
44:1
3B
ALO
VI
A L
UC
IEC
MS
K1
011
52F
emal
e15
0cm
52kg
Som
e ex
er
605
6760
8.7
Larg
e 4
7.5
23.1
111
7917
69 6
.3 1
7.2
34.
8 2
6.4
33.
1 6
6.9
50.
7
26/0
6/20
078:
44:1
3B
ALO
VI
A L
UC
IEC
MS
K1
011
52F
emal
e15
0cm
51kg
Som
e ex
er
592
6259
5.2
Larg
e 4
7.5
22.6
711
7017
55 6
.0 1
6.0
35.
0 2
6.6
31.
4 6
8.6
52.
2
03/0
7/20
078:
44:1
3B
ALO
VI
A L
UC
IEC
MS
K1
011
52F
emal
e15
0cm
53kg
Som
e ex
er
608
6661
1.6
Larg
e 4
7.5
23.5
611
8917
84 6
.2 1
8.1
34.
9 2
6.4
34.
2 6
5.8
49.
8
11/0
7/20
078:
44:1
3B
ALO
VI
A L
UC
IEC
MS
K1
011
52F
emal
e15
0cm
54kg
Som
e ex
er
543
5354
5.6
Larg
e 4
7.5
24.0
011
9917
98 5
.6 1
6.9
37.
1 2
8.5
31.
4 6
8.6
52.
8
18/0
7/20
078:
44:1
3B
ALO
VI
A L
UC
IEC
MS
K1
011
52F
emal
e15
0cm
54kg
Som
e ex
er
551
6055
4.3
Larg
e 4
7.5
24.0
011
9917
98 6
.2 1
7.2
36.
8 2
8.2
31.
9 6
8.1
52.
3
2D
:\BIA
TE
ST
KO
UV
E F
INA
L F
inal
F 2
.xls
BIA
TE
ST
KO
UV
É F
INA
L
Tes
t D
ate
Tes
t T
ime
Las
t N
ame
Fir
st N
ame
Su
bje
ct ID
Ag
eG
end
erH
eig
ht
Wei
gh
tA
ctiv
ity
Lev
elR
esis
tan
ceR
eact
ance
Imp
edan
ceF
ram
e S
ize
Tar
get
W
eig
ht
BM
IB
MR
DE
EP
has
e A
ng
leF
at
wt
FF
M w
tT
BW
lit
ers
Fat
%
of
wt
FF
M %
o
f w
tT
BW
%
of
wt
25/0
7/20
078:
44:1
3B
ALO
VI
A L
UC
IEC
MS
K1
011
52F
emal
e15
0cm
55kg
Som
e ex
er
571
6057
4.1
Larg
e 4
7.5
24.4
412
0818
13 6
.0 1
8.7
36.
3 2
7.7
34.
0 6
6.0
50.
4
01/0
8/20
078:
44:1
3B
ALO
VI
A L
UC
IEC
MS
K1
011
52F
emal
e15
0cm
53kg
Som
e ex
er
590
6459
3.5
Larg
e 4
7.5
23.5
611
8917
84 6
.2 1
7.6
35.
4 2
6.9
33.
3 6
6.7
50.
7
05/0
6/20
079:
00:0
3A
PE
VO
KU
IYA
CM
SK
1 01
240
Fem
ale
158
cm55
kgS
ome
exe
r64
466
647.
4S
mal
l 4
5.3
22.0
312
7919
19 5
.9 1
8.0
37.
0 2
7.4
32.
7 6
7.3
49.
8
12/0
6/20
079:
00:0
3A
PE
VO
KU
IYA
CM
SK
1 01
240
Fem
ale
158
cm55
kgS
ome
exe
r61
957
621.
6S
mal
l 4
5.3
22.0
312
7919
19 5
.3 1
7.3
37.
7 2
8.1
31.
5 6
8.5
51.
1
19/0
6/20
079:
00:0
3A
PE
VO
KU
IYA
CM
SK
1 01
240
Fem
ale
158
cm58
kgS
ome
exe
r63
559
637.
7S
mal
l 4
5.3
23.2
313
0819
62 5
.3 2
0.3
37.
7 2
8.0
34.
9 6
5.1
48.
3
26/0
6/20
079:
00:0
3A
PE
VO
KU
IYA
CM
SK
1 01
240
Fem
ale
158
cm57
kgS
ome
exe
r64
463
647.
1S
mal
l 4
5.3
22.8
312
9819
48 5
.6 1
9.7
37.
3 2
7.6
34.
5 6
5.5
48.
5
03/0
7/20
079:
00:0
3A
PE
VO
KU
IYA
CM
SK
1 01
240
Fem
ale
158
cm59
kgS
ome
exe
r64
064
643.
2S
mal
l 4
5.3
23.6
313
1719
76 5
.7 2
1.2
37.
8 2
8.0
36.
0 6
4.0
47.
4
10/0
7/20
079:
00:0
3A
PE
VO
KU
IYA
CM
SK
1 01
240
Fem
ale
158
cm59
kgS
ome
exe
r60
656
608.
6S
mal
l 4
5.3
23.6
313
1719
76 5
.3 2
0.2
38.
8 2
9.0
34.
3 6
5.7
49.
1
18/0
7/20
079:
00:0
3A
PE
VO
KU
IYA
CM
SK
1 01
240
Fem
ale
158
cm56
kgS
ome
exe
r64
160
643.
8S
mal
l 4
5.3
22.4
312
8919
33 5
.3 1
8.8
37.
2 2
7.6
33.
5 6
6.5
49.
3
25/0
7/20
079:
00:0
3A
PE
VO
KU
IYA
CM
SK
1 01
240
Fem
ale
158
cm59
kgS
ome
exe
r59
656
598.
6S
mal
l 4
5.3
23.6
313
1719
76 5
.4 1
9.9
39.
1 2
9.3
33.
8 6
6.2
49.
6
01/0
8/20
079:
00:0
3A
PE
VO
KU
IYA
CM
SK
1 01
240
Fem
ale
158
cm57
kgS
ome
exe
r68
573
688.
9S
mal
l 4
5.3
22.8
312
9819
48 6
.1 2
0.6
36.
4 2
6.6
36.
2 6
3.8
46.
6
05/0
6/20
079:
31:5
9S
OG
BA
DJI
VE
RO
NIQ
UE
CM
SK
1 01
329
Fem
ale
155
cm48
kgS
ome
exe
r94
148
942.
2S
mal
l 4
2.9
19.9
812
5818
87 2
.9 1
6.6
31.
4 2
0.7
34.
7 6
5.3
43.
0
12/0
6/20
079:
31:5
9S
OG
BA
DJI
VE
RO
NIQ
UE
CM
SK
1 01
329
Fem
ale
155
cm48
kgS
ome
exe
r96
850
969.
3S
mal
l 4
2.9
19.9
812
5818
87 3
.0 1
6.7
31.
3 2
0.3
34.
8 6
5.2
42.
4
19/0
6/20
079:
31:5
9S
OG
BA
DJI
VE
RO
NIQ
UE
CM
SK
1 01
329
Fem
ale
155
cm50
kgS
ome
exe
r85
440
854.
9S
mal
l 4
2.9
20.8
112
7719
16 2
.7 1
7.9
32.
1 2
2.1
35.
8 6
4.2
44.
1
26/0
6/20
079:
31:5
9S
OG
BA
DJI
VE
RO
NIQ
UE
CM
SK
1 01
329
Fem
ale
155
cm49
kgS
ome
exe
r93
153
932.
5S
mal
l 4
2.9
20.4
012
6819
02 3
.3 1
7.4
31.
6 2
0.9
35.
6 6
4.4
42.
6
03/0
7/20
079:
31:5
9S
OG
BA
DJI
VE
RO
NIQ
UE
CM
SK
1 01
329
Fem
ale
155
cm48
kgS
ome
exe
r91
845
919.
1S
mal
l 4
2.9
19.9
812
5818
87 2
.8 1
6.6
31.
4 2
0.9
34.
5 6
5.5
43.
6
11/0
7/20
079:
31:5
9S
OG
BA
DJI
VE
RO
NIQ
UE
CM
SK
1 01
329
Fem
ale
155
cm48
kgS
ome
exe
r97
447
975.
1S
mal
l 4
2.9
19.9
812
5818
87 2
.8 1
6.7
31.
3 2
0.3
34.
8 6
5.2
42.
2
18/0
7/20
079:
31:5
9S
OG
BA
DJI
VE
RO
NIQ
UE
CM
SK
1 01
329
Fem
ale
155
cm48
kgS
ome
exe
r94
752
948.
4S
mal
l 4
2.9
19.9
812
5818
87 3
.1 1
6.7
31.
3 2
0.6
34.
7 6
5.3
42.
9
25/0
7/20
079:
31:5
9S
OG
BA
DJI
VE
RO
NIQ
UE
CM
SK
1 01
329
Fem
ale
155
cm46
kgS
ome
exe
r10
0054
1001
.5S
mal
l 4
2.9
19.1
512
3918
59 3
.1 1
5.1
30.
9 1
9.8
32.
8 6
7.2
42.
9
01/0
8/20
079:
31:5
9S
OG
BA
DJI
VE
RO
NIQ
UE
CM
SK
1 01
329
Fem
ale
155
cm47
kgS
ome
exe
r88
842
889.
0S
mal
l 4
2.9
19.5
612
4918
73 2
.7 1
5.6
31.
4 2
1.2
33.
2 6
6.8
45.
2
05/0
6/20
079:
44:2
3A
ME
GN
AG
LK
OM
LAV
IC
MS
K1
014
46M
ale
172
cm55
kgS
ome
exe
r56
253
564.
5M
ediu
m 6
9.1
18.5
913
7221
96 5
.4 8
.5 4
6.5
34.
5 1
5.5
84.
5 6
2.8
12/0
6/20
079:
44:2
3A
ME
GN
AG
LK
OM
LAV
IC
MS
K1
014
46M
ale
172
cm55
kgS
ome
exe
r56
651
568.
3M
ediu
m 6
9.1
18.5
913
7221
96 5
.1 8
.7 4
6.3
34.
4 1
5.8
84.
2 6
2.5
19/0
6/20
079:
44:2
3A
ME
GN
AG
LK
OM
LAV
IC
MS
K1
014
46M
ale
172
cm57
kgS
ome
exe
r54
540
546.
5M
ediu
m 6
9.1
19.2
714
0022
40 4
.2 9
.2 4
7.8
35.
6 1
6.1
83.
9 6
2.5
26/0
6/20
079:
44:2
3A
ME
GN
AG
LK
OM
LAV
IC
MS
K1
014
46M
ale
172
cm57
kgS
ome
exe
r53
148
533.
2M
ediu
m 6
9.1
19.2
714
0022
40 5
.2 8
.5 4
8.5
36.
3 1
4.8
85.
2 6
3.6
03/0
7/20
079:
44:2
3A
ME
GN
AG
LK
OM
LAV
IC
MS
K1
014
46M
ale
172
cm60
kgS
ome
exe
r51
450
516.
4S
mal
l 6
9.1
20.2
814
4123
06 5
.6 9
.7 5
0.3
37.
6 1
6.2
83.
8 6
2.7
18/0
7/20
079:
44:2
3A
ME
GN
AG
LK
OM
LAV
IC
MS
K1
014
46M
ale
172
cm59
kgS
ome
exe
r52
551
527.
5S
mal
l 6
9.1
19.9
414
2722
84 5
.5 9
.6 4
9.4
36.
9 1
6.3
83.
7 6
2.5
11/0
7/20
079:
44:2
3A
ME
GN
AG
LK
OM
LAV
IC
MS
K1
014
46M
ale
172
cm57
kgS
ome
exe
r52
751
529.
5S
mal
l 6
9.1
19.2
714
0022
40 5
.5 8
.2 4
8.8
36.
4 1
4.5
85.
5 6
3.9
25/0
7/20
079:
44:2
3A
ME
GN
AG
LK
OM
LAV
IC
MS
K1
014
46M
ale
172
cm60
kgS
ome
exe
r52
550
527.
4S
mal
l 6
9.1
20.2
814
4123
06 5
.4 1
0.3
49.
7 3
7.1
17.
2 8
2.8
61.
8
01/0
8/20
079:
44:2
3A
ME
GN
AG
LK
OM
LAV
IC
MS
K1
014
46M
ale
172
cm60
kgS
ome
exe
r51
850
520.
4S
mal
l 6
9.1
20.2
814
4123
06 5
.5 1
0.0
50.
0 3
7.4
16.
6 8
3.4
62.
3
05/0
6/20
0710
:32:
04M
ED
JAG
OK
OF
FI
CM
SK
1 01
660
Mal
e15
7cm
47kg
Som
e ex
er
626
6262
9.1
Med
ium
53.
019
.07
1092
1747
5.7
10.
3 3
6.7
27.
2 2
1.9
78.
1 5
7.8
12/0
6/20
0710
:32:
04M
ED
JAG
OK
OF
FI
CM
SK
1 01
660
Mal
e15
7cm
47kg
Som
e ex
er
621
5862
3.7
Med
ium
53.
019
.07
1092
1747
5.3
10.
2 3
6.8
27.
3 2
1.6
78.
4 5
8.1
19/0
6/20
0710
:32:
04M
ED
JAG
OK
OF
FI
CM
SK
1 01
660
Mal
e15
7cm
48kg
Som
e ex
er
596
5059
8.1
Med
ium
53.
019
.47
1105
1769
4.8
10.
2 3
7.8
28.
2 2
1.2
78.
8 5
8.8
26/0
6/20
0710
:32:
04M
ED
JAG
OK
OF
FI
CM
SK
1 01
660
Mal
e15
7cm
47kg
Som
e ex
er
604
5560
6.5
Med
ium
53.
019
.07
1092
1747
5.2
9.7
37.
3 2
7.8
20.
6 7
9.4
59.
1
03/0
7/20
0710
:32:
04M
ED
JAG
OK
OF
FI
CM
SK
1 01
660
Mal
e15
7cm
47kg
Som
e ex
er
623
5562
5.4
Med
ium
53.
019
.07
1092
1747
5.0
10.
2 3
6.8
27.
2 2
1.8
78.
2 5
8.0
11/0
7/20
0710
:32:
04M
ED
JAG
OK
OF
FI
CM
SK
1 01
660
Mal
e15
7cm
46kg
Som
e ex
er
638
5664
0.5
Med
ium
53.
018
.66
1078
1725
5.0
9.9
36.
1 2
6.6
21.
4 7
8.6
57.
9
18/0
7/20
0710
:32:
04M
ED
JAG
OK
OF
FI
CM
SK
1 01
660
Mal
e15
7cm
45kg
Som
e ex
er
643
5764
5.5
Med
ium
53.
018
.26
1064
1703
5.1
9.2
35.
8 2
6.3
20.
6 7
9.4
58.
5
25/0
7/20
0710
:32:
04M
ED
JAG
OK
OF
FI
CM
SK
1 01
660
Mal
e15
7cm
45kg
Som
e ex
er
680
5868
2.5
Med
ium
53.
018
.26
1064
1703
4.9
10.
1 3
4.9
25.
4 2
2.3
77.
7 5
6.4
05/0
6/20
0710
:48:
34K
OU
MA
SS
IY
AO
VI
CM
SK
1 01
738
Mal
e17
0cm
66kg
Som
e ex
er
455
5545
8.3
Larg
e 7
3.6
22.8
415
6825
10 6
.9 1
1.1
54.
9 4
1.3
16.
9 8
3.1
62.
6
12/0
6/20
0710
:48:
34K
OU
MA
SS
IY
AO
VI
CM
SK
1 01
738
Mal
e17
0cm
66kg
Som
e ex
er
450
5645
3.5
Larg
e 7
3.6
22.8
415
6825
10 7
.1 1
0.8
55.
2 4
1.7
16.
3 8
3.7
63.
1
19/0
6/20
0710
:48:
34K
OU
MA
SS
IY
AO
VI
CM
SK
1 01
738
Mal
e17
0cm
67kg
Som
e ex
er
460
5446
3.2
Larg
e 7
3.6
23.1
815
8225
32 6
.7 1
2.3
54.
7 4
1.2
18.
3 8
1.7
61.
5
26/0
6/20
0710
:48:
34K
OU
MA
SS
IY
AO
VI
CM
SK
1 01
738
Mal
e17
0cm
67kg
Som
e ex
er
452
5545
5.3
Larg
e 7
3.6
23.1
815
8225
32 6
.9 1
1.7
55.
3 4
1.7
17.
4 8
2.6
62.
2
03/0
7/20
0710
:48:
34K
OU
MA
SS
IY
AO
VI
CM
SK
1 01
738
Mal
e17
0cm
68kg
Som
e ex
er
471
5947
4.7
Larg
e 7
3.6
23.5
315
9625
54 7
.1 1
3.8
54.
2 4
0.7
20.
3 7
9.7
59.
9
11/0
7/20
0710
:48:
34K
OU
MA
SS
IY
AO
VI
CM
SK
1 01
738
Mal
e17
0cm
67kg
Som
e ex
er
452
5745
5.6
Larg
e 7
3.6
23.1
815
8225
32 7
.2 1
1.7
55.
3 4
1.7
17.
4 8
2.6
62.
2
18/0
7/20
0710
:48:
34K
OU
MA
SS
IY
AO
VI
CM
SK
1 01
738
Mal
e17
0cm
67kg
Som
e ex
er
482
6048
5.7
Larg
e 7
3.6
23.1
815
8225
32 7
.1 1
3.8
53.
2 3
9.9
20.
6 7
9.4
59.
6
25/0
7/20
0710
:48:
34K
OU
MA
SS
IY
AO
VI
CM
SK
1 01
738
Mal
e17
0cm
68kg
Som
e ex
er
483
6148
6.8
Larg
e 7
3.6
23.5
315
9625
54 7
.2 1
4.6
53.
4 4
0.0
21.
5 7
8.5
58.
9
01/0
8/20
0710
:48:
34K
OU
MA
SS
IY
AO
VI
CM
SK
1 01
738
Mal
e17
0cm
67kg
Som
e ex
er
488
6149
1.8
Larg
e 7
3.6
23.1
815
8225
32 7
.1 1
4.2
52.
8 3
9.6
21.
2 7
8.8
59.
1
05/0
6/20
0711
:09:
06A
KA
KP
OM
AT
HIE
UC
MS
K! 0
1835
Mal
e17
8cm
58kg
Som
e ex
er
628
6363
1.2
Med
ium
75.
518
.31
1518
2430
5.7
11.
2 4
6.8
34.
1 1
9.3
80.
7 5
8.7
12/0
6/20
0711
:09:
06A
KA
KP
OM
AT
HIE
UC
MS
K! 0
1835
Mal
e17
8cm
58kg
Som
e ex
er
605
5660
7.6
Med
ium
75.
518
.31
1518
2430
5.3
10.
3 4
7.7
34.
9 1
7.7
82.
3 6
0.2
3D
:\BIA
TE
ST
KO
UV
E F
INA
L F
inal
F 2
.xls
BIA
TE
ST
KO
UV
É F
INA
L
Tes
t D
ate
Tes
t T
ime
Las
t N
ame
Fir
st N
ame
Su
bje
ct ID
Ag
eG
end
erH
eig
ht
Wei
gh
tA
ctiv
ity
Lev
elR
esis
tan
ceR
eact
ance
Imp
edan
ceF
ram
e S
ize
Tar
get
W
eig
ht
BM
IB
MR
DE
EP
has
e A
ng
leF
at
wt
FF
M w
tT
BW
lit
ers
Fat
%
of
wt
FF
M %
o
f w
tT
BW
%
of
wt
19/0
6/20
0711
:09:
06A
KA
KP
OM
AT
HIE
UC
MS
K! 0
1835
Mal
e17
8cm
60kg
Som
e ex
er
595
5559
7.5
Med
ium
75.
518
.94
1546
2474
5.3
11.
3 4
8.7
35.
7 1
8.9
81.
1 5
9.5
26/0
6/20
0711
:09:
06A
KA
KP
OM
AT
HIE
UC
MS
K! 0
1835
Mal
e17
8cm
60kg
Som
e ex
er
584
5558
6.6
Med
ium
75.
518
.94
1546
2474
5.4
10.
8 4
9.2
36.
1 1
8.0
82.
0 6
0.2
03/0
7/20
0711
:09:
06A
KA
KP
OM
AT
HIE
UC
MS
K! 0
1835
Mal
e17
8cm
60kg
Som
e ex
er
593
5459
5.5
Med
ium
75.
518
.94
1546
2474
5.2
11.
2 4
8.8
35.
8 1
8.7
81.
3 5
9.6
11/0
7/20
0711
:09:
06A
KA
KP
OM
AT
HIE
UC
MS
K! 0
1835
Mal
e17
8cm
60kg
Som
e ex
er
605
6060
8.0
Med
ium
75.
518
.94
1546
2474
5.7
11.
7 4
8.3
35.
3 1
9.6
80.
4 5
8.8
18/0
7/20
0711
:09:
06A
KA
KP
OM
AT
HIE
UC
MS
K! 0
1835
Mal
e17
8cm
59kg
Som
e ex
er
610
5861
2.8
Med
ium
75.
518
.62
1532
2452
5.4
11.
2 4
7.8
34.
9 1
9.0
81.
0 5
9.2
25/0
7/20
0711
:09:
06A
KA
KP
OM
AT
HIE
UC
MS
K! 0
1835
Mal
e17
8cm
60kg
Som
e ex
er
609
5961
1.9
Med
ium
75.
518
.94
1546
2474
5.5
11.
9 4
8.1
35.
1 1
9.8
80.
2 5
8.5
01/0
8/20
0711
:09:
06A
KA
KP
OM
AT
HIE
UC
MS
K! 0
1835
Mal
e17
8cm
61kg
Som
e ex
er
600
6060
3.0
Med
ium
75.
519
.25
1560
2496
5.7
12.
3 4
8.7
35.
6 2
0.1
79.
9 5
8.4
05/0
6/20
0711
:18:
22D
AN
KE
KO
DJO
CM
SK
1 01
943
Mal
e17
6cm
75kg
Som
e ex
er
480
5748
3.4
Med
ium
73.
424
.21
1689
2702
6.8
16.
8 5
8.2
43.
4 2
2.3
77.
7 5
7.8
12/0
6/20
0711
:18:
22D
AN
KE
KO
DJO
CM
SK
1 01
943
Mal
e17
6cm
75kg
Som
e ex
er
477
5448
0.0
Med
ium
73.
424
.21
1689
2702
6.5
16.
5 5
8.5
43.
6 2
2.0
78.
0 5
8.1
19/0
6/20
0711
:18:
22D
AN
KE
KO
DJO
CM
SK
1 01
943
Mal
e17
6cm
75kg
Som
e ex
er
465
5246
7.9
Med
ium
73.
424
.21
1689
2702
6.4
15.
6 5
9.4
44.
3 2
0.8
79.
2 5
9.1
26/0
6/20
0711
:18:
22D
AN
KE
KO
DJO
CM
SK
1 01
943
Mal
e17
6cm
74kg
Som
e ex
er
468
5447
1.1
Med
ium
73.
423
.89
1675
2680
6.6
15.
1 5
8.9
43.
9 2
0.4
79.
6 5
9.4
03/0
7/20
0711
:18:
22D
AN
KE
KO
DJO
CM
SK
1 01
943
Mal
e17
6cm
75kg
Som
e ex
er
478
5948
1.6
Med
ium
73.
424
.21
1689
2702
7.0
16.
6 5
8.4
43.
5 2
2.1
77.
9 5
8.0
11/0
7/20
0711
:18:
22D
AN
KE
KO
DJO
CM
SK
1 01
943
Mal
e17
6cm
74kg
Som
e ex
er
497
6050
0.6
Med
ium
73.
423
.89
1675
2680
6.9
17.
2 5
6.8
42.
2 2
3.2
76.
8 5
7.0
18/0
7/20
0711
:18:
22D
AN
KE
KO
DJO
CM
SK
1 01
943
Mal
e17
6cm
73kg
Som
e ex
er
481
5848
4.5
Med
ium
73.
423
.57
1661
2658
6.9
15.
3 5
7.7
43.
0 2
1.0
79.
0 5
8.9
25/0
7/20
0711
:18:
22D
AN
KE
KO
DJO
CM
SK
1 01
943
Mal
e17
6cm
75kg
Som
e ex
er
464
5246
6.9
Med
ium
73.
424
.21
1689
2702
6.4
15.
5 5
9.5
44.
4 2
0.7
79.
3 5
9.2
01/0
8/20
0711
:18:
22D
AN
KE
KO
DJO
CM
SK
1 01
943
Mal
e17
6cm
77kg
Som
e ex
er
475
5447
8.1
Med
ium
73.
424
.86
1716
2746
6.5
17.
9 5
9.1
44.
0 2
3.2
76.
8 5
7.2
05/0
6/20
0711
:39:
12A
ME
GN
RA
NA
TS
OU
CM
SK
1 02
035
Mal
e17
9cm
67kg
Som
e ex
er
537
5553
9.8
Med
ium
76.
620
.91
1648
2636
5.8
13.
2 5
3.8
39.
8 1
9.7
80.
3 5
9.4
12/0
6/20
0711
:39:
12A
ME
GN
RA
NA
TS
OU
CM
SK
1 02
035
Mal
e17
9cm
67kg
Som
e ex
er
494
4649
6.1
Med
ium
76.
620
.91
1648
2636
5.3
10.
4 5
6.6
42.
1 1
5.6
84.
4 6
2.9
19/0
6/20
0711
:39:
12A
ME
GN
RA
NA
TS
OU
CM
SK
1 02
035
Mal
e17
9cm
69kg
Som
e ex
er
468
4447
0.1
Med
ium
76.
621
.53
1675
2681
5.4
9.9
59.
1 4
4.1
14.
4 8
5.6
63.
9
26/0
6/20
0711
:39:
12A
ME
GN
RA
NA
TS
OU
CM
SK
1 02
035
Mal
e17
9cm
68kg
Som
e ex
er
456
4245
7.9
Med
ium
76.
621
.22
1661
2659
5.3
8.2
59.
8 4
4.7
12.
1 8
7.9
65.
8
03/0
7/20
0711
:39:
12A
ME
GN
RA
NA
TS
OU
CM
SK
1 02
035
Mal
e17
9cm
68kg
Som
e ex
er
501
5150
3.6
Med
ium
76.
621
.22
1661
2659
5.8
11.
6 5
6.4
41.
9 1
7.1
82.
9 6
1.6
11/0
7/20
0711
:39:
12A
ME
GN
RA
NA
TS
OU
CM
SK
1 02
035
Mal
e17
9cm
67kg
Som
e ex
er
512
5551
4.9
Med
ium
76.
620
.91
1648
2636
6.1
11.
6 5
5.4
41.
1 1
7.4
82.
6 6
1.3
18/0
7/20
0711
:39:
12A
ME
GN
RA
NA
TS
OU
CM
SK
1 02
035
Mal
e17
9cm
69kg
Som
e ex
er
580
5058
2.2
Med
ium
76.
621
.53
1675
2681
4.9
16.
9 5
2.1
38.
2 2
4.5
75.
5 5
5.3
25/0
7/20
0711
:39:
12A
ME
GN
RA
NA
TS
OU
CM
SK
1 02
035
Mal
e17
9cm
69kg
Som
e ex
er
588
5259
0.3
Med
ium
76.
621
.53
1675
2681
5.1
17.
3 5
1.7
37.
8 2
5.0
75.
0 5
4.8
01/0
8/20
0711
:39:
12A
ME
GN
RA
NA
TS
OU
CM
SK
1 02
035
Mal
e17
9cm
69kg
Som
e ex
er
504
5650
7.1
Med
ium
76.
621
.53
1675
2681
6.3
12.
6 5
6.4
41.
9 1
8.2
81.
8 6
0.7
05/0
6/20
0711
:53:
26T
EN
GU
EK
OF
FI
CM
SK
1 02
155
Mal
e15
5cm
43kg
Som
e ex
er
555
3755
6.2
Med
ium
50.
917
.90
1060
1697
3.8
5.9
37.
1 2
8.2
13.
6 8
6.4
65.
6
12/0
6/20
0711
:53:
26T
EN
GU
EK
OF
FI
CM
SK
1 02
155
Mal
e15
5cm
43kg
Som
e ex
er
584
4058
5.4
Med
ium
50.
917
.90
1060
1697
3.9
6.8
36.
2 2
7.2
15.
9 8
4.1
63.
4
19/0
6/20
0711
:53:
26T
EN
GU
EK
OF
FI
CM
SK
1 02
155
Mal
e15
5cm
44kg
Som
e ex
er
603
4160
4.4
Med
ium
50.
918
.31
1074
1719
3.9
8.1
35.
9 2
6.8
18.
5 8
1.5
61.
0
26/0
6/20
0711
:53:
26T
EN
GU
EK
OF
FI
CM
SK
1 02
155
Mal
e15
5cm
42kg
Som
e ex
er
580
4158
1.4
Med
ium
50.
917
.48
1047
1675
4.0
6.0
36.
0 2
7.2
14.
2 8
5.8
64.
7
03/0
7/20
0711
:53:
26T
EN
GU
EK
OF
FI
CM
SK
1 02
155
Mal
e15
5cm
42kg
Som
e ex
er
615
4661
6.7
Med
ium
50.
917
.48
1047
1675
4.3
7.0
35.
0 2
6.1
16.
6 8
3.4
62.
2
11/0
7/20
0711
:53:
26T
EN
GU
EK
OF
FI
CM
SK
1 02
155
Mal
e15
5cm
40kg
Som
e ex
er
601
4360
2.5
Med
ium
50.
916
.65
1019
1631
4.1
5.1
34.
9 2
6.2
12.
8 8
7.2
65.
5
18/0
7/20
0711
:53:
26T
EN
GU
EK
OF
FI
CM
SK
1 02
155
Mal
e15
5cm
40kg
Som
e ex
er
620
4762
1.8
Med
ium
50.
916
.65
1019
1631
4.3
5.6
34.
4 2
5.6
14.
1 8
5.9
64.
1
25/0
7/20
0711
:53:
26T
EN
GU
EK
OF
FI
CM
SK
1 02
155
Mal
e15
5cm
41kg
Som
e ex
er
616
4461
7.6
Med
ium
50.
917
.07
1033
1653
4.1
6.3
34.
7 2
5.9
15.
3 8
4.7
63.
2
01/0
8/20
0711
:53:
26T
EN
GU
EK
OF
FI
CM
SK
1 02
155
Mal
e15
5cm
40kg
Som
e ex
er
654
4365
5.4
Med
ium
50.
916
.65
1019
1631
3.8
6.4
33.
6 2
4.7
16.
1 8
3.9
61.
8
12/0
6/20
0712
:12:
45K
PO
EN
OU
KO
FF
I JE
AN
CM
SK
1 02
237
Mal
e17
2cm
59kg
Som
e ex
er
583
5358
5.4
Larg
e 6
9.1
19.9
414
8923
82 5
.2 1
2.4
46.
6 3
4.4
21.
0 7
9.0
58.
3
05/0
6/20
0712
:12:
45K
PO
EN
OU
KO
FF
I JE
AN
CM
SK
1 02
237
Mal
e17
2cm
59kg
Som
e ex
er
591
5459
3.5
Larg
e 6
9.1
19.9
414
8923
82 5
.2 1
2.7
46.
3 3
4.1
21.
6 7
8.4
57.
7
19/0
6/20
0712
:12:
45K
PO
EN
OU
KO
FF
I JE
AN
CM
SK
1 02
237
Mal
e17
2cm
63kg
Som
e ex
er
539
5054
1.3
Larg
e 6
9.1
21.3
015
4424
70 5
.3 1
3.3
49.
7 3
6.9
21.
1 7
8.9
58.
6
03/0
7/20
0712
:12:
45K
PO
EN
OU
KO
FF
I JE
AN
CM
SK
1 02
237
Mal
e17
2cm
63kg
Som
e ex
er
565
5456
7.6
Larg
e 6
9.1
21.3
015
4424
70 5
.5 1
4.6
48.
4 3
5.8
23.
1 7
6.9
56.
8
11/0
7/20
0712
:12:
45K
PO
EN
OU
KO
FF
I JE
AN
CM
SK
1 02
237
Mal
e17
2cm
62kg
Som
e ex
er
551
5255
3.4
Larg
e 6
9.1
20.9
615
3024
48 5
.4 1
3.2
48.
8 3
6.2
21.
2 7
8.8
58.
4
18/0
7/20
0712
:12:
45K
PO
EN
OU
KO
FF
I JE
AN
CM
SK
1 02
237
Mal
e17
2cm
61kg
Som
e ex
er
536
4853
8.1
Larg
e 6
9.1
20.6
215
1624
26 5
.1 1
1.7
49.
3 3
6.7
19.
1 8
0.9
60.
2
25/0
7/20
0712
:12:
45K
PO
EN
OU
KO
FF
I JE
AN
CM
SK
1 02
237
Mal
e17
2cm
63kg
Som
e ex
er
523
4652
5.0
Larg
e 6
9.1
21.3
015
4424
70 5
.0 1
2.4
50.
6 3
7.7
19.
8 8
0.2
59.
8
01/0
8/20
0712
:12:
45K
PO
EN
OU
KO
FF
I JE
AN
CM
SK
1 02
237
Mal
e17
2cm
65kg
Som
e ex
er
556
5355
8.5
Larg
e 6
9.1
21.9
715
7125
15 5
.4 1
5.6
49.
4 3
6.5
24.
0 7
6.0
56.
2
12/0
6/20
0712
:50:
28G
BA
SR
AA
LOE
DE
CM
SK
1 02
333
Fem
ale
153
cm62
kgS
ome
exe
r54
861
551.
4M
ediu
m 4
5.9
26.4
913
7020
55 6
.4 2
2.6
39.
4 3
0.0
36.
5 6
3.5
48.
3
19/0
6/20
0712
:50:
28G
BA
SR
AA
LOE
DE
CM
SK
1 02
333
Fem
ale
153
cm62
kgS
ome
exe
r53
259
535.
3M
ediu
m 4
5.9
26.4
913
7020
55 6
.3 2
2.0
40.
0 3
0.6
35.
4 6
4.6
49.
3
26/0
6/20
0712
:50:
28G
BA
SR
AA
LOE
DE
CM
SK
1 02
333
Fem
ale
153
cm62
kgS
ome
exe
r56
065
563.
8M
ediu
m 4
5.9
26.4
913
7020
55 6
.6 2
3.1
38.
9 2
9.6
37.
2 6
2.8
47.
7
03/0
7/20
0712
:50:
28G
BA
SR
AA
LOE
DE
CM
SK
1 02
333
Fem
ale
153
cm62
kgS
ome
exe
r54
764
550.
7M
ediu
m 4
5.9
26.4
913
7020
55 6
.7 2
2.6
39.
4 3
0.0
36.
4 6
3.6
48.
4
10/0
7/20
0712
:50:
28G
BA
SR
AA
LOE
DE
CM
SK
1 02
333
Fem
ale
153
cm62
kgS
ome
exe
r53
561
538.
5M
ediu
m 4
5.9
26.4
913
7020
55 6
.5 2
2.1
39.
9 3
0.4
35.
6 6
4.4
49.
1
18/0
7/20
0712
:50:
28G
BA
SR
AA
LOE
DE
CM
SK
1 02
333
Fem
ale
153
cm61
kgS
ome
exe
r52
762
530.
6M
ediu
m 4
5.9
26.0
613
6120
41 6
.7 2
0.9
40.
1 3
0.6
34.
3 6
5.7
50.
2
4D
:\BIA
TE
ST
KO
UV
E F
INA
L F
inal
F 2
.xls
BIA
TE
ST
KO
UV
É F
INA
L
Tes
t D
ate
Tes
t T
ime
Las
t N
ame
Fir
st N
ame
Su
bje
ct ID
Ag
eG
end
erH
eig
ht
Wei
gh
tA
ctiv
ity
Lev
elR
esis
tan
ceR
eact
ance
Imp
edan
ceF
ram
e S
ize
Tar
get
W
eig
ht
BM
IB
MR
DE
EP
has
e A
ng
leF
at
wt
FF
M w
tT
BW
lit
ers
Fat
%
of
wt
FF
M %
o
f w
tT
BW
%
of
wt
25/0
7/20
0712
:53:
49G
BA
SR
AA
LOE
DE
CM
SK
1 02
333
Fem
ale
153
cm63
kgS
ome
exe
r55
766
560.
9M
ediu
m 4
5.9
26.9
113
8020
70 6
.8 2
3.8
39.
2 2
9.8
37.
7 6
2.3
47.
3
01/0
8/20
0712
:53:
49G
BA
SR
AA
LOE
DE
CM
SK
1 02
333
Fem
ale
153
cm61
kgS
ome
exe
r56
167
565.
0M
ediu
m 4
5.9
26.0
613
6120
41 6
.8 2
2.3
38.
7 2
9.4
36.
5 6
3.5
48.
2
12/0
6/20
0713
:02:
01O
VO
DE
KO
MLA
NC
MS
K1
024
47M
ale
172
cm58
kgS
ome
exe
r61
759
619.
8M
ediu
m 6
9.1
19.6
114
0722
51 5
.5 1
3.0
45.
0 3
2.9
22.
4 7
7.6
56.
8
19/0
6/20
0713
:02:
01O
VO
DE
KO
MLA
NC
MS
K1
024
47M
ale
172
cm61
kgS
ome
exe
r59
253
594.
4M
ediu
m 6
9.1
20.6
214
4823
17 5
.1 1
4.2
46.
8 3
4.4
23.
3 7
6.7
56.
4
26/0
6/20
0713
:02:
01O
VO
DE
KO
MLA
NC
MS
K1
024
47M
ale
172
cm62
kgS
ome
exe
r57
756
579.
7M
ediu
m 6
9.1
20.9
614
6223
40 5
.5 1
4.3
47.
7 3
5.1
23.
1 7
6.9
56.
7
03/0
7/20
0713
:02:
01O
VO
DE
KO
MLA
NC
MS
K1
024
47M
ale
172
cm63
kgS
ome
exe
r57
955
581.
6M
ediu
m 6
9.1
21.3
014
7623
62 5
.4 1
5.2
47.
8 3
5.2
24.
1 7
5.9
55.
9
11/0
7/20
0713
:04:
38O
VO
DE
KO
MLA
NC
MS
K1
024
47M
ale
172
cm64
kgS
ome
exe
r54
752
549.
5M
ediu
m 6
9.1
21.6
314
9023
84 5
.4 1
4.4
49.
6 3
6.8
22.
6 7
7.4
57.
4
18/0
7/20
0713
:06:
07O
VO
DE
KO
MLA
NC
MS
K1
024
47M
ale
172
cm66
kgS
ome
exe
r53
551
537.
4M
ediu
m 6
9.1
22.3
115
1724
28 5
.4 1
5.3
50.
7 3
7.6
23.
2 7
6.8
57.
0
25/0
7/20
0713
:07:
02O
VO
DE
KO
MLA
NC
MS
K1
024
47M
ale
172
cm67
kgS
ome
exe
r54
255
544.
8M
ediu
m 6
9.1
22.6
515
3124
50 5
.8 1
6.4
50.
6 3
7.5
24.
5 7
5.5
56.
0
01/0
8/20
0713
:07:
02O
VO
DE
KO
MLA
NC
MS
K1
024
47M
ale
172
cm67
kgS
ome
exe
r56
258
565.
0M
ediu
m 6
9.1
22.6
515
3124
50 5
.9 1
7.4
49.
6 3
6.6
25.
9 7
4.1
54.
7
12/0
6/20
0713
:32:
30A
MO
UZ
OU
GT
AT
AC
MS
K1
025
50M
ale
165
cm52
kgS
ome
exe
r52
159
524.
3La
rge
67.
719
.10
1269
2030
6.5
7.2
44.
8 3
3.8
13.
8 8
6.2
65.
0
19/0
6/20
0713
:32:
30A
MO
UZ
OU
GT
AT
AC
MS
K1
025
50M
ale
165
cm54
kgS
ome
exe
r52
259
525.
3La
rge
67.
719
.83
1296
2074
6.4
8.7
45.
3 3
4.1
16.
1 8
3.9
63.
2
26/0
6/20
0713
:32:
30A
MO
UZ
OU
GT
AT
AC
MS
K1
025
50M
ale
165
cm52
kgS
ome
exe
r48
757
490.
3La
rge
67.
719
.10
1269
2030
6.7
5.3
46.
7 3
5.5
10.
2 8
9.8
68.
2
03/0
7/20
0713
:32:
30A
MO
UZ
OU
GT
AT
AC
MS
K1
025
50M
ale
165
cm53
kgS
ome
exe
r51
360
516.
5La
rge
67.
719
.47
1282
2052
6.7
7.5
45.
5 3
4.4
14.
1 8
5.9
64.
8
11/0
7/20
0713
:32:
30A
MO
UZ
OU
GT
AT
AC
MS
K1
025
50M
ale
165
cm54
kgS
ome
exe
r51
358
516.
3La
rge
67.
719
.83
1296
2074
6.5
8.2
45.
8 3
4.5
15.
2 8
4.8
64.
0
18/0
7/20
0713
:32:
30A
MO
UZ
OU
GT
AT
AC
MS
K1
025
50M
ale
165
cm55
kgS
ome
exe
r50
557
508.
2La
rge
67.
720
.20
1310
2096
6.4
8.5
46.
5 3
5.1
15.
5 8
4.5
63.
8
25/0
7/20
0713
:32:
30A
MO
UZ
OU
GT
AT
AC
MS
K1
025
50M
ale
165
cm53
kgS
ome
exe
r51
561
518.
6La
rge
67.
719
.47
1282
2052
6.8
7.6
45.
4 3
4.3
14.
3 8
5.7
64.
7
01/0
8/20
0713
:32:
30A
MO
UZ
OU
GT
AT
AC
MS
K1
025
50M
ale
165
cm53
kgS
ome
exe
r52
356
526.
0La
rge
67.
719
.47
1282
2052
6.1
8.0
45.
0 3
3.9
15.
1 8
4.9
64.
0
19/0
6/20
0713
:50:
44G
UID
IK
OM
I GE
RM
CM
SK
1 02
635
Mal
e17
9cm
68kg
Som
e ex
er
602
6760
5.7
Med
ium
76.
621
.22
1661
2659
6.4
17.
1 5
0.9
37.
1 2
5.2
74.
8 5
4.5
26/0
6/20
0713
:50:
44G
UID
IK
OM
I GE
RM
CM
SK
1 02
635
Mal
e17
9cm
69kg
Som
e ex
er
589
6359
2.4
Med
ium
76.
621
.53
1675
2681
6.1
17.
3 5
1.7
37.
8 2
5.1
74.
9 5
4.7
03/0
7/20
0713
:50:
44G
UID
IK
OM
I GE
RM
CM
SK
1 02
635
Mal
e17
9cm
68kg
Som
e ex
er
577
6458
0.5
Med
ium
76.
621
.22
1661
2659
6.3
16.
0 5
2.0
38.
1 2
3.5
76.
5 5
6.0
11/0
7/20
0713
:50:
44G
UID
IK
OM
I GE
RM
CM
SK
1 02
635
Mal
e17
9cm
66kg
Som
e ex
er
586
6358
9.4
Med
ium
76.
620
.60
1634
2614
6.1
14.
9 5
1.1
37.
4 2
2.6
77.
4 5
6.6
18/0
7/20
0713
:50:
44G
UID
IK
OM
I GE
RM
CM
SK
1 02
635
Mal
e17
9cm
67kg
Som
e ex
er
588
6659
1.7
Med
ium
76.
620
.91
1648
2636
6.4
15.
8 5
1.2
37.
5 2
3.5
76.
5 5
5.9
25/0
7/20
0713
:50:
44G
UID
IK
OM
I GE
RM
CM
SK
1 02
635
Mal
e17
9cm
68kg
Som
e ex
er
608
6761
1.7
Med
ium
76.
621
.22
1661
2659
6.3
17.
4 5
0.6
36.
8 2
5.6
74.
4 5
4.2
01/0
8/20
0713
:50:
44G
UID
IK
OM
I GE
RM
CM
SK
1 02
635
Mal
e17
9cm
70kg
Som
e ex
er
572
6057
5.1
Med
ium
76.
621
.85
1689
2703
6.0
17.
2 5
2.8
38.
7 2
4.6
75.
4 5
5.2
19/0
6/20
0713
:59:
05B
LIM
AM
AV
I IR
EN
CM
SK
1 02
726
Fem
ale
165
cm51
kgS
ome
exe
r67
763
679.
9M
ediu
m 5
6.6
18.7
313
1919
79 5
.3 1
3.1
37.
9 2
7.6
25.
8 7
4.2
54.
1
26/0
6/20
0713
:59:
05B
LIM
AM
AV
I IR
EN
CM
SK
1 02
726
Fem
ale
165
cm50
kgS
ome
exe
r66
565
668.
2M
ediu
m 5
6.6
18.3
713
0919
64 5
.6 1
2.0
38.
0 2
7.8
24.
0 7
6.0
55.
6
03/0
7/20
0713
:59:
05B
LIM
AM
AV
I IR
EN
CM
SK
1 02
726
Fem
ale
165
cm53
kgS
ome
exe
r64
061
642.
9M
ediu
m 5
6.6
19.4
713
3820
08 5
.4 1
3.8
39.
2 2
8.9
26.
0 7
4.0
54.
5
11/0
7/20
0713
:59:
05B
LIM
AM
AV
I IR
EN
CM
SK
1 02
726
Fem
ale
165
cm52
kgS
ome
exe
r69
265
695.
0M
ediu
m 5
6.6
19.1
013
2919
93 5
.4 1
4.3
37.
7 2
7.3
27.
6 7
2.4
52.
6
18/0
7/20
0714
:03:
34B
LIM
AM
AV
I IR
EN
CM
SK
1 02
726
Fem
ale
165
cm53
kgS
ome
exe
r65
561
657.
8M
ediu
m 5
6.6
19.4
713
3820
08 5
.3 1
4.2
38.
8 2
8.4
26.
8 7
3.2
53.
7
25/0
7/20
0714
:03:
34B
LIM
AM
AV
I IR
EN
CM
SK
1 02
726
Fem
ale
165
cm52
kgS
ome
exe
r69
573
698.
8M
ediu
m 5
6.6
19.1
013
2919
93 6
.0 1
4.4
37.
6 2
7.3
27.
7 7
2.3
52.
4
01/0
8/20
0714
:03:
34B
LIM
AM
AV
I IR
EN
CM
SK
1 02
726
Fem
ale
165
cm51
kgS
ome
exe
r66
465
667.
2M
ediu
m 5
6.6
18.7
313
1919
79 5
.6 1
2.8
38.
2 2
8.0
25.
1 7
4.9
54.
8
19/0
6/20
0714
:10:
56K
OM
AK
AA
DJO
CM
SK
1 02
830
Fem
ale
149
cm41
kgS
ome
exe
r82
573
828.
2M
ediu
m 4
2.3
18.4
711
7517
63 5
.1 1
1.7
29.
3 2
0.5
28.
6 7
1.4
50.
0
26/0
6/20
0714
:10:
56K
OM
AK
AA
DJO
CM
SK
1 02
830
Fem
ale
149
cm39
kgS
ome
exe
r10
0010
210
05.2
Med
ium
42.
317
.57
1156
1735
5.8
10.
5 2
8.5
18.
1 2
7.0
73.
0 4
6.5
03/0
7/20
0714
:10:
56K
OM
AK
AA
DJO
CM
SK
1 02
830
Fem
ale
149
cm44
kgS
ome
exe
r78
163
783.
5M
ediu
m 4
2.3
19.8
212
0418
07 4
.6 1
3.9
30.
1 2
1.5
31.
5 6
8.5
48.
9
11/0
7/20
0714
:10:
56K
OM
AK
AA
DJO
CM
SK
1 02
830
Fem
ale
149
cm43
kgS
ome
exe
r81
065
812.
6M
ediu
m 4
2.3
19.3
711
9517
92 4
.6 1
3.3
29.
7 2
0.9
30.
9 6
9.1
48.
7
18/0
7/20
0714
:10:
56K
OM
AK
AA
DJO
CM
SK
1 02
830
Fem
ale
149
cm43
kgS
ome
exe
r77
666
778.
8M
ediu
m 4
2.3
19.3
711
9517
92 4
.9 1
3.0
30.
0 2
1.5
30.
2 6
9.8
50.
0
25/0
7/20
0714
:10:
56K
OM
AK
AA
DJO
CM
SK
1 02
830
Fem
ale
149
cm45
kgS
ome
exe
r77
472
777.
3M
ediu
m 4
2.3
20.2
712
1418
21 5
.3 1
4.6
30.
4 2
1.7
32.
5 6
7.5
48.
3
01/0
8/20
0714
:10:
56K
OM
AK
AA
DJO
CM
SK
1 02
830
Fem
ale
149
cm44
kgS
ome
exe
r74
668
749.
1M
ediu
m 4
2.3
19.8
212
0418
07 5
.2 1
3.5
30.
5 2
2.1
30.
7 6
9.3
50.
3
19/0
6/20
0714
:27:
08D
EG
BE
AF
I AK
OE
LEC
MS
K1
029
33F
emal
e16
7cm
57kg
Som
e ex
er
672
6367
4.9
Med
ium
58.
420
.44
1347
2021
5.4
17.
3 3
9.7
28.
9 3
0.4
69.
6 5
0.6
26/0
6/20
0714
:27:
08D
EG
BE
AF
I AK
OE
LEC
MS
K1
029
33F
emal
e16
7cm
59kg
Som
e ex
er
645
5864
7.6
Med
ium
58.
421
.16
1367
2050
5.1
18.
2 4
0.8
29.
9 3
0.9
69.
1 5
0.6
03/0
7/20
0714
:27:
08D
EG
BE
AF
I AK
OE
LEC
MS
K1
029
33F
emal
e16
7cm
61kg
Som
e ex
er
655
6465
8.1
Med
ium
58.
421
.87
1386
2079
5.6
20.
2 4
0.8
29.
8 3
3.1
66.
9 4
8.9
11/0
7/20
0714
:27:
08D
EG
BE
AF
I AK
OE
LEC
MS
K1
029
33F
emal
e16
7cm
58kg
Som
e ex
er
640
5964
2.7
Med
ium
58.
420
.80
1357
2036
5.3
17.
2 4
0.8
29.
9 2
9.7
70.
3 5
1.6
18/0
7/20
0714
:27:
08D
EG
BE
AF
I AK
OE
LEC
MS
K1
029
33F
emal
e16
7cm
58kg
Som
e ex
er
701
6970
4.4
Med
ium
58.
420
.80
1357
2036
5.6
18.
9 3
9.1
28.
2 3
2.5
67.
5 4
8.6
25/0
7/20
0714
:27:
08D
EG
BE
AF
I AK
OE
LEC
MS
K1
029
33F
emal
e16
7cm
58kg
Som
e ex
er
691
7069
4.5
Med
ium
58.
420
.80
1357
2036
5.8
18.
6 3
9.4
28.
5 3
2.1
67.
9 4
9.1
01/0
8/20
0714
:27:
08D
EG
BE
AF
I AK
OE
LEC
MS
K1
029
33F
emal
e16
7cm
58kg
Som
e ex
er
681
6568
4.1
Med
ium
58.
420
.80
1357
2036
5.5
18.
4 3
9.6
28.
7 3
1.7
68.
3 4
9.5
19/0
6/20
0714
:35:
43A
KA
KP
OD
AK
PE
CM
SK
1 03
050
Fem
ale
168
cm56
kgS
ome
exe
r69
165
694.
1M
ediu
m 5
9.3
19.8
412
6018
90 5
.4 1
6.6
39.
4 2
8.5
29.
7 7
0.3
50.
8
26/0
6/20
0714
:35:
43A
KA
KP
OD
AK
PE
CM
SK
1 03
050
Fem
ale
168
cm55
kgS
ome
exe
r70
869
711.
4M
ediu
m 5
9.3
19.4
912
5018
75 5
.6 1
6.2
38.
8 2
7.9
29.
5 7
0.5
50.
7
5D
:\BIA
TE
ST
KO
UV
E F
INA
L F
inal
F 2
.xls
BIA
TE
ST
KO
UV
É F
INA
L
Tes
t D
ate
Tes
t T
ime
Las
t N
ame
Fir
st N
ame
Su
bje
ct ID
Ag
eG
end
erH
eig
ht
Wei
gh
tA
ctiv
ity
Lev
elR
esis
tan
ceR
eact
ance
Imp
edan
ceF
ram
e S
ize
Tar
get
W
eig
ht
BM
IB
MR
DE
EP
has
e A
ng
leF
at
wt
FF
M w
tT
BW
lit
ers
Fat
%
of
wt
FF
M %
o
f w
tT
BW
%
of
wt
03/0
7/20
0714
:35:
43A
KA
KP
OD
AK
PE
CM
SK
1 03
050
Fem
ale
168
cm56
kgS
ome
exe
r77
383
777.
4M
ediu
m 5
9.3
19.8
412
6018
90 6
.1 1
8.3
37.
7 2
6.5
32.
8 6
7.2
47.
3
11/0
7/20
0714
:35:
43A
KA
KP
OD
AK
PE
CM
SK
1 03
050
Fem
ale
168
cm54
kgS
ome
exe
r71
565
717.
9M
ediu
m 5
9.3
19.1
312
4018
61 5
.2 1
5.5
38.
5 2
7.6
28.
8 7
1.2
51.
1
18/0
7/20
0714
:35:
43A
KA
KP
OD
AK
PE
CM
SK
1 03
050
Fem
ale
168
cm55
kgS
ome
exe
r70
062
702.
7M
ediu
m 5
9.3
19.4
912
5018
75 5
.1 1
6.0
39.
0 2
8.1
29.
1 7
0.9
51.
1
25/0
7/20
0714
:35:
43A
KA
KP
OD
AK
PE
CM
SK
1 03
050
Fem
ale
168
cm56
kgS
ome
exe
r69
865
701.
0M
ediu
m 5
9.3
19.8
412
6018
90 5
.3 1
6.8
39.
2 2
8.3
30.
0 7
0.0
50.
5
01/0
8/20
0714
:35:
43A
KA
KP
OD
AK
PE
CM
SK
1 03
050
Fem
ale
168
cm57
kgS
ome
exe
r69
065
693.
1M
ediu
m 5
9.3
20.2
012
6919
04 5
.4 1
7.4
39.
6 2
8.6
30.
6 6
9.4
50.
2
19/0
6/20
0714
:52:
53S
EN
OU
AG
OS
SO
UC
MS
K1
031
45M
ale
169
cm44
kgS
ome
exe
r75
876
761.
8M
ediu
m 6
5.9
15.4
112
1219
40 5
.7 7
.2 3
6.8
25.
9 1
6.4
83.
6 5
8.8
26/0
6/20
0714
:52:
53S
EN
OU
AG
OS
SO
UC
MS
K1
031
45M
ale
169
cm45
kgS
ome
exe
r70
064
702.
9M
ediu
m 6
5.9
15.7
612
2619
62 5
.2 6
.8 3
8.2
27.
4 1
5.1
84.
9 6
1.0
03/0
7/20
0714
:52:
53S
EN
OU
AG
OS
SO
UC
MS
K1
031
45M
ale
169
cm47
kgS
ome
exe
r72
068
723.
2M
ediu
m 6
5.9
16.4
612
5420
06 5
.4 8
.7 3
8.3
27.
3 1
8.5
81.
5 5
8.1
11/0
7/20
0714
:52:
53S
EN
OU
AG
OS
SO
UC
MS
K1
031
45M
ale
169
cm46
kgS
ome
exe
r67
562
677.
8M
ediu
m 6
5.9
16.1
112
4019
84 5
.2 6
.9 3
9.1
28.
3 1
5.0
85.
0 6
1.5
18/0
7/20
0714
:52:
53S
EN
OU
AG
OS
SO
UC
MS
K1
031
45M
ale
169
cm45
kgS
ome
exe
r69
165
694.
1M
ediu
m 6
5.9
15.7
612
2619
62 5
.4 6
.6 3
8.4
27.
7 1
4.6
85.
4 6
1.5
25/0
7/20
0714
:52:
53S
EN
OU
AG
OS
SO
UC
MS
K1
031
45M
ale
169
cm45
kgS
ome
exe
r71
369
716.
3M
ediu
m 6
5.9
15.7
612
2619
62 5
.5 7
.1 3
7.9
27.
1 1
5.7
84.
3 6
0.2
01/0
8/20
0714
:52:
53S
EN
OU
AG
OS
SO
UC
MS
K1
031
45M
ale
169
cm45
kgS
ome
exe
r69
366
696.
1M
ediu
m 6
5.9
15.7
612
2619
62 5
.4 6
.6 3
8.4
27.
6 1
4.7
85.
3 6
1.4
19/0
6/20
0715
:06:
34A
PE
GN
ON
OA
KO
UV
IC
MS
K1
032
28F
emal
e17
2cm
46kg
Som
e ex
er
727
5972
9.4
Sm
all
62.
915
.55
1274
1912
4.6
7.8
38.
2 2
7.3
17.
1 8
2.9
59.
3
26/0
6/20
0715
:06:
34A
PE
GN
ON
OA
KO
UV
IC
MS
K1
032
28F
emal
e17
2cm
46kg
Som
e ex
er
676
5167
7.9
Sm
all
62.
915
.55
1274
1912
4.3
6.5
39.
5 2
8.6
14.
2 8
5.8
62.
3
03/0
7/20
0715
:06:
34A
PE
GN
ON
OA
KO
UV
IC
MS
K1
032
28F
emal
e17
2cm
46kg
Som
e ex
er
717
6371
9.8
Sm
all
62.
915
.55
1274
1912
5.0
7.6
38.
4 2
7.5
16.
5 8
3.5
59.
8
11/0
7/20
0715
:06:
34A
PE
GN
ON
OA
KO
UV
IC
MS
K1
032
28F
emal
e17
2cm
45kg
Som
e ex
er
715
5471
7.0
Sm
all
62.
915
.21
1265
1897
4.3
6.7
38.
3 2
7.5
15.
0 8
5.0
61.
0
18/0
7/20
0715
:06:
34A
PE
GN
ON
OA
KO
UV
IC
MS
K1
032
28F
emal
e17
2cm
45kg
Som
e ex
er
636
5263
8.1
Sm
all
62.
915
.21
1265
1897
4.7
4.4
40.
6 2
9.8
9.8
90.
2 6
6.1
25/0
7/20
0715
:06:
34A
PE
GN
ON
OA
KO
UV
IC
MS
K1
032
28F
emal
e17
2cm
47kg
Som
e ex
er
636
4663
7.7
Sm
all
62.
915
.89
1284
1926
4.1
6.1
40.
9 3
0.0
12.
9 8
7.1
63.
8
01/0
8/20
0715
:06:
34A
PE
GN
ON
OA
KO
UV
IC
MS
K1
032
28F
emal
e17
2cm
45kg
Som
e ex
er
673
6167
5.8
Sm
all
62.
915
.21
1265
1897
5.2
5.6
39.
4 2
8.6
12.
5 8
7.5
63.
6
04/0
7/20
0715
:20:
30A
ME
TY
KO
DJO
FO
GC
MS
K1
033
30M
ale
167
cm56
kgS
ome
exe
r56
771
571.
4La
rge
70.
120
.08
1470
2352
7.1
11.
4 4
4.6
33.
1 2
0.4
79.
6 5
9.2
11/0
7/20
0715
:20:
30A
ME
TY
KO
DJO
FO
GC
MS
K1
033
30M
ale
167
cm58
kgS
ome
exe
r55
065
553.
8La
rge
70.
120
.80
1497
2396
6.7
12.
2 4
5.8
34.
2 2
1.0
79.
0 5
8.9
18/0
7/20
0715
:20:
30A
ME
TY
KO
DJO
FO
GC
MS
K1
033
30M
ale
167
cm58
kgS
ome
exe
r54
167
545.
1La
rge
70.
120
.80
1497
2396
7.1
11.
8 4
6.2
34.
6 2
0.3
79.
7 5
9.6
25/0
7/20
0715
:20:
30A
ME
TY
KO
DJO
FO
GC
MS
K1
033
30M
ale
167
cm60
kgS
ome
exe
r53
566
539.
1La
rge
70.
121
.51
1525
2440
7.0
12.
9 4
7.1
35.
2 2
1.6
78.
4 5
8.6
01/0
8/20
0715
:20:
30A
ME
TY
KO
DJO
FO
GC
MS
K1
033
30M
ale
167
cm60
kgS
ome
exe
r54
668
550.
2La
rge
70.
121
.51
1525
2440
7.1
13.
5 4
6.5
34.
7 2
2.4
77.
6 5
7.8
04/0
7/20
0715
:33:
21A
KLA
VO
IND
ED
JRO
CM
SK
1 03
430
Mal
e16
9cm
53kg
Som
e ex
er
663
6866
6.5
Sm
all
59.
318
.56
1438
2302
5.9
11.
8 4
1.2
29.
9 2
2.2
77.
8 5
6.4
11/0
7/20
0715
:33:
21A
KLA
VO
IND
ED
JRO
CM
SK
1 03
430
Mal
e16
9cm
54kg
Som
e ex
er
692
7169
5.6
Sm
all
59.
318
.91
1452
2324
5.9
13.
2 4
0.8
29.
2 2
4.5
75.
5 5
4.1
18/0
7/20
0715
:33:
21A
KLA
VO
IND
ED
JRO
CM
SK
1 03
430
Mal
e16
9cm
56kg
Som
e ex
er
690
6869
3.3
Sm
all
59.
319
.61
1480
2368
5.6
14.
7 4
1.3
29.
6 2
6.2
73.
8 5
2.9
25/0
7/20
0715
:33:
21A
KLA
VO
IND
ED
JRO
CM
SK
1 03
430
Mal
e16
9cm
52kg
Som
e ex
er
675
7267
8.8
Sm
all
59.
318
.21
1425
2280
6.1
11.
3 4
0.7
29.
4 2
1.8
78.
2 5
6.4
01/0
8/20
0715
:33:
21A
KLA
VO
IND
ED
JRO
CM
SK
1 03
430
Mal
e16
9cm
54kg
Som
e ex
er
685
7168
8.7
Sm
all
59.
318
.91
1452
2324
5.9
13.
1 4
0.9
29.
4 2
4.2
75.
8 5
4.5
04/0
7/20
0715
:39:
25V
IAG
BO
AT
SO
U P
AU
CM
SK
1 03
558
Mal
e17
2cm
51kg
Som
e ex
er
624
4562
5.6
Sm
all
62.
217
.24
1235
1977
4.1
8.0
43.
0 3
1.5
15.
8 8
4.2
61.
7
11/0
7/20
0715
:39:
25V
IAG
BO
AT
SO
U P
AU
CM
SK
1 03
558
Mal
e17
2cm
48kg
Som
e ex
er
723
6172
5.6
Sm
all
62.
216
.22
1194
1911
4.8
8.6
39.
4 2
8.0
17.
9 8
2.1
58.
4
18/0
7/20
0715
:39:
25V
IAG
BO
AT
SO
U P
AU
CM
SK
1 03
558
Mal
e17
2cm
50kg
Som
e ex
er
688
5869
0.4
Sm
all
62.
216
.90
1222
1955
4.8
9.2
40.
8 2
9.3
18.
4 8
1.6
58.
6
25/0
7/20
0715
:39:
25V
IAG
BO
AT
SO
U P
AU
CM
SK
1 03
558
Mal
e17
2cm
52kg
Som
e ex
er
695
6269
7.8
Sm
all
62.
217
.58
1249
1999
5.1
10.
9 4
1.1
29.
5 2
0.9
79.
1 5
6.7
01/0
8/20
0715
:39:
25V
IAG
BO
AT
SO
U P
AU
CM
SK
1 03
558
Mal
e17
2cm
52kg
Som
e ex
er
655
5565
7.3
Sm
all
62.
217
.58
1249
1999
4.8
9.8
42.
2 3
0.6
18.
8 8
1.2
58.
9
04/0
7/20
0715
:45:
49K
PO
TO
RK
OS
SI A
ME
NCM
SK
1 03
638
Mal
e17
8cm
66kg
Som
e ex
er
561
6656
4.9
Med
ium
75.
520
.83
1608
2574
6.7
14.
1 5
1.9
38.
2 2
1.4
78.
6 5
7.8
11/0
7/20
0715
:45:
49K
PO
TO
RK
OS
SI A
ME
NCM
SK
1 03
638
Mal
e17
8cm
68kg
Som
e ex
er
584
7058
8.2
Med
ium
75.
521
.46
1636
2618
6.8
16.
7 5
1.3
37.
5 2
4.6
75.
4 5
5.2
18/0
7/20
0715
:45:
49K
PO
TO
RK
OS
SI A
ME
NCM
SK
1 03
638
Mal
e17
8cm
70kg
Som
e ex
er
553
6755
7.0
Med
ium
75.
522
.09
1664
2662
6.9
16.
7 5
3.3
39.
2 2
3.8
76.
2 5
6.1
25/0
7/20
0715
:45:
49K
PO
TO
RK
OS
SI A
ME
NCM
SK
1 03
638
Mal
e17
8cm
71kg
Som
e ex
er
523
6052
6.4
Med
ium
75.
522
.41
1677
2684
6.5
15.
7 5
5.3
40.
9 2
2.2
77.
8 5
7.6
01/0
8/20
0715
:47:
54K
PO
TO
RK
OS
SI A
ME
NCM
SK
1 03
638
Mal
e17
8cm
71kg
Som
e ex
er
523
6052
6.4
Med
ium
75.
522
.41
1677
2684
6.5
15.
7 5
5.3
40.
9 2
2.2
77.
8 5
7.6
04/0
7/20
0715
:51:
41T
SR
AT
SE
KO
SS
I KA
SS
CM
SK
1 03
735
Mal
e17
1cm
50kg
Som
e ex
er
664
5366
6.1
Sm
all
61.
217
.10
1373
2197
4.6
8.9
41.
1 2
9.8
17.
8 8
2.2
59.
6
11/0
7/20
0715
:51:
41T
SR
AT
SE
KO
SS
I KA
SS
CM
SK
1 03
735
Mal
e17
1cm
50kg
Som
e ex
er
671
5367
3.1
Sm
all
61.
217
.10
1373
2197
4.5
9.1
40.
9 2
9.6
18.
2 8
1.8
59.
1
18/0
7/20
0715
:51:
41T
SR
AT
SE
KO
SS
I KA
SS
CM
SK
1 03
735
Mal
e17
1cm
51kg
Som
e ex
er
665
5466
7.2
Sm
all
61.
217
.44
1387
2219
4.6
9.7
41.
3 2
9.9
19.
0 8
1.0
58.
7
25/0
7/20
0715
:51:
41T
SR
AT
SE
KO
SS
I KA
SS
CM
SK
1 03
735
Mal
e17
1cm
55kg
Som
e ex
er
626
4862
7.8
Sm
all
61.
218
.81
1442
2308
4.4
11.
4 4
3.6
31.
9 2
0.8
79.
2 5
7.9
01/0
8/20
0715
:51:
41T
SR
AT
SE
KO
SS
I KA
SS
CM
SK
1 03
735
Mal
e17
1cm
56kg
Som
e ex
er
625
4962
6.9
Sm
all
61.
219
.15
1456
2330
4.5
12.
1 4
3.9
32.
1 2
1.7
78.
3 5
7.3
04/0
7/20
0715
:57:
42D
OY
IK
OK
OU
RO
BC
MS
K1
038
31M
ale
172
cm59
kgS
ome
exe
r49
951
501.
6La
rge
69.
119
.94
1529
2447
5.8
8.1
50.
9 3
8.2
13.
7 8
6.3
64.
8
11/0
7/20
0715
:57:
42D
OY
IK
OK
OU
RO
BC
MS
K1
038
31M
ale
172
cm62
kgS
ome
exe
r50
253
504.
8La
rge
69.
120
.96
1571
2514
6.0
10.
5 5
1.5
38.
6 1
6.9
83.
1 6
2.2
18/0
7/20
0715
:57:
42D
OY
IK
OK
OU
RO
BC
MS
K1
038
31M
ale
172
cm63
kgS
ome
exe
r48
252
484.
8La
rge
69.
121
.30
1585
2536
6.2
9.9
53.
1 3
9.8
15.
8 8
4.2
63.
3
25/0
7/20
0715
:57:
42D
OY
IK
OK
OU
RO
BC
MS
K1
038
31M
ale
172
cm65
kgS
ome
exe
r49
455
497.
1La
rge
69.
121
.97
1612
2580
6.4
12.
2 5
2.8
39.
5 1
8.8
81.
2 6
0.8
6D
:\BIA
TE
ST
KO
UV
E F
INA
L F
inal
F 2
.xls
BIA
TE
ST
KO
UV
É F
INA
L
Tes
t D
ate
Tes
t T
ime
Las
t N
ame
Fir
st N
ame
Su
bje
ct ID
Ag
eG
end
erH
eig
ht
Wei
gh
tA
ctiv
ity
Lev
elR
esis
tan
ceR
eact
ance
Imp
edan
ceF
ram
e S
ize
Tar
get
W
eig
ht
BM
IB
MR
DE
EP
has
e A
ng
leF
at
wt
FF
M w
tT
BW
lit
ers
Fat
%
of
wt
FF
M %
o
f w
tT
BW
%
of
wt
01/0
8/20
0715
:57:
42D
OY
IK
OK
OU
RO
BC
MS
K1
038
31M
ale
172
cm65
kgS
ome
exe
r48
855
491.
1M
ediu
m 6
9.1
21.9
716
1225
80 6
.4 1
1.8
53.
2 3
9.9
18.
2 8
1.8
61.
3
01/0
8/20
0710
:32:
04M
ED
JAG
OK
OF
FI
CM
SK
1 01
660
Mal
e15
7cm
47kg
Som
e ex
er
690
5169
1.9
Med
ium
53.
019
.07
1092
1747
4.2
11.
7 3
5.3
25.
5 2
4.9
75.
1 5
4.3
08/0
8/20
0712
:25:
14A
FA
VI
VIC
TO
RIN
EC
MS
K1
001
33F
emal
e15
2cm
54kg
Som
e ex
er
618
7262
2.2
Larg
e 4
9.5
23.3
712
9219
38 6
.6 1
8.5
35.
5 2
6.7
34.
3 6
5.7
49.
4
13/0
8/20
0712
:25:
14A
FA
VI
VIC
TO
RIN
EC
MS
K1
001
33F
emal
e15
2cm
55kg
Som
e ex
er
595
6959
9.0
Larg
e 4
9.5
23.8
113
0119
52 6
.6 1
8.7
36.
3 2
7.4
34.
1 6
5.9
49.
9
22/0
8/20
0712
:25:
14A
FA
VI
VIC
TO
RIN
EC
MS
K1
001
33F
emal
e15
2cm
54kg
Som
e ex
er
603
7160
7.2
Larg
e 4
9.5
23.3
712
9219
38 6
.7 1
8.1
35.
9 2
7.1
33.
6 6
6.4
50.
2
08/0
8/20
0712
:43:
45A
BO
TS
IA
MA
DA
YO
VCM
SK
1 00
225
Fem
ale
167
cm54
kgS
ome
exe
r67
768
680.
4S
mal
l 5
2.6
19.3
613
5620
34 5
.7 1
5.0
39.
0 2
8.4
27.
7 7
2.3
52.
6
13/0
8/20
0712
:43:
45A
BO
TS
IA
MA
DA
YO
VCM
SK
1 00
225
Fem
ale
167
cm53
kgS
ome
exe
r68
069
683.
5S
mal
l 5
2.6
19.0
013
4720
20 5
.8 1
4.2
38.
8 2
8.2
26.
8 7
3.2
53.
2
22/0
8/20
0712
:43:
45A
BO
TS
IA
MA
DA
YO
VCM
SK
1 00
225
Fem
ale
167
cm55
kgS
ome
exe
r68
358
685.
5S
mal
l 5
2.6
19.7
213
6620
49 4
.9 1
5.9
39.
1 2
8.3
29.
0 7
1.0
51.
5
08/0
8/20
0712
:58:
07A
FA
TO
WO
UA
KO
SS
IWA
SC
MS
K1
003
32F
emal
e16
1cm
48kg
Som
e ex
er
605
6460
8.4
Med
ium
53.
018
.52
1255
1882
6.0
10.
0 3
8.0
28.
5 2
0.8
79.
2 5
9.3
13/0
8/20
0712
:58:
07A
FA
TO
WO
UA
KO
SS
IWA
SC
MS
K1
003
32F
emal
e16
1cm
49kg
Som
e ex
er
579
6258
2.3
Med
ium
53.
018
.90
1264
1897
6.1
9.9
39.
1 2
9.4
20.
2 7
9.8
60.
1
22/0
8/20
0712
:58:
07A
FA
TO
WO
UA
KO
SS
IWA
SC
MS
K1
003
32F
emal
e16
1cm
49kg
Som
e ex
er
615
6861
8.7
Med
ium
53.
018
.90
1264
1897
6.3
11.
1 3
7.9
28.
3 2
2.7
77.
3 5
7.7
08/0
8/20
0713
:22:
27K
ON
VI
ME
DO
NU
INA
CM
SK
1 00
441
Fem
ale
158
cm57
kgS
ome
exe
r67
469
677.
5La
rge
55.
422
.83
1294
1941
5.8
20.
4 3
6.6
26.
9 3
5.8
64.
2 4
7.1
13/0
8/20
0713
:22:
27K
ON
VI
ME
DO
NU
INA
CM
SK
1 00
441
Fem
ale
158
cm57
kgS
ome
exe
r68
968
692.
3La
rge
55.
422
.83
1294
1941
5.6
20.
7 3
6.3
26.
5 3
6.3
63.
7 4
6.5
22/0
8/20
0713
:22:
27K
ON
VI
ME
DO
NU
INA
CM
SK
1 00
441
Fem
ale
158
cm56
kgS
ome
exe
r68
472
687.
8La
rge
55.
422
.43
1284
1926
6.0
19.
8 3
6.2
26.
5 3
5.3
64.
7 4
7.3
08/0
8/20
0713
:34:
37K
PA
MA
AD
JOW
A M
AC
MS
K1
005
41F
emal
e16
9cm
71kg
Som
e ex
er
585
6158
8.2
Med
ium
60.
224
.86
1448
2172
6.0
25.
3 4
5.7
33.
7 3
5.6
64.
4 4
7.5
13/0
8/20
0713
:34:
37K
PA
MA
AD
JOW
A M
AC
MS
K1
005
41F
emal
e16
9cm
72kg
Som
e ex
er
580
6258
3.3
Med
ium
60.
225
.21
1457
2186
6.1
25.
9 4
6.1
34.
0 3
5.9
64.
1 4
7.3
22/0
8/20
0713
:34:
37K
PA
MA
AD
JOW
A M
AC
MS
K1
005
41F
emal
e16
9cm
70kg
Som
e ex
er
628
7263
2.1
Med
ium
60.
224
.51
1438
2157
6.5
26.
1 4
3.9
32.
1 3
7.2
62.
8 4
5.9
08/0
8/20
0718
:01:
43Z
IAF
OM
AR
IE M
AD
ECM
SK
1 00
634
Fem
ale
147
cm46
kgS
ome
exe
r61
267
615.
7M
ediu
m 4
0.5
21.2
912
0118
02 6
.2 1
3.4
32.
6 2
4.8
29.
2 7
0.8
54.
0
13/0
8/20
0718
:01:
43Z
IAF
OM
AR
IE M
AD
ECM
SK
1 00
634
Fem
ale
147
cm47
kgS
ome
exe
r61
570
619.
0M
ediu
m 4
0.5
21.7
512
1118
16 6
.5 1
4.3
32.
7 2
4.9
30.
5 6
9.5
52.
9
22/0
8/20
0718
:01:
43Z
IAF
OM
AR
IE M
AD
ECM
SK
1 00
634
Fem
ale
147
cm46
kgS
ome
exe
r64
473
648.
1M
ediu
m 4
0.5
21.2
912
0118
02 6
.5 1
4.1
31.
9 2
4.0
30.
7 6
9.3
52.
3
08/0
8/20
0718
:11:
44A
VO
GN
ON
AD
JO A
NG
EC
MS
K1
007
32F
emal
e15
6cm
48kg
Som
e ex
er
619
7062
2.9
Med
ium
48.
619
.72
1246
1869
6.5
12.
2 3
5.8
26.
9 2
5.4
74.
6 5
6.0
13/0
8/20
0718
:11:
44A
VO
GN
ON
AD
JO A
NG
EC
MS
K1
007
32F
emal
e15
6cm
49kg
Som
e ex
er
612
6361
5.2
Med
ium
48.
620
.13
1255
1883
5.9
12.
8 3
6.2
27.
2 2
6.2
73.
8 5
5.5
22/0
8/20
0718
:11:
44A
VO
GN
ON
AD
JO A
NG
EC
MS
K1
007
32F
emal
e15
6cm
48kg
Som
e ex
er
598
6560
1.5
Med
ium
48.
619
.72
1246
1869
6.2
11.
6 3
6.4
27.
5 2
4.1
75.
9 5
7.3
08/0
8/20
0718
:34:
26K
OU
AY
IJU
LIE
TT
EC
MS
K1
008
35F
emal
e16
0cm
59kg
Som
e ex
er
585
6558
8.6
Med
ium
52.
123
.05
1345
2017
6.3
18.
8 4
0.2
30.
1 3
1.9
68.
1 5
1.0
13/0
8/20
0718
:34:
26K
OU
AY
IJU
LIE
TT
EC
MS
K1
008
35F
emal
e16
0cm
61kg
Som
e ex
er
560
6256
3.4
Med
ium
52.
123
.83
1364
2046
6.3
19.
5 4
1.5
31.
2 3
2.0
68.
0 5
1.2
22/0
8/20
0718
:34:
26K
OU
AY
IJU
LIE
TT
EC
MS
K1
008
35F
emal
e16
0cm
59kg
Som
e ex
er
561
6456
4.6
Med
ium
52.
123
.05
1345
2017
6.5
17.
9 4
1.1
30.
9 3
0.3
69.
7 5
2.5
08/0
8/20
0718
:53:
20T
OK
UIB
OU
PA
OLA
CM
SK
1 00
935
Fem
ale
155
cm50
kgS
ome
exe
r61
272
616.
2S
mal
l 4
2.9
20.8
112
4918
74 6
.7 1
4.0
36.
0 2
7.1
28.
0 7
2.0
54.
1
13/0
8/20
0718
:53:
20T
OK
UIB
OU
PA
OLA
CM
SK
1 00
935
Fem
ale
155
cm51
kgS
ome
exe
r60
472
608.
3S
mal
l 4
2.9
21.2
312
5918
88 6
.8 1
4.6
36.
4 2
7.4
28.
7 7
1.3
53.
7
22/0
8/20
0718
:53:
20T
OK
UIB
OU
PA
OLA
CM
SK
1 00
935
Fem
ale
155
cm50
kgS
ome
exe
r62
574
629.
4S
mal
l 4
2.9
20.8
112
4918
74 6
.8 1
4.4
35.
6 2
6.7
28.
7 7
1.3
53.
4
08/0
8/20
0719
:13:
19D
JAG
OE
LIS
EC
MS
K1
010
25F
emal
e15
9cm
47kg
Som
e ex
er
596
6259
9.2
Sm
all
46.
118
.59
1275
1912
5.9
9.6
37.
4 2
8.1
20.
4 7
9.6
59.
9
13/0
8/20
0719
:13:
19D
JAG
OE
LIS
EC
MS
K1
010
25F
emal
e15
9cm
47kg
Som
e ex
er
624
7362
8.3
Sm
all
46.
118
.59
1275
1912
6.7
10.
5 3
6.5
27.
3 2
2.2
77.
8 5
8.1
22/0
8/20
0719
:13:
19D
JAG
OE
LIS
EC
MS
K1
010
25F
emal
e15
9cm
45kg
Som
e ex
er
570
5857
2.9
Sm
all
46.
117
.80
1255
1883
5.8
7.0
38.
0 2
8.8
15.
5 8
4.5
64.
0
08/0
8/20
078:
44:1
3B
ALO
VI
A L
UC
IEC
MS
K1
011
52F
emal
e15
0cm
54kg
Som
e ex
er
584
6558
7.6
Larg
e 4
7.5
24.0
011
9917
98 6
.4 1
8.3
35.
7 2
7.2
33.
9 6
6.1
50.
3
13/0
8/20
078:
44:1
3B
ALO
VI
A L
UC
IEC
MS
K1
011
52F
emal
e15
0cm
54kg
Som
e ex
er
589
6359
2.4
Larg
e 4
7.5
24.0
011
9917
98 6
.1 1
8.4
35.
6 2
7.0
34.
2 6
5.8
50.
1
22/0
8/20
078:
44:1
3B
ALO
VI
A L
UC
IEC
MS
K1
011
52F
emal
e15
0cm
54kg
Som
e ex
er
551
6255
4.5
Larg
e 4
7.5
24.0
011
9917
98 6
.4 1
7.2
36.
8 2
8.2
31.
9 6
8.1
52.
3
08/0
8/20
079:
00:0
3A
PE
VO
KU
IYA
CM
SK
1 01
240
Fem
ale
158
cm57
kgS
ome
exe
r61
058
612.
8S
mal
l 4
5.3
22.8
312
9819
48 5
.4 1
8.7
38.
3 2
8.6
32.
8 6
7.2
50.
2
13/0
8/20
079:
00:0
3A
PE
VO
KU
IYA
CM
SK
1 01
240
Fem
ale
158
cm57
kgS
ome
exe
r64
867
651.
5S
mal
l 4
5.3
22.8
312
9819
48 5
.9 1
9.8
37.
2 2
7.5
34.
7 6
5.3
48.
3
22/0
8/20
079:
00:0
3A
PE
VO
KU
IYA
CM
SK
1 01
240
Fem
ale
158
cm56
kgS
ome
exe
r60
358
605.
8S
mal
l 4
5.3
22.4
312
8919
33 5
.5 1
7.7
38.
3 2
8.7
31.
5 6
8.5
51.
3
08/0
8/20
079:
31:5
9S
OG
BA
DJI
VE
RO
NIQ
UE
CM
SK
1 01
329
Fem
ale
155
cm46
kgS
ome
exe
r90
652
907.
5S
mal
l 4
2.9
19.1
512
3918
59 3
.3 1
4.8
31.
2 2
0.9
32.
3 6
7.7
45.
4
13/0
8/20
079:
31:5
9S
OG
BA
DJI
VE
RO
NIQ
UE
CM
SK
1 01
329
Fem
ale
155
cm47
kgS
ome
exe
r86
245
863.
2S
mal
l 4
2.9
19.5
612
4918
73 3
.0 1
5.4
31.
6 2
1.6
32.
9 6
7.1
46.
0
22/0
8/20
079:
31:5
9S
OG
BA
DJI
VE
RO
NIQ
UE
CM
SK
1 01
329
Fem
ale
155
cm45
kgS
ome
exe
r86
242
863.
0S
mal
l 4
2.9
18.7
312
2918
44 2
.8 1
3.8
31.
2 2
1.4
30.
6 6
9.4
47.
5
08/0
8/20
079:
44:2
3A
ME
GN
AG
LK
OM
LAV
IC
MS
K1
014
46M
ale
172
cm59
kgS
ome
exe
r52
451
526.
5S
mal
l 6
9.1
19.9
414
2722
84 5
.6 9
.5 4
9.5
36.
9 1
6.2
83.
8 6
2.6
13/0
8/20
079:
44:2
3A
ME
GN
AG
LK
OM
LAV
IC
MS
K1
014
46M
ale
172
cm60
kgS
ome
exe
r51
452
516.
6S
mal
l 6
9.1
20.2
814
4123
06 5
.8 9
.7 5
0.3
37.
6 1
6.2
83.
8 6
2.7
22/0
8/20
079:
44:2
3A
ME
GN
AG
LK
OM
LAV
IC
MS
K1
014
46M
ale
172
cm60
kgS
ome
exe
r51
351
515.
5S
mal
l 6
9.1
20.2
814
4123
06 5
.7 9
.7 5
0.3
37.
7 1
6.1
83.
9 6
2.8
08/0
8/20
0710
:32:
04M
ED
JAG
OK
OF
FI
CM
SK
1 01
660
Mal
e15
7cm
47kg
Som
e ex
er
609
4961
1.0
Med
ium
53.
019
.07
1092
1747
4.6
9.8
37.
2 2
7.6
20.
9 7
9.1
58.
8
13/0
8/20
0710
:32:
04M
ED
JAG
OK
OF
FI
CM
SK
1 01
660
Mal
e15
7cm
46kg
Som
e ex
er
619
5762
1.6
Med
ium
53.
018
.66
1078
1725
5.3
9.4
36.
6 2
7.2
20.
4 7
9.6
59.
1
22/0
8/20
0710
:32:
04M
ED
JAG
OK
OF
FI
CM
SK
1 01
660
Mal
e15
7cm
46kg
Som
e ex
er
630
5463
2.3
Med
ium
53.
018
.66
1078
1725
4.9
9.7
36.
3 2
6.9
21.
0 7
9.0
58.
4
08/0
8/20
0710
:48:
34K
OU
MA
SS
IY
AO
VI
CM
SK
1 01
738
Mal
e17
0cm
68kg
Som
e ex
er
461
5946
4.8
Larg
e 7
3.6
23.5
315
9625
54 7
.3 1
3.1
54.
9 4
1.3
19.
2 8
0.8
60.
8
7D
:\BIA
TE
ST
KO
UV
E F
INA
L F
inal
F 2
.xls
BIA
TE
ST
KO
UV
É F
INA
L
Tes
t D
ate
Tes
t T
ime
Las
t N
ame
Fir
st N
ame
Su
bje
ct ID
Ag
eG
end
erH
eig
ht
Wei
gh
tA
ctiv
ity
Lev
elR
esis
tan
ceR
eact
ance
Imp
edan
ceF
ram
e S
ize
Tar
get
W
eig
ht
BM
IB
MR
DE
EP
has
e A
ng
leF
at
wt
FF
M w
tT
BW
lit
ers
Fat
%
of
wt
FF
M %
o
f w
tT
BW
%
of
wt
13/0
8/20
0710
:48:
34K
OU
MA
SS
IY
AO
VI
CM
SK
1 01
738
Mal
e17
0cm
67kg
Som
e ex
er
470
6147
3.9
Larg
e 7
3.6
23.1
815
8225
32 7
.4 1
3.0
54.
0 4
0.6
19.
4 8
0.6
60.
6
22/0
8/20
0710
:48:
34K
OU
MA
SS
IY
AO
VI
CM
SK
1 01
738
Mal
e17
0cm
67kg
Som
e ex
er
470
6347
4.2
Larg
e 7
3.6
23.1
815
8225
32 7
.6 1
3.0
54.
0 4
0.6
19.
4 8
0.6
60.
6
08/0
8/20
0711
:09:
06A
KA
KP
OM
AT
HIE
UC
MS
K! 0
1835
Mal
e17
8cm
60kg
Som
e ex
er
596
6059
9.0
Med
ium
75.
518
.94
1546
2474
5.7
11.
4 4
8.6
35.
6 1
8.9
81.
1 5
9.4
13/0
8/20
0711
:09:
06A
KA
KP
OM
AT
HIE
UC
MS
K! 0
1835
Mal
e17
8cm
61kg
Som
e ex
er
600
6260
3.2
Med
ium
75.
519
.25
1560
2496
5.9
12.
3 4
8.7
35.
6 2
0.1
79.
9 5
8.4
22/0
8/20
0711
:09:
06A
KA
KP
OM
AT
HIE
UC
MS
K! 0
1835
Mal
e17
8cm
59kg
Som
e ex
er
599
5760
1.7
Med
ium
75.
518
.62
1532
2452
5.4
10.
7 4
8.3
35.
3 1
8.2
81.
8 5
9.9
08/0
8/20
0711
:18:
22D
AN
KE
KO
DJO
CM
SK
1 01
943
Mal
e17
6cm
74kg
Som
e ex
er
485
6048
8.7
Med
ium
73.
423
.89
1675
2680
7.1
16.
4 5
7.6
42.
9 2
2.1
77.
9 5
8.0
13/0
8/20
0711
:18:
22D
AN
KE
KO
DJO
CM
SK
1 01
943
Mal
e17
6cm
73kg
Som
e ex
er
470
5647
3.3
Med
ium
73.
423
.57
1661
2658
6.8
14.
5 5
8.5
43.
6 1
9.9
80.
1 5
9.8
22/0
8/20
0711
:18:
22D
AN
KE
KO
DJO
CM
SK
1 01
943
Mal
e17
6cm
74kg
Som
e ex
er
466
5446
9.1
Med
ium
73.
423
.89
1675
2680
6.6
15.
0 5
9.0
44.
1 2
0.2
79.
8 5
9.6
08/0
8/20
0711
:39:
12A
ME
GN
RA
NA
TS
OU
CM
SK
1 02
035
Mal
e17
9cm
66kg
Som
e ex
er
521
5652
4.0
Med
ium
76.
620
.60
1634
2614
6.1
11.
5 5
4.5
40.
4 1
7.4
82.
6 6
1.3
13/0
8/20
0711
:39:
12A
ME
GN
RA
NA
TS
OU
CM
SK
1 02
035
Mal
e17
9cm
68kg
Som
e ex
er
486
5448
9.0
Med
ium
76.
621
.22
1661
2659
6.3
10.
6 5
7.4
42.
8 1
5.6
84.
4 6
2.9
22/0
8/20
0711
:39:
12A
ME
GN
RA
NA
TS
OU
CM
SK
1 02
035
Mal
e17
9cm
65kg
Som
e ex
er
529
6053
2.4
Med
ium
76.
620
.29
1620
2592
6.5
11.
2 5
3.8
39.
8 1
7.3
82.
7 6
1.3
08/0
8/20
0711
:53:
26T
EN
GU
EK
OF
FI
CM
SK
1 02
155
Mal
e15
5cm
40kg
Som
e ex
er
693
5269
4.9
Med
ium
50.
916
.65
1019
1631
4.3
7.2
32.
8 2
3.8
18.
0 8
2.0
59.
5
13/0
8/20
0711
:53:
26T
EN
GU
EK
OF
FI
CM
SK
1 02
155
Mal
e15
5cm
39kg
Som
e ex
er
701
5370
3.0
Med
ium
50.
916
.23
1005
1609
4.3
6.6
32.
4 2
3.5
16.
9 8
3.1
60.
1
22/0
8/20
0711
:53:
26T
EN
GU
EK
OF
FI
CM
SK
1 02
155
Mal
e15
5cm
40kg
Som
e ex
er
605
3960
6.3
Med
ium
50.
916
.65
1019
1631
3.7
5.2
34.
8 2
6.1
13.
1 8
6.9
65.
2
08/0
8/20
0712
:12:
45K
PO
EN
OU
KO
FF
I JE
AN
CM
SK
1 02
237
Mal
e17
2cm
64kg
Som
e ex
er
512
5051
4.4
Larg
e 6
9.1
21.6
315
5824
92 5
.6 1
2.6
51.
4 3
8.4
19.
6 8
0.4
60.
0
13/0
8/20
0712
:12:
45K
PO
EN
OU
KO
FF
I JE
AN
CM
SK
1 02
237
Mal
e17
2cm
66kg
Som
e ex
er
547
5454
9.7
Larg
e 6
9.1
22.3
115
8525
37 5
.6 1
5.9
50.
1 3
7.1
24.
1 7
5.9
56.
2
22/0
8/20
0712
:12:
45K
PO
EN
OU
KO
FF
I JE
AN
CM
SK
1 02
237
Mal
e17
2cm
65kg
Som
e ex
er
506
4850
8.3
Larg
e 6
9.1
21.9
715
7125
15 5
.4 1
2.9
52.
1 3
8.9
19.
9 8
0.1
59.
8
08/0
8/20
0712
:53:
49G
BA
SR
AA
LOE
DE
CM
SK
1 02
333
Fem
ale
153
cm61
kgS
ome
exe
r55
669
560.
3M
ediu
m 4
5.9
26.0
613
6120
41 7
.1 2
2.1
38.
9 2
9.6
36.
2 6
3.8
48.
5
13/0
8/20
0712
:53:
49G
BA
SR
AA
LOE
DE
CM
SK
1 02
333
Fem
ale
153
cm62
kgS
ome
exe
r54
670
550.
5M
ediu
m 4
5.9
26.4
913
7020
55 7
.3 2
2.5
39.
5 3
0.0
36.
3 6
3.7
48.
5
22/0
8/20
0712
:53:
49G
BA
SR
AA
LOE
DE
CM
SK
1 02
333
Fem
ale
153
cm61
kgS
ome
exe
r57
171
575.
4M
ediu
m 4
5.9
26.0
613
6120
41 7
.1 2
2.6
38.
4 2
9.1
37.
1 6
2.9
47.
7
29/0
8/20
0712
:53:
49G
BA
SR
AA
LOE
DE
CM
SK
1 02
333
Fem
ale
153
cm63
kgS
ome
exe
r56
474
568.
8M
ediu
m 4
5.9
26.9
113
8020
70 7
.5 2
4.0
39.
0 2
9.5
38.
1 6
1.9
46.
9
08/0
8/20
079:
21:1
7O
VO
DE
KO
MLA
NC
MS
K1
024
47M
ale
172
cm66
kgS
ome
exe
r57
163
574.
5M
ediu
m 6
9.1
22.3
115
1724
28 6
.3 1
7.0
49.
0 3
6.1
25.
8 7
4.2
54.
7
13/0
8/20
079:
21:1
7O
VO
DE
KO
MLA
NC
MS
K1
024
47M
ale
172
cm68
kgS
ome
exe
r56
763
570.
5M
ediu
m 6
9.1
22.9
915
4524
72 6
.3 1
8.3
49.
7 3
6.6
27.
0 7
3.0
53.
8
22/0
8/20
079:
21:1
7O
VO
DE
KO
MLA
NC
MS
K1
024
47M
ale
172
cm67
kgS
ome
exe
r56
359
566.
1M
ediu
m 6
9.1
22.6
515
3124
50 6
.0 1
7.4
49.
6 3
6.6
26.
0 7
4.0
54.
6
29/0
8/20
079:
21:1
7O
VO
DE
KO
MLA
NC
MS
K1
024
47M
ale
172
cm66
kgS
ome
exe
r58
270
586.
2M
ediu
m 6
9.1
22.3
115
1724
28 6
.9 1
7.5
48.
5 3
5.6
26.
5 7
3.5
54.
0
08/0
8/20
0713
:32:
30A
MO
UZ
OU
GT
AT
AC
MS
K1
025
50M
ale
165
cm53
kgS
ome
exe
r51
760
520.
5La
rge
67.
719
.47
1282
2052
6.6
7.7
45.
3 3
4.2
14.
5 8
5.5
64.
5
13/0
8/20
0713
:32:
30A
MO
UZ
OU
GT
AT
AC
MS
K1
025
50M
ale
165
cm53
kgS
ome
exe
r52
661
529.
5La
rge
67.
719
.47
1282
2052
6.6
8.2
44.
8 3
3.8
15.
4 8
4.6
63.
7
22/0
8/20
0713
:32:
30A
MO
UZ
OU
GT
AT
AC
MS
K1
025
50M
ale
165
cm53
kgS
ome
exe
r52
161
524.
6La
rge
67.
719
.47
1282
2052
6.7
7.9
45.
1 3
4.0
14.
9 8
5.1
64.
1
29/0
8/20
0713
:32:
30A
MO
UZ
OU
GT
AT
AC
MS
K1
025
50M
ale
165
cm53
kgS
ome
exe
r50
058
503.
4La
rge
67.
719
.47
1282
2052
6.6
6.8
46.
2 3
5.0
12.
8 8
7.2
66.
0
08/0
8/20
0713
:50:
44G
UID
IK
OM
I GE
RM
CM
SK
1 02
635
Mal
e17
9cm
70kg
Som
e ex
er
568
6257
1.4
Med
ium
76.
621
.85
1689
2703
6.2
17.
0 5
3.0
38.
9 2
4.3
75.
7 5
5.5
13/0
8/20
0713
:50:
44G
UID
IK
OM
I GE
RM
CM
SK
1 02
635
Mal
e17
9cm
68kg
Som
e ex
er
574
6557
7.7
Med
ium
76.
621
.22
1661
2659
6.5
15.
9 5
2.1
38.
2 2
3.3
76.
7 5
6.2
22/0
8/20
0713
:50:
44G
UID
IK
OM
I GE
RM
CM
SK
1 02
635
Mal
e17
9cm
68kg
Som
e ex
er
581
6558
4.6
Med
ium
76.
621
.22
1661
2659
6.4
16.
2 5
1.8
37.
9 2
3.8
76.
2 5
5.8
29/0
8/20
0713
:50:
44G
UID
IK
OM
I GE
RM
CM
SK
1 02
635
Mal
e17
9cm
70kg
Som
e ex
er
544
6154
7.4
Med
ium
76.
621
.85
1689
2703
6.4
15.
8 5
4.2
40.
0 2
2.5
77.
5 5
7.1
06/0
9/20
0713
:50:
44G
UID
IK
OM
I GE
RM
CM
SK
1 02
635
Mal
e17
9cm
70kg
Som
e ex
er
563
6356
6.5
Med
ium
76.
621
.85
1689
2703
6.4
16.
8 5
3.2
39.
1 2
4.0
76.
0 5
5.8
08/0
8/20
0714
:03:
34B
LIM
AM
AV
I IR
EN
CM
SK
1 02
726
Fem
ale
165
cm52
kgS
ome
exe
r67
168
674.
4M
ediu
m 5
6.6
19.1
013
2919
93 5
.8 1
3.8
38.
2 2
7.9
26.
6 7
3.4
53.
6
13/0
8/20
0714
:03:
34B
LIM
AM
AV
I IR
EN
CM
SK
1 02
726
Fem
ale
165
cm52
kgS
ome
exe
r63
564
638.
2M
ediu
m 5
6.6
19.1
013
2919
93 5
.8 1
2.8
39.
2 2
8.9
24.
6 7
5.4
55.
6
22/0
8/20
0714
:03:
34B
LIM
AM
AV
I IR
EN
CM
SK
1 02
726
Fem
ale
165
cm52
kgS
ome
exe
r64
866
651.
4M
ediu
m 5
6.6
19.1
013
2919
93 5
.8 1
3.2
38.
8 2
8.5
25.
4 7
4.6
54.
9
29/0
8/20
0714
:03:
34B
LIM
AM
AV
I IR
EN
CM
SK
1 02
726
Fem
ale
165
cm52
kgS
ome
exe
r63
871
641.
9M
ediu
m 5
6.6
19.1
013
2919
93 6
.4 1
2.9
39.
1 2
8.8
24.
8 7
5.2
55.
4
06/0
9/20
0714
:03:
34B
LIM
AM
AV
I IR
EN
CM
SK
1 02
726
Fem
ale
165
cm54
kgS
ome
exe
r62
567
628.
6M
ediu
m 5
6.6
19.8
313
4820
22 6
.1 1
4.1
39.
9 2
9.5
26.
2 7
3.8
54.
5
08/0
8/20
0714
:10:
56K
OM
AK
AA
DJO
CM
SK
1 02
830
Fem
ale
149
cm43
kgS
ome
exe
r74
170
744.
3M
ediu
m 4
2.3
19.3
711
9517
92 5
.4 1
2.6
30.
4 2
2.1
29.
3 7
0.7
51.
4
13/0
8/20
0714
:10:
56K
OM
AK
AA
DJO
CM
SK
1 02
830
Fem
ale
149
cm43
kgS
ome
exe
r76
173
764.
5M
ediu
m 4
2.3
19.3
711
9517
92 5
.5 1
2.8
30.
2 2
1.7
29.
8 7
0.2
50.
5
22/0
8/20
0714
:10:
56K
OM
AK
AA
DJO
CM
SK
1 02
830
Fem
ale
149
cm44
kgS
ome
exe
r76
672
769.
4M
ediu
m 4
2.3
19.8
212
0418
07 5
.4 1
3.7
30.
3 2
1.8
31.
2 6
8.8
49.
5
29/0
8/20
0714
:10:
56K
OM
AK
AA
DJO
CM
SK
1 02
830
Fem
ale
149
cm44
kgS
ome
exe
r53
261
535.
5M
ediu
m 4
2.3
19.8
212
0418
07 6
.5 8
.6 3
5.4
27.
5 1
9.5
80.
5 6
2.5
06/0
9/20
0714
:10:
56K
OM
AK
AA
DJO
CM
SK
1 02
830
Fem
ale
149
cm45
kgS
ome
exe
r78
274
785.
5M
ediu
m 4
2.3
20.2
712
1418
21 5
.4 1
4.7
30.
3 2
1.6
32.
7 6
7.3
48.
0
08/0
8/20
0714
:27:
08D
EG
BE
AF
I AK
OE
LEC
MS
K1
029
33F
emal
e16
7cm
58kg
Som
e ex
er
617
6061
9.9
Med
ium
58.
420
.80
1357
2036
5.6
16.
5 4
1.5
30.
6 2
8.4
71.
6 5
2.8
13/0
8/20
0714
:27:
08D
EG
BE
AF
I AK
OE
LEC
MS
K1
029
33F
emal
e16
7cm
58kg
Som
e ex
er
647
6565
0.3
Med
ium
58.
420
.80
1357
2036
5.7
17.
4 4
0.6
29.
7 3
0.1
69.
9 5
1.2
22/0
8/20
0714
:27:
08D
EG
BE
AF
I AK
OE
LEC
MS
K1
029
33F
emal
e16
7cm
58kg
Som
e ex
er
648
6665
1.4
Med
ium
58.
420
.80
1357
2036
5.8
17.
5 4
0.5
29.
7 3
0.1
69.
9 5
1.2
29/0
8/20
0714
:27:
08D
EG
BE
AF
I AK
OE
LEC
MS
K1
029
33F
emal
e16
7cm
58kg
Som
e ex
er
644
6564
7.3
Med
ium
58.
420
.80
1357
2036
5.8
17.
3 4
0.7
29.
8 2
9.9
70.
1 5
1.4
8D
:\BIA
TE
ST
KO
UV
E F
INA
L F
inal
F 2
.xls
BIA
TE
ST
KO
UV
É F
INA
L
Tes
t D
ate
Tes
t T
ime
Las
t N
ame
Fir
st N
ame
Su
bje
ct ID
Ag
eG
end
erH
eig
ht
Wei
gh
tA
ctiv
ity
Lev
elR
esis
tan
ceR
eact
ance
Imp
edan
ceF
ram
e S
ize
Tar
get
W
eig
ht
BM
IB
MR
DE
EP
has
e A
ng
leF
at
wt
FF
M w
tT
BW
lit
ers
Fat
%
of
wt
FF
M %
o
f w
tT
BW
%
of
wt
05/0
9/20
0714
:27:
08D
EG
BE
AF
I AK
OE
LEC
MS
K1
029
33F
emal
e16
7cm
58kg
Som
e ex
er
649
6365
2.1
Med
ium
58.
420
.80
1357
2036
5.5
17.
5 4
0.5
29.
6 3
0.2
69.
8 5
1.1
08/0
8/20
0714
:35:
43A
KA
KP
OD
AK
PE
CM
SK
1 03
050
Fem
ale
168
cm56
kgS
ome
exe
r71
267
715.
1M
ediu
m 5
9.3
19.8
412
6018
90 5
.4 1
7.1
38.
9 2
7.9
30.
6 6
9.4
49.
8
13/0
8/20
0714
:35:
43A
KA
KP
OD
AK
PE
CM
SK
1 03
050
Fem
ale
168
cm57
kgS
ome
exe
r70
470
707.
5M
ediu
m 5
9.3
20.2
012
6919
04 5
.7 1
7.8
39.
2 2
8.2
31.
2 6
8.8
49.
5
22/0
8/20
0714
:35:
43A
KA
KP
OD
AK
PE
CM
SK
1 03
050
Fem
ale
168
cm57
kgS
ome
exe
r69
668
699.
3M
ediu
m 5
9.3
20.2
012
6919
04 5
.6 1
7.6
39.
4 2
8.4
30.
9 6
9.1
49.
9
29/0
8/20
0714
:35:
43A
KA
KP
OD
AK
PE
CM
SK
1 03
050
Fem
ale
168
cm54
kgS
ome
exe
r70
472
707.
7M
ediu
m 5
9.3
19.1
312
4018
61 5
.8 1
5.3
38.
7 2
7.9
28.
3 7
1.7
51.
6
05/0
9/20
0714
:35:
43A
KA
KP
OD
AK
PE
CM
SK
1 03
050
Fem
ale
168
cm57
kgS
ome
exe
r72
275
725.
9M
ediu
m 5
9.3
20.2
012
6919
04 5
.9 1
8.2
38.
8 2
7.8
31.
9 6
8.1
48.
7
08/0
8/20
0714
:52:
53S
EN
OU
AG
OS
SO
UC
MS
K1
031
45M
ale
169
cm45
kgS
ome
exe
r70
268
705.
3M
ediu
m 6
5.9
15.7
612
2619
62 5
.5 6
.8 3
8.2
27.
4 1
5.2
84.
8 6
0.9
13/0
8/20
0714
:52:
53S
EN
OU
AG
OS
SO
UC
MS
K1
031
45M
ale
169
cm47
kgS
ome
exe
r70
670
709.
5M
ediu
m 6
5.9
16.4
612
5420
06 5
.7 8
.4 3
8.6
27.
6 1
7.9
82.
1 5
8.8
22/0
8/20
0714
:52:
53S
EN
OU
AG
OS
SO
UC
MS
K1
031
45M
ale
169
cm46
kgS
ome
exe
r69
467
697.
2M
ediu
m 6
5.9
16.1
112
4019
84 5
.5 7
.4 3
8.6
27.
8 1
6.1
83.
9 6
0.4
29/0
8/20
0714
:52:
53S
EN
OU
AG
OS
SO
UC
MS
K1
031
45M
ale
169
cm46
kgS
ome
exe
r69
866
701.
1M
ediu
m 6
5.9
16.1
112
4019
84 5
.4 7
.5 3
8.5
27.
7 1
6.3
83.
7 6
0.2
06/0
9/20
0714
:52:
53S
EN
OU
AG
OS
SO
UC
MS
K1
031
45M
ale
169
cm46
kgS
ome
exe
r72
878
732.
2M
ediu
m 6
5.9
16.1
112
4019
84 6
.1 8
.1 3
7.9
26.
9 1
7.7
82.
3 5
8.5
08/0
8/20
0715
:06:
34A
PE
GN
ON
OA
KO
UV
IC
MS
K1
032
28F
emal
e17
2cm
47kg
Som
e ex
er
658
5566
0.3
Sm
all
62.
915
.89
1284
1926
4.8
6.8
40.
2 2
9.3
14.
5 8
5.5
62.
3
13/0
8/20
0715
:06:
34A
PE
GN
ON
OA
KO
UV
IC
MS
K1
032
28F
emal
e17
2cm
46kg
Som
e ex
er
670
5767
2.4
Sm
all
62.
915
.55
1274
1912
4.9
6.3
39.
7 2
8.8
13.
8 8
6.2
62.
6
22/0
8/20
0715
:06:
34A
PE
GN
ON
OA
KO
UV
IC
MS
K1
032
28F
emal
e17
2cm
47kg
Som
e ex
er
659
5966
1.6
Sm
all
62.
915
.89
1284
1926
5.1
6.8
40.
2 2
9.3
14.
6 8
5.4
62.
3
29/0
8/20
0715
:06:
34A
PE
GN
ON
OA
KO
UV
IC
MS
K1
032
28F
emal
e17
2cm
48kg
Som
e ex
er
645
6064
7.8
Sm
all
62.
916
.22
1293
1940
5.3
7.2
40.
8 2
9.8
15.
0 8
5.0
62.
1
05/0
9/20
0715
:06:
34A
PE
GN
ON
OA
KO
UV
IC
MS
K1
032
28F
emal
e17
2cm
50kg
Som
e ex
er
652
5865
4.6
Sm
all
62.
916
.90
1313
1969
5.1
9.1
40.
9 2
9.8
18.
2 8
1.8
59.
6
08/0
8/20
0715
:20:
30A
ME
TY
KO
DJO
FO
GC
MS
K1
033
30M
ale
167
cm60
kgS
ome
exe
r55
172
555.
7La
rge
70.
121
.51
1525
2440
7.4
13.
7 4
6.3
34.
5 2
2.8
77.
2 5
7.5
13/0
8/20
0715
:20:
30A
ME
TY
KO
DJO
FO
GC
MS
K1
033
30M
ale
167
cm60
kgS
ome
exe
r54
572
549.
7La
rge
70.
121
.51
1525
2440
7.5
13.
4 4
6.6
34.
7 2
2.4
77.
6 5
7.9
22/0
8/20
0715
:20:
30A
ME
TY
KO
DJO
FO
GC
MS
K1
033
30M
ale
167
cm59
kgS
ome
exe
r53
368
537.
3La
rge
70.
121
.16
1511
2418
7.3
12.
1 4
6.9
35.
1 2
0.5
79.
5 5
9.5
29/0
8/20
0715
:20:
30A
ME
TY
KO
DJO
FO
GC
MS
K1
033
30M
ale
167
cm57
kgS
ome
exe
r52
470
528.
7La
rge
70.
120
.44
1484
2374
7.6
10.
2 4
6.8
35.
1 1
7.9
82.
1 6
1.6
05/0
9/20
0715
:20:
30A
ME
TY
KO
DJO
FO
GC
MS
K1
033
30M
ale
167
cm60
kgS
ome
exe
r53
672
540.
8La
rge
70.
121
.51
1525
2440
7.7
13.
0 4
7.0
35.
1 2
1.7
78.
3 5
8.5
12/0
9/20
0715
:20:
30A
ME
TY
KO
DJO
FO
GC
MS
K1
033
30M
ale
167
cm60
kgS
ome
exe
r52
870
532.
6La
rge
70.
121
.51
1525
2440
7.6
12.
6 4
7.4
35.
5 2
1.0
79.
0 5
9.1
19/0
9/20
0715
:20:
30A
ME
TY
KO
DJO
FO
GC
MS
K1
033
30M
ale
167
cm60
kgS
ome
exe
r53
572
539.
8La
rge
70.
121
.51
1525
2440
7.7
12.
9 4
7.1
35.
2 2
1.6
78.
4 5
8.6
08/0
8/20
0715
:33:
21A
KLA
VO
IND
ED
JRO
CM
SK
1 03
430
Mal
e16
9cm
53kg
Som
e ex
er
688
7869
2.4
Sm
all
59.
318
.56
1438
2302
6.5
12.
4 4
0.6
29.
2 2
3.4
76.
6 5
5.0
13/0
8/20
0715
:33:
21A
KLA
VO
IND
ED
JRO
CM
SK
1 03
430
Mal
e16
9cm
55kg
Som
e ex
er
642
7064
5.8
Sm
all
59.
319
.26
1466
2346
6.2
12.
6 4
2.4
30.
9 2
3.0
77.
0 5
6.1
22/0
8/20
0715
:33:
21A
KLA
VO
IND
ED
JRO
CM
SK
1 03
430
Mal
e16
9cm
52kg
Som
e ex
er
656
6765
9.4
Sm
all
59.
318
.21
1425
2280
5.8
10.
8 4
1.2
29.
9 2
0.8
79.
2 5
7.5
29/0
8/20
0715
:33:
21A
KLA
VO
IND
ED
JRO
CM
SK
1 03
430
Mal
e16
9cm
52kg
Som
e ex
er
674
7567
8.2
Sm
all
59.
318
.21
1425
2280
6.3
11.
3 4
0.7
29.
4 2
1.8
78.
2 5
6.5
05/0
9/20
0715
:33:
21A
KLA
VO
IND
ED
JRO
CM
SK
1 03
430
Mal
e16
9cm
53kg
Som
e ex
er
676
6967
9.5
Sm
all
59.
318
.56
1438
2302
5.8
12.
1 4
0.9
29.
5 2
2.8
77.
2 5
5.7
12/0
9/20
0715
:33:
21A
KLA
VO
IND
ED
JRO
CM
SK
1 03
430
Mal
e16
9cm
53kg
Som
e ex
er
670
7367
4.0
Sm
all
59.
318
.56
1438
2302
6.2
11.
9 4
1.1
29.
7 2
2.5
77.
5 5
6.0
08/0
8/20
0715
:39:
25V
IAG
BO
AT
SO
U P
AU
CM
SK
1 03
558
Mal
e17
2cm
51kg
Som
e ex
er
643
5764
5.5
Sm
all
62.
217
.24
1235
1977
5.1
8.7
42.
3 3
0.8
17.
0 8
3.0
60.
5
13/0
8/20
0715
:39:
25V
IAG
BO
AT
SO
U P
AU
CM
SK
1 03
558
Mal
e17
2cm
51kg
Som
e ex
er
636
5563
8.4
Sm
all
62.
217
.24
1235
1977
4.9
8.4
42.
6 3
1.1
16.
6 8
3.4
60.
9
22/0
8/20
0715
:39:
25V
IAG
BO
AT
SO
U P
AU
CM
SK
1 03
558
Mal
e17
2cm
50kg
Som
e ex
er
659
6166
1.8
Sm
all
62.
216
.90
1222
1955
5.3
8.4
41.
6 3
0.2
16.
8 8
3.2
60.
3
29/0
8/20
0715
:39:
25V
IAG
BO
AT
SO
U P
AU
CM
SK
1 03
558
Mal
e17
2cm
50kg
Som
e ex
er
594
5459
6.4
Sm
all
62.
216
.90
1222
1955
5.2
6.2
43.
8 3
2.4
12.
4 8
7.6
64.
7
05/0
9/20
0715
:39:
25V
IAG
BO
AT
SO
U P
AU
CM
SK
1 03
558
Mal
e17
2cm
53kg
Som
e ex
er
629
6063
1.9
Sm
all
62.
217
.92
1263
2021
5.4
9.7
43.
3 3
1.6
18.
3 8
1.7
59.
7
12/0
9/20
0715
:39:
25V
IAG
BO
AT
SO
U P
AU
CM
SK
1 03
558
Mal
e17
2cm
54kg
Som
e ex
er
614
5761
6.6
Sm
all
62.
218
.25
1277
2043
5.3
9.9
44.
1 3
2.3
18.
3 8
1.7
59.
9
19/0
9/20
0715
:39:
25V
IAG
BO
AT
SO
U P
AU
CM
SK
1 03
558
Mal
e17
2cm
54kg
Som
e ex
er
598
5760
0.7
Sm
all
62.
218
.25
1277
2043
5.4
9.3
44.
7 3
2.9
17.
2 8
2.8
61.
0
08/0
8/20
0715
:47:
54K
PO
TO
RK
OS
SI A
ME
NCM
SK
1 03
638
Mal
e17
8cm
69kg
Som
e ex
er
552
7255
6.7
Med
ium
75.
521
.78
1650
2640
7.4
15.
9 5
3.1
39.
1 2
3.0
77.
0 5
6.7
13/0
8/20
0715
:47:
54K
PO
TO
RK
OS
SI A
ME
NCM
SK
1 03
638
Mal
e17
8cm
70kg
Som
e ex
er
516
6552
0.1
Med
ium
75.
522
.09
1664
2662
7.2
14.
6 5
5.4
41.
1 2
0.8
79.
2 5
8.7
22/0
8/20
0715
:47:
54K
PO
TO
RK
OS
SI A
ME
NCM
SK
1 03
638
Mal
e17
8cm
69kg
Som
e ex
er
514
6451
8.0
Med
ium
75.
521
.78
1650
2640
7.1
13.
7 5
5.3
41.
0 1
9.9
80.
1 5
9.5
29/0
8/20
0715
:47:
54K
PO
TO
RK
OS
SI A
ME
NCM
SK
1 03
638
Mal
e17
8cm
69kg
Som
e ex
er
535
7253
9.8
Med
ium
75.
521
.78
1650
2640
7.7
15.
0 5
4.0
39.
9 2
1.7
78.
3 5
7.9
05/0
9/20
0715
:47:
54K
PO
TO
RK
OS
SI A
ME
NCM
SK
1 03
638
Mal
e17
8cm
69kg
Som
e ex
er
504
6150
7.7
Med
ium
75.
521
.78
1650
2640
6.9
13.
1 5
5.9
41.
6 1
8.9
81.
1 6
0.3
12/0
9/20
0715
:47:
54K
PO
TO
RK
OS
SI A
ME
NCM
SK
1 03
638
Mal
e17
8cm
68kg
Som
e ex
er
531
6853
5.3
Med
ium
75.
521
.46
1636
2618
7.3
14.
0 5
4.0
40.
0 2
0.6
79.
4 5
8.8
19/0
9/20
0715
:47:
54K
PO
TO
RK
OS
SI A
ME
NCM
SK
1 03
638
Mal
e17
8cm
68kg
Som
e ex
er
520
6752
4.3
Med
ium
75.
521
.46
1636
2618
7.3
13.
3 5
4.7
40.
5 1
9.6
80.
4 5
9.6
08/0
8/20
077:
25:4
3T
SR
AT
SE
KO
SS
I KA
SS
CM
SK
1 03
735
Mal
e17
1cm
54kg
Som
e ex
er
590
4859
1.9
Sm
all
61.
218
.47
1428
2285
4.7
9.4
44.
6 3
3.0
17.
3 8
2.7
61.
0
13/0
8/20
077:
25:4
3T
SR
AT
SE
KO
SS
I KA
SS
CM
SK
1 03
735
Mal
e17
1cm
54kg
Som
e ex
er
617
5561
9.4
Sm
all
61.
218
.47
1428
2285
5.1
10.
4 4
3.6
32.
0 1
9.2
80.
8 5
9.2
22/0
8/20
077:
25:4
3T
SR
AT
SE
KO
SS
I KA
SS
CM
SK
1 03
735
Mal
e17
1cm
55kg
Som
e ex
er
608
5261
0.2
Sm
all
61.
218
.81
1442
2308
4.9
10.
8 4
4.2
32.
5 1
9.6
80.
4 5
9.0
29/0
8/20
077:
25:4
3T
SR
AT
SE
KO
SS
I KA
SS
CM
SK
1 03
735
Mal
e17
1cm
55kg
Som
e ex
er
625
5762
7.6
Sm
all
61.
218
.81
1442
2308
5.2
11.
4 4
3.6
31.
9 2
0.7
79.
3 5
8.0
05/0
9/20
077:
25:4
3T
SR
AT
SE
KO
SS
I KA
SS
CM
SK
1 03
735
Mal
e17
1cm
54kg
Som
e ex
er
626
5462
8.3
Sm
all
61.
218
.47
1428
2285
4.9
10.
7 4
3.3
31.
7 1
9.8
80.
2 5
8.7
9D
:\BIA
TE
ST
KO
UV
E F
INA
L F
inal
F 2
.xls
BIA
TE
ST
KO
UV
É F
INA
L
Tes
t D
ate
Tes
t T
ime
Las
t N
ame
Fir
st N
ame
Su
bje
ct ID
Ag
eG
end
erH
eig
ht
Wei
gh
tA
ctiv
ity
Lev
elR
esis
tan
ceR
eact
ance
Imp
edan
ceF
ram
e S
ize
Tar
get
W
eig
ht
BM
IB
MR
DE
EP
has
e A
ng
leF
at
wt
FF
M w
tT
BW
lit
ers
Fat
%
of
wt
FF
M %
o
f w
tT
BW
%
of
wt
12/0
9/20
077:
25:4
3T
SR
AT
SE
KO
SS
I KA
SS
CM
SK
1 03
735
Mal
e17
1cm
55kg
Som
e ex
er
638
5564
0.4
Sm
all
61.
218
.81
1442
2308
4.9
11.
8 4
3.2
31.
5 2
1.5
78.
5 5
7.2
19/0
9/20
077:
25:4
3T
SR
AT
SE
KO
SS
I KA
SS
CM
SK
1 03
735
Mal
e17
1cm
55kg
Som
e ex
er
613
5661
5.6
Sm
all
61.
218
.81
1442
2308
5.2
11.
0 4
4.0
32.
3 1
9.9
80.
1 5
8.7
08/0
8/20
0715
:57:
42D
OY
IK
OK
OU
RO
BC
MS
K1
038
31M
ale
172
cm68
kgS
ome
exe
r47
658
479.
5M
ediu
m 6
9.1
22.9
916
5426
46 6
.9 1
3.2
54.
8 4
1.1
19.
4 8
0.6
60.
4
13/0
8/20
0715
:57:
42D
OY
IK
OK
OU
RO
BC
MS
K1
038
31M
ale
172
cm68
kgS
ome
exe
r47
858
481.
5M
ediu
m 6
9.1
22.9
916
5426
46 6
.9 1
3.3
54.
7 4
1.0
19.
6 8
0.4
60.
2
22/0
8/20
0715
:57:
42D
OY
IK
OK
OU
RO
BC
MS
K1
038
31M
ale
172
cm67
kgS
ome
exe
r47
754
480.
0M
ediu
m 6
9.1
22.6
516
4026
24 6
.5 1
2.5
54.
5 4
0.8
18.
7 8
1.3
61.
0
29/0
8/20
0715
:57:
42D
OY
IK
OK
OU
RO
BC
MS
K1
038
31M
ale
172
cm66
kgS
ome
exe
r47
262
476.
1M
ediu
m 6
9.1
22.3
116
2626
02 7
.5 1
1.4
54.
6 4
1.0
17.
3 8
2.7
62.
1
05/0
9/20
0715
:57:
42D
OY
IK
OK
OU
RO
BC
MS
K1
038
31M
ale
172
cm68
kgS
ome
exe
r45
968
464.
0M
ediu
m 6
9.1
22.9
916
5426
46 8
.4 1
2.0
56.
0 4
2.1
17.
6 8
2.4
61.
9
12/0
9/20
0715
:57:
42D
OY
IK
OK
OU
RO
BC
MS
K1
038
31M
ale
172
cm68
kgS
ome
exe
r46
958
472.
6M
ediu
m 6
9.1
22.9
916
5426
46 7
.0 1
2.7
55.
3 4
1.5
18.
7 8
1.3
61.
0
19/0
9/20
0715
:57:
42D
OY
IK
OK
OU
RO
BC
MS
K1
038
31M
ale
172
cm68
kgS
ome
exe
r46
058
463.
6M
ediu
m 6
9.1
22.9
916
5426
46 7
.2 1
2.0
56.
0 4
2.0
17.
7 8
2.3
61.
8
19/0
9/20
0715
:33:
21A
KLA
VO
IND
ED
JRO
CM
SK
1 03
430
Mal
e16
9cm
53kg
Som
e ex
er
654
7265
8.0
Sm
all
59.
318
.56
1438
2302
6.3
11.
5 4
1.5
30.
1 2
1.7
78.
3 5
6.9
05/0
6/20
073:
43:0
1T
OK
UIB
OU
PA
OLA
CM
SK
1 00
935
Fem
ale
155
cm50
kgS
ome
exe
r59
271
596.
2S
mal
l 4
2.9
20.8
112
4918
74 6
.8 1
3.4
36.
6 2
7.7
26.
8 7
3.2
55.
3
05/0
6/20
074:
55:5
6A
NA
GLA
KO
KO
U K
AK
CM
SK
1 01
525
Mal
e16
7cm
55kg
Som
e ex
er
602
6760
5.7
Med
ium
63.
719
.72
1490
2384
6.4
12.
0 4
3.0
31.
7 2
1.9
78.
1 5
7.6
12/0
6/20
074:
55:5
6A
NA
GLA
KO
KO
U K
AK
CM
SK
1 01
525
Mal
e16
7cm
55kg
Som
e ex
er
595
6459
8.4
Med
ium
63.
719
.72
1490
2384
6.1
11.
8 4
3.2
31.
9 2
1.4
78.
6 5
8.1
19/0
6/20
074:
55:5
6A
NA
GLA
KO
KO
U K
AK
CM
SK
1 01
525
Mal
e16
7cm
56kg
Som
e ex
er
628
6963
1.8
Med
ium
63.
720
.08
1504
2406
6.3
13.
6 4
2.4
31.
0 2
4.3
75.
7 5
5.4
26/0
6/20
074:
55:5
6A
NA
GLA
KO
KO
U K
AK
CM
SK
1 01
525
Mal
e16
7cm
56kg
Som
e ex
er
586
6358
9.4
Med
ium
63.
720
.08
1504
2406
6.1
12.
2 4
3.8
32.
4 2
1.8
78.
2 5
7.9
03/0
7/20
074:
55:5
6A
NA
GLA
KO
KO
U K
AK
CM
SK
1 01
525
Mal
e16
7cm
57kg
Som
e ex
er
581
6558
4.6
Med
ium
63.
720
.44
1518
2428
6.4
12.
7 4
4.3
32.
8 2
2.3
77.
7 5
7.5
11/0
7/20
074:
55:5
6A
NA
GLA
KO
KO
U K
AK
CM
SK
1 01
525
Mal
e16
7cm
55kg
Som
e ex
er
578
6558
1.6
Med
ium
63.
719
.72
1490
2384
6.4
11.
1 4
3.9
32.
5 2
0.3
79.
7 5
9.2
18/0
7/20
074:
55:5
6A
NA
GLA
KO
KO
U K
AK
CM
SK
1 01
525
Mal
e16
7cm
58kg
Som
e ex
er
588
6759
1.8
Med
ium
63.
720
.80
1531
2451
6.5
13.
7 4
4.3
32.
7 2
3.7
76.
3 5
6.4
25/0
7/20
074:
55:5
6A
NA
GLA
KO
KO
U K
AK
CM
SK
1 01
525
Mal
e16
7cm
58kg
Som
e ex
er
563
6256
6.4
Med
ium
63.
720
.80
1531
2451
6.3
12.
7 4
5.3
33.
7 2
2.0
78.
0 5
8.0
01/0
8/20
074:
55:5
6A
NA
GLA
KO
KO
U K
AK
CM
SK
1 01
525
Mal
e16
7cm
58kg
Som
e ex
er
593
7159
7.2
Med
ium
63.
720
.80
1531
2451
6.8
13.
9 4
4.1
32.
5 2
4.0
76.
0 5
6.1
08/0
8/20
074:
55:5
6A
NA
GLA
KO
KO
U K
AK
CM
SK
1 01
525
Mal
e16
7cm
58kg
Som
e ex
er
574
6557
7.7
Med
ium
63.
720
.80
1531
2451
6.5
13.
2 4
4.8
33.
2 2
2.7
77.
3 5
7.3
13/0
8/20
074:
55:5
6A
NA
GLA
KO
KO
U K
AK
CM
SK
1 01
525
Mal
e16
7cm
59kg
Som
e ex
er
562
6256
5.4
Med
ium
63.
721
.16
1545
2473
6.3
13.
4 4
5.6
33.
9 2
2.8
77.
2 5
7.4
22/0
8/20
074:
55:5
6A
NA
GLA
KO
KO
U K
AK
CM
SK
1 01
525
Mal
e16
7cm
55kg
Som
e ex
er
584
6858
7.9
Med
ium
63.
719
.72
1490
2384
6.6
11.
4 4
3.6
32.
3 2
0.7
79.
3 5
8.8
10D
:\BIA
TE
ST
KO
UV
E F
INA
L F
inal
F 2
.xls